patents and designs journal - nevo.co.il · 3 may 31, 2010- " "patents 16 % 1967 notice...

May-ע"ח בסיון התש"י 31, 20101

רשומותISRAEL STATE RECORDS

11.2009ע"תש/א'"א

יומ� הפטנטי� והמדגמי�PATENTS AND DESIGNS JOURNAL

Page/עמודPatentsפטנטי5Applicationsת שהוגשובקשו filed

142Applicationsבקשות שקובלו accepted472Patentsפטנטי שניתנו granted472Patentsפטנטי שחודשו renewed

473Patentsפטנטי שתוקפ פקע not in force473Patentsפטנטי שחודשו לעשרי שנה renewed for 20 years

Changes 478שינויי בפרטי רשומי בפנקס in particulars entered inregister

488Countryקודי למדינות codes459Indicesמפתחות לבקשות שהתקבלו of applications accepted

Designsמדגמי440Designsמדגמי שנרשמו registered457Desginsמדגמי שחודשו renewed458Designsמדגמי שבוטלו void


ידיעות כלליות

אל' וכו, מסמכים, מכתבים :בענייני פטנטים ומדגמים יש לשלוחה .ירושלים, מלחה5בנין, גנים טכנולוגיים ירושלים, פטנטים והמדגמיםרשם

' אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מסיש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה. 0-24145-2

.שולמה

GENERAL INFORMATION

Letters, documents, etc. concerning Patents and Designs should be addressed to:The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of theAuthority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the officetogether with the application for the action for which the fee has been paid.

זכות היוצרים בתקצירים אלה שמורה למדינתאין להעתיק מתקצירים אלה אלא, ישראל

.ברשות לשכת הפטנטים

Copyright by the State of Israel. NoExtracts may be published except with thepermission of the Patent Office.


PATENTS פטנטי�-ז"תשכ, לחוק הפטנטים16הודעה לפי סעיף

1967 NOTICE UNDER SECTION 16 OF THEPATENTS LAW, 5727-1967

להלן רשימת בקשות חדשות הממלאות אחרלתקנות)א(32הדרישות שנקבעו בתקנה

:1968-ח"תשכ, הפטנטים

In the following there are listed newapplications complying with the provisionsof rule 32(a) of the Patent Regulations, 5728-1968:

Particulars: פרטי הבקשות מובאים לפי סדר זה of the applications are given inthe following order:

ותאריך הגשתה וארבעה–מספר הבקשה הסמנים הראשונים של הסיווג הבינלאומי

Number and date of application and the firstfour symbols of the InternationalClassification.

ע(שם האמצאה Title)י המבקש"כפי שהוצע of invention (as proposed by applicant)Applicant המבקש

Convention–מדינת האיגוד: דין קדימה country-Priority right:Number תאריך ומספר and date ofForeign בקשת החוץ application

International מספר בקשה בינלאומית Application NumberInternational מספר פרסום בינלאומי Publication Number


)2010.01 (A61K20012628/07/2009

שלVתהליך חדש לקבלת צורה גבישית אגומלאטין

NEW PROCESS FOR OBTAINING THECRYSTALLINE FORM V OFAGOMELATINELES LABORATOIRES SERVIER

05/08/200808/04466FR

)2010.01 (C07B20012728/07/2009

NEW תהליך חדש להכנת רגומלאטין PROCESS FOR THE SYNTHESISOF AGOMELATINELES LABORATOIRES SERVIER

05/08/200808/04463FR

)2010.01 (C07B20013729/07/2009

NEW תהליך חדש להכנת אגומלאטין PROCESS FOR THE SYNTHESISOF AGOMELATINELES LABORATOIRES SERVIER

05/08/200808/04465FR

)2010.01 (A61K20017230/07/2009

IMPROVED תהליך משופר להכנת דפטומיצין PROCESS FOR THEPRODUCTION OF DAPTOMYCINANTIBIOTICOS S.P.A.

01/08/200808161630.2EP


)2010.01 (A61K20017503/02/2008

חלקיקים המכילים ציפוי מתכת אוקסידיתושיטות להכנת חלקיקים המכילים ציפוי

מתכת אוקסידית

METHOD FOR PREPARINGPARTICLES COMPRISING METALOXIDE COATING AND PARTICLESWITH METAL OXIDE COATING

בע'ג-סול SOL-GELמ"ל טכנולוגיות TECHNOLOGIES LTD.01/02/200760/898700US

PCT/IL/2008/000141WO/2008/093347

)2010.01 (C07K20020202/08/2009

NOVEL חלבונים חדשים PROTEINSבע2 TWOמ"לביוטק TO BIOTECH LTD

)2010.01 (A61K20024905/08/2009

קומפוזיציה פרמצבטית המכילה רכיביםרפואיים טבעיים המיועדת לריפוי

ים תרופייםפסוריאזיס וכיב

PARMACEUTICAL COMPOSITIONCONTAINING NATURAL MEDICINALCOMPONENS INTENDED FORTREATMENT OF PSORIASIS ANDULCUS TROFI

GALINA גלינה קנטר KANTER

)2010.01 (C23C20028406/08/2009


תהליך להפקת כלוריד מתכתי מתמיסה מימית שלו

A PROCESS FOR THE RECOVERY OFA METAL CHLORIDE FROM ANAQUEOUS SOLUTION THEREOF

בע'ס' אייץ HCLמ"אל קלינטג CLEANTECH LTD.

)2010.01 (C22B20030910/08/2009

CREEP-RESISTANT סגסוגת מגנזיום חסינת התגנבות MAGNESIUMALLOYGKSS-FORSCHUNGSZENTRUMGEESTHACHT GMBH

26/08/2008102008039683.4DE

)2010.01 (G01N20035212/08/2009

ANALYTE שיטה ומערכת לבדיקת אנליט TESTING METHOD ANDSYSTEMLIFESCAN SCOTLAND LTD.

15/08/200861/089343US

)2010.01 (B07B20035912/08/2009

PARTICLE הפרדת חלקיקים SEPARTATIONSENG ENTERPRISES LTD.

)2010.01 (B01D20036612/08/2009


שיטה ומערכת להזרעה בחלקיקיםמעובדים לזרז הצטברות בתהליך של

טיפול במים

METHOD AND SYSTEM FORSEEDING WITH MATURE FLOC TOACCELERATE AGGREGATION IN AWATER TREATMENT PROCESSPALO ALTO RESEARCH CENTER,INCORPORATED

19/09/200812/234373US

)2010.01 (A01K20041028/02/2008

שיטה,Aנגזרות חדשות של פסמאפליןלסינטוזן ושימוש בהן למניעת וטיפול

בסרטן

NOVEL DERIVATIVES OFPSAMMAPLIN A, A METHOD FORTHEIR SYNTHESIS AND THEIR USEFOR THE PREVENTION ORTREATMENT OF CANCERCENTRE NATIONAL DE LARECHERCHE SCIENTIFIQUE

28/02/200707290253.9EPPCT/IB/2008/001887WO/2008/125988

)2010.01 (A01G20045118/08/2009

ב –דידקול–חיטוי האדמה בשימוש אמוניום ברומיד–דימטיל

SOIL DISINFECTION USINGDIDECYL-DIMETHYL AMMONIUMBROMIDE

משרד החקלאות ופיתוח, מדינת ישראלמרכז, מינהל המחקר החקלאי, הכפר וולקני

YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM

)2010.01 (A61K20050920/08/2009

שיטה ומשטר מינון חיסול של חומר כימי בדם

METHOD AND DOSAGE REGIMENSFOR ELIMINATING A CHEMICALSUBSTANCE IN BLOOD


WEI-WEI CHANG20/08/200812/195143US

)2010.01 (B05C20053920/05/2008

שיטה ומערכת לשינוי פני שטח של סובסטרטים שטוחים

METHOD AND APPARATUS FOR THESURFACE MODIFICATION OF FLATSUBSTRATESRENA GMBH

25/05/2007102007024667.8DEPCT/EP/2008/004053WO/2008/145285

)2010.01 (F24J20075406/03/2008

SOLAR מערכת אנרגיה סולרית ENERGY SYSTEMSOLAR & ENVIRONMENTALTECHNOLOGIES CORP.

06/03/200711/682407USPCT/US/2008/056049WO/2008/109746

)2010.01 (F22B20091306/03/2008

שיטה והתקן עבור חימום יתר שלחומר ביניים מוצת במהלך אידוי סולרי

ישיר בתחנת כח תרמית סולרית

METHOD AND DEVICE FOR FIREDINTERMEDIATE OVERHEATINGDURING DIRECT SOLARVAPOURISATION IN A SOLARTHERMAL POWER STATIONSIEMENS AKTIENGESELLSCHAFT

20/03/2007102007013852.2DEPCT/EP/2008/001808WO/2008/113482


)2010.01 (A61B20119026/03/2008

סטנט היברידי בעל סיב או חוט מתכת כתומך

HYBRID STENT HAVING A FIBER ORWIRE BACKBONE

MEDINOL LTD28/03/200711/729516US

PCT/IB/2008/002515WO/2009/007850

)2010.01 (F24J20120728/03/2008

INFLATABLE קולט סולרי הניתן להרחבה SOLAR COLLECTORHELIOVIS AG

30/03/2007A 512/2007ATPCT/AT/2008/000117WO/2008/119094

)2010.01 (C12N20120815/10/2003

הכנסה באתר בררני של קטו חומצות אמינו לתוך חלבונים

SITE SPECIFIC INCORPORATION OFKETO AMINO ACIDS INTO PROTEINS

THE SCRIPPS RESEARCH INSTITUTE16/10/200260/419265US23/10/200260/420990US

PCT/US/2003/032576WO/2004/035743

)2010.01 (C07D20120911/04/2008

–7–פירימידין]D–2,3[ות פירידו תרכוב אלפא לטיפול בסרטן–K3PIאון כמעכבי

PYRIDO [2, 3 - D] PYRIMIDIN - 7 -ONE COMPOUNDS AS INHIBITORSOF PI3K - ALPHA FOR THETREATMENT OF CANCEREXELIXIS, INC.

11/04/200760/911160USPCT/US/2008/004807WO/2008/127712


)2010.01 (C07D20121015/11/2004

Bאנטגוניסטים של קולטן אדנוזין 2 AA2B ADENOSINE RECEPTORANTAGONISTSGILEAD PALO ALTO, INC.

21/11/200310/719102USPCT/US/2004/038136WO/2005/051951

)2010.01 (A61K20121108/04/2008

Kשילוב טיפולים הכולל מעכבי 3 I P–אלפא קווינוקסלינים לשימוש בטיפול

בסרטן

COMBINATION THERAPIESCOMPRISING QUINOXALINEINHIBITORS OF PI3K-ALPHA FORUSE IN THE TREATMENT OFCANCEREXELIXIS, INC.

11/04/200760/923164USPCT/US/2008/004570WO/2008/127594

)2010.01 (H04L20121208/04/2008

שיטה לניהול ניידות במערכתארכיטקטורית התומכת בניידות בין

מערכות גישה שונות

A METHOD FOR MOBILITYMANAGEMENT IN A SYSTEMARCHITECTURE SUPPORTINGMOBILITY BETWEEN DIFFERENTACCESS SYSTEMSALCATEL LUCENT

12/04/200707290450.1EPPCT/EP/2008/054225WO/2008/125547

)2010.01 (E05B20121328/03/2008

KEY חלק ממפתח ללא קוד ומפתח BLANK AND KEYMEDECO SECURITY LOCKS, INC.


30/03/200711/694097USPCT/US/2008/004078WO/2008/121336

)2010.01 (G06Q20121431/03/2008

DETERMINING קביעת המרת פרסום ADVERTISINGCONVERSIONGOOGLE INC.

30/03/200711/694635USPCT/US/2008/058906WO/2008/121962

)2010.01 (H04L20121527/03/2008

שיטה ומערכת לציון חסימת זרימה זמניתחוסר/אשר אליה ממוען שדה אישור

PIGGYBACKEDאישור מסוג

METHOD AND APPARATUS FORINDICATING A TEMPORARY BLOCKFLOW TO WHICH A PIGGYBACKEDACKNOWLEDGEMENT/NON-ACKNOWLEDGEMENT FILD ISADDRESSEDINTERDIGITAL TECHNOLOGYCORPORATION

28/03/200760/908535US19/06/200760/945057US19/06/200760/944982US19/06/200760/945034US20/08/200760/956765US

PCT/US/2008/004003WO/2008/121299

)2010.01 (C11B20121607/03/2008

תהליך משולב להכנת חומצה שומני)ביודיזל(מתיל אסטר

AN INTEGRATED PROCESS FOR THEPREPARATION OF FATTY ACIDMETHYL ESTER (BIODIESEL)RELIANCE LIFE SCIENCES PVT. LTD.

30/03/2007654/MUM/2007INPCT/IN/2008/000128WO/2008/120223


)2010.01 (C12Q20121726/03/2008

–ו2CHRגבי–ואריאנטים גנטיים על16CHRאבחון, כסמנים להערכת סיכון ,

וטיפול של סרטן השד, פרוגנוזה

GENETIC VARIANTS ON CHR2 ANDCHR16 AS MARKERS FOR USE INBREAST CANCER RISKASSESSMENT, DIAGNOSIS,PROGNOSIS AND TREATMENTDECODE GENETICS EHF.

26/03/20078625IS25/05/20078648IS

PCT/IS/2008/000009WO/2008/117314

)2010.01 (A61F20121817/10/2007

ספיקת שסתום–התקן רפואי לטיפול באי לב או סטנוסיס

MEDICAL DEVICE FOR TREATING AHEART VALVE INSUFFICIENCY ORSTENOSISJENAVALVE TECHNOLOGY INC.

13/04/200720 2007 005491.2

DE

13/04/200711/785072US15/05/200707009728.2EP14/06/200707110318.8EP14/06/200711/812095US

PCT/EP/2007/061117WO/2008/125153

)2010.01 (F24J20121907/03/2008

PARABOLIC קולט אבוס פראבולי TROUGH COLLECTORAMA TON SA

30/03/200710 2007 015850.7

DE

05/06/2007 10 2007 026 473.0 DE

PCT/EP/2008/001829WO/2008/119435


)2010.01 (H01S20122009/04/2008

התקן לייצוב וכיוון פס רוחב של אור לייזרAPPARATUS FOR STABILIZING ANDTUNING THE BANDWIDTH OFLASER LIGHTCYMER, INC

13/04/200760/923486USPCT/US/2008/004598WO/2008/127599

)2010.01 (H02K01221229/09/2009

מחולל בעל שני רוטורים לייצור יעיל של חשמל חילופין

BI-ROTOR GENERATOR FOREFFICIENT PRODUCTION OF ACELECTRICITY

RE-10מ"בע10-רי LTD

)2010.01 (F01D20122229/09/2009

טורבינה ספיראלית חלולה קונית להמרת אנרגיה

TAPERED HOLLOW HELICALTURBINE FOR ENERGYTRANSDUCTION

RE-10מ"בע10-רי LTD

)2010.01 (G01N01225203/04/2008

שיטות להערכת מרכיבי תרבית תאים ופינוטיפ תאי

METHOD FOR EVALUATING THECOMPOSITION OF A CELL CULTUREAND CELL PHENOTYPEGENZYME CORPORATION

06/04/200760/910574US


PCT/US/2008/059275WO/2008/124508

)2010.01 (A61K20122607/03/2008

תכשירים המכילים אגוניסטי אופיאטיםלשימוש בטיפול בסינדרום מעי, קאפא

מגורה המתבטאת בעיקר בשלשול

COMPOSITIONS CONTAININGKAPPA-OPIATE AGONISTS FOR USEIN THE TREATMENT OF DIARRHEA-PREDOMINANT AND ALTERNATINGIRRITABLE BOWEL SYNDROMETIOGA PHARMACEUTICALS INC.

30/03/200760/920841USPCT/US/2008/056317WO/2008/121496

)2010.01 (C07K20122728/03/2008

STITCHED פוליפפטידים תפורים POLYPEPTIDESPRESIDENT AND FELLOWS OFHARVARD COLLEGE

28/03/200760/908566USPCT/US/2008/058575WO/2008/121767

)2010.01 (C12P20122827/03/2008

METHODS שיטות לשכפול וביטוי גנים OF GENE AMPLIFICATIONAND EXPRESSIONMEDAREX, INC.

28/03/200760/908529USPCT/US/2008/058436WO/2008/121711

)2010.01 (C07D12292028/03/2008

ACETONE סולבט אצטון של פתאלאויל אמודיפין SOLVATE OF PHTHALOYLAMLODIPINE


ESTEVE QUIMICA, S.A.30/03/200707380086.4EP

PCT/EP/2008/053737WO/2008/119759

)2010.01 (G06F20123031/03/2008

מערכת ושיטה לחיפוש תוכן עבור ניווט וגילוי ידע

SYSTEM AND METHOD FORWIKIFYING CONTENT FORKNOWLEDGE NAVIGATION ANDDISCOVERYKNEWCO, INC.

30/03/200760/909072US21/02/200861/064211US29/02/200861/064345US19/03/200861/064670US26/03/200861/064780US

PCT/US/2008/004151WO/2008/121377

)2010.01 (C07H20123128/03/2008

אלמנטים של וקטור ביטוי רקומביננטי)REVES(עבור הגברת ביטוי חלבונים

רקומביננטים בתאים פונדקאים

RECOMBINANT EXPRESSIONVECTOR ELEMENTS (REVES) FORENHANCING EXPRESSION OFRECOMBINANT PROTEINS IN HOSTCELLSABBOTT LABORATORIES

30/03/200760/921141USPCT/US/2008/004063WO/2008/121324

)2010.01 (G06F20123231/03/2008

מערכת ושיטה עבור ניווט, מבנה מידע וגילוי ידע

DATA STRUCTURE, SYSTEM ANDMETHOD FOR KNOWLEDGENAVIGATION AND DISCOVERYKNEWCO, INC.

30/03/200760/909072US21/02/200861/064211US


29/02/200861/064345US19/03/200861/064670US26/03/200861/064780US

PCT/US/2008/004161WO/2008/121382

)2010.01 (A01N20123428/03/2008

A2AADENOSINEאנטגוניסטים לרצפטור אדנוזין A2A RECEPTORANTAGONISTSKING PHARMACEUTICALSRESEARCH & DEVELOPMENT, INC.

30/03/200760/909106US27/03/200812/056403US27/03/200812/056423US

PCT/US/2008/058544WO/2008/121748

)2010.01 (C07D20123503/04/2008

THERAPEUTIC חומרים רפואיים AGENTSMERCK SHARP & DOHME CORP.

04/04/200960/921759USPCT/US/2008/004336WO/2008/124030

)2010.01 (G06F20123728/03/2008

שיטות ומערכות לאבטחה באינטרנט דרך תוכנה וירטואלית

METHODS AND SYSTEMS FORINTERNET SECURITY VIA VIRTUALSOFTWAREMURPHY, CHRISTOPHER

29/03/200760/920613USPCT/US/2008/004105WO/2008/121345


)2010.01 (H05B20123804/03/2008

INDUCTIVE גלאי עומס השראתי למעגל עמעם LOAD SENSOR FORDIMMER CIRCUITMASCO CORPORATION

05/04/200711/696772USPCT/US/2008/055765WO/2008/124225

)2010.01 (C07H20123926/03/2008

NUCLEOSIDE תרכובות של נוקליאוסיד פוספוראמידט PHOSPHORRAMIDATEPRODRUGSPHARMASSET, INC.

30/03/200760/909315US24/10/200760/982309US21/03/200812/053015US

PCT/US/2008/058183WO/2008/121634

)2010.01 (B01D20124006/03/2008

CYCLONIC מפריד זורמים ציקלוני FLUID SEPARATORTWISTER B.V.

26/03/200707104888.8EPPCT/EP/2008/052703WO/2008/116732

)2010.01 (C07K20124125/03/2008

PERTUSSISחיסונים משופרים כנגדBORDETELLAמבוססים על מוטנטיםה

GLYCOSYLTRANSFERASEשל

IMPROVED VACCINES AGAINSTBORDETELLA PERTUSSIS BASED ONLPS GLYCOSYLTRANSFERASEMUTANTSDE STAAT DER NEDERLANDEN,VERTEGENWOORDIGD DOOR DEMINISTER VANVOLKSGEZONDHEID, WELZIJN ENSPORT

26/03/200707104885.4EP


PCT/NL/2008/050169WO/2008/118015

)2010.01 (A01H20124209/04/2008

פוליפפטידים ושיטות, פולינוקלאוטידיםלהגברת תכולת שמן קצב גידול וביומסה

בצמחים

POLYNUCLEOTIDES, POLYPEPTIDESAND METHODS FOR INCREASINGOIL CONTENT, GROWTH RATE ANDBIOMASS OF PLANTS

בע'אבוג EVOGENEמ"ן LTD.09/04/200760/907568US

PCT/IL/2008/000489WO/2008/122980

)2010.01 (C07K20124327/03/2008

נוגדנים שיטות וערכות לאבחון וטיפול של מלנומה

ANTIBODIES, METHODS AND KITSFOR DIAGNOSING AND TREATINGMELANOMA

TECHNIONמ"מוסד הטכניון למחקר ופתוח בע RESEARCH ANDDEVELOPMENT FOUNDATION LTD.

29/03/200760/907343US21/05/200760/924549US

PCT/IL/2008/000436WO/2008/120202

)2010.01 (A47J20124427/03/2008

חלוקה וסגירה, חיטוי, מכשיר לשטיפת עבור בקבוק לתינוק ומרכיביו

WASHING , STERILIZING,DISPENSING AND CLOSING DEVICEFOR BABY BOTTLE AND ITSCOMPONENTSAMIR LANIADO

02/04/200760/907443US27/06/200760/946412US

PCT/IL/2008/000427WO/2008/120197


)2010.01 (C07D20124528/03/2008

AN תהליך משופר להכנת סוליפנאצין IMPROVED PROCESS FOR THESYNTHESIS OF SOLIFENACINMEDICHEM, S.A.

30/03/200760/921027US08/05/200760/928199US

PCT/IB/2008/000749WO/2008/120080

)2010.01 (A61B20124630/09/2009

A מכשיר לקילוף העור SKIN RESURFACING DEVICEMICHAEL מיכאל זלטקין SLATKINE

)2010.01 (A61K72012407/04/2008

COMBINATIONS שילוב סטטין ונוגדי השמנת יתר OF STATINS ANDANTI-OBESITY AGENTSCIDOSE LLC.

09/04/200760/922454USPCT/US/2008/004492WO/2008/124120

)2010.01 (C07B20124811/04/2008

Fפולאטים מסומני 1818F - LABELLED FOLATESMERCK EPROVA AG

11/04/200707105976.0EPPCT/EP/2008/054404WO/2008/125613


)2010.01 (C07D49201211/04/2008

Fפולאטים מסומני 1818F - LABELLED FOLATESMERCK EPROVA AG

11/04/200707105987.7EPPCT/EP/2008/054408WO/2008/125617

)2010.01 (C07D20125011/04/2008

תצמידי פולאט וקומפלקסים של כלאטלשימוש בהדמיה, מתכתי התואמים להם אבחונית ורדיותרפיה

FOLATE - CONJUGATES ANDCORRESPONDING METAL -CHELATE COMPLEXES FOR USE ISDIAGNOSITIC IMAGING ANDRADIOTHERAPYMERCK EPROVA AG

11/04/200907105980.2EPPCT/EP/2008/054409WO/2008/125618

)2010.01 (C07D20125111/04/2008

F1818Fפולאטים מסומני - LABELLED FOLATESMERCK EPROVA AG

11/04/200707105984.4EPPCT/EP/2008/054406WO/2008/125615

)2010.01 (C07D20125211/04/2008

, תרכובות הטרוציקליות חנקניות חדשותושימוש שלהן כתרופות, הכנה שלהן

בקטריאליות–אנטי

NEW NITROGENATEDHETEROCYCLIC COMPOUNDS,THEIR PREPARATION AND USE ASANTIBACTERIAL DRUGSNOVEXEL

12/04/20070702663FRPCT/FR/2008/000509WO/2008/142285


)2010.01 (C07D20125329/03/2008

נואינדולים אמי–Nסינתזה קטליטית של באמצעות מתכת מעבר

A TRANSITION METAL CATALYZEDSYNTHESIS OF N - AMINOINDOLES

SANOFI AVENTIS13/04/200907007585.8EP

PCT/EP/2008/002519WO/2008/125207

)2010.01 (C07D20125422/03/2008

איזוקסאזולים כמעכבי–אוקסו–5 ליפאזים ופוספוליפאזים

5 - OXO - ISOXAZOLES ASINHIBITORS OF LIPASES ANDPHOSPHOLIPASESSANOFI AVENTIS

05/04/200707007251.7EPPCT/EP/2008/002314WO/2008/122357

)2010.01 (C07D20125520/03/2008

נגזרות אימידאזולידין קרבוקסיאמיד כמעכבות ליפאז ופוספוליפאז

IMIDAZOLIDINE CARBOXAMIDEDERIVATIVES AS LIPASE ANDPHOSPHOLIPASE INHIBITORSSANOFI AVENTIS

05/04/200707007161.8EPPCT/EP/2008/002231WO/2008/122352

)2010.01 (G06M20125601/04/2008

METERED-DOSE משאף מנה מדודה INHALERIVAX PHARMACEUTICALS IRELAND

02/04/200760/921320US11/04/20070706999.0GB

PCT/EP/2008/002590WO/2008/119552


)2010.01 (H04L20125726/02/2008

MECHANISM מנגנון לביצוע גילוי שרת FOR EXECUTINGSERVER DISCOVERYNOKIA CORPORATION

13/04/200711/785030USPCT/EP/2008/052282WO/2008/125378

)2010.01 (C12Q20125802/04/2008

שיטות לדטקציה של תאי סרטן ושימושיהן באיבחון וטיפול של המחלה

METHODS OF DETECTING CANCERCELLS AND USE OF SAME FORDIAGNOSING AND MONITORINGTREATMENT OF THE DISEASE

בע-רמות ליד אוניברסיטת תל RAMOTמ"אביב AT TEL-AVIV UNIVERSITYLTD.

02/04/200760/907441USPCT/IL/2008/000457WO/2008/120216

)2010.01 (C23C20125931/03/2008

COATING ציפויINNOVATIVE MATERIALSTECHNOLOGIES INC

30/03/200760/909066USPCT/CA/2008/000598WO/2008/119173

)2010.01 (B29C20126001/04/2007

METHOD שיטה ומערכת לייצור תלת מימדי AND SYSTEM FOR THREE-DIMENSIONAL FABRICATION

בע'אובג OBJETמ"ט גאומטריות GEOMETRIES LTD.


PCT/IL/2007/000429WO/2008/120183

)2010.01 (C07D20126108/04/2008

תכשירים, אטרופאיזומר של צאצאי פירול המכילים אותם ושימושים בהם

ATROPISOMER OF PYRROLEDERIVATIVES, COMPOSITIONSCOMPRISING THE SAME AND USESTHEREOFDAIICHI SANKYO COMPANY,LIMITED

09/04/20072007-101938

JP

PCT/JP/2008/056907WO/2008/126831

)2010.01 (A61K20126204/04/2008

אנטגוניסטים לקולטני גונדוטרופין משחררן ושימוש בהםהורמו

GONADOTROPIN-RELEASINGHORMONE RECEPTORANTAGONISTS AND USES THEREOFNEUROCRINE BIOSCIENCES, INC.

06/04/200760/910621USPCT/US/2008/059438WO/2008/124610

)2010.01 (C10G20126305/03/2008

ו PROCESS קסילין–מתקן לייצור פרא–תהליך AND APPARATUS FORPARA-XYLENE PRODUCTIONEXXONMOBIL CHEMICAL PATENTSINC.

04/04/200760/921729USPCT/US/2008/055845WO/2008/124228

)2010.01 (C07D20126411/04/2008


צאצאי חומצה נוראמינית ושיטות לייצרםNEURAMINIC ACID DERIVATIVESAND METHODS OFMANUFACTURING THE SAMEDAIICHI SANKYO COMPANY,LIMITED

11/04/20072007-103585

JP

PCT/JP/2008/057557WO/2008/126943

)2010.01 (G01S20126507/04/2008

לייזרי לגילוי מערכות–שיטה והתקן דו אופטיות מגדילות

METHOD AND DUAL LASER DEVICEFOR DETECTING MAGNIFYINGOPTICAL SYSTEMSCOMPAGNIE INDUSTRIELLE DESLASERS CILAS

11/04/200707/02630FRPCT/FR/2008/000485WO/2008/142270

)2010.01 (G01S20126607/04/2008

שיטה והתקן עם לייזר יחיד לגילוי מערכות אופטיות מגדילות

METHOD AND SINGLE LASERDEVICE FOR DETECTINGMAGNIFYING OPTICAL SYSTEMSCOMPAGNIE INDUSTRIELLE DESLASERS CILAS

11/04/200707/02629FRPCT/FR/2008/000484WO/2008/142269

)2010.01 (C11D20126817/03/2008

LIQUID דטרגנט נוזלי עם חלקיק שובר קרן אור DETERGENT WITHREFRACTIVE PARTICLECOLGATE-PALMOLIVE COMPANY

02/04/200760/909574US01/02/200812/024200US

PCT/US/2008/057200


WO/2008/121541

)2010.01 (A61K20126902/04/2008

שיטות ותכשירים להפחתת תופעות לוואי של טיפולים רפואיים

METHODS AND COMPOSITIONS FORREDUCTION OF SIDE EFFECTS OFTHERAPEUTIC TREATMENTSPARKINSON'S INSTITUTE

02/04/200760/909637US16/08/200760/956296US17/08/200760/956657US

PCT/US/2008/059174WO/2008/122049

)2010.01 (G08B01270201/10/2009

A מערכת ריכבית לאתראה על מרחק בטוח VEHICULAR SAFETY DISTANCEALERTING SYSTEM

TAMIRמ"תמיר יועצים לאבטחת מידע בע COUNSELLING DATAPROTECTION LTD

)2010.01 (A47B20127101/10/2009

MEDICAL כרית שינה רפואית SLEEPING PILLOWGIL גיל טבע TEVA

)2010.01 (B23C20127201/10/2009

CUTTING ור עבורהשימה חיתוך ושיטת ייצ INSERT AND METHOD OFMANUFACTURE THEREOF

ISCARמ"ישקר בע LTD.


)2010.01 (A01B20127304/04/2008

AUXILIARY ידית עזר לכלים HANDLE FOR TOOLSALEHUAL E, S.L.

04/04/2007U-200700779

ES

PCT/ES/2008/000209WO/2008/122684

)2010.01 (G01N20127614/04/2008

מערכת ושיטה לקביעת מצב הכשרות של דג

SYSTEM AND METHOD FORDETERMING THE KOSHER STATUSOF FISHWINTERLAB LI MITED

13/04/200760/923379USPCT/US/2008/004836

)2010.01 (B23B20127701/10/2009

חפץ הנתן תפסן לחפץ ושיטה לתפיסת להזזה

AN OBJECT ATTACHER AND AMETHOD FOR ATTACHING AMOVABLE OBJECT

MOSHE משה רז כהן RAZ COHEN

)2010.01 (C07K20127821/11/2003


דיפרנציאלית תוצרים גנטיים המבוטאים בגידולים ושימוש בהם

GENETIC PRODUCTSDIFFERENTIALLY EXPRESSED INTUMORS AND THE USE THEREOFGANYMED PHARMACEUTICALS AG

22/11/200210254601.0DEPCT/EP/2003/013091WO/2004/047863

)2010.01 (C08G20127902/05/2008

שיטה והתקן לניקוי פוליאסטר בעל יכולת ספיגה

METHOD AND DEVICE FOR CLEANINGAN ABSORPTIVE POLYESTERBOEHRINGER INGELHEIM PHARMAGMBH & CO. KG

04/05/2007102007020951.9DEPCT/EP/2008/055408WO/2008/135523

)2010.01 (A61K20128008/04/2008

ב (S(–בוטיל–) ניטרואוקסי(–4–שימוש– 2 – –) נפתיל–2–מתוקסי–6)

פרופנואט לטיפול בכאב ובדלקת

USE OF 4 - (NITROOXY) - BUTYL -(S)-2- 6 - METHOXY-2 - NAPHYTL) -PROPANOATE FOR TREATING PAINAND INFLAMMATIONNICOX S.A.

25/04/200760/907970USPCT/EP/2008/054188WO/2008/132025

)2010.01 (C07K20128127/04/2007

A17נוגדנים הקושרים – ILו–F17 – IL ושיטות לשימוש בהם

ANTIBODIES THAT BIND BOTH IL -17A AND IL-17F AND METHODS OFUSING THE SAMEZYMOGENETICS INC.

PCT/US/2007/067637WO/2008/133684


)2010.01 (E05B20128209/04/2008

DOOR מנעול דלת LOCKABLOY OY

27/04/200720075295FIPCT/FI/2008/050170WO/2008/132272

)2010.01 (A61K20128311/04/2008

HYDROQUINONE פורמולציות אנסמיצין הידרוקווינון ANSAMYCINFORMULATIONSINFINITY DISCOVERY, INC.

12/04/200760/911330USPCT/US/2008/060063WO/2008/128063

)2010.01 (A61K20128409/04/2008

שיטות לטיפול בסרטן המשתמשות אלפאK3PIבפירידופירימידינון מעכבי

METHODS OF TREATING CANERUSING PYRIDOPYRIMIDINONEINHIBITORS OF PI3K ALPHAEXELIXIS, INC.

10/04/200760/922899USPCT/US/2008/004573WO/2008/124161

)2010.01 (A01N20128521/04/2008

תרכובות של נגזרת סטירניל לטיפול סדרים עיניים–במחלות ואי

STYRENYL DERIVATIVECOMPOUNDS FOR TREATINGOPHTHALMIC DISEASES ANDDISORDERSACUCELA INC

20/04/200760/913241US22/06/200760/937002US

PCT/US/2008/061073


WO/2008/131368

)2010.01 (H05H20128604/04/2008

מערכת ושיטה ליצירת קריסה מאולצתט יפות נוזל של חללים הנגרמת מפגיעת

ע י"גרעיניים של ננוחלקיקים המוקרנים לייזר עבור תגובות גרעיניות מבוקרות

SYSTEM AND METHOD FORCREATING LIQUID DROPLETIMPACT FORCED COLLAPSE OFLASER NANOPARTICLE NUCLEATEDCAVITIES FOR CONTROLLEDNUCLEAR REACTIONSSYNERGY INNOVATIONS INC

04/04/200711/696491USPCT/US/2008/059383WO/2008/124574

)2010.01 (C07C20128814/04/2008

INSECTICIDAL אריל פירולידינים קוטלי חרקים ARYL PYRROLIDINESBAYER CROPSCIENCE AG

23/04/20072007-112855

JP

PCT/EP/2008/003105WO/2008/128711

)2010.01 (E21B20128921/05/2008

תהליך ליצור נוזלים פחמימניים המשלבג, חימום פנימי זתחנת כוח ותחנת

A PROCESS FOR PRODUCINGHYDROCARBON FLUIDSCOMPINING IN SITU HEATING, APOWER PLANT AND A GAS PLANTEXXONMOBIL UPSTREAMRESEARCH COMPANY

25/05/200760/931940USPCT/US/2008/006462WO/2008/153697


)2010.01 (E21B20129021/05/2008

נמוך שנוצר במהלךBTUניצול גז עם חימום פנימי של סלע עשיר בחומר אורגני

UTILIZATION OF LOW BTU GASGENERATED DURING IN SITUHEATING OF ORGANIC-RICH ROCKEXXONMOBIL UPSTREAMRESEARCH COMPANY

25/05/200760/931820USPCT/US/2008/006463WO/2008/147503

)2010.01 (B65D20129109/04/2008

EASY מיכל גמיש קל לפתיחה - OPENING FLEXIBLECONTAINERTHE PROCTER & GAMBLECOMPANY

10/04/200711/784813USPCT/IB/2008/051347WO/2008/122961

)2010.01 (A61F20129209/04/2008

APPLICATOR מוליך בעל איזור אחיזה משופר HAVING ANENHANCED GRIPPING REGIONTHE PROCTER & GAMBLECOMPANY

13/04/200711/786837USPCT/IB/2008/051348WO/2008/126016

)2010.01 (C07D20129312/08/1999

–1,3שיטה ליצורם של אנלוגים לאן נוקלאוזידיםאוקסאתיאו

METHOD OF MANUFACTURE OF 1, 3- OXATHIOLANE NUCLEOSIDESANALOGSGILEAD SCIENCES, INC.

12/08/199860/096214US04/03/199960/122841US

PCT/US/1999/018584


WO/2000/009494

)2010.01 (C08B20129421/05/2008

–קומפלקסים של נגזרות ברזלהכנתם, קרבוהידראט מסיסים במים

ותרופות המכילות אותם

WATER - SOLUBLE IRON-CARBOHYDRATE DERIVATIVECOMPLEXES, PREPARATIONTHEREOF AND MEDICAMENTSCOMPRISING THEMVIFOR (INTERNATIONAL) AG.

29/05/200707109081.5EPPCT/EP/2008/056276WO/2008/145586

)2010.01 (C12Q20129809/04/2008

חיזוי הישרדות לאחר טיפול של חוליא"סרטן באמצעות מיקרו רנ

PREDICTING POST- TREATMENTSURVIVAL IN CANCER PATIENTSWITH MICRORNASNATIONAL T AIWAN UNIVERSITY

10/04/200760/910993USPCT/US/2008/059767WO/2008/124777

)2010.01 (C07D01299215/04/2008

HCVתהליך עבור חומר ביניים למעכב פרוטיאז

PROCESS FOR HCV PROTEASEINHIBITOR INTERMEDIATE

F. HOFFMANN-LA ROCHE AG24/04/200707106771.4EP

PCT/EP/2008/054518WO/2008/128921

)2010.01 (C07D20130027/03/2008


פירידין]A–1,2[תרכובות אימידאזו כמעכבי קולטן טירוסין קינאז

IMIDAZO [1, 2 - A] PYRIDINECOMPOUNDS AS RECEPTORTYROSINE KINASE INHIBITORSARRAY BIOPHARMA INC.

03/04/200760/909857USPCT/US/2008/058395WO/2008/124323

)2010.01 (A23L20130110/04/2008

GRAIN מכשיר לתפיחת דגנים PUFFING APPARATUSKI HONG CHOI

10/04/200710-2007-0035152

KR

PCT/KR/2008/002001WO/2008/123746

)2010.01 (A61K20130207/04/2008

–בתא17/משטר חדש של דרוספירנוןמוצר שילוב רוקחי וערכה, אסטראדיאול

לביצוע המשטר

NEW DROSPIRENONE /17 BETA-ESTRADIOL REGIMEN,PHARMACEUTICAL COMPOSITIONPRODUCT AND KIT FORPERFORMING THIS REGIMENBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

05/04/200760/910326US10/03/200861/035285US28/03/200861/040494US

PCT/EP/2008/002823WO/2008/122439

)2010.01 (G01N20130304/04/2008

מערכות ושיטות, התקנים, תכשירים לשימוש בנקבובית בגודל ננו

COMPOSITIONS, DEVICES, SYSTEMS,AND METHODS FOR USING ANANOPORETHE REGENTS OF THE UNIVERSITYOF CALIFORNIA

04/04/200760/921787US


21/05/200760/931115US30/07/200760/962530US04/09/200760/967539US25/01/200861/062391US

PCT/US/2008/004467WO/2008/124107

)2010.01 (A61K20130403/04/2008

שיטה לייצור טבליות המתמוססות במהירות

A METHOD OF PRODUCING FASTDISSOLVING TABLETSROYAL COLLEGE OF SURGEONS INIRELAND

03/04/200707394008.2EP09/04/200760/922313US

PCT/IE/2008/000036WO/2008/120181

)2010.01 (A47K20130501/10/2009

I יעול במוצר הכוסות חד פעמי MPROVEMENT, IN PLASTIC, CUPS יעקב ישראלי

)2010.01 (C12Q20130610/04/2008

שיטה וערכת בדיקה לזיהוי מהיר ואפיון של תאים

A METHOD AND TEST KIT FOR THERAPID IDENTIFICATION ANDCHARACTERIZATION OF CELLS

יישום חברה לפיתוח המחקר שלמ"האוניברסיטה העברית בירושלים בע

YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD

12/04/200760/907630USPCT/IL/2008/000495WO/2008/126081


)2010.01 (C07F20130701/04/2008

IBANDRONATE תהליך איבנדרונאטי PROCESSF. HOFFMANN-LA ROCHE AG

11/04/200707105915.8EPPCT/EP/2008/053876WO/2008/125483

)2010.01 (C07D20130817/04/2008

–2תהליך חדש לייצור התרכובת–4–מורפולינ–5[–3–הידרוקסי5–אינדול–1H]יל–2–פירידינ) ילמתיל

701קרבוניטריל–

A NEW PROCESS FOR THEMANUFACTURING OF THECOMPOUND 2 - HYDROXY - 3 - [5 -(MORPHOLIN - 4 - YLMETHYL)PYRIDIN - 2 - YL] 1H - INDOLE - 5 -CARBONITRILE 701ASTRAZENECA AB

18/04/200760/912527USPCT/SE/2008/050432WO/2008/130312

)2010.01 (C07D20130922/04/2008

Nתולדות חדשות של – (8––2–הטרוארילטטראהידרונפתלינ

–הטרוארילכרומאנ–N– (5או) ילקרבוקסאמיד לטיפול)יל–3

בכאב

NOVEL N - (8 -HETEROARYLTETRAHYDRONAPHTALENE- 2YL) OR N - (5 - HETEROARYLCHROMANE- 3 - YL) CARBOXAMIDE DERIVATIVES FORTHE TREATMENT OF PAIN

ASTRAZENECA AB23/04/200760/913312US

PCT/SE/2008/050459WO/2008/130320

)2010.01 (C07D20131007/06/2002


תולדות חומצה תיאואצטית ותהליך להכנתן

THIOACETIC ACID DERIVATIVESAND A METHOD FOR THEIRSYNTHESISSOCIETE DE CONSEILS DERECHERCHES ET D'APPLICATIONSSCIENTIFIQUES S.A.S.

08/06/200160/297059USPCT/US/2002/017859WO/2002/100888

)2010.01 (G11B20131104/04/2008

מדית הקלטה נוחה עבור יישומים הולוגרפים

ADVANTAGEOUS RECORDINGMEDIA FOR HOLOGRAPHICAPPLICATIONSBAYER MATERIALSCIENCE AG

11/04/200760/907629USPCT/EP/2008/002677WO/2008/125229

)2010.01 (A01N20131202/04/2008

–פירידין–1H–דיהידרו–5,6תרכובות און–2

5, 6 - DIHYDRO - 1H - PYRIDIN - 2 -ONE COMPOUNDS

ANADYS PHARMACEUTICALS, INC03/04/200760/907478US

PCT/US/2008/059164WO/2008/124450

)2010.01(H04J20131413/03/2008

מערכת ושיטה לבחינת משדרי נתונים מרובי יחידות

SYSTEM AND METHOD FORTESTING MULTIPLE PACKET DATATRANSMITTERSLITEPOINT CORPORATION

05/04/200711/696921USPCT/US/2008/056827WO/2008/124250


)2010.01 (C12Q20131509/04/2008

SELECTION שיטת בחירה עבור הפנמת חומצות גרעין METHOD FOR CELLINTERNALIZING NUCLEIC ACIDSBOARD OF REGENTS, THEUNIVERSITY OF TEXAS SYSTEM

09/04/200760/910792US01/11/200760/984656US

PCT/US/2008/059805WO/2008/124798

)2010.01 (C07D20131709/04/2008

פירולידין כאנטגוניסטים דואליים תולדות/3NKלקולטן 1NK

PYRROLIDINE DERIVATIVES ASDUAL NK1/NK3 RECEPTORANTAGONISTSF. HOFFMANN-LA ROCHE AG

20/04/200707106666.6EPPCT/EP/2008/054261WO/2008/128891

)2010.01 (A61K20131802/05/2008

לטיפול בסרטניםHDACשימוש במעכבי של הקיבה והמעיים

USE OF HDAC INHIBITORS FOR THETREATMENT OFGASTROINTESTINAL CANCERSNOVARTIS AG

04/05/200760/915996USPCT/US/2008/062341WO/2008/137630

)2010.01 (C07D20131916/05/2008

פירימידיניל–תולדות קוטל פטריות פניל אמינו–

FUNGICIDE PHENYL - PYRIMIDINYL- AMINO DERIVATIVES

BAYER CROPSCIENCE S.A.16/05/200707356067.4EP


PCT/EP/2008/056072WO/2008/138992

)2010.01 (C07D20132025/03/2008

) מתילקרבמויל–2[–6צורות קריסטל שלE–3–] פנילסולפניל – –2–פירידינ(–2]

אזול המתאימות לטיפול אתניל אינד) יל בגדילת תאים לא נורמאלית ביונקים

CRYSTALLINE FORMS OF 6 - [2 -(METHYLCARBAMOYL)PHENYLSULFANYL] - 3 - E - [2 -(PYRIDIN - 2 - YL] ETHENYL]INDAZOLE SUITABLE FOR THETREATMENT OF ABNORMAL CELLGROWTH IN MAMMALSPFIZER PRODUCTS INC.

05/04/200760/910379US01/10/200760/976546US26/02/200861/031554US

PCT/IB/2008/000792WO/2008/122858

)2010.01 (C07D20132124/03/2006

NOVEL תרכובות חדשות COMPOUNDSGLAXO GROUP LIMITED

25/03/200560/665347USPCT/US/2006/010792WO/2006/104889

)2010.01 (A61K20132203/04/2008

גורמים מקומיים נגד פטריות לטיפול נייםבבעיות בציפור

TOPICAL FUNGICIDAL AGENTS FORTREATING NAIL DISORDERS

BIOEQUAL AG20/04/200700656/07CH

PCT/EP/2008/002642WO/2008/128627


)2010.01 (B65D20132301/10/2009

התקן להעברת נוזלים להרכבה בקבוקון עם חיבור נקבה מותקן מראש

FLUID TRANSFER DEVICE FORASSEMBLING A VIAL WITH PRE-ATTACHED FEMALE CONNECTOR

MEDIMOPמ"מדימופ פרויקטים רפואיים בע MEDICAL PROJECTS LTD.

)2010.01 (A61J20132416/04/2008

התקן לבקרת נוזלים בעל מפעיל לחוץ באופן ידני

FLUID CONTROL DEVICE WITHMANUALLY DEPRESSED ACTUATOR

MEDIMOPמ"מדימופ פרויקטים רפואיים בע MEDICAL PROJECTS LTD.17/04/2007182605IL

PCT/IL/2008/000517WO/2008/126090

)2010.01 (A61J20132504/05/2008

מתקן אוטומטי להכנת תרופה נוזלית עבור הכנת מנת תרופה נוזלית שנקבע מראש

AUTOMATIC LIQUID DRUGPREPARATION APPARATUS FOR THEPREPARATION OF APREDETERMINED DOSAGE OFLIQUID DRUG

MEDIMOPמ"מדימופ פרויקטים רפואיים בע MEDICAL PROJECTS LTD.02/05/2007182922IL

PCT/IL/2008/000606WO/2008/135989

)2010.01 (C07D20132602/04/2008

FUSED צאצאי ביציקליק הטרואריל משולב BICYCLIC HETEROARYLDERIVATIVESDAIICHI SANKYO COMPANY,LIMITED

05/04/20072007-099413

JP

PCT/JP/2008/056541


WO/2008/126732

)2010.01 (C01B20132717/04/2007

שיטה לתפעול מקביל של כורים המייצרים לחות

METHOD FOR PARALLELOPERATION OF REACTORS THATGENERATE MOISTUREFUJIKIN INCORPORATED

PCT/JP/2007/000419WO/2008/136042

)2010.01 (A61F20132912/05/2008

מערכת צנתר, ידית לתפעול קצה צנתרומערכת רפואית להכנסת סטנט לשסתום

לב הניתן להרחבה עצמית

HANDLE FOR MANIPULATING ACATHETER TIP, CATHETER SYSTEMAND MEDICAL INSERTION SYSTEMFOR INSERTING A SELF-EXPANDABLE HEART VALVE STENTJENAVALVE TECHNOLOGY INC.

15/05/200707009728.2EP14/06/200707110318.8EP14/06/200711/812095EP

PCT/EP/2008/003803WO/2008/138584

)2010.01 (G01C20133101/10/2009

IMPACT פלס טורפדו חסין אימפקט RESISTANT TORPEDOSPIRIT LEVEL

KAPROמ"קפרו תעשיות בע INDUSTRIES LTD.

)2010.01 (C07D20133209/04/2008


להדברת תהליך לייצור תרכובות בנזאמיד מזיקים

PROCESS FOR PRODUCINGPESTICIDAL BENZAMIDECOMPOUNDSSUMITOMO CHEMICAL COMPANY,LIMITED

11/04/20072007103614JPPCT/JP/2008/057376WO/2008/126933

)2010.01 (C07D20133309/04/2008

METHOD שיטה לייצור תרכובות אמיד FOR PRODUCING AMIDECOMPOUNDSUMITOMO CHEMICAL COMPANY,LIMITED

11/04/20072007-103615

JP

PCT/JP/2008/056998WO/2008/126858

)2010.01 (F28C20133506/04/2008

כונן מקורר פעיל משולב עבור ציוד/ארון אלקטרוני

AN INTEGRATED ACTIVE COOLEDCABINET/RACK FOR ELECTRONICEQUIPMENTSGIGUSHINSKY YEKUTIEL

05/04/200760/910216USPCT/IL/2008/000474WO/2008/122977

)2010.01 (H01L20133708/04/2008

שיטה לניטור סורפקטנט באמצעות פלואורסצנטיות בתהליך מיקרואלקטרוני

A METHOD OF MONITORING ASURFACTANT IN AMICROELECTRONIC PROCSS BYFLUORESCENCENALCO COMPANY

05/04/200711/696760USPCT/US/2008/059642WO/2009/126147


)2010.01 (C07K20133803/04/2008

CROSS ספציפיים במינים שונים–חומרי קישור דו - SPECIES - SPECIFICBISPECIFIC BINDERSMICROMET AG

03/04/200707006990.1EP03/04/200707006988.5EP24/04/200760/913668US22/10/200707020641.2EP22/10/200707020646.1EP22/10/200707020640.4EP13/03/200808004741.8EP

PCT/EP/2008/002663WO/2008/119566

)2010.01 (H01L20133908/04/2008

שיטה לניטור סורפקטנט באמצעות ספיגה בתהליך מיקרואלקטרוני

A METHOD OF MONITORING ASURFACTANT IN AMICROELECTRONIC PROCESS BYABSORBANCENALCO COMPANY

05/04/200711/696797USPCT/US/2008/059644WO/2009/126148

)2010.01 (C07K20134003/04/2008

CROSSאפסילון במינים שונים–3DCאזור הקושר - SPECIES - SPECIFIC CD3 -EPSILON BINDING DOMAINMICROMET AG

03/04/200707006990.1EP03/04/200707006988.5EP24/04/200760/931668US13/03/2008080047418EP

PCT/EP/2008/002664WO/2008/119567


)2010.01 (C23C20134131/03/2008

MULTILAYER רב שכבתיCVDציפוי CVD COATINGCERATIZIT AUSTRIAGESELLSCHAFT M.B.H

02/04/2007GM212/2007

AT

PCT/AT/2008/000118WO/2008/119095

)2010.01 (B01D20134220/03/2008

התקן סינון בפרט, התקן לטיפול במים ומחסנית

DEVICE FOR THE TREATMENT OFWATER, IN PARTICULAR A FILTERDEVICE, AND CARTRIDGEBRITA GMBH

05/04/200710 2007 017388.3

DE

PCT/EP/2008/053344WO/2008/122496

)2010.01 (B24B20134328/05/2004

PLANETARY תיבת הילוכים פלנטרית GEARBOXREM TECHNOLOGIES, INC.

30/05/200360/474836US02/06/200360/475210US

PCT/US/2004/017079WO/2004/108356

)2010.01 (B24B44201328/05/2004

METHOD שיטה לגימור גלגל שיניים חלול OF SUPERFINISHING AHOLLOW WHEEL GEARREM TECHNOLOGIES, INC.

30/05/200360/474836US02/06/200360/475210US


PCT/US/2004/017079WO/2004/108356

)2010.01 (H04B20134520/06/2003

מודות העברה מגוונות עבור מערכות(MIMO(תקשורת מימו OFDM

DIVERSITY TRANSMISSION MODESFOR MIMO OFDM COMMUNICATIONSYSTEMSQUALCOMM INCORPORATED

24/06/200210/179439USPCT/US/2003/019466WO/2004/002011

)2010.01 (A01N20134603/04/2008

NEWCOMPOSITIONS הרכבים חדשים ושיטות להרג תאים AND METHODSFOR CELL KILLINGOPLON B.V.

03/04/200760/907463USPCT/IL/2008/000465WO/2008/120219

)2010.01 (C07C20134702/04/2008

עם–4,1 ,1 מורכביםRUמימון של דיאנים 4 - HYDROGENATION OF DIENESWITH RU COMPLEXESFIRMENICH SA

03/04/200707105554.5EPPCT/IB/2008/051227WO/2008/120175

)2010.01 (C07C20134802/04/2008

עם–4,1 ,1 מורכביםRUמימון של סורבול 4 HYDROGENATION OF SORBOLWITH RU COMPLEXESINNOVAROMA SA

03/04/200707105557.8EP


PCT/IB/2008/051222WO/2008/120174

)2010.01 (F42B20134926/03/2008

SUBPROJECTILE קליע בעל תכולת אנרגיה–תת HAVING AN ENERGYCONTENTRWM SCHWEIZ AG

05/04/2007102007016828.6DE08/05/2007102007021451.2DE

PCT/EP/2008/002378WO/2008/122365

)2010.01 (B29C20135011/04/2008

ס רטי פוליליפין בעלי חוזק שיטה ליצורחמרי יריעה טקסטיל והנדסה, רב

ושימוש באלו כאמצעי, המיוצרים מהםהגנה לשם מתן הגנה כנגד קליעים

בליסטיים וכדומה

METHOD OF PRODUCING HIGH-STRENGHT POLYOLEFIN RIBBONS,TEXTILE AND ENGINEERING SHEETMATERIALS PRODUCED THEREFROM,AND USE THE LATTER IN PROTECTIVEBODIES FOR PROVIDING PROTECTIONAGAINST BALLISTIC PROJECTILESAND THE LIKETEIJIN MONOFILAMENT GERMANYGMBH

12/04/2007102007017621.1DEPCT/EP/2008/002887WO/2008/125298

)2010.01 (G06F20135101/10/2009

התקן ושיטה לחתימה אלקטרונית באמצעות בא כוח

DEVICE AND METHOD FORELECTRONIC SIGNATURE VIAPROXY

MICHAEL מיכאל פלדבאו FELDBAU


)2010.01 (A61K20135214/04/2008

ננים סלקטיביים של רצפטור מאפ האנדרוגן לטיפול בסכרת

SELECTIVE ANDROGEN RECEPTORMODULATORS FOR TREATINGDIABETESUNIVERSITY OF TENNESSEERESEARCH FOUNDATION

13/04/200711/785064USPCT/US/2008/004816WO/2008/127717

)2010.01 (B32B20135310/04/2008

שכבת פולימר בעלות פני שטח מומסים וסדוקים

MULTILPLE LAYER POLYMERINTERLAYERS HAVING A MELTFRACTURED SURFACESOLUTIA INC.

13/04/200711/734797USPCT/US/2008/059961WO/2008/128003

)2010.01 (F41B20135426/04/2007

SYSTEMS מערכת ושיטה לאספקת פולסים AND METHODS FORPULSE DELIVERYTASER INTERNATIONAL, INC.

19/04/200711/737374USPCT/US/2007/067543WO/2008/130414

)2010.01 (B29C20135503/01/2005

–שיטה ליצירת מיקרוסטרוקטורה תלתותוצרי, שימושיה, מימדית על פני משטח

מיקרוסטרוקטורה שנבנו בדרך זאת

METHOD OF FORMING A THREE-DIMENSIONAL MICROSTRUCTUREON A SURFACE, USES THEREOF,AND MICROSTRUCTUREDPRODUCTS SO OBTAINED


MACTAC EUROPE S.A.29/12/200303079017.4EP

PCT/BE/2005/000001WO/2005/063464

)2010.01 (C07D20135609/04/2008

אנלוגים של הטרואריל אמידל 7X2Pכאנטגוניסטים

HETEROARYL AMIDE AMIDEANALOGUES AS P2X7ANTAGONISTSH. LUNDBECK A/S

10/04/200760/910864USPCT/US/2008/004563WO/2008/124153

)2010.01 (A61F20135704/04/2008

מכשיר ושיטה לגילוף שטח הפנים של מפרק

APPARATUS AND METHOD FORSCULPTING THE SURFACE OF A JOINTALEXA NDRIA RESEARCH TECHNOLOGIESLLC

04/04/200760/910131US02/05/2007PCT/US2007/010655US

PCT/US/2008/059482WO/2008/124633

)2010.01 (H04M20135802/04/2007

מעבר נתונים בפס רחב ותקשורת קולית על גבי רשתות אלחוט וחשמל היברידיות

BROADBAND DATA AND VOICECOMMUNICATIONS OVERWIRELESS AND POWERLINEHYBRID NETWORKSAMPERION INC

PCT/US/2007/065752WO/2008/123876


)2010.01 (F41A20135907/04/2008

מחסנית מקושתת לכלי ירי ושיטה לייצורה

ARCUATE MAGAZINE FOR AFIREARM AND A METHOD FORMAKING THE SAMEAIRTRONIC USA, INC

06/04/200760/922104USPCT/US/2008/059584WO/2008/156902

)2010.01 (H02M20136011/10/2009

מערכת בקרת עומסים ואיתור הפסקות חשמל לרשת חכמה

LOADS MANAGEMENT ANDOUTAGES DETECTION FOR SMARTGRID

MOSHE משה הניג HENIG

)2010.01 (F16L20136103/03/2008

IRRIGATION השקיהצינור PIPENETAFIMמ"נטפים בע LTD

10/04/200711/783608USPCT/IL/2008/000271WO/2008/122972

)2010.01 (G06F20136211/10/2009

מידע במערך רב ערוצי איסוף ושיחזור תוך שימוש במטריצות סיכום אוניפולריות

INFORMATION GATHERING ANDRETRIEVAL OVER MULTIPLECHANNELS USING UNIPOLARMATRIX SUMMING

.DRר דורון קויאט"ד DORON KWIAT01/10/20090000000IL


)2010.01 (C07D20136514/04/2008

תולדות פירימידין כמעכבי קינאז–3–פוספאטידילינוסיטול

PYRIMIDINE DERIVATIVES ASINHIBITORS OFPHOSPHATIDYLINOSITOL - 3KINASETHE INSTITUTE OF CANCERRESEARCH: ROYAL CANCERHOSPITAL

12/04/20070707088.1GB19/04/20070707611.0GB

PCT/GB/2008/001301WO/2008/125839

)2010.01 (C07D20136614/04/2008

PHARMACEUTICAL תרכובות רוקחות COMPOUNDSTHE INSTITUTE OF CANCERRESEARCH: ROYAL CANCERHOSPITAL

12/04/20070707086.5GB19/04/20070707613.6GB

PCT/GB/2008/001292WO/2008/125833

)2010.01 (C07D20136714/04/2008

פירימידינים–יל–4–מורפולין–2K3PIכמעכבי

2 - MORPHOLIN - 4 - YL -PYRIMIDINES AS PI3K INHIBITORSTHE INSTITUTE OF CANCERRESEARCH: ROYAL CANCERHOSPITAL

12/04/20070707087.3GBPCT/GB/2008/001294WO/2008/125835


)2010.01 (G06F20136803/04/2008

ניהול אוטומטי של אימות דרישות תוכנהAUTOMATED MANAGEMENT OFSOFTWARE REQUIREMENTSVERIFICATIONLDRA TECHNOLOGY, INC

03/04/200760/907474USPCT/US/2008/004349WO/2008/124038

)2010.01 (A61K20136911/10/2009

A מכשיר דרמטולוגי BERMATOLOGY APPARATUSMICHAEL מיכאל זלטקין SLATKINE

)2010.01 (E04B20137011/10/2009

A ערכה ושיטה להצמדת אריחים KIT AND METHOD FORATTACHING TILES

MOSHE משה שאול SHAUL

)2010.01 (B60R20137111/10/2009

IMPROVEMENT שיפור בטיחות החגירה של ילד במכונית OF CHILD SAFETYSEAT SET-UP IN A VEHICLE

YAIR יעל דוד DAVID27/04/200912/430137US


)2009.01 (G10L20137210/08/2005

ערוצי–התקן ושיטה לייצור אות רב או קבוצת נתוני פרמטר

DEVICE AND METHOD FORGENERATING A MULTI-CHANNELSIGNAL OR A PARAMETER DATA SETFRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V.

08/09/2004102004043521.9DEPCT/EP/2005/008694WO/2006/027079

)2010.01 (H04L20137304/04/2008

התקן להוצאת שעון עם מנעול פאזהמ צריך בקרה חיצוניתדיגיטלי שאינו

CLOCK EXTRACTION DEVICE WITHDIGITAL PHASE LOCK, REQUIRINGNO EXTERNAL CONTROLCENTRE NATIONAL D'ETUDESSPATIALES

06/04/20070702552FRPCT/FR/2008/000479WO/2008/139064

)2010.01 (C07C20137424/04/2008

גורמים, אלכוהול אלקוקסילאטיםהמכילים אותם ושימוש באלכוהול

אלקוקסילאטים כחומרים מסייעים בתחום האגרוכימי

ALCOHOL ALKOXYLATES, AGENTSCONTAINING THESE, AND USE OFTHE ALCOHOL ALKOXYLATES ASADJUVANTS FOR THEAGROCHEMICAL FIELDBASF SE

25/04/200707106961.1EPPCT/EP/2008/055034WO/2008/132150

)2010.01 (C07D20137509/05/2008


תהליך, תולדות פירידופיראזין חדשות והשימוש בהן לייצורן

NOVEL PYRIDOPYRAZINEDERIVATIVES, PROCESS OFMANUFACTURING AND USESTHEREOFAETERNA ZENTARIS GMBH

10/05/200707107976.8EP10/05/200760/917129US

PCT/EP/2008/055728WO/2008/138878

)2010.01 (A61K20137610/04/2008

ו או טיפול במחלות/מוצרים לטיפול מונע ויראליות ושיטה להכנה ולשימוש בהם

PRODUCTS FOR PROPHYLAXIS AND/OR TREATMENT OF VIRALDISEASES AND METHOD OFMAKING AND USING SAME

OMRIXמ"בע אומריקס ביופארמאצבטיקה BIOPHARMACEUTICALSLTD.

12/04/200760/911373USPCT/US/2008/059891WO/2009/005870

)2010.01 (H04L20137704/04/2008

שיטה ומערכת לזיהוי יכולות פרוטוקולת ניידתשל רש

METHOD AND APPARATUS FORIDENTIFING MOBILE NETWORKPROTOCOL CAPABILITIESINTERDIGITAL TECHNOLOGYCORPORATION

06/04/200760/910494USPCT/US/2008/059440WO/2008/124612

)2010.01 (C07D20137830/04/2008

תולדות טריאמינופירימידין כמעכבי25CDCפוספטאז

TRIAMINOPYRIMIDINEDERIVATIVES AS INHIBITORS OFCDC25 PHOSPHATASEIPSEN PHARMA S.A.S

04/05/20070703233FR


PCT/FR/2008/000620WO/2008/152223

)2010.01 (C07D20137929/04/2008

IAPINHIBITORSמעכבי IAPGENENTECH, INC.

30/04/200760/915010USPCT/US/2008/061891WO/2008/134679

)2010.01 (C07D20138011/04/2008

COMPOUNDS סרטנית–תרכובות עם פעילות אנטי WITH ANTI- CANCERACTIVITYCANBAS CO. LTD.

11/04/200760/911258USPCT/IB/2008/003036WO/2009/031040

)2010.01 (A01H20138204/07/2008

שיטה לזיהוי חומר צמחי המראהצמחים המזוהים, היעלמות צבע מופחתת

כך ושימוש בצמחים מזוהים לייצור יבול צמחי מסחרי המראה היעלומות צבע

מופחתת

METHOD FOR IDENTIFYING PLANTMATERIAL THAT SHOWS AREDUCED DISCOLOURATION,PLANTS THUS IDENTIFIED AND USEOF THE IDENTIFIED PLANTS FORTHE PRODUCTION OF COMMERCIALCROP PLANTS SHOWING AREDUCED DISCOLOURATIONRIJK ZWAAN ZAADTEELT ENZAADHANDEL B.V.

06/07/200707075565.7EPPCT/EP/2008/005491WO/2008/007066


)2010.01 (A61K20138310/04/2008

טבלית מלאטונין ושיטות להכנה ושימושMELATONIN TABLET ANDMETHODS OF PREPARATION ANDUSEJOHN A. MCCARTY

11/04/200760/922921USPCT/US/2008/004615WO/2008/127609

)2009.01 (C12N20138407/04/2008

גזע ספיציפים לחולה הנגזרים–סוגי תאימתאים בלסטוציסטים אנושיים בלתי

מופרים

PATIENT - SPECIFIC STEM CELLLINES DERIVED FROM HUMANPARTHENOGENETIC BLASTOCYSTS

INTERNATIONAL STEM CELLCORPORATION

06/04/200760/922244USPCT/US/2008/004529WO/2008/124142

)2010.01 (B65D20138518/06/2008

WRAPPED אריזת צרור של פריטי עישון BUNDLE OF SMOKINGARTICLESPHILIP MORRIS PRODUCTS S.A.

20/06/200707110699.1EPPCT/EP/2008/057705WO/2008/155356

)2010.01 (C12N20138610/04/2008

TEM8 וחיסונים המכילים אותם8TEMפפטידים PEPTIDES AND VACCINESCOMPRISING THE SAMEONCOTHERAPY SCIENCE, INC.

11/04/200760/911194USPCT/JP/2008/000932WO/2008/126413


)2010.01 (A61K20138711/10/2009

SKIN-CARE תכשירים לטיפול בעור ושימושם COMPOSITIONS ANDUSES THEREOF

בע-אהבה -AHAVAמ"מעבדות ים המלח DEAD SEA LABORATORIESLTD.

07/10/200861/136834US

)2010.01 (C07K20138828/05/2008

IMMUNOGLOBULIN טיהור אימונוגלובולין PURIFICATIONF. HOFFMANN-LA ROCHE AG

01/06/200707010840.2EPPCT/EP/2008/004231WO/2008/145351

)2010.01 (A61K20138910/04/2008

ל ומניעת יתר אוקסאזולידינון לטיפו לחץ דם ריאתי

OXAZOLIDINONE FOR THETREATMENT AND PROPHYLAXIS OFPULMONARY HYPERTENSIONBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

20/04/2007102007018662.4DEPCT/EP/2008/002829WO/2008/128653

)2010.01 (B65B20139017/04/2008

מערכות ושיטות להוצאת תרופה מאריזהSYSTEMS AND METHODS FORREMOVING MEDICATION FROMPACKAGINGMTS MEDICATION TECHNOLOGIES,INC.,

19/04/200711/737644USPCT/US/2008/060628


WO/2008/131100

)2010.01 (A61K20139122/04/2008

METHOD שיטה לייצוב חלבון FOR STABILIZING APROTEINF. HOFFMANN-LA ROCHE AG

02/05/200707107353.0EPPCT/EP/2008/054835WO/2008/135380

)2010.01 (A61K20139216/05/2008

)יל–1–פירולידין(–4שימוש בתרכובותקווינולין להריגת מיקרואורגניזמים

הרדומים מבחינה קלינית

USE OF 4 - PYRROLIDIN- 1 - YL)QUINOLINE COMPOUNDS TO KILLCLINICALLY LATENTMICROORGANISMSHELPERBY THERAPEUTICS LIMITED

17/05/20070709489.9GB24/04/20080807591.3GB

PCT/GB/2008/001694WO/2008/142384

)2010.01 (H04L20139307/05/2003

מערכת המאפשרת בקרה של ניקוי נקודתבאמצועת בקרת שרת של מערכתBקשר

רדיו תקשורת

SYSTEM FOR PERMITTINGCONTROL OF THE PURGING OF ANODE B BY THE SERVING RADIONETWORK CONTROLLERINTERDIGITAL TECHNOLOGYCORPORATION

10/05/200260/379828USPCT/US/2003/014187WO/2003/096712

)2010.01 (A61K20139404/04/2008


NIACIN תכשירי רוקחות המבוססים על ניאצין - BASED PHARMACEUTICALCOMPOSITIONSTHOMAS H., HIGHT

04/04/200760/921727US16/01/200861/011302US04/02/200861/063484US31/03/200861/072489US

PCT/US/2008/059425WO/2008/127893

)2010.01 (C12N20139521/05/2008

רבשיטה לייצור חלבו –ן רקומביננטי שבוטי

METHOD FOR MANUFACTURING ARECOMBINANT POLYCLONALPROTEINSYMPHOGEN A/S

25/05/2007PA200700764DK07/09/2007PA200701292DK

PCT/DK/2008/050116WO/2008/145133

)2010.01 (C08K20139611/04/2008

, תהליך להכנת מוצר מילוי מינרלי מטופל מוצר המילוי המינרלי המתקבל ושימושין

PROCESS FOR THE PREPARTION OFA TREATED MINERAL FILLERPRODUCT, THE OBTAINED MINERALFILLER PRODUCT AND ITS USESOMYA DEVELOPMENT AG

13/04/200707007599.9EPPCT/IB/2008/000889WO/2008/125955

)2010.01 (C07D20139725/04/2008

תכשירים המכילים, תולדות טריאזיןתולדות אלו ושיטות לטיפול בסרטן

אוטואימוניות באמצעות שימוש ומחלות בתולדות הללו

TRIAZINE DERIVATIVES,COMPOSITIONS CONTAINING SUCHDERIVATIVES, AND METHODS OFTREATMENT OF CANCER ANDAUTOIMMUNE DISEASES USINGSUCH DERIVATIVES


PROMETIC BIOSCIENCES, INC.30/04/200760/924111US

PCT/CA/2008/000796WO/2008/131547

)2010.01 (C07K20139804/06/2008

תחומים משתני נוגדן, פוליפפטידים ואנטגוניסטים

POLYPEPTIDES, ANTIBODYVARIBLE DOMAINS ANDANTAGONISTSDOMANTIS LIMITED

06/06/200760/933632US13/12/20070724331.4GB

PCT/GB/2008/050407WO/2008/149150

)2010.01 (C07K20139903/06/2008

תחומים משתני נוגדן, פוליפפטידים ואנטגוניסטים

POLYPEPTIDES, ANTIBODYVARIABLE DOMAINS ANDANTAGONISTSDOMANTIS LIMITED

06/06/200760/933632USPCT/GB/2008/050404WO/2008/149147

)2010.01 (G06Q20140009/05/2008

VIRTUAL ודות מסלקה וירטואליותנק POINTS CLEARINGHOUSEMICROSOFT CORPORATION

10/05/200711/747104USPCT/US/2008/063269WO/2008/141199

)2010.01 (C07D20140111/04/2008


ו–Nולדותת די/אוקסיד אוקסיד–N–אומאפנני קולטן דופאמין/של מייצבי

המציגות פרופילים משופרים של תופעות לוואי של הלב וכלי הדם

N - OXIDE AND/OR DI-N-OXIDEDERIVATIVES OF DOPAMINERECEPTORSTABILIZERS/MODULATORSDISPLAYING IMPROVEDCARDIOVASCULAR SIDE-EFFECTSPROFILESNSAB, FILIAL AF NEUROSEARCHSWEDEN AB, SVERIGE

12/04/20070700893-1SEPCT/SE/2008/050414WO/2008/127188

)2010.01 (C07D20140210/04/2008

חדשה בעלת מבנה של תרכובת פירימידין דיבנזילאמין ותרופה המכילה אותה

NOVEL PYRIMIDINE COMPOUNDHAVING DIBENZYLAMINESTRUCTURE AND MEDICAMENTCOMPRISING THE SAMEKOWA COMPANY, LTD.

13/04/200760/911620USPCT/JP/2008/057058WO/2008/129951

)2010.01 (C07K20140411/04/2008

אינטרפרונים ממקור רזוס וסינאמולגוס ושימוש בהם

INTERFERONS OF RHESUS ANDCYNOMOLGUS ORIGIN AND USESTHEREOFPESTKA BIOMEDICALLABORATORIES, INC.

11/04/200760/923069US18/04/200760/925281US

PCT/US/2008/004805WO/2008/127711

)2010.01 (H04M20140511/04/2008


VOIPשיטה ומערכת לשילוב לקוח נייד סלולריPCבכרטיס

METHOD AND APPARATUS FORINTEGRATING A SOFT MOBILE VOIPCLIENT IN A CELLULAR PC CARDINTERDIGITAL TECHNOLOGYCORPORATION

13/04/200760/911631USPCT/US/2008/004800WO/2008/127706

)2010.01 (A61K20140611/04/2008

פרפוזיה/ תכשירי הגנה מפני איסכמיה חוזרת ושיטות לשימוש

ISCHEMIA / REPERFUSIONPROTECTION COMPOSITIONS ANDMETHODS OF USINGREGENTS OF THE UNIVERSITY OFMINNESOTA,

12/04/200760/911460US05/02/200861/026321US

PCT/US/2008/060100WO/2008/128095

)2010.01 (C07D20140729/07/2003

–דיהידרו– 4,5–הלו–3שיטה להכנתH1–פיראזולים

METHOD FOR PREPARING 3-HALO-4,5-DIHYDRO-1H-PYRAZOLESE.I. DU PONT DE NEMOURS ANDCOMPANY

31/07/200260/400356US11/02/200360/446451US

PCT/US/2003/023820WO/2004/011453

)2010.01 (G02B20140810/04/2008

מתגים אופטיים ושערים לוגיים המשתמשים בהם

OPTICAL SWITCHES AND LOGICGATES EMPLOYING SAME

GALTRONICSמ"גלטרוניקס קורפוריישן בע OPTICAL LTD12/04/200711/734747US12/04/200711/734750US


12/04/200760/911469USPCT/IL/2008/000494WO/2008/126080

)2010.01 (A61K20140909/12/2004

CD40 ושיטות40CDפורמולציה של נוגדן ANTIBODY FORMULATIONAND METHODSPFIZER PRODUCTS INC.

22/12/200360/531639USPCT/IB/2004/004103WO/2005/063289

)2010.01 (H04Q20141025/04/2008

ROUTE פיקוח ניתוב PROTOCOLQUALCOMM INCORPORATED

25/04/200760/913988US12/06/200760/949297US21/04/200812/107000US

PCT/US/2008/061588WO/2008/134519

)2010.01 (H04W20141101/05/2008

טיפול ביכולת ציוד משתמש במערכות מתפתחות לטווח ארוך

USER EQUIPMENT CAPABILITYHANDLING IN LONG - TERMEVOLUTION SYSTEMSQUALCOMM INCORPORATED

01/05/200760/915384US30/04/200812/112357US

PCT/US/2008/062276WO/2008/137582

)2010.01 (H04W20141225/04/2008


החלפת נקודות גישה המשמשות קישורב סיס וקישור לתחנת בסיסמתחנת

CHANGES OF FORWARD-LINK ANDREVERS-LINK SERVING ACCESSPOINTSQUALCOMM INCORPORATED

25/04/200760/913911US12/06/200760/943434US24/04/200812/109043US

PCT/US/2008/061624WO/2008/134546

)2010.01 (H04L20141325/04/2008

שיטה והתקן להפקת מפתח חדש בהעברת ברשתות אלחוטיות

A METHOD AND APPARATUS FORNEW KEY DERIVATION UPONHANDOFF IN WIRELESS NETWORKSQUALCOMM INCORPORATED

26/04/200760/914033US24/04/200812/109082US

PCT/US/2008/061645WO/2008/134564

)2010.01 (H04B20141425/04/2008

מבנה משוחלף עבור קידוד טרומי על בסיס גיוון שהייה מחזורית

TRANSPOSED STRUCTURE FORCYCLIC DELAY DIVERSITY (CDD)BASED PRECODINGQUALCOMM INCORPORATED

25/04/200760/914031US24/04/200812/109068US

PCT/US/2008/061630WO/2008/134551

)2010.01 (C02F20141510/04/2008

מתקן ומערכת תת מימי לעיבוד פלסמהושיטה לעיבוד מי ייצוב של ספינה על ידי

שימוש במתקן האמור

UNDERWATER PLASMAPROCESSING APPARATUS ANDSYSTEM AND METHOD FORPROCESSING BALLAST WATER OFSHIP USING THE SAME21C SHIPBUILDING CO., LTD.


10/04/200710-2007-0035299

KR

PCT/KR/2008/002010WO/2008/123749

)2010.01 (C07D20141616/04/2008

, קרבוקסאמיד–נגזרות טריאזולופירידין הכנתן ושימושן התרפיוטי

TRIAZOLOPYRIDINE CARBOXAMIDEDERIVATIVES, PREPARATIONTHEREOF AND THERAPUTIC USETHEREOFSANOFI-AVENTIS

18/04/20070702807FRPCT/FR/2008/000535WO/2008/145842

)2010.01 (G06F20141715/04/2008

ה להצגה מוקדמת של תוכן התקן ושיט פס נמוך–וידאו בעמדת הצגה ברוחב

APPARATUS AND METHOD FORLOW BANDWIDTH PLAY POSITIONPREVIEWING OF VIDEO CONTENTDIGITAL FOUNTAIN, INC.

23/04/200711/738778USPCT/US/2008/060363WO/2008/130936

)2010.01 (F24F20141911/04/2008

מערכת עיבוי להסרת לחות והתפלהCONDENSATION SYSTEM FORDEHUMIDIFICATION ANDDESALINATIONVINSTEVE INVESTMENTS INC.

12/04/200760/907643USPCT/CA/2008/000690WO/2008/124935


)2010.01 (C12Q20142004/04/2008

קומפלקסים, אנזימי חומצות גרעין ושימושיהם

NUCLEIC ACID ENZYMES ANDCOMPLEXES AND METHODS FORTHEIR USEJOHNSON & JOHNSON RESEARCHPTY, LIMITED

05/04/20072007901833AU05/04/200711/697021US05/04/200760/910427US

PCT/AU/2008/000492WO/2008/122084

)2010.01 (C07F20142123/04/2008

פירידין מותמרת עם הטרוציקל נגזרתופוספונאמינו וגורם נגד פטריות המכיל

אותו

PYRIDINE DERIVATIVESSUBSTITUTED BY HETEROCYCLICRING AND PHOSPHONOAMINOGROUP, AND ANTI-FUNGAL AGENTCONTAINING SAMEEISAI R & D MANAGEMENT CO. LTD.

27/04/20072007-118356

JP

27/04/200760/914615USPCT/JP/2008/057851WO/2008/136324

)2010.01 (C07D20142225/04/2008

THERAPEUTIC סוכנים רפואיים היעילים לטיפול בכאב AGENTS USEFUL FORTREATING PAINPURDUE PHARMA L.P.

27/04/200760/924056US11/05/200760/924377US

PCT/US/2008/005329WO/2008/133973

)2010.01 (A01N20142323/04/2008

FUNGICIDAL הרכבים קוטלי פטריות COMPOSITIONS


SYNGENTA PARTICIPATIONS AG25/04/200707008370.4EP

PCT/EP/2008/003279WO/2008/131901

)2010.01 (C07D20142404/04/2008

מלחים לאיזופוספוראמיד חרדל לוגים שלוואנא

SALTS OF ISOPHOSPHORAMIDEMUSTARD AND ANALOGS THEREOF

ZIOPHARM ONCOLOGY, INC.06/04/200760/922148US02/05/200760/927363US15/06/200760/934914US30/10/200761/001237US

PCT/US/2008/004449WO/2008/124097

)2010.01 (A61K20142517/04/2008

תרכובות לריפוי פציעה המכילות ביומטריאלים עם קראטין

WOUND HEALING COMPOSITIONSCONTAINING KERATINBIOMATERIALSWAKE FOREST UNIVERSITYHEALTH SCIENCES

17/04/200760/912265USPCT/US/2008/004984WO/2008/130607

)2010.01 (A61K20142624/04/2008

שילוב תרופתי והשימוש בו בטיפול באובדן שריר

DRUG COMBINATION AND ITS USEIN THE TREATMENT OF MUSCLELOSSACACIA PHARMA LIMITED

24/04/20070707930.4GB24/04/20070707931.2GB25/05/20070710101.7GB

PCT/GB/2008/001452WO/2008/129308


)2010.01 (C07K20142708/04/2008

סרין3NSתרכובות גפרית כמעכביCפרוטאז של וירוס הפטיטיס

SULFUR COMPOUNDS ASINHIBITORS OF HEPATITIS C VIRUSNS3 SERINE PROTEASESCHERING CORPORATION

10/04/200711/733479USPCT/US/2008/004549WO/2008/124148

)2010.01 (A61B20142804/04/2008

שיטה ומכשיר עבור השגת מערכת נתוני נפח של רקמה ניידת או איבר של מטופל

METHOD AND DEVICE FOROBTAINING A VOLUME DATA SETOF A MOBILE TISSUE OR ORGAN OFA PATIENTBIOSENSE WEBSTER, INC.

10/04/200710 2007 016902.9

DE

PCT/EP/2008/054076WO/2008/122599

)2010.01 (C12N20142904/04/2008

METHODS שיטות והרכבים לוירוסים חיים מוחלשים AND COMPOSITIONS FORLIVE ATTENUATED VIRUSESINVIRAGEN, INC

06/04/200760/910579USPCT/US/2008/059472WO/2009/014774

)2010.01 (A61K20143008/04/2008


או שיטות והרכבים המכילים דסוונלפקסיןדולוקסטין לטיפול בהפרעות נשימה

הקשורות לשינה

METHODS AND COMPOSITIONSCOMPRISING DESVENLAFAXINE ORDULOXETINE FOR TREATING SLEEPRELATED BREATHING DISORDERSSEPRACOR INC.

09/04/200760/922466USPCT/US/2008/004508WO/2008/124128

)2010.01(G06F20143114/04/2008

התנהגויות אוטונומיות ברכב המופעל בשלט רחוק

AUTONOMOUS BEHAVIORS FOR AREMOTE VEHICLE

IROBOT CORPORATION14/05/200711/748363US14/05/2007PCT/US07/68890IB

PCT/US/2008/060286WO/2008/144135

)2010.01 (C07D20143216/04/2008

–1כמעכב7אינדול המותמר בעמדהMCL

7 - SUBSTITUTED INDOLE MCL - 1INHIBITORSABBOTT LABORATORIES

16/04/200760/912038US13/07/200760/949650US

PCT/US/2008/060472WO/2008/131000

)2010.01 (A61K20143311/04/2008

טיפול מונע קרישה משולב עם תרכובתXAכמעכב פקטור הפועלת

COMBINATION ANTICOAGULANTTHERAPY WITH A COMPOUND THATACTS AS A FACTOR XA INHIBITORMILL ENNIUM PHARMACEUTICALS,INC.

13/04/200760/911852USPCT/US/2008/004760WO/2008/127682


)2010.01 (C07D20143420/06/2003

מותמרות כתכשירים–Nתולדות פיפרדין לרצפטורי סרוטונין

N - SUBSTITUTED PIPERIDINEDERIVATIVES AS SEROTONINRECEPTOR AGENTSACADIA PHARMACEUTICALS, INC.

24/06/200260/391269USPCT/US/2003/019797WO/2004/000808

)2010.01 (F16K20143530/10/2007

מערכת ושיטה לניהול הידרואולי שללחץ ניגר במורד הזרם משסתום ראשי בין

נקודות קבועות

SYSTEM AND METHOD FORHYDRAULICALLY MANAGINGFLUID PRESSURE DOWNSTREAMFROM A MAIN VALVE BETWEENSET POINTSCLA -VAL CO

13/04/200760/911604US29/10/200711/927474US

PCT/US/2007/083008WO/2008/127392

)2010.01 (B62D20143630/04/2008

ROLL התקן גלגל חמישי לייצוב טלטול - STABILIZING FIFTH WHEELAPPARATUSSILVER EAGLE MANUFACTURINGCO.

30/04/200760/915081USPCT/US/2008/062105WO/2008/134756

)2010.01 (C07D20143724/02/1998


מערכת למתן טרנסדרמלי של ביופרנאורפין לשימוש לטיפול בכאב

TRANSDERMAL DELIVERYSYSTEMS OF BUPRENORPHINE FORUSE IN TREATING PAINEURO-CELTIQUE S.A.

24/02/199760/038919US29/09/199760/939068US

PCT/US/1998/003584WO/1998/036728

)2010.01 (C07C20143811/04/2008

דו–שימוש בטרנס –קארוטנוידייםטיפול ובטיפול במחלת–קוטביים כקדם

וורידים פריפריאלית

USE OF BIPOLAR TRANSCAROTENOIDS AS APRETREATMENT AND IN THETREATMENT OF PERIPHERALVASCULAR DISEASEDIFFUSION PHARMACEUTICALSLLC

13/04/200760/907718USPCT/US/2008/004708WO/2008/136900

)2010.01 (A61K20143909/05/2008

USE בטיפול במלנומהHDACשימוש במעכבי OF HDAC INHIBITORS FOR THETREATMENT OF MELANOMANOVARTIS AG

11/05/200760/917345US16/05/200760/938272US

PCT/US/2008/063136WO/2008/141114

)2010.01 (A42B20144117/04/2008

שיטה להכנת מוצר מעוקל העשוי מסיב מתוח ומוצר שנוצר בשיטה זו

METHOD OF PRODUCING AFILAMENT WOUND CURVEDPRODUCT AND PRODUCT OBTAINEDTHEREBYDSM IP ASSETS B.V.

18/04/200707007850.6EP


02/04/200808006711.9EPPCT/EP/2008/003099WO/2008/128708

)2010.01 (B29C20144217/04/2008

שיטה להכנת מוצר מעוקל המכיל מרכיביחיזוק פולימר מתוח ומוצר הנוצר

מהשיטה האמורה

METHOD OF PRODUCING A CURVEDPRODUCT COMPRISING DRAWNPOLYMER REINFORCING ELEMENTSAND PRODUCT OBTAINED THEREBYDSM IP ASSETS B.V.

18/04/200707007850.6EP02/04/200808006711.9EP

PCT/EP/2008/003119WO/2008/128715

)2010.01 (C12N20144302/05/2008

CANCEROUS נוגדנים המשנים מחלה סרטנית DISEASE MODIFYINGANTIBODIESF. HOFFMANN-LA ROCHE AG

07/05/200760/916333USPCT/CA/2008/000842WO/2008/134876

)2010.01 (C07D46201414/05/2008

HETEROARYLAMIDE תרכובות הטרוארילאמיד פירידון PYRIMIDONECOMPOUNDSSANOFI-AVENTIS

16/05/200707290628.2EPPCT/IB/2008/002445WO/2008/155668

)2010.01 (A61K20144716/04/2008


ב N–ציקלופרופילמתוקסי–4שימוש –(3, –4–אוקסידופירידין–1–דיכלורו–5–2–פירידין) מתוקסי(–5–) איל

קרבוקסאמיד לטיפול בטראומות גולגולתיות

USE OF 4 - CYCLOPROPYLMETHOXY- N - (3, 5 - DICHLORO - 1 -OXIDOPYRIDIN - 4 - YL) - 5 -(METHOXY) PYRIDINE - 2 -CARBOXAMIDE FOR THETREATMENT OF CRANIALTRAUMASSANOFI-AVENTIS

19/04/20070702852FRPCT/FR/2008/000531WO/2008/145838

)2010.01 (A61K20144816/04/2008

ב N–ציקלופרופילמתוקסי–4שימוש –(3, –4–אוקסידופירידין–1–דיכלורו–5–2–פירידין) מתוקסי(–5–) איל

קרבוקסאמיד לטיפול בהפרעות מוטוריות הקשורות למחלת פרקינסון

USE OF 4 - CYCLOPROPYLMETHOXY- N - (3, 5 - DICHLORO - 1 -OXIDOPYRIDIN - 4 - YL) - 5 -(METHOXY) PYRIDINE - 2 -CARBOXAMIDE FOR THETREATMENT OF MOTOR DISORDERSRELATED TO PARKINSON'S DISEASESANOFI-AVENTIS

19/04/20070702853FRPCT/FR/2008/000534WO/2008/145841

)2010.01 (C07D20144914/05/2008

נגזרות פירימידון מותמרותבהטרוארילאמיד לטיפול במחלות

נאורודגנרטיביות

HETEROARYLAMIDE-SUBSTITUTEDPYRIMIDONE DERIVATIVES FORTHE TREATMENT OFNEURODEGENERATIVE DISEASESSANOFI-AVENTIS

16/05/200707290627.4EPPCT/IB/2008/002429WO/2008/155666

)2010.01 (C07D20145016/04/2008


קרבוקסאמיד–נגזרות טריאזולופירידיןהכנתן, קרבוקסאמיד–וטריאזולופירימידין ושימושן התרפיוטי

TRIAZOLOPYRIDINE CARBOXAMIDEDERIVATIVES ANDTRIAZOLOPYRIMIDINECARBOXAMIDE DERIVATIVES,PREPARATION THEREOF ANDTHERAPEUTIC USE THEREOFSANOFI-AVENTIS

18/04/20070702809FRPCT/FR/2008/000532WO/2008/145839

)2010.01 (A61K20145116/04/2008

ב N–ציקלופרופילמתוסי–4שימוש – (3,–4–אוקסידופירידין–1–דיכלורו–5

–2–פירידין) מתוקסי(–5–) אילקרבוקסאמיד לטיפול בטראומה לחוט

השדרה

USE OF 4 - CYCLOPROPYLMETHOXY- N - (3, 5 - DICHLORO - 1 -OXIDOPYRIDIN - 4 - YL) - 5 -(METHOXY) PYRIDINE - 2 -CARBOXAMIDE FOR THETREATMENT OF SPINAL CORDTRAUMASSANOFI-AVENTIS

19/04/20070702851FRPCT/FR/2008/000533WO/2008/145840

)2010.01 (C12Q20145206/04/2008

MEANSצעים ושיטות לאיתור חיידקים בדגימהאמ AND METHODS FORDETECTING BACTERIA IN A SAMPLE

OPTICULמ"אופטיקאל דיאגנוסטיקה בע DIAGNOSTICS LTD04/04/200760/921730US

PCT/IL/2008/000472WO/2008/122975

)2010.01 (A01G20145302/04/2008

COVER כיסוי למצע לגידול שתילים FOR PLANT GROWINGMEDIUMSTEVEN WILLIAM GALLO

05/04/200711/784072US


PCT/CA/2008/000621WO/2008/122113

)2010.01 (G01S20145410/03/2008

שיטה ליצירת עקבות מיקום המסמנות מטרה

METHOD FOR GENERATION OFTARGET - MARKING BEARING TRACKS

ATLAS ELEKTRONIK GMBH25/04/2007102007019445.7DE

PCT/EP/2008/001887WO/2008/131826

)2010.01 (C07D20145510/04/2008

PROCESS תהליך לייצור טופוטקאן FOR MAKING TOPOTECANSCINOPHARM TAIWAN, LTD

11/04/200760/922918USPCT/US/2008/004610WO/2008/127606

)2010.01 (B60W20145813/04/2008

VIBRATING זוחל רובוטי רוטט ROBOTIC CRAWLER


13/04/200760/907691USPCT/IL/2008/000505WO/2008/126087

)2010.01 (C12N20145907/04/2008

PARABEN תרכובות פאראבן COMPOUNDSUNIVERSITE PIERRE ET MARIECURIE (PARIS 6)

10/04/200707290438.6EPPCT/IB/2008/002297WO/2008/122897


)2010.01 (C07D20146010/04/2008

נגזרות פתאלאזינון והשימוש בהן כתרופה לטיפול בסרטן

PHTHALAZINONE DERIVATIVESAND THEIR USE AS MEDICAMENTTO TREAT CANCERKUDOS PHARMACEUTICALSLIMITED

10/04/200760/910887USPCT/GB/2008/001259WO/2008/122810

)2010.01 (F02K20146312/10/2009

השיטה של הקטנת הפליטה חלקיקיהמסה הסילונית וכן מכשיר ליישומה

תעופה, בתור מנוע סילון דור הבא בחלל ובשאר התחומים מדע וטכנולוגיה

A METHOD FOR REDUCING THEVELOCITY OF REACTIVE MASSDISCHARGE AND A DEVICE FORTHE REALIZATION OF THE METHODIN THE FORM OF A NEW TYPE OFENGINES FOR AVIATION , SPACERESEARCH AND OTHER FIELDS OFSCIENCE AMD ENGINEERING.

YOHAI יוחאי טהור TAHOR

)2010.01 (G07B20146412/10/2009

שיטה ומערכת לביצוע מבצע ציבוריבתשלום באמצעות מכשיר טרמינל של

השחקן ושרת רישום

THE METHOD AND SYSTEM FORREALIZATION OF A PAID PUBLICACTION USING A TERMINAL UNITOF PLAYER AND A REGISTRATIONSERVER UNIT

NATALIA נטליה זוויגינה ZVIAGUINA


)2010.01 (A61K20146505/05/2008

תכשירים רפואיים שעוברים פרסיפיטציה עצמית לשחרור מותאם של חומר פעיל

SELF-PRECIPITATINGPHARMACEUTICAL FORMULATIONSFOR THE MODIFIED RELEASE OFACTIVE PRINCIPLEFLAMEL TECHNOLOGIES

03/05/20070703186FRPCT/EP/2008/055506WO/2008/135562

)2010.01 (A61K20146628/05/2008

לטיפול בהרסHDACשימוש במעכבי עצם

USE OF HDAC INHIBITORS FOR THETREATMENT OF BONEDESTRUCTIONNOVARTIS AG

30/05/200760/940735USPCT/US/2008/064944WO/2008/150782

)2010.01 (H01S20146719/12/2007

OPTICAL ינוי רוחב של פולס אופטימבנה לש PULSE-WIDTH MODIFIERSTRUCTURERAYTHEON COMPANY

26/04/200711/789935USPCT/US/2007/026032WO/2008/133671

)2010.01 (A61P20146807/04/2008

נגזרות סולפונילאמיד לטיפול בהתפתחות תאית חריגה

SULFONYL AMIDE DERIVATIVESFOR THE TREATMENT OFABNORMAL CELL GROWTHPFIZER PRODUCTS INC.

18/04/200760/912597US


PCT/IB/2008/000845WO/2008/129380

)2010.01 (C07D20147116/04/2008

קרבוקסאמיד–נגזרות טריאזולופירידיןהכנתן, קרבוקסאמיד–וטריאזולופירימידין ושימושן התרפיוטי

TRIAZOLOPYRIDINE CARBOXAMIDEDERIVATIVES ANDTRIAZOLOPYRIMIDINECARBOXAMIDE DERIVATIVES,PREPARATION THEREOF ANDTHERAPEUTIC USE THEREOFSANOFI-AVENTIS

18/04/20070702808FRPCT/FR/2008/000536WO/2008/145843

)2010.01 (G08B20147329/06/2008

ע חדי"הגנה על רשתות בקרה –חיבור כיווני

PROTECTION OF CONTROLNETWORKS USING A ONE -WAYLINK

WATERFALLמ"ווטרפול סקיוריטי סולושינס בע SECURITY SOLUTIONSLTD.

29/06/200711/823950USPCT/IL/2008/000886WO/2009/004611

)2010.01 (A61K20147414/04/2008

, חיקויי סמאק דיאזו ביציקליים והשימושים בהם

DIAZO BICYCLIC SMAC MIMETICSAND THE USES THEREOFTHE REGENTS OF THE UNIVERSITYOF MICHIGAN

13/04/200760/923348USPCT/US/2008/060215WO/2008/128171


)2010.01 (G01R20147504/03/2008

PROBE מוליך–בחון לבדיקת התקני חצי FOR TESTINGSEMICONDUCTOR DEVICESTOUCHDOWN TECHNOLOGIES, INC.

12/04/200711/734434USPCT/US/2008/055835WO/2008/127801

)2010.01 (C07K20147622/05/2008

–מניעה וטיפול בתנאי עיניים קשורים משלימים

PREVENTION AND TREATMENT OFCOMPLEMENT-ASSOCIATED EYECONDITIONSGENENTECH, INC.

23/05/200760/939791USPCT/US/2008/064526WO/2008/147883

)2010.01 (H04B20147716/05/2008

METHOD שיטה לייעול קישורי שדה קרוב FOR OPTIMIZING NEARFIELD LINKSMICROSOFT CORPORATION

23/05/200760/939827US14/09/200711/855913US

PCT/US/2008/063859WO/2008/147728

)2010.01 (A24D20147822/05/2008

SMOKING חדשהפריט עישון עם אריזה ARTICLE WITH NOVELWRAPPERPHILIP MORRIS PRODUCTS S.A.

24/05/200760/924666USPCT/IB/2008/002394WO/2008/149241


)2010.01 (A61K20147921/04/2008

TITRATIONה של טאפנטאדולטיטרצי OF TAPENTADOLGRUNENTHAL GMBH

23/04/200707008218.5EPPCT/EP/2008/003178WO/2008/128740

)2010.01 (A61L20148018/04/2008

לים תרכובות תכשירי פיברין המכי סטרונטיום

FIBRIN COMPOSITIONSCONTAINING STRONTIUMCOMPOUNDSBAXTER INTERNATIONAL INC.

23/04/200760/925716USPCT/US/2008/060720WO/2008/131154

)2010.01 (G01N20148125/04/2008

DEVICE התקן ושיטות לגילוי גורמים מוטסים AND METHODS FORDETECTION OF AIRBORNE AGENTSTHE REGENTS OF THE UNIVERSITYOF CALIFORNIA

27/04/200760/914603USPCT/US/2008/005345WO/2009/020479

)2010.01 (H04L20148202/05/2008

מודול יישום ושרת ניהול מרוחק עם מודל תיאור פרמטר

APPLICATION MODULE ANDREMOTE MANAGEMENT SERVERWITH PARAMETER DESCRIPTIONMODELALCATEL LUCENT

07/05/200707290579.7EPPCT/EP/2008/003654


WO/2008/135279

)2010.01 (G06K20148316/05/2008

שיטה ומערכת לדיאגנוזה של סרטן מסוייעת מחשב ומוצר

METHOD AND APPARATUS FORCOMPUTER-AIDED DIAGNOSIS OFCANCER AND PRODUCT

YEDAמ"ידע חברה למחקר ופיתוח בע RESEARCH ANDDEVELOPMENT CO. LTD

17/05/200760/938626US15/02/200861/029072US

PCT/US/2008/063936WO/2008/144539

)2010.01 (C07D20148406/05/2008

NEW מאפנני קולטן פרוגסטרון חדשים PROGESTERONE RECEPTORMODULATORSN.V. ORGANON

07/05/200707107639.2EPPCT/EP/2008/003714WO/2008/135291

)2010.01 (A61K20148525/04/2008

NEW תרכובות פפטידיות ציקליות חדשות CYCLIC PEPTIDE COMPOUNDSASTELLAS PHARMA INC.

02/05/20072007-902312

AU

PCT/JP/2008/058456WO/2008/139986

)2010.01 (B23B20148613/10/2009

TWIST מקדח DRILLISCARמ"ישקר בע LTD.


)2010.01 (G06F20148713/10/2009

THREE חיפוש תלת ממדמערכת DIMENSION SEARCH ENGINESYSTEM

IDO עידו פוריצקי PORITZKY

)2010.01 (H04L20148828/03/2008

שיטה לייעול מאפיין של העברהה עברה בפאזה מינימלית ומערכת

נלווית

METHOD FOR OPTIMIZING A MINIMAL-PHASE TRANSMISSIONCHARACTERISTIC AND ASSOCIATEDTRANSMISSION SYSTEMROHDE & SCHWARZ GMBH & CO. KG

17/04/2007102007018093.6DE20/08/2007102007039158.9DE26/11/2007102007056728.8DE

PCT/EP/2008/002490WO/2008/125206

)2010.01 (H04L20148928/03/2008

שיטה ומאזן לגילוי רצפים של סמלימידע המשודרים בערוץ שידור משתנה

בזמן

METHOD AND EQUALIZER FORDETECTING DATA SYMBOLSEQUENCES TRANSMITTED VIA ATIME-VARIABLE TRANSMISSIONCHANNELROHDE & SCHWARZ GMBH & CO. KG

17/04/2007102007018094.4DE20/08/2007102007039159.7DE26/11/2007102007056726.1DE

PCT/EP/2008/002489WO/2008/125205


)2010.01 (G06K20149014/04/2008

מאפיין ההמאמץ מנגנון המרת קרן אורוהשיטה השייכת לגילוי אובייקטים המורכבים מקווים עקומים בתמונה

A FEATURE ADAPTED BEAMLETTRANSFORM APPARATUS ANDASSOCIATED METHODOLOGY OFDETECTING CURVILINEAR OBJECTSOF AN IMAGEINSTITUT PASTEUR

13/04/200760/911797USPCT/EP/2008/054508WO/2008/125663

)2010.01 (C07D20149115/04/2008

תרכובות אמינואלקוקסי אריל6סולפונאמיד ושימושן כליגנדים של

HT –5

AMI NOALKOXY ARYL SULFONAMIDECOMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS

SUVEN LIFE SCIENCES LIMITED03/05/2007940/CHE/2007IN

PCT/IN/2008/000247WO/2008/136017

)2010.01 (H04L20149201/05/2008

מ ספר רצף לשכבת פרוטוקול הצפנת סמוך בתקשורת חבילת נתונים

CIPHERING SEQUENCE NUMBERFOR AN ADJACENT LAYERPROTOCOL IN DATA PACKETCOMMUNICATIONSQUALCOMM INCORPORATED

01/05/200760/915404US04/05/200760/916261US30/04/200812/112431US

PCT/US/2008/062293WO/2008/137598

)2010.01 (C04B20149316/04/2008


שיטה להכנתו, תוסף במשקל נמוך ושימושים שלו

LIGHT WEIGHT ADDITIVE, METHODOF MAKING AND USES THEREOFJAMES HARDIE TECHNOLOGYLIMITED

16/04/200760/923591USPCT/US/2008/060514WO/2008/131026

)2010.01 (H04B20149401/05/2008

EXTENDED שינה זעירה ממושכת לתקשורת MICROSLEEP FORCOMMUNICATIONSQUALCOMM INCORPORATED

01/05/200760/915421US30/04/200812/112268US

PCT/US/2008/062291WO/2008/137596

)2010.01 (A23L20149514/04/2008

ם משובצים במטריצה חומרי סיכה נוזליי להכנת טבליות

EMBEDDED LIQUID LUBRICANTSFOR TABLETING

WYETH LLC16/04/200711/787381US

PCT/US/2008/060188WO/2008/130883

)2010.01 (C12N20149617/04/2008

גליקוליזציה של יונקים בצמחים על ידי יונקיים–ביטוי גליקוזילטרנספראזים לא

MAMMALIAN-TYPEGLYCOSYLATION IN PLANTS BYEXPRESSION OF NON-MAMMALIANGLYCOSYLTRANSFERASESSTICHTING DIENSTLANDBOUWKUNDIG ONDERZOEK

17/04/200707106337.4EPPCT/IB/2008/000944WO/2008/125972


)2010.01 (A63B20149713/10/2009

COMPRESSION שק לחץ BAGMEGOמ"מגו אפק שיתופית חקלאית בע AFEK AC LTD.

)2010.01 (A61K20149815/04/2008

שימוש בדימיראצטאם לטיפול בכאב כרוני

USE OF DIMIRACETAM IN THETREATMENT OF CHRONIC PAIN

NEUROTUNE AG16/04/2007MI2007A000770IT

PCT/EP/2008/054553WO/2008/125674

)2010.01 (G06K20149920/04/2007

VOLUME שיטה ומערכת לזיהוי נפחים RECOGNITION METHODAND SYSTEMSOFTKINETIC S.A

PCT/EP/2007/053895WO/2008/128568

)2010.01 (A61M20150009/04/2008

INJECTION מתקן הזרקה לפיזור של תרופה DEVICE FOR DISPENSING AMEDICAMENTSANOFI-AVENTIS DEUTSCHLANDGMBH

18/04/2007102007018696.9DEPCT/EP/2008/002787WO/2008/128645


)2010.01 (H01L20150114/04/2008

פונקציונאלי לגלאי–מארז קתודה מולטי מצב מוצק לקרינה

MULTI- FUNCTIONAL CATHODEPACKAGING DESIGN FOR SOLID-STATE RADIATION DETECTORSREDLEN TECHNOLOGIES

17/04/200711/785319USPCT/US/2008/004773WO/2008/130522

)2010.01 (A61K20150210/04/2008

תכשירים לטיפול תומך בסרטןMETHODS AND COMPOSITIONS FORCONTRIBUTING TO THETREATMENT OF CANCERSTHE BOARD OF TRUSTEES OF THEUNIVERSITY OF ILLINOIS

13/04/200760/911773USPCT/US/2008/059949WO/2008/127996

)2010.01 (B26B20150318/04/2008

RAZOR ראש סכין גילוח עם ציר קדמי CARTRIDGE WITH FRONTPIVOT AXISTHE GILLETTE COMPANY

20/04/200711/788538USPCT/IB/2008/051511WO/2008/129498

)2010.01 (B26B20150418/04/2008

RAZOR ראש סכין גילוח צירי CARTRIDGE PIVOT AXISTHE GILLETTE COMPANY

20/04/200711/788672USPCT/IB/2008/051512WO/2008/129499


)2010.01 (C07D20150516/04/2008

ליגנדים חדשים לקולטן ונילואיד ושימושם להכנת תכשירי רוקחות

NOVEL VANILLOID RECEPTOR LIGANDSAND THE USE THEREOF FOR THEPRODUCTION OF PHARMACEUTICALSGRUNENTHAL GMBH

16/04/2007102007018149.5DE15/04/2008PCT/EP08/002997EP15/04/200812/103667US

PCT/EP/2008/003027WO/2008/125342

)2010.01 (C07D20150615/04/2008

ליגנדים חדשים לקולטן ונילואיד והשימוש בהם להכנת תכשירי רוקחות

NOVEL VANILLOID RECEPTORLIGANDS AND THE USE THEREOF FORTHE PRODUCTION OFPHARMACEUTICALSGRUNENTHAL GMBH

16/04/2007102007018151.7DEPCT/EP/2008/002994WO/2008/125337

)2010.01 (H01M20150724/04/2008

מודול עבור מכלול אחסון אנרגיה חשמלית

MODULE FOR AN ELECTRICENERGY STORAGE ASSEMBLY

BATSCAP24/04/20070754650FR

PCT/EP/2008/054971WO/2008/132122

)2010.01 (A61K08201522/04/2008


ייצוב תמיסות נוזליות של חלבון רקומביננטי לאחסון בהקפאה

STABILIZATION OF LIQUIDSOLUTIONS OF RECOMBINANTPROTEIN FOR FROZEN STORAGEBAYER HEALTHCARE LLC

26/04/200760/926698USPCT/US/2008/061147WO/2008/134310

)2010.01 (A61K20150929/04/2008

ותצריפיהם לטיפולsGCמעוררי ומשפעלי באי סדרים אורולוגיים

sGC STIMULATORS, sGCACTIVATORS AND COMBINATIONSFOR THE TREATMENT OFUROLOGICAL DISORDERSBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

12/05/200707009557.5EPPCT/EP/2008/003450WO/2008/138483

)2010.01 (G06F20151027/05/2008

DISPLAY תצוגה ורשומה של תוצאות מנוע חיפוש OF SEARCH-ENGINERESULTS AND LISTMICROSOFT CORPORATION

08/06/200711/760492USPCT/US/2008/064863WO/2008/154156

)2010.01 (C07D20151113/05/2008

ה מותמרות תיואוריא–תרכובות אמינו להדברת מזיקי בעלי חיים

SUBSTITUTED AMINO-THIOUREACOMPOUNDS FOR COMBATINGANIMAL PESTSBASF SE

24/05/200760/939931USPCT/EP/2008/055851WO/2008/141980


)2010.01 (H04H20151328/02/2008

פרסומות טלביזיוניות מטרתיות מבוססות על התנהגות מכווננת

TARGETED TELEVISIONADVERTISEMENTS BASED ONONLINE BEHAVIORALMONDNET, INC.

17/04/200711/736544USPCT/US/2008/055298WO/2008/130736

)2010.01 (G06K20151415/04/2007

מנגנון מערכת ושיטה לממשק בין אדם למכונה

AN APPARATUS SYSTEM ANDMETHOD FOR HUMAN-MACHINE-INTERFACE

EXTREMEמ"אקסטרים ריאליטי בע REALITY LTD

PCT/IL/2007/000475WO/2008/126069

)2010.01 (H04L20151502/05/2008

CAZACבחירת אינדקסי שורש בסדרות מופעיות–רב

SELECTION OF ROOT INDICES INPOLYPHASE CAZAC SEQUENCES

QUALCOMM INCORPORATED02/05/200760/915434US01/05/200812/113409US

PCT/US/2008/062554WO/2008/137781

)2010.01 (H04W20151602/05/2008

איתות גמיש של משאבים בערוץ פיקוחFLEXIBLE SIGINALING OFRESOURCES ON A CONTROLCHANNELQUALCOMM INCORPORATED

02/05/200760/915660US


01/05/200812/113808USPCT/US/2008/062559WO/2008/137786

)2010.01 (A61K20151725/04/2008

מערכת אמצעים לטיפול בפתולוגיהמחלה אוטואימונית או מחלה, ממאירה זיהומית

SET OF MEANS FOR TREATING AMALIGNANT PATHOLOGY, ANAUTOIMMUNE DISEASE OR ANINFECTIOUS DISEASELFB BIOTECHNOLOGIES

25/04/20070703013FRPCT/FR/2008/000598WO/2008/145866

)2010.01 (G01S20151814/05/2008

שיטות והתקן לבקרת ירייה בזמן שיגור טיל

METHODS AND APPARATUS FORFIRE CONTROL DURING LAUNCH OFAN EFFECTORRAYTHEON COMPANY

14/05/200760/917816USPCT/US/2008/063577WO/2009/023318

)2010.01 (H04L20151907/05/2008

זמנון מתמיד למחצה מבוסס על למידה בתקשורת אלחוטית

LEARNING -BASED SEMI-PERSISTENT SCHEDULING INWIRELESS COMMUNICATIONSQUALCOMM INCORPORATED

07/05/200760/916517US06/05/200812/116146US

PCT/US/2008/062960WO/2008/137959


)2010.01 (G06F20152001/05/2008

בקרה הידודית של גישה לשירותים ויכולות של התקן נייד

INTERACTIVE CONTROL OF ACCESSTO SERVICES AND CAPABILITIESOF A MOBILE DEVICEQUALCOMM INCORPORATED

03/05/200711/743833USPCT/US/2008/062252WO/2008/137566

)2010.01 (F41F20152114/05/2008

שיטות והתקן לתקשורת בין מערכת בקרת ירייה וטיל

METHODS AND APPARATUS FORCOMMUNICATIONS BETWEEN AFIRE CONTROL SYSTEM AND ANEFFECTORRAYTHEON COMPANY

14/05/200760/917729USPCT/US/2008/063586WO/2009/023319

)2010.01 (B65D20152214/10/2009

מערכת ידידותית לסביבה להחלפת נוזלים בעוקה

ENVIRONMENTAL FRIENDLYSYSTEM FOR REPLACING FLUID INFLUID-SUMPS

SHIRA שירה לוטן LOTAN

)2010.01 (A61K20152318/04/2008

כדורית מתכלה ביולוגית–תערובת מיקרוהמתאימה לשחרור מבוקר של פפטיד

יר עבורוהשולט בגלוקוזה ותכש

A BIODEGRADABLE MICROSPHERECOMPOSITION SUITABLE FOR THECONTROLLED RELEASE OFGLUCOSE CONTROLLING PEPTIDEAND FORMULATION THEREOFDONG-A PHARMACEUTICAL CO.LTD.


19/04/2007KR10-2007-0038467

KR

PCT/KR/2008/002216WO/2008/130158

)2010.01 (C07D20152418/04/2008

מעכב ומונע פעולה כימית4–.פי.פי.דישיטת הכנה, אמינו–המכיל קבוצת בטא

עבורו ותערובת רוקחותית המכילה אותו למניעה וטיפול בסכרת או עודף שומן

DPP-IV INHIBITOR INCLUDINGBETA-AMINO GROUP, PREPARATIONMETHOD THEREOF ANDPHARMACEUTICAL COMPOSITIONCONTAINING THE SAME FORPREVENTING AND TREATING ADIABETES OF AN OBESITYDONG-A PHARM. CO. LTD.

19/04/2007KR10-2007-0038462

KR

PCT/KR/2008/002203WO/2008/130151

)2010.01 (A61K20152718/04/2008

N–תכשירים המכילים נוגדן ספציפי לקצהה–לשימוש בטיפול באנגיופתי?Aשל

אמיליודית צרברלית

COMPOSITIONS COMPRISING ANANTIBODY SPECIFIC FOR THE N -TERMINUS OF A? FOR USE INTREATING CEREBRAL AMYLOIDANGIOPATHYWYETH LLC

18/04/200760/925228USPCT/US/2008/060926WO/2008/131298

)2010.01 (A61B20152809/04/2008

מערכת ושיטה לניטור ובקרת רמות אנליט בדם

DEVICE SYSTEM AND METHOD FORMONITORING AND CONTROLLINGBLOOD ANALYTE LEVELS

C.G.M.3מ"בע3.אם.י'ג.סי LTD19/04/200760/907845US29/11/200760/996676US


PCT/IL/2008/000488WO/2008/129532

)2010.01 (F03D20152915/04/2008

מ עגנרטור כח FLUIDי נוזל"ונע POWERED ENERGYGENERATORAEROKINETIC ENERGYCORPORATION

17/04/200760/912231USPCT/US/2008/060374WO/2008/130942

)2010.01 (H02K20153015/04/2008

ע FLUIDי נוזל"גנרטור המונע POWERED GENERATORAEROKINETIC ENERGYCORPORATION

17/04/200760/912227USPCT/US/2008/060371WO/2008/130942

)2010.01 (F24J20153115/04/2008

HELIOSTAT היליוסטס ומערכת AND SYSTEMBRIGHTSOURCE ENERGY, INC.

15/04/200760/911893USPCT/US/2008/060388WO/2008/128237

)2010.01 (C07D20153313/05/2008

2פארזין חדשים כאנטגוניסטים מלחי פיD/3 D

NOVEL PIPERAZINE SALTS AS D3/D2ANTAGONISTSRICHTER GEDEON NYRT.

11/05/2007P0700339HUPCT/HU/2008/000044


WO/2008/139235

)2010.01 (C07D20153415/05/2008

) תיאו(מטבוליטים של תולדות ציקלוהקסאן–קרבאמויל

METABOLITES OF (THIO)CARBAMOYL-CYCLHOXANEDERIVATIVESRICHTER GEDEON NYRT.

18/05/2007P0700353HUPCT/HU/2008/000046WO/2008/142461

)2010.01 (A61B20153521/04/2008

שיטה לקביעת רגישות לאינסולין וספיגת גלוקוזה

A METHOD FOR DETERMININGINSULIN SENSITIVITY ANDGLUCOSE ABSORPTIONVERIDEX, LLC

20/04/200760/912998US16/10/200760/980230US

PCT/US/2008/060993WO/2008/131324

)2010.01 (E04H20153615/04/2008

TELESCOPING תורן טלסקופי MASTFALCK SCHMIDT DEFENCE SYSTEMSA/S

16/04/2007PA200700552DKPCT/DK/2008/000133WO/2008/125110

)2010.01 (C07D20153708/05/2008


תולדות פיראזול מותמרות בהטרוארילשל–המשמשות לטיפול באי סדרים

התרבות יתר ומחלות הקשורות דם חדשים–להיווצרות כלי

HETEROARYL SUBSTITUTEDPYARZOLE DERIVATIVES USEFULFOR TREATING HYPER-PROLIFERATIVE DISORDERS ANDDISEASES ASSOCIATED WITHANGIOGENESISBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

18/05/200760/930816USPCT/EP/2008/003681WO/2008/141731

)2010.01 (A61F20153816/04/2008

INTERSPINOUS מרווח בין חוליות עמוד השדרה SPACERVERTIFLEX, INC.

16/04/200760/923841US17/04/200760/923971US

PCT/US/2008/004901WO/2008/130564

)2010.01 (A24D15392023/05/2008

PATTERNED נייר אריזה מעוצב עם גורם נגד קמטים WRAPPER PAPER WITHAN ANTI-WRINKLING AGENTPHILIP MORRIS PRODUCTS S.A.

24/05/200760/924666US25/05/200760/924676US01/06/200760/924825US28/06/200760/929452US29/08/200760/935751US05/03/200861/064438US

PCT/IB/2008/002399WO/2009/004482

)2010.01 (C02F20154026/07/2007

מערכת ושיטה לטיהור מים באמצעות שימוש באוגר סולרי

SYSTEM AND METHOD FOR WATERPURIFICATION USING A SOLARCOLLECTOR


TURK GESELLSCHAFT FURPRODUCKTMARKETING UNDWERBEMITTEL MBH,

03/05/2007102007020765.6DEPCT/DE/2007/001321WO/2008/134999

)2010.01 (C25B20154114/05/2008

אלקטרודה עבור תאי אלקטרוליזה ממברנים

ELECTRODE FOR MEMBRANEELECTROLYSIS CELLS

INDUSTRIE DE NORA S.P.A15/05/2007MI2007A000980IT

PCT/EP/2008/055887WO/2008/138945

)2010.01 (G06F20154202/06/2008

צבירה וחיפוש נתוני פרופיל משירותים רבים

AGGREGATING AND SEARCHINGPROFILE DATA FROM MULTIPLESERVICESMICROSOFT CORPORATION

21/06/200711/766363USPCT/US/2008/065475WO/2009/002658

)2010.01 (A24D20154329/05/2008

CRENELLATED נייר סיגריות מלוכד מחוזק BANDEDCIGARETTE PAPERPHILIP MORRIS PRODUCTS S.A.

01/06/200760/924825USPCT/IB/2008/002463WO/2008/146170

)2010.01 (B60K20154415/10/2009


A מערכת ושיטה להתנעת רכב VEHICULAR ACTIVATION SYSTEMAND METHOD

SHAI שי כהן COHEN

)2010.01 (G02B20154527/04/2008

מערכת הדמייה ושיטה לשימוש בניטור שדה התבוננות

IMAGING SYSTEM AND METHODFOR USE IN MONITORING A FIELDOF REGARD

בע.פי.וי.די .D.V.Pמ"טכנולוגיות TECHNOLOGIES LTD.19/04/2007182672IL28/02/2008189832IL

PCT/IL/2008/000554WO/2008/129552

)2010.01 (C07D20154625/08/2005

S–טריאזוליל מרקפטואצטאנילידים רברס טרנסקריפטאזHIVכמעכבי

S-TRIAZOLYL ?-MERCAPTOACETANILDES ASINHIBITORS OF HIV REVERSETRANSCRIPTASEARDEA BIOSCIENCES, INC.

25/08/200460/604219US25/08/200460/604220US31/05/200560/686351US

PCT/US/2005/030259WO/2006/026356

)2010.01 (C02F20154727/04/2008

FILTER אמצעי סינון MEDIUMH2Q WATER INDUSTRIES LTDH2Q WATER INDUSTRIES LTD.

18/04/200760/907817USPCT/IL/2008/000553WO/2008/129551


)2010.01 (G06T20154816/04/2008

METHOD שיטה ומערכת עבור שימוש בנפח AND SYSTEM FORVOLUME RENDERING

בע-קמרו CAMERO-TECHמ"טק LTD18/04/200711/785580US

PCT/IL/2008/000516WO/2008/129538

)2010.01 (G06E20154927/04/2008

METHOD שיטה ומערכת להדמייה דחוסה AND SYSTEM FORCOMPRESSED IMAGING

OPTICAL COMPRESSED SENSINGOPTICAL COMPRESSED SENSING24/04/200760/907943US

PCT/IL/2008/000555WO/2008/129553

)2010.01 (A61L20155017/04/2008

סטנטים בעלי שכבות שעוברות פירוק ביולוגי

STENTS HAVING BIODEGRADABLELAYERS

MICELL TECHNOLOGIES, INC.17/04/200760/912394US17/04/200760/912408US19/10/200760/981445US

PCT/US/2008/060671WO/2008/131131

)2010.01 (C07K20155217/04/2008

ILANTIBODIES–25נוגדנים נגד AGAINST IL-25MEDICAL המועצה למחקר רפואי RESEARCH COUNCIL

18/04/20070707505.4GB18/04/200760/912474US

PCT/GB/2008/001365WO/2008/129263


)2010.01 (H04W20155316/04/2008

TDOA–Uרשתות איתור אלחוטיות מפוזרות

SPARSED U-TDOA WIRELESSLOCATION NETWORKS

TRUEPOSITION, INC18/04/200711/736868US

PCT/US/2008/060507WO/2008/131020

)2010.01 (H04W20155416/04/2008

TDOA–Uרשתות איתור אלחוטיות מפוזרות



PCT/US/2008/060528WO/2008/131036

)2010.01 (H04W20155517/04/2008

TDOA–U רשתות איתור אלחוטיות מפוזרות



PCT/US/2008/060661WO/2008/131122

)2010.01 (H04W20155617/04/2008

TDOAרשתות איתור אלחוטיות – U מפוזרות



PCT/US/2008/060665WO/2008/131125


)2010.01 (A61K20155707/05/2007

צורות מינון מוצקות המכילות ציפויהמתפרק במעיים עם שחרור מואץ של

התרופה

SOLID DOSAGE FORMS COMPRISINGAN ENTERIC COATING WITHACCELERATED DRUG RELEASE

EVONIK ROHM GMBH

PCT/EP/2007/054398WO/2008/135090

)2010.01 (A61B20155816/04/2008

, מיפוי מבני ושיטות משוב כוחניות התקנים ומערכות

FRAME MAPPING AND FORCEFEEDBACK METHODS, DEVICESAND SYSTEMSNEUROARM SURGICAL LTD,

16/04/200760/912144USPCT/IB/2008/003363WO/2009/034477

)2010.01 (A61B20155916/04/2008

התקנים ומערכות עבור, שיטותו או תכנות/הגבלה שאינה מכאנית

תנועה של כלי של מניפולטור לאורך ציר יחיד

METHODS, DEVICES, AND SYSTEMS FORNON-MECHANICALLY RESTRICTINGAND/OR PROGRAMMING MOVEMENT OFA TOOL OF A MANIPULATOR ALONG ASINGLE AXISNEUROARM SURGICAL LTD,

16/04/200760/912146US16/04/2008PCT/IB2008/003351IB

PCT/IB/2008/003323WO/2009/037576

)2010.01 (G01S20156014/05/2008


שיטות והתקנים לבחירת מטרה מנתונים עוקב"מכ

METHODS AND APPARATUS FORSELECTING A TARGET FROMRADAR TRACKING DATARAYTHEON COMPANY

14/05/200760/917782USPCT/US/2008/063604WO/2009/023322

)2010.01 (B60N20156117/04/2008

מושב רכב להפחתת הסיכון של פגיעות ראש ושדרה של צוותי רכבים קרביים

VEHICLE SEAT FOR REDUCING THERISK OF SPINAL AND HEADINJURIES OF PERSONNEL INCOMBAT VEHICLESRONALD P. DELLANNO

19/04/200760/925346USPCT/US/2008/004981WO/2009/017523

)2010.01 (C07D20156214/05/2008

נגזרות ארילאמיד פירימידון לטיפול במחלות של התנוונות העצב

ARYLAMIDE PYRIMIDONEDERIVATIVES FOR THE TREATMENTOF NEURODEGENERATIVEDISEASESSANOFI-AVENTIS

16/05/200707290625.8EPPCT/IB/2008/002446WO/2008/155669

)2010.01 (A61K20156301/05/2008

פפטידים דרך ריריתתכשיר למתן פוליCOMPOSITION FORTRANSMUCOSAL DELIVERY OFPOLYPEPTIDESCEPHALON, INC.

01/05/200760/927006USPCT/US/2008/005655WO/2008/137054


)2010.01 (C07D20156401/05/2008

6Sמעכבי 70Pקינאז P70 S6 KINASE INHIBITORSELI LILLY AND COMPANY

11/05/200760/917331USPCT/US/2008/062143WO/2008/140947

)2010.01 (C07K20156504/06/2008

תרכובת של נוגדן מונוקלונאלי ראשון לאמסומן הנקשר לאנטיגן של גידול ונוגדן

NIRמונוקלונאלי שני המסומן עם סמן –פלואורסנטי שאינו עובר קרוס

ראקטיבציה

COMPOSITION OF A FIRST NON-LABELED MONOCLONALANTIBODY BINDING TO A TUMORANTIGEN AND A NON-CROSSREACTIVE SECOND MONOCLONALANTIBODY LABELED WITH A NIRFLUORESCENCE LABELF. HOFFMANN-LA ROCHE AG

06/06/200707011087.9EPPCT/EP/2008/004456WO/2008/148546

)2010.01 (C07D15662030/04/2008

הטארילאנילינים כמאפננים לאמילואיד בטא

HETARYLANILINES ASMODULATORS FOR AMYLOID BETA

F. HOFFMANN-LA ROCHE AG11/05/200707108004.8EP

PCT/EP/2008/055290WO/2008/138753

)2010.01 (C07D20156921/04/2008

פירידין קרבוקסאמיד–2תולדות כמודולטורים של תעלות נתרן

2-PYRIDINE CARBOXAMIDEDERIVATIVES AS SODIUM CHANNELMODULATORSPFIZER LIMITED


03/05/200760/915745US23/08/200760/957536US

PCT/IB/2008/001050WO/2008/135826

)2010.01 (A61K20157123/05/2008

תכשיר לשחרור מושהה המכיל תולדת סומאטוסטטין במיקרוחלקיקים

AN EXTENDED-RELEASECOMPOSITION COMPRISING ASOMATOSTATIN DERIVATIVE INMICROPARTICLESNOVARTIS AG

24/05/200707108796.9EPPCT/EP/2008/056347WO/2008/142153

)2010.01 (C07D20157206/05/2008

–אימידאזוקווינולינים עם מאפייני איפנון חיסוני

IMIDAZOQUINOLINES WITHIMMUNO-MODULATINGPROPERTIESDAINIPPON SUMITOMO PHARMACO. LTD.

08/05/200760/916586US31/01/200861/024957US

PCT/GB/2008/050328WO/2008/135791

)2010.01 (B23B20157314/04/2008

TOOL מערכת הנחתה למחזיק כלי HOLDER DAMPENINGSYSTEMHAROLD D. COOK

18/04/200711/787875US17/12/200712/002368US

PCT/US/2008/004771WO/2008/130521


)2010.01 (C23C20157418/04/2008

A כלי חיתוך מצופה ושיטה להכנתו COATED CUTTING TOOL ANDMETHOD OF PREPARING THE SAMESANDVIK I NTELLECTUALPROPERTY AB

18/04/20070700947-5SEPCT/SE/2008/050442WO/2008/130316

)2010.01 (G06K20157516/04/2008

התקנים ומערכות המתייחסים, שיטותלמצלמות המיועדות להתקנה בתוך קדח

אר.במגנט והארת חלל קדח אמ

METHODS, DEVICES, AND SYSTEMSRELATING TO CAMERASCONFIGURED TO BE POSITIONEDWITHIN THE BORE OF A MAGNETAND MR BORE SPACEILLUMINATIONNEUROARM SURGICAL LTD,

16/04/200760/912148USPCT/IB/2008/003669WO/2009/050589

)2010.01 (F02M20157616/04/2007

טה להפעלת מנוע התקן ושי, מערכת בעירה פנימית

SYSTEM, DEVICE AND METHODFOR OPERATION OF INTERNALCOMBUSTION ENGINE

ZION סעדי אילן BADASH

PCT/IL/2007/000479WO/2008/010201

)2010.01 (C12Q20157717/04/2008

MICROBIAL ניתוח אוכלוסיה מיקרוביאלית POPULATION ANALYSIS


VERENIGING VOOR CHRISTELIJKHOGER ONDERWIJS,WETENSCHAPPELIJK ONDERZOEKEN PATIENTENZORG

17/04/200707075289.4EPPCT/EP/2008/003200WO/2008/125365

)2010.01 (A61B20157816/04/2008

התקנים ומערכות לשימוש, שיטות ברישומים

METHODS, DEVICES, AND SYSTEMSUSEFUL IN REGISTRATION

NEUROARM SURGICAL LTD,16/04/200760/912140US17/04/200760/912169US

PCT/IB/2008/003353WO/2009/040677

)2010.01 (A61N20157927/04/2008

תהליך ומוצר לגירוי העצב והשריר ולטיפול בכאב

METHOD AND APPARATUS FORNERVE AND MUSCLE STIMULATIONAND PAIN TREATMENT

PAINLESSמ"פיינלס טכנולוגיה רפואית בע LTD.19/04/200760/912797US

PCT/IL/2008/000557WO/2008/129555

)2010.01 (G06F20158015/05/2008

ומערכת לארגון של בסיס נתונים שיטה תמונות–מבוסס

A METHOD AND SYSTEM FORORGANIZING AN LMAGE BASEDDATABASE

SUPERFISHמ"סופרפיש בע LTD17/05/200760/938482US

PCT/IL/2008/000672WO/2008/142675


)2010.01 (A61K20158117/04/2008

תערובות פרמצבטיות המכילות נגזרות של חומצת שומן

PHARMACEUTICAL FORMULATIONSCONTAINING LIPOIC ACIDDERIVATIVESCORNERSTONEPHARMACEUTICALS, INC.

18/04/200760/912605USPCT/US/2008/060650WO/2008/131114

)2010.01 (A61M20158217/04/2008

CONTAINER מיכל עבור מזרק אוטומטי FOR AN AUTOMATICINJECTORMERIDIAN MEDICALTECHNOLOGIES, INC.

18/04/200760/925283USPCT/US/2008/004936WO/2008/130583

)2010.01 (A61M20158327/03/2008

מזרק לשימוש חד פעמי המכיל לפחותוו שאיבה אחד ותמסורת קונית הנעה

לשם פתיחת אלמנט הנעילה

DISPOSABLE INJECTOR COMPRISINGAT LEAST ONE DRAW HOOK AND ASLIDING WEDGE-TYPE GEAR FORUNLOCKING A LOCKING ELEMENTLTS-LOHMANN THERAPIE-SYSTEMEAG

19/04/2007102007018868.6DEPCT/EP/2008/002391WO/2008/128615

)2010.01 (A61K20158617/02/2003

סינתזה מבוקרת של זיפרסידון ותכשירים שלו

CONTROLLED SYNTHESIS OFZIPRASIDONE AND COMPOSITIONSTHEREOF


PFIZER PRODUCTS, INC.20/02/200260/358806US21/02/200260/359038US27/02/200260/360459US

PCT/IB/2003/000642WO/2003/070246

)2010.01 (A47F20158715/10/2009

A ערכה למתקן תליית כביסה KIT FOR CLOTHESLINE DEVICEBARZILY ברזילי אברהם מאיה AVRAHAM MAYA

)2010.01 (H05B20158823/04/2008

MULTIPLE מערכת בקרת העמסה רב מקומית LOCATION LOADCONTROL SYSTEMLUTRON ELECTRONICS CO., INC.

23/04/200760/925782US21/12/200761/016027US21/04/200812/106614US

PCT/US/2008/005187WO/2008/133879

)2010.01 (G06F20158907/04/2008

שיטה והתקן להגנת מידע על מנעולבהתקן)SIMLOCK(מודול זיהוי מנוי

אלקטרוני

METHOD AND APPARATUS FORPROTECTING SIMLOCKINFORMATION IN AN ELECTRONICDEVICETELEFONAKTIEBOLAGET LMERICSSON (PUBL)

20/04/200760/913102US21/12/200711/962356US

PCT/EP/2008/054138WO/2008/128875


)2010.01 (A61L20159002/02/2006

ARTICLE התקן לעיבוד פריטים ושיטות נילוות PROCESSING APPARATUSAND RELATED METHODSBIODEFENSE CORPORATION

04/02/200511/050651USPCT/US/2006/003568WO/2006/083967

)2010.01 (F16K20159112/04/2005

FLUID שיטה לסניקת ניגרים DELIVERY VALVE METHODHYDROPAC/LAB PRODUCTS, INC.

13/04/200410/824224USPCT/US/2005/012263WO/2005/099446

)2010.01 (C12Q20159218/04/2008

STABLE רקומביננט אדנוסין דיאמונז יציב RECOMBINANT ADENOSINEDEAMINASEENZON PHARMACEUTICALS, INC.

20/04/200760/913009USPCT/US/2008/060805WO/2008/131208

)2010.01 (C12Q20159318/04/2008

תכשירים המכילים אדנוסין דיאמינז לשימוש בטיפול בגידולים

COMPOSITIONS COMPRISINGADENOSINE DEAMINASE FOR USEIN TREATING TUMORSENZON PHARMACEUTICALS, INC.

20/04/200760/913039USPCT/US/2008/060733WO/2008/131163


)2010.01 (A47D20159418/10/2009

CUPBOARD ארן עם מדפים נעים WITH ADJUSTABLESHELFS

MEIRAV מירב זהבי ZEHAVI

)2010.01 (A61B20159516/04/2008

התקנים להשקה בין מניפולטורים למכשירים כירורגיים

DEVICES FOR INTERFACINGBETWEEN MANIPULATORS ANDSURGICAL TOOLSNEUROARM SURGICAL LTD,

16/04/200760/912153USPCT/IB/2008/003465WO/2009/027848

)2010.01 (H04Q20159630/04/2008

WIRELESS מערכת תקשורת אלחוטי COMMUNICATIONSYSTEM

VISONICמ"ויסוניק בע LTD.02/05/200760/927506US

PCT/IL/2008/000581WO/2008/135975

)2010.01 (C07D20159725/04/2008

BYCYCLIC צקלית ושימושה הפרמצבטי–תרכובת דו COMPOUND ANDPHARMACEUTICAL USE THEREOFTAKEDA PHARMACEUTICALCOMPANY LIMITED

26/04/20072007-117676

JP

PCT/JP/2008/058020


WO/2008/136382

)2010.01 (E04H20159818/10/2009

מערכות קבורה ושיטות לבנייתןBURIAL SYSTEMS ANDCONSTRUCTION METHODSTHEREFOR

WOLFMANמ"וולפמן תעשיות בע INDUSTRIES LTD

)2010.01 (G01S20159921/04/2008

CURVED מתקן ושיטות למערך חיישן מעוקם SENSOR ARRAYAPPARATUS AND METHODSLUCID DIMENSIONS, LLC

20/04/200760/925512US28/02/200861/067420US

PCT/US/2008/005129WO/2009/017524

)2009.01 (C12N20160027/04/2008

תאי פיגמנט אפיתליילים של הרטינה הממויינים מתאי גזע

STEM CELL-DERIVED RETINALPIGMENT EPITHELIAL CELLS

HADASITמ"הדסית שירותי מחקר רפואי ופיתוח בע MEDICAL RESEARCHSERVICES AND DEVELOPMENT LTD

18/04/200760/907818USPCT/IL/2008/000556WO/2008/129554

)2010.01 (C07K20160117/04/2008

נוגדנים מונוקלוניים חדשים ממקור אנושי במלואם

VAP–1נגד

NOVEL FULLY HUMAN ANTI-VAP-1MONOCLONAL ANTIBODIES


BIOTIE THERAPIES CORPORATION20/04/200720075278FI20/04/200760/907904US

PCT/FI/2008/050199WO/2008/129124

)2010.01 (A61B20160216/04/2008

חוסם עורקים כירורגי הניתן להתאמה ושיטה

ADAPTIVE SURGICAL TOURNIQUETAPPARATUS AND METHODWESTERN CLINICAL ENGINEERINGLTD

19/04/200711/737258USPCT/CA/2008/000718WO/2008/128332

)2010.01 (C07D20160314/04/2008

ורות גבישיות של טופוטקאןצ הידרוכלוריד ותהליכים לייצורן

CRYSTALLINE FORMS OFTOPOTECAN HYDROCHLORIDE ANDPROCESSES FOR MAKING THE SAMESCINOPHARM TAIWAN, LTD

19/04/200760/925280USPCT/US/2008/004840WO/2008/130534

)2010.01 (H01L20160417/04/2008

THIN-FILM וולטאי משכבה דקה–פוטו–תא PVNANOCO TECHNOLOGIES LIMITED

18/04/200760/923984US30/11/200760/991510US01/12/20070723539.3GB

PCT/GB/2008/001349WO/2008/129250


)2010.01 (A61B20160516/04/2008

התקנים ומערכות להנעה, שיטות אוטומאטית המערבת רובוטים רפואיים

METHODS, DEVICES AND SYSTEMSFOR AUTOMATED MOVEMENTSINVOLVING MEDICAL ROBOTSNEUROARM SURGICAL LTD,

16/04/200760/912142USPCT/IB/2008/003351WO/2009/044287

)2010.01 (H04M20160721/04/2008

COMMUNICATIONמערכת תקשורת עבור אנשים לקויי דיבור SYSTEM FORSPEECH DISABLED INDIVIDUALSO'BRIEN TECHNOLOGIES, INC.

19/04/200760/907857USPCT/US/2008/061069WO/2008/131365

)2010.01 (F16L20160818/04/2008

CONNECTOR מחברDESIGN TECHNOLOGY ANDINNOVATION LIMITED

18/04/20070707438.8GBPCT/GB/2008/001363WO/2008/129261

)2010.01 (G09B20160917/04/2008

ת ממוחשבת שיטה ומערכת לפרסומ בשירות עצמי

SELF SERVICE ADVERTISINGMETHOD AND SYSTEM

YITSHAK יצחק בראשי 90% BARASHI19/04/2007IL182702IL

PCT/IL/2008/000533WO/2008/129543


)2010.01 (F01D20161018/10/2009

USE שימוש בגזים חמים ומתקנים OF HOT GASES AND DEVICESISRAEL ישראל הירשברג HIRSHBERG

)2010.01 (A01N20161117/04/2008

LIPOIC חומצה ליפואית תולדות ACID DERIVATIVESCORNERSTONEPHARMACEUTICALS, INC.

18/04/200760/912598USPCT/US/2008/060655WO/2008/131117

)2010.01 (G01S20161203/03/2008

METHOD שיטה לקביעה פסיבית של נתוני מטרה FOR PASSIVEDETERMINATION OF TARGET DATAATLAS ELEKTRONIK GMBH

25/04/2007102007019444.9DEPCT/EP/2008/001651WO/2008/131824

)2010.01 (G06M20161321/04/2008

METHODS שיטות לספירת תאים FOR COUNTING CELLSTHE GENERAL HOSPITALCORPORATION

20/04/200760/925368USPCT/US/2008/005066WO/2008/130655

)2010.01 (E05B20161419/10/2009


CYLINDER מערכת הגנה למנעול צילינדר LOCK PROTECTIVESYSTEM

MOSHE משה אהרון AHARON

)2010.01 (C07C20161514/05/2008

METHOD שיטה להכנת תרכובת בנזאלדאיד FOR PRODUCINGBENZALDEHYDE COMPOUNDSUMITOMO CHEMICAL COMPANY,LIMITED

22/05/20072007-135064

JP

PCT/JP/2008/059288WO/2008/143264

)2010.01 (B32B20161625/04/2008

בעדיפות לאריזת, שכבתי גמיש–חומר רבושיטה לייצור אריזה, בלון שניתן לנפח

לניפוח

FLEXIBLE MULTI-LAYERMATERIAL, PREFERABLY FOR ANINFLATABLE BALLOON CASING,AND METHOD FOR THEPRODUCTION OF AN INFLATABLECASINGALAVI , KAMAL

28/04/200700702/07CHPCT/EP/2008/003347WO/2008/131916

)2010.01 (A01C20161824/04/2008

AN מתקן השקייה IRRIGATION DEVICEH2OPTIFLOW LIMITED

24/04/20070707932.0GBPCT/GB/2008/001475WO/2008/129310


)2010.01 (A45D20161919/10/2009

שיטה ומערכת לחימום אוזניים באביזרי ראש ומערכת ווקאלית

METHOD AND SYSTEM FOR EARSHEATING INTEGRATED WITH HEADACCESSORIES COMBINED WITHVOCAL SYSTEM

AVIRAM אבירם קליך KELICH

)2010.01 (C07D20162009/04/2008

ד קרבוקסאמי–נגזרות קווינולין12Yכאנטגוניסים של 2P

QUINOLINE-CARBOXAMIDEDERIVATIVES AS P2Y12ANTAGONISTSSANOFI AVENTIS

23/04/200707008209.4EPPCT/EP/2008/002790WO/2008/128647

)2010.01 (A23G20162118/04/2008

תהליך לריסוס שכבה המכילה שומן וסוכר על פני מוצר אכיל

PROCESS FOR SPRAYING A LAYERCONTAINING FAT AND SUGAR ON ASURFACE OF AN EDIBLE PRODUCTGENERALE BISCUIT

24/04/200707290506.0EPPCT/IB/2008/001226WO/2008/129417

)2010.01 (C12Q20162230/04/2008

INSECT צמח עמיד לחרק RESISTANT PLANTSYNGENTA PARTICIPATIONS AG

02/05/200707290556.5EP30/10/200707119649.7EP


PCT/EP/2008/055374WO/2008/135510

)2010.01 (C07D20162306/06/2008

אמינו–פירימידיניל–תולדות הטרוציקליל קוטלות פטריות

FUNGICIDE HETEROCYCLYL-PYRIMIDINYL-AMINO DERIVATIVES

BAYER CROPSCIENCE SA08/06/200707356077.3EP

PCT/EP/2008/057126WO/2008/148889

)2010.01 (H04L20162415/05/2008

ENHANCED אות ניסוי משופר PILOT SIGNALQUALCOMM INCORPORATED

08/05/200760/939035US05/10/200760/978068US18/12/200761/014706US21/12/200761/016101US21/03/200861/038660US01/05/200812/113810US01/05/200812/113900US01/05/200812/113903US

PCT/US/2008/063800WO/2008/144450

)2010.01 (C07D20162514/05/2008

ARYLAMIDE תרכובות ארילאמיד פירימידון PYRIMIDONECOMPOUNDSSANOFI-AVENTIS

16/05/200707290626.6EPPCT/IB/2008/002458WO/2008/155670


)2010.01 (C07D20162702/05/2008

וR(–2–(שיטות להכנת –(–מתילפירולידין2–)Sמתילפירולידין ומלחי טרטרט שלהם

PROCESSES FOR PREPARING (R)-2-METHYLPYRROLIDINE AND (S)-2- METHYLPYRROLIDINE ANDTARTRATE SALTS THEREOFCEPHALON, INC.

03/05/200760/927356USPCT/US/2008/005702WO/2008/137087

)2010.01 (A61B20163015/04/2008

שיטה ומערכת לחיזוי פעילות חשמלית ללא דופק

METHOD, APPARATUS AND SYSTEMFOR PREDICTINGELECTROMECHANICALDISSOCIATIONCHEETAH MEDICAL LTD

19/04/200760/907847US13/08/200711/889395US

PCT/IL/2008/000509WO/2008/129535

)2010.01 (H04R20163118/04/2008

מערכת למיקום אולטרה סוני עם תפקודיות קולית

VOICE AND POSTITIONLOCALIZATION

EPOSמ"אפוס פיתוח בע DEVELOPMENT LTD19/04/200760/907846US

PCT/EP/2008/054721WO/2008/128989

)2010.01 (A61K20163216/04/2008

שירים המכילים פורמוטרול שימוש בתכו או/ובקלומטאזון דיפרופיונאט למניעה

טיפול בהחמרה של אסטמה

USE OF A COMPOSITIONCOMPRISING FORMOTEROL ANDBECLOMETASONE DIPROPIONATEFOR THE PREVENTION AND/ORTREATMENT OF AN EXACERBATIONOF ASTHMA


CHIESI FARMACEUTICI S.P.A.19/04/200707007930.6EP

PCT/EP/2008/003012WO/2008/128685

)2010.01 (H05K20163320/05/2008

שיטה לייצור מוצרים מורכבים מרבדים המצופים במתכת

METHOD FOR THE PRODUCTION OFMETAL-COATED BASE LAMINATES

BASF SE24/05/200707108827.2EP

PCT/EP/2008/056146WO/2008/142064

)2010.01 (A24D20163427/06/2008

PATTERNED נייר אריזה מעוצב עם רמת גיר גבוהה WRAPPAR PAPER WITHELEVATED CHALK LEVELPHILIP MORRIS PRODUCTS S.A.

28/06/200760/929452USPCT/IB/2008/002635WO/2009/001223

)2010.01 (A61K20163524/04/2008

פות ושיטות לטיפול במחלה תרו אוטואימונית וסרטן

MEDICAMENTS AND METHODS TOTREAT AUTOIMMUNE DISEASE ANDCANCERDIAMY D THERAPEUTICS AB

24/04/200760/926121US13/09/200760/993640US

PCT/IB/2008/001830WO/2008/129426

)2010.01 (C07C20163605/05/2007


תהליך עבור דיספרופורציונאציה ארומטית ברירתית עם המרה מוגברת

PROCESS FOR SELECTIVEAROMATICS DISPROPORTIONATIONWITH INCREASED CONVERSIONUOP LLC

PCT/US/2007/068310WO/2008/136829

)2010.01 (C12N20163725/06/2008

CHOCHOתא CELLF. HOFFMANN-LA ROCHE AG

29/06/200707012773.3EPPCT/EP/2008/005134WO/2009/003621

)2010.01 (C12Q20163802/10/2003

המכילה, פרוטיאזה שעברה שינוי, מוטציות בפיגום של פרוטיאזה טבעי

ושימוש בה

MODIFIED PROTEASE COMPRISINGMUTATIONS IN A WILDTYPEPROTEASE SCAFFOLD AND USETHEREOF

THE REGENTS OF THE UNIVERSITYOF CALIFORNIA

02/10/200560/415388USPCT/US/2003/031719WO/2004/031733

)2010.01 (C07C20163924/01/2003

ה יפנוטיים חומרי ביניים להכנת גורמים משככים לטווח קצר

INTERMEDIATES FOR PREPARATIONOF SHORT-ACTING SEDATIVEHYPNOTIC AGENTSTHERAVANCE, INC.

25/01/200260/351385US09/05/200260/379219US

PCT/US/2003/002227WO/2004/037750


)2010.01 (C07K20164030/04/2008

קולטנים מסיסים וחלבוני קישור ששונו בגליקן והשימוש בהם

GLYCAN MODIFIED SOLUBLERECEPTORS AND BINDINGPROTEINS AND THEIR USE

YEDAמ"ידע חברה למחקר ופיתוח בע RESEARCH ANDDEVELOPMENT CO. LTD

03/05/2007182956ILPCT/IL/2008/000574WO/2008/135972

)2010.01 (C12N20164222/11/2001

נגיף ואוקסיניה אנקרה משתנה שעבר שינוי

MODIFIED VACCINIA ANKARA VIRUSVARIANT

BAVARIAN N ORDIC A/S23/11/2000PA200001764DK

PCT/EP/2001/013628WO/2002/042480

)2010.01 (A24D20164322/05/2008

PRINTING תהליך הדפסה עבור נייר עטיפה מעוצב PROCESS FORPATTERNED WRAPPER PAPERPHILIP MORRIS PRODUCTS S.A.

25/05/200760/924676USPCT/IB/2008/001839WO/2008/146158

)2010.01 (H01L20164417/04/2008

כגון לוח מבנה נשיאה עבור לוחפוטואלקטרי וקיר חיצוני לבנין הכולל

מבנה כזה

BEARING FRAME FOR A PANELSUCH AS A PHOTOELECTRIC PANELAND BUILDING EXTERNAL WALLINCLUDING SUCH FRAMESOLARTE

20/04/20070754611FR


PCT/FR/2008/050689WO/2008/145903

)2010.01 (H01L20164517/04/2008

מבנה נשיאה עבור לוח פעיל מבחינה חשמלית כגון לוח פוטואלקטרי

BEARING FRAME FOR ANELECTRICALLY ACTIVE PANELSUCH AS PHOTOVOLTAIC PANELSOLARTE

20/04/20070754616FRPCT/FR/2008/050681WO/2008/145898

)2010.01 (H01L20164618/04/2008

מבנה להרכבה על מסגרות קיר בנין להחזקת לוחות כגון לוחות פוטואלקטרים

STRUCTURE FOR MOUNTING ON ABUILDING WALL FRAMES FORHOLDING PANELS SUCH ASPHOTOVOLTAIC PANELSSOLARTE

20/04/20070754606FRPCT/FR/2008/050699WO/2008/145913

)2010.01 (H04R20164717/04/2008

SOUNDלמתמר קו TRANSDUCERSWING S.R.L.

20/04/2007TV2007A000070ITPCT/EP/2008/054674WO/2008/128966

)2010.01 (H04L20164819/04/2008


שיטה ומערכת לציון חסימת זרימה זמניתחוסר/מצעות שימוש בשדה אישורבא

PIGGYBACKEDאישור מסוג

METHOD AND APPARATUS FORINDICATING A TEMPORARY BLOCKFLOW USING A PIGGYBACKEDACK/NACK FIELDINTERDIGITAL TECHNOLOGYCORPORATION

20/04/200760/913179US21/09/200760/974293US23/10/200760/981980US

PCT/US/2008/005122WO/2008/130694

)2010.01 (A61K20165018/04/2008

מעכבי קינאז המשמשים לטיפול במחלותשל ריבוי מרכיבי מח עצם ומחלות שגשוג

נוספות

KINASE INHIBITORS USEFUL FORTHE TREATMENT OFMYLEOPROLIFERATIVE DISEASESAND OTHER PROLIFERATIVEDISEASESDECIPHERA PHARMACEUTICALS,LLC

20/04/200760/913216USPCT/US/2008/060833WO/2008/131227

)2010.01 (A61F20165128/04/2008

התקנים תומכים פעילים והניתנים להתאמה

DYNAMIC AND ADJUSTABLESUPPORT DEVICESTHE BOARD OF TRUSTEES OF THELELAND STANFORD JUNIORUNIVERSITY

28/04/200760/926561USPCT/US/2008/005488WO/2008/134064

)2010.01 (G10L20165219/05/2008

PERSONALITY-BASED התקן המבוסס על אישיות DEVICEMICROSOFT CORPORATION


24/05/200711/752989USPCT/US/2008/064151WO/2008/147755

)2010.01 (F16L20165320/10/2009

בסיס להב מאוורר אוניברסאלי ומאוורר תקרה הכולל אותו

UNIVERSAL FAN BLADE MOUNTAND CEILING FAN EMPLOYINGSAME

YUVAL יובל גורלי GORALI24/10/200861/108228US

)2010.01 (C01B20165417/04/2008

שיטה והתקן לייצור גז מנוזל מיימי והתוצר של השיטה

METHOD FOR MAKING A GAS FROMAN AQUEOUS FLUID, PRODUCT OFTHE METHOD, AND APPARATUSTHEREFORLSG PARTNERS, LLC

21/04/200711/738476USPCT/US/2008/060666WO/2008/131126

)2010.01 (F24J20165503/04/2008

DEVICE התקן להרכבת יחידות סולריות FOR MOUNTING SOLARMODULESHATICON GMBH

23/04/2007102007020234.4DE23/04/2007102007006153.6DE

PCT/DE/2008/000590WO/2008/128506

)2010.01 (H04B20165602/05/2008


שיטה והתקן לשידור וקליטת ערוציבקרה על ידי צמצום מערך ערוצי

הבקרה במערכת תקשורת אלחוטית

METHOD AND APPARATUS FORTRANSMITTING AND RECEIVINGCONTROL CHANNELS BYRESTRICTING A SET OF THE CONTROLCHANNELS IN A WIRELESSCOMMUNICATION SYSTEMSAMSUNG ELECTRONICS CO, LTD.

02/05/20071020070042817KR07/08/20071020070079269KR

PCT/KR/2008/002507WO/2008/136616

)2010.01 (G01N20165703/06/2008

חיישן מבוסס על סריג המשלב גילויקישור ללא סימון והגברת

ומערכת לחיישן, אורסנטציותפלו

GRATING-BASED SENSORCOMBINING LABEL-FREE BINDINGDETECTION AND FLUORESCENCEAMPLIFICATION AND READOUTSYSTEM FOR SENSORSRU BIOSYSTEMS, INC.

15/06/200711/818742USPCT/US/2008/007031WO/2008/156560

)2010.01 (C07D20165809/12/2002

חלקיקי של אנטגוניסט–הרכב רוקחי נאנו לרצפטור הקושר תכיקינין

PHARMACEUTICALNANOPARTICULATE COMPOSITIONOF A TACHYKININ RECEPTORANTAGONISTMERCK SHARP & DOHME CORP.

10/12/200160/340040USPCT/US/2002/041655WO/2003/049718

)2010.01 (C07D20165909/04/2004

CGRPCGRPאנטגוניסטים של רצפטור הקושר RECEPTOR ANTAGONISTSMERCK SHARP & DOHME CORP.


15/04/200360/463089US10/10/200360/510352US

PCT/US/2004/011280WO/2004/092168

)2010.01 (B60K20166021/10/2009

BIDIRECTIONAL מקריןכיווני–מחוון דו PROJECTING GAUGEGONTMACHER גונטמאכר אלכסנדר ALEXANDER

18/10/20090000000000000IL

)2010.01 (C07D20166118/04/2008

ירות זולים כמפרידים במה) דיא(תיא2אנטגוניסטים לקולטן דופאמין

THIA(DIA) ZOLES AS FASTDISSOCIATING DOPAMINE 2RECEPTOR ANTAGONISTS

JANSSEN PHARMACEUTICA, N.V.23/04/200707106706.0EP

PCT/EP/2008/054732WO/2008/128996

)2010.01 (C07D20166218/04/2008

תולדות פירידין כמפרידות במהירות2אנטגוניסטים של קולטן דופאמין

PYRIDINE DERIVATIVES AS FASTDISSOCIATING DOPAMINE 2RECEPTOR ANTAGONISTS

JANSSEN PHARMACEUTICA, N.V.23/04/200707106702.9EP

PCT/EP/2008/054730WO/2008/128994

)2010.01 (C07D20166318/04/2008


אלקוקסיפירידזין כמפרידות–4תולדותבמהירות אנטגוניסטים של קולטן דופאמין

2

4-ALKOXYPYRIDAZINEDERIVATIVES AS FASTDISSOCIATING DOPAMINE 2RECEPTOR ANTAGONISTSJANSSEN PHARMACEUTICA, N.V.

23/04/200707106704.5EPPCT/EP/2008/054731WO/2008/128995

)2010.01 (A61K20166421/04/2008

TAPENTADOL טפנתדול לטיפול בכאב מדלקת פרקים FOR TREATING PAINFROM ARTHRITISGRUNENTHAL GMBH

23/04/2007102007019417.1DEPCT/EP/2008/003177WO/2008/128739

)2010.01 (G09B20166514/04/2008

EDUCATIONAL ציוד חינוכי עם קונפיגורציות רבות EQUIPMENT WITHMULTIPLE CONFIGURATIONSJEAN-LOUP DRUON

26/04/20070703040FRPCT/FR/2008/000520WO/2008/142292

)2010.01 (C07K20166627/05/2008

לטיפול18CLDשבטיים נגד–נוגדנים חד בסרטן

MONOCLONAL ANTIBODIESAGAINST CLAUDIN-18 FORTREATMENT OF CANCERJOHANNES GUTENBERG-UNIVERSITAT MAINZ OF

29/05/200707010622.4EP29/05/200760/932099US

PCT/EP/2008/004197WO/2008/145338


)2010.01 (G06Q20166711/06/2008

) תנועתי(בחירת מהלך מלחמתי באמצעות מודעות למצבים

COMBAT ACTION SELECTION USINGSITUATIONAL AWARENESS

MICROSOFT CORPORATION21/06/200711/820968US

PCT/US/2008/066532WO/2009/002706

)2010.01 (F16L20166814/05/2008

מצמד צינורות בעל יכולת אחיזת גופים נעה

PIPE COUPLING HAVING MOVABLEGRIPPING BODIES

VICTAULIC COMPANY15/05/200760/938003US

PCT/US/2008/063587WO/2008/144332

)2010.01 (C07D20166920/06/2008

קטילת תרכובות פיפראזין עם פעילות של עשבים

PIPERAZINE COMPOUNDS WITHHERBICIDAL ACTION

BASF SE22/06/200707110913.6EP

PCT/EP/2008/057830WO/2009/000757

)2010.01 (C07D20167023/06/2008

–ציאנו–5–אמינו–2ת נגזרות שיטה להכנ חומצה בנזואית

PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACIDDERIVATIVESE.I. DU PONT DE NEMOURS ANDCOMPANY,INC.

29/06/200760/937815USPCT/US/2008/067826WO/2009/006061


)2010.01 (C07D20167120/06/2008

חוליות–גורמים להדברת מזיקים חסרי מבוססים על נפתאלן איזוקסאלין

NAPHTHALENE ISOXAZOLINEINVERTEBRATE PEST CONTROLAGENTSE.I. DU PONT DE NEMOURS ANDCOMPANY,INC.

26/06/200760/937285USPCT/US/2008/067576WO/2009/002809

)2010.01 (H01L20167219/02/2008

תמיסה לפלנריזצית פוליסיליקון עבורפלנריזציה בטמפרטורה נמוכה של

שכבה מפוליסיליקון–פאנלים דקי

POLYSILICON PLANARIZATIONSOLUTION FOR PLANARIZING LOWTEMPERATURE POLYSILICON THINFILM PANELSMAL LINCKRODT BAKER, INC.

26/04/200760/914105USPCT/US/2008/002169WO/2008/133767

)2010.01 (C07K20167329/10/2002

שיטות ואמצעים להפקת חלבוניםבאמצעות שינויים שלאחר תרגום

הקבועים מראש

METHODS AND MEANS FORPRODUCING PROTEINS WITHPREDETERMINED POST-TRANSLATIONAL MODIFICATIONSCRUCELL HOLLAND B.V.

29/10/2001PCT/NL01/00792NL19/04/2002PCT/NL02/00257NL

PCT/NL/2002/000686WO/2003/038100

)2010.01 (C07K20167429/10/2002


שיטות ואמצעים להפקת חלבוניםבאמצעות שינויים שלאחר תרגום

הקבועים מראש

METHODS AND MEANS FORPRODUCING PROTEINS WITHPREDETERMINED POST-TRANSLATIONAL MODIFICATIONSCRUCELL HOLLAND B.V.

29/10/2001PCT/NL01/00792NL19/04/2002PCT/NL02/00257NL

PCT/NL/2002/000686WO/2003/038100

)2010.01 (G07B20167522/10/2009

A קופה רושמת ושיטה עבורה CASH REGISTER AND METHODTHEREFOR

ALON אלון שרעבי SHARABI

)2010.01 (A61K20167627/04/2008

ORAL פפטידים וחלבונים למתן דרך הפה DELIVERY OF PROTEINS ANDPEPTIDES


26/04/200760/914134USPCT/IL/2008/000539WO/2008/132727

)2010.01 (G01N20167705/05/2008

זיהוי אנטיגן המבוסס על מספר רב של אימונואפיניות

MULTI-IMMUNOAFFINITY BASEDANTIGEN IDENTIFICATION

BIOSYSTEMS INTERNATIONAL SAS04/05/200760/915941US

PCT/EP/2008/055492WO/2008/135553


)2010.01 (G01N20167805/06/2008

7(7שימוש בפיברובלסט פקטור גדילהFGF(ובקולטןB 2 FR G Fכסמנים

ביולוגיים

USE OF FIBROBLAST GROWTH FACTOR7 (FGF7) AND OF THE RECEPTORFGFR2B AS BIOMARKERS

BAYER SCHERING PHARMAAKTIENGESELLSCHAFT

08/06/2007102007026877.9DE15/06/200760/944153US

PCT/EP/2008/004675WO/2008/148582

)2010.01 (A61K20167923/04/2008

הנגזרים מתאי ברווז שורות תאי גזע עובריים לייצור חיסונים ויראליים

DUCK EMBRYONIC DERIVED STEMCELL LINES FOR THE PRODUCTIONOF VIRAL VACCINESVIVALIS

24/04/200707300979.7EPPCT/EP/2008/054912WO/2008/129058

)2010.01 (A61J20168327/04/2008

שיטה ומכשיר להעברה נקייה מזיהום של סם רעיל

METHOD AND APPARATUS FORCONTAMINATION-FREE TRANSFEROF A HAZARDOUS DRUG

PLASTMEDמ"פלאסטמד בע LTD.23/04/2007182743IL18/02/2008189584IL

PCT/IL/2008/000550WO/2008/129550

)2010.01 (G09B20168422/10/2009

SOUND מערכת קול וראייה לקהל AND VISION SYSTEM FORAUDIENCE


SHABTAI שבתאי לוי LEVY

)2010.01 (A61P20168520/05/2008

4CXCRCYCLICפפטיד ציקלי כאנטגוניסטים של PEPTIDE CXCR4ANTAGONISTSELI LILLY AND COMPANY

30/05/200760/940802US31/05/200760/940996US

PCT/US/2008/064177WO/2008/150689

)2010.01 (C07D20168613/05/2008

דיהידרוקווינוןJNKמעכבי ודיהידרונפתרידין

DIHYDROQUINONE ANDDIHYDRONAPHTHRIDINEINHIBITORS OF JNKF. HOFFMANN-LA ROCHE AG

14/05/200760/930054USPCT/EP/2008/055807WO/2008/138920

)2010.01 (A61B20168723/04/2008

SYSTEM מערכת ושיטה לניטור לב AND METHOD FOR HEARTMONITORINGLIFESCIENCE SOLUTIONS, LLC

23/04/200711/738962USPCT/US/2008/061260WO/2008/131413

)2010.01 (C07D20168825/04/2008


מושים ושי1TRPVאנטגוניסטים של שלהם

TRPV1 ANTAGONISTS AND USESTHEREOF

SHIONOGI & CO., LTD.27/04/200760/926661US11/05/200760/930036US21/06/200760/937003US27/07/200760/962409US

PCT/IB/2008/001069WO/2008/132600

)2010.01 (A61K20168905/05/2008

חלקיקי שחרור מבוקר המבוססים עלפוליאלקטרוליטים ועל חומר פעיל

ותכשירים רפואיים המכילים חלקיקים אלו

MODIFIED-RELEASE PARTICLESBASED ON POLYELECTROLYTESAND ON AN ACTIVE PRINCIPLE ANDPHARMACEUTICAL FORMULATIONSCONTAINING THESE PARTICLESFLAMEL TECHNOLOGIES

03/05/20070703187FRPCT/EP/2008/055505WO/2008/135561

)2010.01 (A61K20169021/05/2008

לטיפול בסרטן של בלוטתRAFמעכבי התריס

RAF INHIBITORS FOR THETREATMENT OF THYROID CANCER

NOVARTIS AG23/05/200760/939625US

PCT/US/2008/064280WO/2008/147782

)2010.01 (C07D20169102/05/2008

–2–פורינ–H9–)יל–3–פיראזול(–9תולדותו אימידאזו–H3–)יל–3–פיראזול(–3–אמין

]4,5–B[אמין ושימושן לטיפול–5–פירידינ בסרטן

9-(PYRAZOL-3-YL)-9H-PURINE-2-AMINE AND 3-(PYRAZOL-3-YL)-3H-IMIDAZO [4,5-B]PYRIDIN-5-AMINEDERIVATIVES AND THEIR USE FORTHE TREATMENT OF CANCERASTRAZENECA AB


04/05/200760/916270USPCT/GB/2008/050321WO/2008/135785

)2010.01 (H04L20169211/03/2008

WIRELESS רחב אלחוטית–טיפול ברשת פס BROADBAND NETWORKMANAGEMENTUBO WIRELESS PTY LIMITED

30/04/20072007202006AUPCT/AU/2008/000330WO/2008/131473

)2010.01 (A47J20169321/05/2008

ת קפה או חומרים תזונתיים התקן לטחינ אחרים

DEVICE FOR GRINDING COFFEE OROTHER ALIMENTARY SUBSTANCES

RHEA VENDORS S.P.A.23/05/200707010231.4EP

PCT/IB/2008/001264WO/2008/142536

)2010.01 (A61M20169403/06/2008

INJECTION התקן הזרקה DEVICEBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

08/06/2007202007008068.9DE08/09/2007202007012637.9DE

PCT/EP/2008/004412WO/2008/148518

)2010.01 (C07C20169522/04/2008


, אריל מותמר בהלוגן–אוליגומר אתר ותכשירים מעכבי להבות המכילים אותו

A HALOGENATED ARYL ETHEROLIGOMER AND FLAMERETARDANT COMPOSITIONSCOMPRISING THE SAMECHEMTURA CORPORATION

25/04/200760/926374US16/04/200812/148188US

PCT/US/2008/061097WO/2008/134294

)2010.01 (C07D20169624/04/2007

תרכובת מטילאמין מותמר וצאצא טריאזין ושיטה להכנתם

SUBSTITUTED METHYLAMINECOMPOUND AND TRIAZINEDERIVATIVE AND PROCESS FORPRODUCING THE SAMENIPPON SODA COMPANY LTD.

PCT/JP/2007/058842WO/2008/136093

)2010.01 (G06F20169708/05/2008

התקן לבקרת ביצוע מעבד בסביבה מובטחת

APPARATUS FOR CONTROLLINGPROCESSOR EXECUTION IN ASECURE ENVIRONMENTECHOSTAR TECHNOLOGIES L.L.C.

11/05/200760/917582USPCT/US/2008/063089WO/2008/141100

)2010.01 (G06F20169814/05/2008

שיטות והתקנים לבדיקת תוכנה עם נתוני מקור בזמן אמת מטיל

METHODS AND APPARATUS FORTESTING SOFTWARE WITH REAL -TIME SOURCE DATA FROM APROJECTILERAYTHEON COMPANY

14/05/200760/917743USPCT/US/2008/006183


WO/2008/143899

)2010.01 (A61N20169925/04/2008

התקן לחדירת עור לחישת אנליט או מתן תרופות דרך העור

SKIN PERMEATION DEVICE FORANALYTE SENSING ORTRANSDERMAL DRUG DELIVERYECHO THERAPEUTICS, INC.

27/04/200760/914552USPCT/US/2008/061623WO/2008/134545

)2010.01 (H04B20170006/06/1997

שיטה והתקן לביצוע העברה פסיבית כת תקשורת מכפליםבמער

METHOD AND APPARATUS FORPERFORMING IDLE HANDOFF IN AMULTIPLE ACCESSCOMMUNICATION SYSTEMQUALCOMM INCORPORATED

07/06/1996660436USPCT/US/1997/009903WO/1997/047154

)2010.01 (H04B20170106/06/1997

שיטה והתקן לביצוע העברה פסיבית במערכת תקשורת מכפלים

METHOD AND APPARATUS FORPERFORMING IDLE HANDOFF IN AMULTIPLE ACCESSCOMMUNICATING SYSTEMQUALCOMM INCORPORATED

07/06/1996660436USPCT/US/1997/009903WO/1997/047154

)2008.04 (H04Q20170206/06/1997


שיטה והתקן לביצוע העברה פסיבית במערכת תקשורת מכפלים

METHOD AND APPARATUS FORPERFORMING IDLE HANDOFF IN AMULTIPLE ACCESSCOMMUNICATING SYSTEMQUALCOMM INCORPORATED

07/06/1996660436USPCT/US/1997/009903WO/1997/047154

)2010.01 (F41A20170323/04/2008

ACTUATING מכשיר הפעלה DEVICEHECKLER & KOCH GMBH

24/04/2007102007019310.8DEPCT/EP/2008/003281WO/2008/128773

)2010.01 (H04B20170422/04/2008

מערכת ושיטה לפיצוי על היחלשות אות)ATTENUATION(עקב תנאי מזג אויר

בחיבור לוויני

METHOD AND APPARATUS FORCOMPENSATION FOR WEATHER -BASED ATTENUATION IN ASATELLITE LINK

SHIRONמ"בע) 1996(שירון תקשורת לוינים SATELLITECOMMUNICATIONS (1996) LTD.

23/04/200760/907930USPCT/IB/2008/051537WO/2008/129509

)2010.01 (C12N20170513/10/2004

שילוב ספציפי למיקום של חומצות אמינו מחזרות פעילות לתוך חלבונים

SITE-SPECIFIC INCORPORATION OFREDOX ACTIVE AMINO ACIDS INTOPROTEINSTHE SCRIPPS RESEARCH INSTITUTE

14/10/200360/511532USPCT/US/2004/034089WO/2005/038002


)2010.01 (G06Q20170612/06/2008

RESPONSIVE מפסיקי תצוגה מגיבים במשחקי וידיאו CUTSCENES IN VIDEOGAMESMICROSOFT CORPORATION

21/06/200711/766483USPCT/US/2008/066649WO/2009/002713

)2010.01 (G06Q20170712/06/2008

LIVE מבואה למשחק פעיל GAME LOBBYMICROSOFT CORPORATION

21/06/200711/766466USPCT/US/2008/066652WO/2008/157206

)2010.01 (A61K20170828/05/2008

חומרים מעוצבים עם מיסוך טעם משופר

IMPROVED TASTE-MASKINGEXTRUDATES

BAYER ANIMAL HEALTH GMBH08/06/2007102007026550.8DE

PCT/EP/2008/004218WO/2008/148484

)2010.01 (C02F20170925/04/2008

WATERםמערכת לטיפול במי TREATMENT SYSTEMRESOURCE BALLASTTECHNOLOGIES (PROPRIETARY)LIMITED

26/04/20072007/03422ZA17/08/20072007/06898ZA

PCT/IB/2008/051604WO/2008/132681


)2010.01 (A01N20171016/05/2008

ZIPRASIDONE תכשירי זיפראסידון FORMULATIONSSCIDOSE LLC.

18/05/200760/930824USPCT/US/2008/006268WO/2008/143960

)2010.01 (A61K12017127/04/2008

מערכת להחדרת תרופות לתאים חיים ולגרעינים של תאים

A SYSTEM FOR DELIVERINGTHERAPEUTIC AGENTS INTO LIVINGCELLS AND CELLS NUCLEI

SEGEVמ"שגב מעבדות בע LABORATORIES LIMITED23/04/200760/907929US17/05/200760/924490US

PCT/IL/2008/000548WO/2008/129548

)2010.01 (H01L20171225/04/2008

וולטאיים היברידיים ושיטות–תאים פוטו נלוות

HYBRID PHOTOVOLTAIC CELLSAND RELATED METHODS

NANOCO TECHNOLOGIES LIMITED25/04/200760/926103US

PCT/GB/2008/001457WO/2008/132455

)2010.01 (H04L20171326/03/2008

מערכת קשר ושיטה לקביעת פרמטרים של ערוצים

COMMUNICATION SYSTEM ANDMETHOD FOR DETERMININGCHANNEL PARAMETERSROHDE & SCHWARZ GMBH & CO. KG

24/04/2007102007019292.6DEPCT/EP/2008/002382WO/2008/128614


)2010.01 (A01H20171425/04/2008

יצור סחלב עש עם צבע עלי שיטה לי כותרת שעבר שינוי

METHOD FOR PRODUCTION OFMOTH ORCHID HAVING MODIFIEDFLOWER COLORISHIHARA SANGYO KAISHA LTD.

26/04/20072007-116396

JP

PCT/JP/2008/058126WO/2008/136434

)2010.01 (A61K20171525/04/2008

מים אלקטרוליטיים יציבים מאוד עם רוחב מופחתNMRחצי קו

HIGHLY STABLE ELECTROLYTICWATER WITH REDUCED NMR HALFLINE WIDTHAKUATECH S.R.L.

25/04/200760/926182USPCT/EP/2008/003383WO/2008/131936

)2010.01 (C01B20171624/04/2008

HYDROGEN-CATALYST מימן–מגיב זרז REACTORBLACKLI GHT POWER, INC.

24/04/200760/913556US27/07/200760/952305US07/08/200760/954426US09/08/200760/935373US13/08/200760/955465US20/08/200760/956821US23/08/200760/957540US14/09/200760/972342US21/09/200760/974191US26/09/200760/975330US28/09/200760/976004US09/10/200760/978435US13/11/200760/987552US14/11/200760/987946US


21/11/200760/989677US30/11/200760/991434US03/12/200760/991974US05/12/200760/992601US10/12/200761/012717US19/12/200761/014860US26/12/200761/016790US09/01/200861/020023US15/01/200861/021205US17/01/200861/021808US18/01/200861/022112US23/01/200861/022949US24/01/200861/023297US25/01/200861/023687US30/01/200861/024730US01/02/200861/025520US14/02/200861/028605US21/02/200861/030468US06/03/200861/064453US21/03/200861/064723US17/04/200861/071191US

PCT/US/2008/061455WO/2008/134451

)2010.01 (G06F20171716/05/2008

עם בקר חיצוני מופשטKVMמערכת מתגA KVM SWITCH SYSTEM WITH ASIMPLIFIED EXTERNALCONTROLLERAVOCENT CORPORATION

18/05/200711/802015USPCT/US/2008/006377WO/2008/144027

)2010.01 (A47J20171823/05/2008

APPLIANCE כלי להתאמת נוזל על בסיס חלב FOR CONDITIONING AMILK-BASED LIQUIDNESTEC S.A.

23/05/2007202007007340.2DE23/05/2007202007007339.9DE23/05/2007202007007338.0DE


23/05/2007202007007337.2DE24/12/200707124050.1EP

PCT/EP/2008/056349WO/2008/142154

)2010.01 (C12N20171922/04/2008

ש ימוש שיטות לייצור חלבונים באמצעות בתרכובות נוגדות הזדקנות

METHODS OF PROTEINPRODUCTION USING ANTI-SENESCENCE COMPOUNDSWYETH LLC

23/04/200760/913382USPCT/US/2008/061125WO/2008/131375

)2010.01 (C12N20172022/04/2008

ו ב/שימוש בטמפרטורה נמוכה PH–או נמוך בתרבית תאים

USE OF LOW TEMPERATUREAND/OR LOW PH IN CELL CULTURE

WYETH LLC23/04/200760/913382US

PCT/US/2008/061123WO/2008/131374

)2010.01 (C07D20172124/04/2008

ל 3–נגזרות איזוקינולינון כאנטגוניסטיםNK

ISOQUINOLINONE DERIVATIVES ASNK3 ANTAGONISTSH. LUNDBECK A/S

26/04/2007PA200700620

DK

PCT/DK/2008/050092WO/2008/131779

)2010.01 (B23C20172222/10/2009

MILLING כרסום CUTTER


ISCARמ"ישקר בע LTD.


-ז"לחוק הפטנטים תשכ26הודעה לפי סעיף1976

NOTICE UNDER SECTION 26 OF THEPATENTS LAW, 5727-1967

הבקשות שפרטיהן מתפרסמים להלן קובלוכל המעונין. לחוק הפטנטים17לפי סעיף

להתנגד למתן פטנט על פי בקשה מהבקשות תוך שלושה חדשים, המתפרסמות רשאי

להגיש לרשם הפטנטים, מתאריך יומן זהלחוק הפטנטים30הודעת התנגדות לפי סעיף

ואילך לתקנות57בדרך הקבועה בתקנה .1968–ח"תשכ, הפטנטים

The applications, particulars of which are setout below, have been accepted pursuant toSection 17 of the Patents Law. Any personwishing to oppose the grant of a patent on anyof the applications published here, may,within three months from the date of thisjournal, give to the Commissioner of Patentsnotice under Section 30 of the Patents Law, inthe manner prescribed in regulations 57 et seqof the Patents Regulations, 5728-1968

לפי פרטי הבקשות במידה ויישימים מובאים:סדר זה

Particulars of the applications, whereapplicable, are given in the following order:

[11] מספר הבקשה [21] Number of application[54] שם האמצאה Title of invention

[22] תאריך הבקשה Application dateמדינת–מספר ותאריך של בקשות החוץ

האגוד[31] [32] [33] Number and date of foreignapplication – convention country.

[51]* סיווג בינלאומי* Int.Cl.[61] בקשה לפטנט מוסף Application for patent of addition

[62] בקשת חלוקה Divisional application[71] המבקש Applicant[72] הממציא Inventor

[87]ם של בקשה הבינלאומיתפרסו' מס International Publication Number[74] מען למסירת מסמכים Address for service

[57])בשפה בה ערוך הפירוט(תקציר האמצאה Abridgement of invention (in thelanguage in which the specification is drawnup)

שפ: הערה** ורסמו ביומן בקשות הפטנטיםזה סווגו בהתאם לגרסת הסיווג הבינלאומי

.שהייתה בתוקף בעת הכנת הבקשות לפרסום

*Note:, patent applications published in thisjournal were classified according to theInternational Classification version that wasin force when this journal was prepared.


[][]מספר הבקשה

Title ש� האמצאה Of Invention[] Application Date[]

Country[] Date[]Number[] Int. Cl.[] Additional Patent[] Divisional[]

[]Applicant המבקש []Inventor הממציא

No Inter Publication[] []Address כתובת

Abstract[] Image

לתקנות35פירוט זה נבח$ בהתא לתקנה 1968–ח"תשכ, הפטנטי

This specification was examined inaccordance with regulation 35 of the PatentRegulations, 5728 - 1968

The טר פורסמהשלבקשה זו הורהתבקש parent application from whichthis application has been dividedhas not yet been published

בקשות חלוקה מבקשה זו.שטר פורסמו

The applications fordivision from thisapplication have not yetbeen published

__________________

108328]21][11[

תכשירי רוקחות המכילי� תמוזולומיד ומעכבשל אתאז להגברה של רעילות תמוזולומיד לתאי

סרט� בבני אד�

PHARMACEUTICALCOMPOSITIONS CONTAININGTEMOZOLOMIDE AND ATASEINHIBITOR FOR POTENTIATIONOF TEMOZOLOMIDE TOXICITYTO HUMAN TUMOR CELLS

]54[

13.01.1994]22[US]33[14.01.1993]32[08/004754]31[

Int. Cl.(2009.01) C07D 487/04]51[CANCER RESEARCH CAMPAIGNTECHNOLOGY LIMITED, UNITEDKINGDOM

]71[

,לצר וכהן צדק, פרל, איתן7רחוב שנקר

EITAN, PEARL, LATZER ANDCOHEN ZEDEK,

]74[


.P.O.B הרצליה12688.ד.ת, 12688,HERZLIYA 46733The toxicity of temozolomide an anti-tumor agent useful in the treatment of variousmammallan neoplasms, can be potentiated by the prior administration of an ATaseinhibiting agent, i.e., O6-benzylguanine.

]57[


166976,The applications for divisionfrom this application havenot yet been published

__________________

121243]21][11[

מ –רעל� חלבוני ריקומביננטי קוטל חרקי�PHOTORHABDUSפולינוקליוטיד המקודד

ע"לחלבו� הנ י"ל ושיטה לשלוט על מזיקי�ל"שימוש בחלבו� הנ

PECOMBINANT INSECTICIDALPROTEIN TOXIN FROMPHOTORHABDUS,POLYNUCLEOTIDE ENCODINGSAID PROTEIN AND METHODOF CONTROLLING PESTSUSING SAID PROTEIN

]54[

06.07.1997]22[Int. Cl.(2009.01) A01H 05/00, A01N 63/00, C07K 14/24, C12N 05/10, 15/31]51[WISCONSIN ALUMNI RESEARCHFOUNDATION, U.S.A.

]71[

WO/1997/017432]87[,ריינהולד כהן ושותפיו

'א26רחוב הברזל רמת החייל

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,RAMAT HACHAYAL 69710

]74[

Proteins from the genus Photorhabdus are toxic to insects upon exposure.Photorhabdus luminescens (formerly Xenorhabdus luminescens) have been found inmammalian clinical samples and as a bacterial symbiont of entomopathogenicnematodes of genus Heterorhabditis. These protein toxins can be applied to, orgenetically engineered into, insect larvae food and plants for insect control.

]57[

__________________


123646]21][11[

REMOTE צנתור בשלט רחוק CONTROLCATHETERIZATION

]54[

11.03.1998]22[Int. Cl.(2009.01) A61B 01/00, A61M 25/00, 37/00]51[

CORINDUS חיפה,מ"קורינדוס בע LTD]71[REFAEL דליה ביאר,ל ביאררפא BEYAR, DALIA BEYAR]72[

,פרל כהן צדק לצר5שנקר'רח,1ים-מרכז גב

הרצליה12704.ד.ת,

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,P.O.B. 12704,HERZLIYA 46733

]74[

A remote control catheterization system (20) for coaxially inserting into thevasculature of a patient at least a first elongated probe (26) and a second elongatedprobe (42), the system comprising:a propelling device (28) for controllably inserting the elongated probes, comprising atleast a first mechanism for propelling the first elongated probe and a secondmechanism for propelling the second elongated probe, the propelling mechanismoperating coaxially;a control console (34), in communication with the propelling device, and comprisinguser control which are operated by a user of the system remote from the patient tocontrol insertion of the elongated probes into the vasculature by the propelling device.wherein the propelling device comprising a force sensor which measures a forceapplied during insertion of the elongated probe, the force sensor comprises a torquegauge which measures a required to move the elongated probe.

]57[


__________________

126126]21][11[

השימוש בה� ושיטות, כרומוזומי� מלאכותיי� להכנת�

ARTIFICIAL CHROMOSOMES,USES THEREOF AND METHODSFOR PREPARING ARTIFICIALCHROMOSOMES

]54[

10.04.1997]22[US]33[10.04.1996]32[692822]31[US15.07.1996 682080 US07.08.1996695191

Int. Cl.(2009.01) A01H 05/00, A01K 67/02, 67/027, C12N 05/10, 15/09, 15/11,15/62, 15/82, 15/85

]51[

THE BIOLOGICAL RESEARCHCENTER OF THE HUNGARIANACADEMY OF SCIENCES,HUNGARYCHROMOS MOLECULARSYSTEMS, INC., CANADA

]71[

WO/1997/040183]87[,נהולד כהן ושותפיוריי



]74[

Methods for preparing cell lines that contain artificial chromosomes, methods forpreparation of artificial chromosomes, methods for purification of artificialchromosomes, methods for targeted insertion of heterologous DNA into artificialchromosomes, and methods for delivery of the chromosomes to selected cells andtissues are provided. Also provided are cell lines for use in the methods, and cell linesand chromosomes produced by the methods. In particular, satellite artificial

]57[


chromosomes that, except for inserted heterologous DNA, are substantially composedof heterochromatin, are provided. Methods for use of the artificial chromosomes,including for gene therapy, production of gene products and production of transgenicplants and animals are also provided.

__________________

331128]21][11[

תכשירי רוקחות לטיפול בגדילת יתר של בלוטת הערמונית ובסרט� בלוטת הערמונית

PHARMACEUTICALCOMPOSITIONS FOR THETREATMENT OF PROSTATEHYPERTROPHY AND PROSTATECANCER

]54[

01.09.1997]22[US]33[12.09.1996]32[60/025990]31[US10.04.1997 60/043228

Int. Cl.(2009.01) A61K 38/09, 45/06, A61P 13/08, 35/00, C07K 07/23]51[AETERNA ZENTARIS GMBH,GERMANY

]71[



REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,RAMAT HACHAYAL 69710

]74[

A regime for therapeutic management of a benign prostatic hyperplasia and prostaticcancer employs Cetrorelix alone or in combination with alpha-reductase inhibitors oralpha-receptor blocking agents. The regimen reduces the volume of the prostate andavoids the side effects associated with testosterone levels being in a castration range.Cetrorelix is administered at dosages between 0.5 mg/day and 20 mg/week or about0.014 mg/kg body weight per day to 0.30 mg/kg body weight per week or at levels ofabout 25 to 120 mg of Cetrorelix per month or 0.376 mg/kg to 1.71 mg/kg per month.Cetrolix can be administered with alpha-reductase inhibitors or alpha-receptorblocking agents.

]57[




__________________

131149]21][11[

התק� ושיטה למיקו� ולמניפולציה של מכשיר באופ� סלקטיבי

APPARATUS AND METHOD FORSELECTIVELY POSITIONING ADEVICE AND MANIPULATING IT

]54[

28.07.1999]22[US]33[31.07.1998]32[09/127222]31[

Int. Cl.(2009.01) A61B 01/00, A61M 31/00, H01L 41/00]51[OSCILLON אביב-תל,מ"אוסצילון בע LTD.]71[

י דין ועורכי עורכ, קבוצת איתן מהולל,פטנטים

10שדרות אבא אבן הרצליה2081.ד.ת,

EITAN MEHULAL LAW GROUP,10 ABBA EBEN BLVD.,P.O. B. 2081,HERZLIYA 46120

]74[

An apparatus, comprising: a cylindrically shaped motor (1), said motor having alongitudinal bore (5), said motor provided with a motor friction area disposed withinsaid longitudinal bore; a guide wire (2) disposed within said longitudinal bore, saidguide wire and said longitudinal bore sized and adapted to impart friction between saidfriction area of said motor and said guide wire in an amount sufficient to permit saidmotor to change position relative to said guide wire by crawling against said guidewire when said motor is energized; and further comprising a biasing means to bias saidguide wire against said friction area.

]57[


__________________


131561]21][11[

�השימוש בבופרנורפי� בהכנת מערכת למת� דר העור לטיפול בכאב

USE OF BUPRENORPHINE INTHE PREPARATION OF ATRANSDERMAL DELIVERYSYTEM FOR TREATING PAIN

]54[

24.02.1998]22[US]33[24.02.1997]32[60/038919]31[US29.09.1997 60/939068

Int. Cl.(2009.01) A61K 09/70, 31/485, 45/00, A61P 25/04, 25/36, C07D 489/12]51[EURO-CELTIQUE S.A.,LUXEMBOURG

]71[

WO/1998/036728]87[,ברגמן וגולר, וולף

ירושלים1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,JERUSALEM 91013

]74[

The use of buprenorphine in the preparation of a medicament for a method ofeffectively treating pain in humans is achieved by administering buprenorphine in amanner indicative of first order pharmacokinetics over an initial three-day dosinginterval, such that a maximum plasma concentration from about 20 pg/ml to about1052 pg/ml is attained, and thereafter maintaining the administration of buprenorphinefor at least an additional two-day dosing interval in a manner indicative of zero orderkinetics, such that the patients experience analgesia throughout the at least two-dayadditional dosing interval.

]57[



__________________

132049]21][11[

METHOD תקינה של מדפסת–שיטה לאיתור פעולה לא OF SENSING]54[


IMPROPER OPERATION OF ANINK JET PRINTER

26.03.1998]22[US]33[28.03.1997]32[08/827577]31[

Int. Cl.(2009.01) B41J 02/11, 02/125, 29/393]51[ג'ג בע'מטקס אינק JEMTEX לוד,מ"ט פרינטינג INK JET PRINTING LTD.]71[

WO/1998/043817]87[,מ"בע) 1995(ארליך.אי.י'ג

11רחוב מנחם בגין,15קומה, מגדל איילון רמת גן

G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,11 MENACHEM BEGIN ST.,RAMAT GAN 52521

]74[

A method and apparatus are described for operating an ink-jet printer (10) by:controlling the printer's nozzles (20) to print a pattern of test marks (24) on a test strip(25) while relative movement is effected between the printhead (11) and the test strip(25); sensing and analyzing the pattern of test marks (24) with respect to a number ofprinting parameters to detect errors and to determine whether such errors are withinpredetermined tolerance limits; automatically controlling the plurality of nozzles (20)to compensate for those errors within the predetermined tolerance limits; andautomatically terminating the operation of the printer (10) upon detection of an errorexceeding a predetermined tolerance limit.

]57[

__________________

132670]21][11[

�שימוש של הפריני� בעלי משקל מולקולרי נמולהכנת תרופות למניעה וטיפול בנפיחויות של

המוח

USE OF LOW-MOLECULAR-WEIGHT HEPARINS IN THEPREPARATION OFMEDICAMENTS FORPREVENTING AND TREATINGCEREBRAL EDEMAS

]54[


25.05.1998]22[FR]33[28.05.1997]32[97/06551]31[

Int. Cl.(2009.01) A61K 31/727, A61P 07/10, C08B 37/10]51[AVENTIS PHARMA S.A., FRANCE]71[WO/1998/053834]87[

,לוצאטו את לוצאטו עומר, גן תעשייה

באר שבע5352.ד.ת,

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,P.O.B. 5352,BEER-SHEVA 84152

]74[

The invention concerns the use of low-molecular-weight heparins for preventing andtreating cerebral edemas.

]57[

__________________

135607]21][11[

ל –חומצות גרעי� מבודדות המבוטאות בתגובהWnt–1

ISOLATED NUCLEIC ACIDSINDUCIBLE BY WNT-1

]54[

29.10.1998]22[US]33[29.10.1997]32[60/063704]31[US04.02.1998 60/073612

Int. Cl.(2009.01) A61K 38/17, C07K 14/47, C12N 15/12]51[GENENTECH, INC., U.S.A.]71[WO/1999/021999]87[

,ריינהולד כהן ושותפיו'א26רחוב הברזל רמת החייל


]74[

DNAs are provided, whose genes are induced at least by Wnt-1. Also provided arenucleic acid molecules encoding those polypeptides, as well as vectors and host cellscomprising those nucleic acid sequences, chimeric polypeptide molecules comprisingthe polypeptides fused to heterologous polypeptide sequences, antibodies which bindto the polypeptides, and methods for producing the polypeptides.

]57[


__________________

137489]21][11[

תכשירי רוקחות המכילי� מעקבי נתיב לימפוטוקסי�

PHARMACEUTICALCOMPOSITIONS CONTAININGINHIBITORS OF THELYMPHOTOXIN PATHWAY

]54[

29.01.1999]22[US]33[30.01.1998]32[60/073112]31[US02.02.1998 60/073410

Int. Cl.(2009.01) A61K 35/12, 38/17, 39/395, 45/00, C07K 14/525, 16/28]51[BIOGEN IDEC MA INC., U.S.A.NEW YORK UNIVERSITY, U.S.A.

]71[



]74[

Therapeutic uses of inhibitors of the Lymphotoxin Pathway to treat tumors,specifically to treat follicular lymphomas.

]57[

__________________

138473]21][11[

פסוריאזיס המכילי� תכשירי� רפואיי� כנגד תמציות צמחי�

PHARMACEUTICALCOMPOSITIONS COMPRISING

]54[


HERB EXTRACTS FORTREATING PSORIASIS

14.09.2000]22[Int. Cl.(2009.01) A61K 35/00, 36/00]51[

בע ATTAREX נצרת עלית,מ"עטרקס LTD.]71[ ערן, חאלד חליל, עומר סעיד, סטפן פולדר

כהןSTEPHEM FULDER, OMAR SAID,KHALID KHALIL, ERAN COHEN

]72[

,עומר סעיד 2205.ד.ת,

OMAR SAID,P.O.B 2205KFAR KANNA 16930

]74[

An extract for topical use having anti-psoriatic activity obtained from any combinationof the groups of plants, selected from the group comprising Eruca sp., Nigella sp.,Citrus medica/limonum/acida sp. and Hypericum sp., their leaves, fruits and seeds.

]57[

__________________

140090]21][11[

METHOD שיטה ומתק� למדידת הספק של סוללה OF AND APPARATUSFOR MEASURING BATTERYCAPACITY

]54[

15.06.1999]22[KR]33[16.06.1998]32[98/22540]31[KR25.06.1998 98/24134

Int. Cl.(2010.01) G01R 13//36]51[KOREA KUMNHOPETROCHEMICAL CO., LTD.,REPUBLIC OF KOREA

]71[

CHUL OH YOON, YEVGENBARSUKOV, JONG HYUN KIM

]72[

WO/1999/066340]87[בע"ד ,מ"ר מרק פרידמן

ז,54.ק, מגדל משה אביב 7בוטינסקי'רחגן-רמת

DR. MARK FRIEDMAN LTD.,MOSHE AVIV TOWER, 54THFLOOR,7 JABOTINSKY ST.,RAMAT GAN 52520

]74[

Provided is a method of measuring battery capacity using parameters obtained from avoltage response signal of a current waveform or an impedance spectrum generatedthereof where the method includes the steps of: measuring voltage response signalsbased on a current waveform applied to a primary or secondary battery; obtaining

]57[


parameters of an equivalent circuit composed of model parameters such as resistors,capacitors and transmission lines either directly from voltage response or after itsconversion to frequency dependent impedance; and determining the unknown batterycapacity from the voltage response characteristics based on a correlation between themeasured capacity and the model parameters, which correlation is previouslydetermined by a real-time discharge method, thereby takes a shorter time than a real-time discharge method and delivering efficiency and reliability in determining modelparameters of an equivalent circuit which are in close correlation with thecharge/discharge condition of the battery.

__________________

140937]21][11[

תכשירי� רוקחיי� המכילי� רצ� חומצות אמינוLDCAMהמכילי� פוליפפטיד מסיס של

PHARMACEUTICALCOMPOSITIONS COMPRISINGAN AMINO ACID SEQUENCECOMPRISING SOLUBLE LDCAMPOLYPEPTIDE

]54[

05.08.1999]22[US]33[07.08.1998]32[60/095672]31[

Int. Cl.(2009.01) A61K 38/17, C07K 14/47, 16/18]51[IMMUNEX CORPORATION, U.S.A.]71[WO/2000/008158]87[



]74[

The invention is directed to LDCAM as a purified and isolated protein, the DNAencoding the LDCAM, host cells transfected with cDNAs encoding LDCAM,processes for preparing LDCAM polypeptides and compositions and methods fortreating utilizing LDCAM polypeptides.

]57[




__________________

141531]21][11[

שימוש במטבוליט של סיבוטראמי� לייצור)ADD(תרופה לטיפול בהפרעת הקשב והריכוז

USE OF A SIBUTRAMINEMETABOLITE FOR THEMANUFACTURE OF AMEDICAMENT FOR TREATINGATTENTION DEFICIT DISORDER(ADD)

]54[

23.08.1999]22[US]33[24.08.1998]32[60/097665]31[US02.09.1998 60/099306 US11.08.199909/372158

Int. Cl.(2009.01) A61K 31/00, 31/13, 31/135, A61P 25/28]51[SEPRACOR INC., U.S.A.]71[WO/2000/010551]87[



]74[

Methods are disclosed for the treatment and prevention of disorders and conditionsincluding, but are not limited to, erectile dysfunction, affective disorders, weight gain,cerebral functional disorders, pain, obsessive-compulsive disorder, substance abuse,chronic disorders, anxiety, eating disorders, migraines, and incontinence. The methodscomprise the administration of a dopamine reuptake inhibitor and optionally anadditional pharmacologically active compound. Pharmaceutical compositions anddosage forms are also disclosed that comprise a dopamine reuptake inhibitor andoptionally an additional pharmacologically active compound. Preferred dopaminereuptake inhibitors are racemic or optically pure sibutramine metabolites likedesmethylsibutramine and didesmethylsibutramine and pharmaceutically acceptablesalts, solvates, and clathrates thereof. Preferred additional pharmacologically activecompounds include drugs that affect the central nervous system, such as 5-HT3antagonists.

]57[

__________________


141613]21][11[

KDA–120חלבו� וג� אימונודומיננטי אנטיגניEHRLICHIA CANIS

EHRLICHIA CANIS 120-KDAIMMUNODOMINANT ANTIGENICPROTEIN AND GENE

]54[

27.08.1999]22[US]33[27.08.1998]32[09/141047]31[

Int. Cl.(2009.01) A61K 39/02, A61P 31/04, C07K 14/29, 16/12, C12N 01/21]51[RESEARCH DEVELOPMENTFOUNDATION, U.S.A.

]71[

H. DAVID WALKER, XU-JIE YU]72[WO/2000/012688]87[

בע"ד ,מ"ר מרק פרידמןז,54.ק, מגדל משה אביב 7בוטינסקי'רח

גן-רמת


]74[

The present invention provides a 120-kDa protein gene ofEhrlichia canis, amplifiedby PCR using primers derived from the DNA sequences flanking theEhrlichiachaffeensis 120-kDa protein gene. The recombinantE. canis 120-kDa protein contains14 tandem repeat units with 36 amino acids each. The repeat units are hydrophilic andpredicted to be surface-exposed. Also disclosed is that the recombinantE. canis 120-kDa protein is antigenic and reacts with sera from dogs convalescent from canineehrlichiosis.

]57[

__________________

141759]21][11[

MULTIHUED תוויות מרובות גווני� LABELS]54[

30.08.1999]22[US]33[03.09.1998]32[09/146984]31[US14.06.1999 09/332613

Int. Cl.(2009.01) G01N 21/64, 33/58]51[TRELLIS BIOINFORMATICS, INC.,U.S.A.

]71[

WO/2000/014545]87[REINHOLD,ריינהולד כהן ושותפיו COHN AND PARTNERS,]74[



26A HABARZEL ST.,RAMAT HACHAYAL 69710

Particulate labels that can be individually identified comprise particulate supports towhich are bound at least two distinguishable signal-generating moieties, such asfluorophores emitting at different wavelengths, which signals are detectable andmeasurable in situ. By varying the ratio and/or amounts of the signal-generatingmoieties, a multiplicity of different and distinguishable labels is obtained. Eachdifferent label can then be coupled to a different reagent and the individual interactionsof each reagent with a target observed in parallel.

]57[



__________________

141797]21][11[

ו או אנרגיה/שיטות לשימוש תהודה אקוסטיתו–אלקטרו–תהודה אקוסטו או/מגנטית לזיהוי

השפעה על מבני�

METHODS FOR USINGRESONANT ACOUSTIC AND/ORRESONANT ACOUSTO-EMENERGY TO DETECT AND/ORAFFECT STRUCTURES

]54[

10.09.1999]22[US]33[11.09.1998]32[60/099995]31[

Int. Cl.(2009.01) A61B 05/055, A61N 02/00]51[GR INTELLECTUAL RESERVE,LLC,, U.S.A.

]71[

WO/2000/015097]87[ט ',קולב ושות. סנפורד מרמורק,4שער הגיא

רחובות2273.ד.ת,

SANFORD T.COLB & CO.,P.O.B. 2273,REHOVOT 76122

]74[


The present invention makes use of resonant acoustic and/or acousto-EM energyapplied to inorganic or biologic structures for the detection and/or identification, andfor augmentation and/or disruption of function within the biologic structure. Inparticular, the invention provides a method of generating resonant acoustic and/oracousto-EM energy in biologic structures such as virus, bacteria, fungi, worms andtumors for the detection and disruption of these structures. Moreover, the inventionprovides a method of augmenting functions of biologic structures such as bone throughthe generation of resonant acoustic and/or acousto-EM energy in the structure. Systemsare also provided for the generation and detection of resonant acoustic and/or resonantacousto-EM energy.

]57[

__________________

142231]21][11[

ג� נבחר ומוטנט של תכשיר אנטיגני המכיל אנטישיטה לייצור, ובנט'כולרה הולוטוקסי� כאדג

בו, מוטנט כולרה הולוטוקסי� כזה ושימוש בתכשיר אנטיגני

ANTIGENIC COMPOSITIONCOMPRISING A SELECTEDANTIGEN AND A MUTANTCHOLERA HOLOTOXIN AS ANADJUVANT, A METHOD OFPRODUCING SUCH MUTANTCHOLERA HOLOTOXIN AND USETHEREOF IN AN ANTIGENICCOMPOSITION

]54[

30.09.1999]22[US]33[30.09.1998]32[60/102430]31[

Int. Cl.(2009.01) A61K 39/095, 39/102, 39/106, 39/15, 39/155, 39/295, 39/39, A61P37/04, C07K 14/28, C12N 15/31

]51[

WYETH HOLDINGSCORPORATION, U.S.A.THE GOVERNMENT OF THEUNITED STATES OF AMERICA ASREPRESENTED BY THEUNIFORMED SERVICESUNIVERSITY OF THE HEALTHSCIENCES, U.S.A.

]71[


WO/2000/018434]87[',הורוביץ ושות.ש

31רחוב אחד העם תל אביב2499.ד.ת,

S. HOROWITZ & CO.,31 AHAD HAAM STREETP.O. BOX 2499TEL AVIV 65202

]74[

A mutant cholera holotoxin featuring a point mutation at amino acid 29 of the Asubunit, wherein the glutamic acid residue is replaced by an amino acid other thanaspartic acid, is useful as an adjuvant in an antigenic composition to enhance theimmune response in a vertebrate host to a selected antigen from a pathogenicbacterium, virus, fungus or parasite. In a particular embodiment, the amino acid 29 ishistidine. The mutant cholera holotoxin may contain at least one additional mutation inthe A subunit at a position other than amino acid 29. The antigenic composition mayinclude a second adjuvant in addition to the mutant cholera holotoxin.

]57[

__________________

142516]21][11[

–6–שינויי� גנטיות ספציפיי� של טרהאלוזפוספט סינטאז וביטוי לפעילות מוגברת ביצורי�

אאוקריוטי�

SPECIFIC GENETICMODIFICATIONS OFTREHALOSE-6-PHOSPHATESYNTHASE FOR INCREASEDACTIVITY IN EUCARIOTICORGANISMS

]54[

15.10.1999]22[EP]33[15.10.1998]32[98203469.6]31[

Int. Cl.(2009.01) A01H 05/00, 05/10, C12N 01/15, 01/19, 05/10, 09/10, 09/16, 15/54,15/82, C12Q 01/25

]51[

VLAAMS INTERUNIVERSITAIRINSTITUUT VOORBIOTECHNOLOGIE V.Z.W (VIB),BELGIUM

]71[

WO/2000/022141]87[,פרל כהן צדק לצר

5שנקר'רח,1ים-מרכז גב הרצליה12704.ד.ת,


]74[

The present invention relates to a method for the preparation of a eukaryotic organism,for example selected from plants, animals and fungi, showing constitutive, inducibleand/or organ specific expression of a specifically modified TPSgene, which comprisesthe steps of providing a TPSgene; designing a suitable modification to the TPSgeneby aligning the gene with the corresponding gene of yeast and establishing which part

]57[


of the gene extends beyond the 5' terminus of the yeast gene; deleting or inactivating apart of the N-terminal region of the TPSgene extending beyond the 5' terminus of theyeast gene, preferably the complete extending part thereof, in order to achieve anincreased trehalose-6-phosphate synthase activity; cloning the thus modified gene intoan expression vector under the control of a constitutive, inducible and/or organ-specific promoter; transforming a plant cell or tissue with the thus obtained expressionvector; and regenerating a complete plant from the transformed plant cell or tissue.

__________________

142631]21][11[

הכנת� ותכשירי�, חלקי�13אזאלידי� בעלי תרופתיי� הכוללי� אות�

13-MEMBERED AZALIDES,THEIR PREPARATION ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHEM

]54[

09.11.1999]22[US]33[20.11.1998]32[60/109399]31[

Int. Cl.(2009.01) A61K 31/7048, A61P 31/04, 33/02, C07H 17/08, C12P 19/62]51[PFIZER PRODUCTS, INC., U.S.A.]71[WO/2000/031097]87[




]74[

The invention relates to a method of preparing compounds of formula (1) and topharmaceutically acceptable salts thereof. The compounds of formula (1) areantibacterial agents that may be used to treat various bacterial and protozoa infections.The invention also relates to pharmaceutical compositions containing the compoundsof formula (1) and to methods of treating bacterial protozoa infections byadministering the compounds of formula (1). The invention also relates to methods ofpreparing the compounds of formula (1) and to intermediates useful in suchpreparation.

]57[


__________________

142852]21][11[

אמילואיד–bע�2Qקומפלקס של שפרו� ושיטות המשתמשות בקומפלקסי� אלו

COMPLEX OF A CHAPERONE Q2WITH BETA-AMYLOID AND

METHODS EMPLOYING THISCOMPLEX

]54[

29.10.1999]22[US]33[30.10.1998]32[60/106398]31[US10.03.1999 60/123564

Int. Cl.(2009.01) C07K 14/47, 16/18, G01N 33/68]51[JORDAN L. HOLTZMAN, U.S.A.]71[WO/2000/026251]87[




]74[

A chaperone protein Q2 and ß-amyloid can form a complex. This complex can bedetected in a biological sample, such as, for example, tissues or fluids from a mammal.Q2 levels can also be detected in a biological sample. A method for determining theQ2 level in a biological sample and comparing that level to a normal Q2 level can beused to detect, screen, diagnose, or otherwise determine a person's susceptibility toAlzheimer's disease such as, for example, the presence or absence of Alzheimer'sdisease, of symptoms of this disease, of factors leading to or associated with thisdisease, of likelihood of developing this disease, and the like. In one embodiment, adecline in Q2 level correlates to an increased likelihood of developing Alzheimer'sdisease. In another embodiment, a decline in Q2 level correlates to an increase in ß-amyloid aggregation. The method may further include screening for an apolipoproteinE genetype, which is associated with Alzheimer's disease.

]57[

__________________

142959]21][11[

היטירוביציקלי� הכולל חנק� ותרכובות הכוללות אות�

NITROGEN CONTAININGHETEROBICYCLES ANDPHARMACEUTICAL

]54[


COMPOSITIONS COMPRISINGSAME

17.12.1999]22[US]33[23.12.1998]32[60/113628]31[US 02.04.1999 60/127633

Int. Cl.(2009.01) A61K 31/4353, A61P 07/00, C07D 471/04, 498/04, 513/04, 519/00]51[BRISTOL-MYERS SQUIBBPHARMA COMPANY, U.S.A.

]71[




]74[

The present application describes nitrogen containing heterobicyclics and derivativesthereof, or pharmaceutically acceptable salt forms thereof, which are useful asinhibitors of factor Xa.

]57[

__________________

143534]21][11[

מערכת תו� כלי ד� לטיפול בהיצרות הקרוטיד וקטטר למערכת זו

ENDOVASCULAR SYSTEM FORTHE TREATMENT OF STENOSESOF THE CAROTID ANDCATHETER FOR THIS SYSTEM

]54[

30.11.1999]22[IT]33[03.12.1998]32[SV98A000070]31[

Int. Cl.(2009.01) A61M 25/00, 25/10, 29/00]51[ROBERTO BENEDINI, ITALYGIOACCHINO COPPI, ITALYANTONIO GARDELLI, ITALY

]71[




]74[

The invention relates to a catheter, in particular for endovascular applications,comprising a long and flexible, hollow, tubular body (1) having an insertion end (4)and a connection end (3) intended to remain outside the body. According to theinvention, the catheter comprises in the insertion end (4) at least two elements (9, 12)

]57[


which are expandable/contractible by means of external operation. Said elements arelocated at a distance from each other, one upstream and the other downstream of agiven section of a vessel. With the catheter it is possible to operate in the sectioncomprised between the two expandable elements (9, 12) and, if necessary, in theintermediate arterial branch which, on account of the two elements (9, 12) upstreamand downstream, will have a zero flow.

__________________

144467]21][11[

תהליכי� לייצור של פוספאטאז אלקאלי אאוקריוטי בתאי שמר

PROCESSES FOR THEPRODUCTION OF EUKARYOTICALKALINE PHOSPHATASE INYEAST CELLS

]54[

19.07.2001]22[DE]33[25.07.2000]32[10036491.8]31[

Int. Cl.(2009.01) C12N 01/19, 09/14, 15/55, 15/68, 15/81]51[F. HOFFMANN-LA ROCHE AG,SWITZERLAND

]71[




]74[

The invention concerns a process for the recombinant production and expression ofeukaryotic alkaline phosphatase in yeast cells in which in particular a DNA coding fora eukaryotic highly active alkaline phosphatase having a specific activity above 3000U/mg is used. The invention additionally concerns a process for insertingcorresponding nucleic acid sequences into a vector for expression in methylotrophicyeast strains and it concerns appropriate vectors and host strains.

]57[


__________________

145395]21][11[

POWDERED אבקת תוס� לחיזוק חלב א� HUMAN MILKFORTIFIER

]54[

07.04.2000]22[US]33[09.04.1999]32[60/128575]31[

Int. Cl.(2009.01) A23C 09/20, A23L 01/29]51[ABBOTT LABORATORIES, U.S.A.]71[WO/2000/060949]87[

',ר שלמה כהן ושות"ד 124אבן גבירול

תל אביב11490.ד.ת,

DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,P.O.B. 11490,TEL AVIV 62038

]74[

The invention relates to a powdered human milk fortifier comprising a proteincomponent typically present in an amount of from about 24 wt/wt% to about 55wt/wt% of the fortifier powder, and a fat component typically present in an amount offrom about 1 wt/wt% to about 30 wt/wt% of the fortifier powder and a carbohydratecomponent present in a quantity of from about 15 wt/wt% to about 75 wt/wt% of thefortifier powder. Preferably, the powdered human milk fortifier is provided in a unitdose container which holds from about 0.5 gm to about 10 gm of powder. The instantinvention also relates to a method of providing nutrition to preterm infants by adding afortifier powder to human milk and administering the fortified human milk to apremature infant. The invention further provides a method of promoting growth of apremature infant by administering fortified human milk to a premature infant.

]57[

__________________

145536]21][11[

חומצות אמיניות ומקדימי� ביוכימיי�, חלבוני�שלה� המסומני� באתרי� ספציפיי� על ידי

איזוטופי� והכנת�

SITE-SPECIFIC ISOTOPICALLY-LABELED PROTEINS, AMINOACIDS AND BIOCHEMICALPRECURSORS THEREFOR ANDTHEIR PREPARATION

]54[

07.04.2000]22[US]33[09.04.1999]32[09/289517]31[


Int. Cl.(2009.01) C07B 59/00, C07C 229/08, 59/185, C07K 01/13, C12P 21/00]51[ABBOTT LABORATORIES, U.S.A.]71[WO/2000/061525]87[




]74[

Site-specific isotopically-labeled valine, leucine, and isoleucine and biosyntheticprecursors for these amino acids are provided. The amino acids are labeled with 13Cor 14C at the methyl group carbon atom(s) most remote from the carboxyl group. Alsodisclosed are the biochemical precursors of these labeled amino acids, 2-keto-4-(nC)butyric acid and 2-keto-3-(nC-methyl)-4-(nC)-butyric acid in which n, at eachoccurrence, is 13 or 14. Also disclosed are proteins, protein fragments, andpolypeptides containing these site-specifically isotopically labeled amino acids, andmethods for preparing the biochemical precursors, the amino acids, and the proteins,protein fragments, and polypeptides.

]57[

__________________

145895]21][11[

וויסות פעילות ריקמה הניתנת לעירור על ידי אריתרופויטי� המסופק בצורה היקפית

MODULATION OF EXCITABLETISSUE FUNCTION BYPERIPHERALLY ADMINISTEREDERYTHROPOIETIN

]54[

13.04.2000]22[US]33[13.04.1999]32[290938]31[US11.04.2000 547220

Int. Cl.(2009.01) A61K 38/00, 38/19, A61P 25/00, 27/00, C07K 14/505, C12N 15/19]51[THE KENNETH S. WARRENINSTITUTE, INC., U.S.A.

]71[




]74[

Methods and compositions are provided for protecting or enhancing excitable tissuefunction in mammals by systemic administration of an erythropoietin receptor activitymodulator, such as erythropoietin, which signals via an EPO-activated receptor tomodulate the function of excitable tissue. Excitable tissues include central neuronaltissues, such as the brain, peripheral neuronal tissues, retina, and heart tissue.

]57[


Protection of excitable tissues provides treatement of hypoxia, seizure disorders,neurodegenerative diseases, hypoglycemia, and neurotoxin poisoning. Enhancement offunction is useful in learning and memory. The invention is also directed tocompositions and methods for facilitating the transport of molecules across endothelialcell tight junction barriers, such as the blood-brain barrier, by association of moleculeswith an erythropoietin receptor activity modulator, such as an erythropoietin.

__________________

146193]21][11[

חייש� אנזימטי ושיטה לניתוח דוגמאות לנוכחותשל תרכובות אורגניות של זרח� או גופרית

ושיטת יצירתו של החייש�

ENZYME BIOSENSOR ANDMETHOD FOR ANALYZINGSAMPLES FOR THE PRESENCEOF ORGANOPHOSPHORUS ORORGANOSULFUR COMPOUNDSAND A METHOD FOR MAKINGSAID BIOSENSOR

]54[

26.04.2000]22[US]33[26.04.1999]32[60/130989]31[

Int. Cl.(2009.01) C12Q 01/34, 01/46, G01N 33/543]51[U.S. ARMY MEDICAL RESEARCHAND MATERIEL COMMAND, U.S.A.

]71[

WO/2000/065081]87[,לוצאטו את לוצאטו

עומר, גן תעשייה באר שבע5352.ד.ת,


]74[

Methods, compositions and materials useful in the detection of organophosphorousand organosulfur are disclosed. In particular, biosensors wherein a porous e.g. foam ora non-porous support having an enzyme covalently immobilized upon or within aredisclosed. The biosensors exhibit enzymatic stability at extreme temperatures and/ordenaturing conditions, and similar kinetic characteristics of the soluble form of theenzymes utilized. The enzyme does not leach from the porous or non-porous supportand the material retains enzymatic activity after prolonged storage. Differentialbiosensors are also disclosed.

]57[


__________________

146295]21][11[

, תהלי� להכנתו, קופוליאמיד מסוע� עד מאוד שימושיו ותכשירי� המבוססי� עליו

HYPERBRANCHEDCOPOLYAMIDE, PROCESS FORITS PRODUCTION, ITS USES ANDCOMPOSITIONS BASED ON SAIDHYPERBRANCHEDCOPOLYAMIDE

]54[

05.05.2000]22[FR]33[05.05.1999]32[99/05885]31[

Int. Cl.(2009.01) C08G 83/00]51[RHODIANYL, FRANCE]71[WO/2000/068298]87[



]74[

The invention concerns hyperbranched copolyamides (HBPA), the method forobtaining them and their use as additive, in particular as melted viscosity modifier inthermoplastic polymer compositions. Said copolyamide is obtained by reacting amonomer (I): A-R-Bf where A and B = polymerisation functions of first and secondtypes respectively, capable of reacting with each other; R = hydrocarbon entity and f =total number of B per monomer (preferably 2 m f m(F) 10); with a monomer (II): A'-R'-B' or the corresponding lactams, where A', B', R' having the same definition asabove respectively for A, B, R. Said HBPA has a I/II molar ratio such that 0.125 $m(F)I/II $m(F) 2. One of the entities R or R' of (I) or (II) is aliphatic, cycloaliphatic orarylaliphatic. For example: A = NH¿2? AND B = COOH or A = COOH and B = NH2with F = 2. A' = NH2 and B' = COOH or A' = COOH and B' = NH2. A-R-B2, forexample: 5-aminoisophthalic acid or 3,5-diaminobenzoic acid and A'-R'-B' = e-caprolactam. The invention also concerns the yarns, fibres, moulded parts obtained

]57[


from polymer compositions (for example, P.A) containing the inventive HBPA asadditive.

__________________

146486]21][11[

1H–5,4[אימידאזו–C[אמיני�–4–קווינולי�מותמרי� בסולפונאמידי� ובסולפאמידי�

ותכשירי רוקחות המכילי� אות�1בעמדה

1-(SULFONAMIDE ANDSULFAMIDE SUBSTITUTED)-1H-IMIDAZO[4,5-C]QUINOLINE-4-AMINES ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHEM

]54[

08.06.2000]22[US]33[10.06.1999]32[60/138365]31[US07.06.2000 09/589216

Int. Cl.(2009.01) A61K 31/4745, A61P 31/12, 35/00, 37/02, C07D 471/04]51[COLEY PHARMACEUTICALGROUP, INC., U.S.A.

]71[




]74[

Imidazoquinoline and tetrahydroimidazoquinoline compounds that containsulfonamide or sulfonamide functionality at the 1-position are useful as immuneresponse modifiers. The compounds and compositions of the invention can induce thebiosynthesis of various cytokines and are useful in the treatment of a variety ofconditions including viral diseases and neoplastic diseases.

]57[

__________________

146659]21][11[

METHODS שיטות ליצירת טבלאות נקבוביות לתרופה FOR PREPARING APOROUS MATRIX OF DRUG

]54[


25.05.2000]22[US]33[27.05.1999]32[60/136323]31[US08.10.1999 60/158659 US04.11.199909/433486US02.03.200060/186310

Int. Cl.(2009.01) A61K 09/00, 09/16]51[ACUSPHERE, INC., U.S.A.]71[WO/2000/072827]87[

ט ',קולב ושות. סנפורד מרמורק,4שער הגיא



]74[

Drugs, especially low aqueous solubility drugs, are provided in a porous matrix form,preferably microparticles, which enhances dissolution of the drug in aqueous media.The drug matrices preferably are made using a process that includes (i) dissolving adrug, preferably a drug having low aqueous solubility, in a volatile solvent to form adrug solution, (ii) combining at least one pore forming agent with the drug solution toform an emulsion, suspension, or second solutions, and (iii) removing the volatilesolvent and pore forming agent from the emulsion, suspension, or second solution toyield the porous matrix of drug. The pore forming agent can be either a volatile liquidthat is immiscible with the drug solvent or a volatile solid compound, preferably avolatile salt. In a preferred embodiment, spray drying is used to remove the solventsand the pore forming agent. The resulting porous matrix has a faster rate of dissolutionfollowing administration to a patient, as compared to non-porous matrix forms of thedrug. In a preferred embodiment, microparticles of the porous drug matrix arereconstituted with an aqueous medium and administered parenterally, or processedusing standard techniques into tablets or capsules for oral admisnistration. Paclitaxel ordocetaxel can be provided in a porous matrix form, which allows the drug to beformulated without solubilizing agents and administered as a bolus. rocessed usingstandard techniques into tablets or capsules for oral administration. Paclitaxel ordocetaxel can be provided in a porous matrix form, which allows the drug to beformulated without solubilizing agents and administered as a bolus.

]57[

__________________

147446]21][11[

חלש נגי� פאראאינפלואנזה רקומביננטי אשר הובאמצעות הסרה או מחיקה של גני� לא נחוצי�

ל"ותכשיר אימונוגני המכיל את הנגי� הנ

RECOMBINANTPARAINFLUENZA VIRUSATTENUATED BY DELETION ORABLATION OF A NON-ESSENTIAL GENE AND

]54[


IMMUNOGENIC COMPOSITIONCOMPRISING SAID VIRUS

06.07.2000]22[US]33[09.07.1999]32[350821]31[

Int. Cl.(2009.01) A61K 39/155, 48/00, A61P 31/16, C07K 14/115]51[THE GOVERNMENT OF THEUNITED STATES OF AMERICA ASREPRESENTED BY THESECRETARY OF THEDEPARTMENT OF HEALTH ANDHUMAN SERVICES, U.S.A.

]71[




]74[

Recombinant parainfluenza virus (PIV) are provided in which expression of the C, Dand/or V translational open reading frame(s) (ORFs) is reduced or ablated to yieldnovel PIV vaccine candidates. Expression of the C, D and/or V ORF(s) is reduced orablated by modifying a recombinant PIV genome or antigenome, for example byintroduction of a stop codon, by a mutation in an RNA editing site, by a mutation thatalters the amino acid specified by an initiation codon, or by a frame shift mutation inthe targeted ORF(s). Alternatively, the C, D and/or V ORF(s) is deleted in whole or inpart to render the protein(s) encoded thereby partially or entirely non-functional or todisrupt protein expression altogether. C, D and/or V ORF(s) deletion and knock outmutants possess highly desirable phenotypic characteristics for vaccine development.These deletion and knock out mutations changes specify one or more desiredphenotypic changes in the resulting virus or subviral particle. Vaccine candidates aregenerated that show a change in viral growth characteristics, attenuation, plaque size,and/or a change in cytopathogenicity, among other novel phenotypes. A variety ofadditional mutations and nucleotide modifications are provided within the C, D and/orV ORF(s) deletion or ablation mutant PIV of the invention to yield desired phenotypicand structural effects

]57[


__________________

147447]21][11[

תכשיר אימונוגני המכיל נגי� נשימתיסינסיציאלי כימרי ממקור בקר וב� אד� מדבק ומולקולה פולינוקליטיד המכיל את הגנו� של

ל"הנגי� הנ

IMMUNOGENIC COMPOSITIONCOMPRISING AN INFECTIOUSBOVINE-HUMAN CHIMERICRESPIRATORY SYNCYTIALVIRUS AND POLYNUCLETIDEMOLECULE COMPRISING THEGENOME OF SAID VIRUS

]54[

24.06.2000]22[US]33[09.07.1999]32[60/143132]31[

Int. Cl.(2009.01) A61K 39/12, A61P 11/00, C07K 14/135, 19/00, C12N 15/40, 15/62,15/86

]51[

THE GOVERNMENT OF THEUNITED STATES OF AMERICA ASREPRESENTED BY THESECRETARY OF THEDEPARTMENT OF HEALTH ANDHUMAN SERVICES, U.S.A.

]71[




]74[

Chimeric human-bovine respiratory syncytial virus (RSV) are infectious andattenuated in humans and other mammals and useful in vaccine formulations foreliciting an anti-RSV immune response. Also provided are isolated polynucleotidemolecules and vectors incorporating a chimeric RSV genome or antigenome whichincludes a partial or complete human or bovine RSV 'background' genome orantigenome combined or integrated with one or more heterologous gene(s) or genomesegment(s) of a different RSV strain. Chimeric human-bovine RSV of the inventioninclude a partial or complete 'background' RSV genome or antigenome derived from orpatterned after a human or bovine RSV strain or subgroup virus combined with one ormore heterologous gene(s) or genome segment(s) of a different RSV strain orsubgroup virus to form the human-bovine chimeric RSV genome or antigenome. Inpreferred aspects of the invention, chimeric RSV incorporate a partial or completebovine RSV background genome or antigenome combined with one or moreheterologous gene(s) or genome segment(s) from a human RSV. Genes of interestinclude any of the NS1, NS2, N, P, M, SH, M2(ORF1), M2(ORF2), L, F or G genes ora genome segment including a protein or portion thereof. A variety of additionalmutations and nucleotide modifications are provided within the human-bovine

]57[


chimeric RSV of the invention to yield desired phenotypic and structural effects.

__________________

147472]21][11[

מערכת ושיטה לשיקו� ממשק משתמש באמצעות מער� ניהול

SYSTEM AND METHOD FORUSER INTERFACE MIRRORINGUTILIZING A LAYOUTMANAGER

]54[

03.01.2002]22[US]33[05.01.2001]32[755982]31[

Int. Cl.(2009.01) G06F 03/048, 09/44, G09G 05/00]51[MICROSOFT CORPORATION,U.S.A.

]71[



]74[

A system and method for user interface mirroring are provided. User interface objectsare defined according to an object hierarchy that defines a logical relationship betweena root element and one or more child elements, additionally, the root element includesa directional property that is inherited by the child elements. A layout manager obtainsthe logical relationship and the specified directional property and correlates a set ofphysical coordinates each display object according to the directional property, whilemaintaining the logical relationship.

]57[

__________________


147715]21][11[

WATER מזקקת מי� ושיטת הפעלתה STILL AND METHOD OFOPERATION THEREOF

]54[

03.08.2000]22[US]33[06.08.1999]32[369805]31[

Int. Cl.(2009.01) B01D 03/00, 61/36, C02F 01/14]51[E.I. DU PONT DE NEMOURS ANDCOMPANY, U.S.A.DESIGN TECHNOLOGY ANDIRRIGATION LIMITED, UNITEDKINGDOM

]71[




]74[

A mechanical water still (10) includes an imprevious dome-like upper surface (12) anda membrane base (14) that is coupled (26) to the imprevious dome-like structure (12)to form, when inflated, a chamber (20). The membrane base (14) supports a waterpervaporation process therethrough. A water collection well (16) has an opening intowhich water droplets condensed from the water pervaporation process collect. Thewater collection well (16) is sited within the membrane base (14) and generallyextends outwardly and downwardly from the membrane base (14), as shown (in fig.1).In use, a contaminated water source (24) is brought into, ideally, complete contact withthe membrane base (14), with the water collection well (16) arranged both to act as aheat sink into the water source (24) and to provide stability to the water still (10) whenfloating and immersed in the water source (24).

]57[

__________________


148113]21][11[

תאי� סרטניי� משחלה וגליקופרוטאיני� מפנינוגדני� עבור�, שטח של שאת תאי מיח עצ�

תכשירי� רוקחיי� המכילי� אות� והשימוש בה�

OVARIAN CANCER CELL ANDMYELOMA CELL SURFACEGLYCOPROTEINS, ANTIBODIESTHERETO, PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM AND USES THEREOF

]54[

08.08.2000]22[US]33[13.08.1999]32[09/374367]31[

Int. Cl.(2009.01) A61K 39/395, A61P 35/00, C07K 14/435, 14/705, 16/30, G01N33/574

]51[

IMMUNOCELLULARTHERAPEUTICS, LTD, U.S.A.

]71[




]74[

The present invention is directed to cell surface antigenes found on myeloma cells andon ovarian cancer cells that are recognized by monoclonal antibodies, and antibodybinding fragments thereof, as described. The monoclonal antibodies of the inventionare capable of being used for therapeutic, screening, diagnostic and cell purificationpurposes. A representative and exemplified monoclonal antibody of the presentinvention recognizes and binds to an epitope common to a surface antigen that isexpressed on multiple myeloma cells and to a surface antigen that is expressed onovarian cancer cells. The function of this monoclonal antibody bothin vivo andin vitrois demonstrated.

]57[

__________________


148261]21][11[

INTEGRATED מתג במעגל משולב ע� מעבד CIRCUIT SWITCHWITH EMBEDDED PROCESSOR

]54[

07.09.2000]22[US]33[08.09.1999]32[60/152849]31[US10.01.2000 60/175339

Int. Cl.(2009.01) H04L 12/24, 12/40, 12/46, 12/56]51[MELLANOX יוקנעם,מ"מלנוקס טכנולוגיות בע TECHNOLOGIES LTD.]71[

WO/2001/018977]87[בער מרק"ד ,מ"פרידמן



]74[

A switching interface (20) for a packet-switching network (22), including a packetswitch (24), adapted to convey data packets generated in the packet-switchingnetwork; and a central processing unit (CPU) (30), adapted to control the packetswitch, such that the packet switch and CPU are implemented as a single integratedcircuit device. Preferably, the single device also includes a channel adapter (26).

]57[

__________________

148582]21][11[

CLEANING אביזר ניקוי ARTICLE]54[

05.07.2001]22[JP]33[10.07.2000]32[2000-208756]31[JP12.04.2001 2001-113750

Int. Cl.(2009.01) A47L 13/12, 13/20, 13/38]51[UNI-CHARM CORPORATION,JAPAN

]71[

YOSHINORI TANAKA,MASATOSHI FUJIWARA, AKEMI

]72[


TSUCHIYAWO/2002/003847]87[



]74[

There is disclosed a cleaning article (1) including a brush portion (26). The brushportion (26) has a plurality of strips (12, 17) and at least one layer of a fiber bundle (3,4, 6).

]57[

__________________

149142]21][11[

, וק המופעל על ידי ליגאנדחלבו� המווסת שיעתבו"מולקולת חומצת גרעי� המקודד לנ ל ושימוש

LIGAND ACTIVATEDTRANSCRIPTIONALREGULATOR FUSION PROTEIN,NUCLEIC ACID MOLECULEENCODING THE SAME AND USETHEREOF

]54[

23.10.2000]22[US]33[25.10.1999]32[09/433042]31[US02.06.2000 09/586625

Int. Cl.(2009.01) A61K 48/00, C07K 14/47, 19/00, C12N 15/62]51[THE SCRIPPS RESEARCHINSTITUTE, U.S.A.

]71[




]74[


Fusion proteins for use as ligand-dependent transcriptional are provided. The fusionproteins include a nucleotide binding domain operatively linked to a ligand-bindingdomain. They also can include a transcription regulating domain. The nucleotidebinding domain is a zinc-finger peptide that binds to a targeted contiguous nucleotidesequence of from 3 to 18 nucleotides are provided. The fusion proteins are used forgene therapy. Also provided are polynucleotides encoding the fusion proteins,expression vectors, and transfected cells.

]57[

__________________

149282]21][11[

EDIBLE תכשיר לציפוי אכיל COATINGCOMPOSITION

]54[

07.02.2000]22[US]33[29.10.1999]32[60/162514]31[US24.11.1999 60/167407 US17.12.199960/172526US27.01.200009/491724

Int. Cl.(2009.01) A61K 09/00]51[144352]61[FMC CORPORATION, U.S.A.]71[WO/2001/032150]87[

,לוצאטולוצאטו את עומר, גן תעשייה



]74[

An edible, hardenable coating composition containing microcrystalline cellulose andcarrageenan and at least one of a strengthening polymer, a plasticizer, a surface activeagent or a combination thereof. The coating composition of the present invention maybe applied to pharmaceutical and veterinary solid dosage forms, confectionery, seeds,animal feed, fertilizers, pesticide tablets, and foods and provides an elegant prompt

]57[


release coating which does not retard the release of active ingredients from the coatedsubstrate.

__________________

150243]21][11[

שיטה ומערכת להערכה ההפרעות האופטיות קולי–המתרחשות בשדה זרימה על

METHOD AND SYSTEM FOREVALUATING OPTICALDISTURBANCES OCCURING INA SUPERSONIC FLOW FIELD

]54[

16.06.2002]22[Int. Cl.(2009.01) G01M 11/02]51[

מ"רפא בעל ,מ"ערכות לחימה מתקדמות חיפה

RAFAEL ADVANCED DEFENSESYSTEMS LTD.

]71[

EVGENY עופר פדה, יבגני פרומקר FRUMKER, OFER PADE]72[בע"ד ,מ"ר מרק פרידמן



]74[

A method of evaluating optical disturbances occurring in a supersonic flow fieldaround a solid body, comprising the steps of:(a) performing a computational fluid dynamics (CFD) calculation to obtain a three-dimensional index-of-refraction field outside the solid body; and(b) performing at least one ray tracing calculation based on said index-of-refractionfield to obtain a numerical estimate of the optical disturbances.

]57[

__________________

150350]21][11[

מאפנני� חדשי� של העברה עצבית על ידי דופאמי�

MODULATORS OF DOPAMINENEUROTRANSMISSION

]54[

22.12.2000]22[SE]33[22.12.1999]32[9904723-5 ]31[


Int. Cl.(2009.01) A61K 31/445, A61P 25/00, C07D 211/18]51[NSAB, FILIAL AF NEUROSEARCHSWEDEN AB, SVERIGE, DENMARK

]71[

BENGT ANDERSSON (DECEASED),CLAS SONESSON, SUSANNAWATERS, NICHOLAS WATERS,JOAKIM TEDROFF

]72[

WO/2001/046146]87[מ עורכי דין ועורכי, הוללקבוצת איתן

,פטנטים10שדרות אבא אבן



]74[

New substituted 4-(phenyl N-alkyl)-piperazine and 4-(phenyl-N-alkyl)-piperidinecompounds of Formula (1) wherein X is N, CH, or C, however X may only be C whenthe compound comprises a double bind at the dotted line; R1 is CF3, OSO2CF3,OSO2CH3, SOR7, SO2R7, COR7, CN, OR3, NO2, CONHR3, 3-thiophene, 2-thiophene, 3-furane, 2-furane, F, Cl, Br, or I; R2 is F, Cl, Br, I, CN, CF3, CH3, OCH3,OH, and NH2; R3 and R4 are independently H or a C1-C4 alkyl; R5 is a C1-C4 alkyl,an allyl, CH2SCH3, CH2CH2OCH3, CH2CH2CH2F, CH2CF3, 3,3,3-trifluoropropyl,4,4,4-trifluorobutyl, or -(CH2)-R6; R6 is a C3-C6 cycloalkyl, 2-tetrahydrofurane, or 3-tetrahydrofurane; R7 is a C1-C3 alkyl, CF3, or N(R4)2, and pharmaceuticallyacceptable salts thereof are disclosed. Also pharmaceutical compositions comprisingthe above compounds and methods wherein the above compounds are used fortreatment of disorders in the central nervous system are disclosed.

]57[

__________________

151211]21][11[

, פוליפפטיד הפועל הדדית ע� ג� הפרקי�הרכבי� רוקחיי� המכילי� אותו לשימוש

בטיפול בפתולוגיות ניאורודגנרטיביות ושיטה להכנתו

POLYPEPTIDE THAT INTERACTSWITH PARKIN.PHARMACEUTICALCOMPOSITIONS COMPRISINGTHE SAME FOR TREATINGNEURODEGENERATIVEPATHOLOGIES AND METHOD

]54[


FOR PRODUCING SAIDPOLYPEPTIDE

15.02.2001]22[FR]33[17.02.2000]32[00/01980]31[US18.04.2000 60/198489

Int. Cl.(2009.01) A61K 38/17, C07K 14/47, C12N 05/10, 15/12, G01N 33/50]51[INSERMAVENTIS PHARMA S.A., FRANCE

]71[




]74[

The invention concerns novel compounds and their uses, in particular pharmaceutical,diagnostic or as pharmacological targets. More particularly, the invention concerns anovel protein, called PAP1, and novel peptides and compounds capable of modulatingat least partially parkin gene activity.

]57[



__________________

151353]21][11[

APPARATUS מתק� למחיקת קווי סימו� על כבישי� FOR ERASINGROAD LANE LINES

]54[

20.08.2002]22[Int. Cl.(2009.01) E01H 01/05]51[

ZAMIR ראשון לציון, זמיר מנור MANOR]71[,ריינהולד כהן ושותפיו



]74[

An apparatus for erasing a road marking on a road lane comprising:a chassis adapted to travel over said road lane;a heating source mounted to the chassis; andat least one positively driven rotatable brush mounted to said chassis, said at least onebrush having bristles adapted for being heated directly by the heating source and

]57[


contactable with said road marking for applying heat thereto for removing the markingfrom said road, such that the only portion of the road that is significantly heated is thatportion contacted by the bristles.

__________________

151479]21][11[

METHODS שיטות להכנת צמחי� טרנספלסטומיי� FOR MAKINGTRANSPLASTOMIC PLANTS

]54[

22.03.2001]22[US]33[22.03.2000]32[60/191147]31[

Int. Cl.(2009.01) A01H 05/00, C12N 15/87]51[ICON GENETICS, INC., U.S.A.]71[WO/2001/070939]87[




]74[

Disclosed are methods for transforming plastids and moving transformed plastids fromone plant to another. Also disclosed are transplastomic plants, parts thereof, and seedderived therefrom. Further disclosed is a cell or protoplast of a plant, or a culturethereof (e.g., a callus culture) wherein the cell or protoplast contains a plastid obtainedfrom a cell of a genetically distinct plant and that contains a nucleic acid of interest.

]57[

__________________

151570]21][11[

שיטה לאבחו� רגישות למזו� של מערכת חיסונית

METHOD FOR DIAGNOSINGIMMUNOLOGIC FOODSENSITIVITY

]54[

13.03.2001]22[US]33[15.03.2000]32[60/189668]31[US10.08.2000 60/224470 US02.03.200109/798557


Int. Cl.(2009.01) G01N 33/53]51[KENNETH D. FINE, U.S.A.]71[WO/2001/069251]87[




]74[

The invention includes novel methodology for diagnosing immunologic food or drugsensitivities. The method for diagnosing food sensitivities includes using diagnoses ofother related disorders, such as microscopic colitis or other chronicimmunologic/autoimmune syndromes, chronic diarrhea, irritable bowel syndrome, andhepatitis C and other hepatic diseases, Crohn's disease, alcoholism, and otheridiopathic neuropsychiatric and neurologic disorders, as indicators in the diagnosis ofthe food sensitivity. Additionally, failure to respond to or a relapse after treatment formicroscopic colitis with bismuth subsalicylate is disclosed by the present invention asbeing a further indicator in the diagnosis of immunologic food sensitivity. Finally, thepresence of certain HLA-DQ alleles, particularly HLA-DQ1,3; -DQ1,7; -DQ1,8; and -DQ1,9, HLA-DQ1,1, and at least two subtypes of the HLA-DQ1 allele identified bymolecular analysis as HLA-DQB1*0501 and HLA-DQB1*0602, as indicators indiagnosing immunologic food sensitivity, particularly gluten sensitivity or celiacsprue, and in diagnosing the related disease of microscopic colitis and otherautoimmune disorders is also disclosed by the invention. A method for food sensitivitypanel testing (for sensitivities other than gluten sensitivity) by detecting IgA antibodiesin serum is also disclosed. A method for testing stool samples for the presence ofparticular antibodies, which is more sensitive and less invasive than prior art testingmethods, is also disclosed for diagnosing immunologic food sensitivities. Thesemethods of diagnosis may be used alone or in combination to further enhance theaccuracy of diagnosis.

]57[

__________________

151857]21][11[

בקוויVIIIיצור גורמי קרישת ד� רקומביננטי תאי� ממקור אנושי

PRODUCTION OFRECOMBINANT BLOODCLOTTING FACTOR VIII INHUMAN CELL LINES

]54[

21.03.2001]22[EP]33[22.03.2000]32[00106225.6]31[US08.05.2000 60/203249

Int. Cl.(2009.01) A61K 38/37, 48/00, A61P 07/04, C07K 14/755, C12N 01/15, 01/19,]51[


01/21, 05/10, 15/12, 15/63OCTAGENE GMBH, GERMANY]71[WO/2001/070968]87[



]74[

The present invention relates to a method for the production of recombinant humanblood clotting factors, in particular of factor VIII and factor IX, utilizing animmortalized human cell line stably expressing viral transcription activator proteinsand carrying a vector having a promoter functionally linked to a DNA sequence codingfor a blood coagulating factor, provided that said promoter is not a viral promoterwhich is stimulated by said viral transcription activator proteins; an immortalizedhuman cell line carrying said vector; factor VIII muteins particularly suitable for theabove production method; pharmaceutical compositions comprising such factor VIIImuteins and the use of such factor VIII muteins for preparing a medicament fortreating hemophilia.

]57[

__________________

152215]21][11[

שיטה והתק� לשידור מחדש מהיר של אותות במערכת תקשורת

METHOD AND APPARATUS FORA QUICK RETRANSMISSION OFSIGNALS IN A COMMUNICATIONSYSTEM

]54[

13.04.2001]22[US]33[14.04.2000]32[09/549017]31[

Int. Cl.(2009.01) H04L 01/16, 01/18]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

A transmitting terminal, transmits signals in a form of packets to a receiving terminal,if the packet was intended for the receiving terminal, if so, the receiving terminaldemodulates the packet. The receiving terminal then computes a quality metric of thepacket, and compares the computed quality metric with a quality metric contained inthe packet. If the quality metrics match, the packet is forwarded for further processing.

]57[


If the quality metrics fail to match, the receiving terminal sends a request forretransmission of the packet. The transmitting terminal determines which packet needsto be retransmitted based on the request for retransmission. If delivery of the packet inaccordance with the aforementioned description fails, retransmission in accordancewith conventional sequence-number-based schemes, e.g., radio link protocol, isattempted.


204473,204470,203783,The applications for divisionfrom this application havenot yet been published

__________________

228415]21][11[

תכשירי, תהלי� להכנת�, נגזרות אוקסאזולידינו�רוקחות המכילי� אות� והשימוש בה� ליצור

–תרופות וכתרופות ליצירת אפקט אנטי בקטריאלי

OXAZOLIDINONE DERIVATIVES,PROCESS FOR THEIRPREPARATION,PHARMACEUTICALCOMPOSITIONS CONTAININGTHEM AND USE THEREOF INTHE MANUFACTURE OFMEDICAMENTS AND ASMEDICAMENTS FOR THEPRODUCTION OF ANANTIBACTERIAL EFFECT

]54[

23.04.2001]22[GB]33[25.04.2000]32[0009803.8]31[

Int. Cl.(2009.01) A61K 31/42, C07D 413/00]51[ASTRAZENECA AB, SWEDEN]71[WO/2001/081350]87[

',הורוביץ ושות.ש31רחוב אחד העם



]74[

Compounds of formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, wherein HET is an N-linked 5-membered heteroaryl ring,

]57[


optionally substituted on a C atom by an oxo or thioxo group; and/or by 1 or 2(1-4C)alkyl groups; and/or on an available nitrogen atom by (1-4C)alkyl; or HET is an N-linked 6-membered heteroaryl ring containing up to three nitrogen heteroatoms intotal, optionally substituted on a C atom as above; Q is selected from, for example,(Q1), R2 and R3 are independently hydrogen or fluoro; T is selected from a range ofgroups, for example, of formula (TC5), wherein Rc is, for example, R13CO-, R13SO2-or R13CS-; wherein R13 is, for example, optionally substituted (1-10C)alkyl orR14C(O)O(1-6C)alkyl wherein R14 is optionally substituted (1-10C)alkyl; are usefulas antibacterial agents; and processes for their manufacture and pharmaceuticalcompositions containing them are described.

__________________

152317]21][11[

THERMAL תהנלי� חומרני להכנת גרנולות מבעבעות HEAT PROCESS FORPREPARING EFFERVESCENTGRANULES

]54[

20.04.2001]22[US]33[20.04.2000]32[09/553528]31[

Int. Cl.(2009.01) A61K 09/00, 09/16, 09/20, 09/48, 47/46]51[ETHYPHARM, FRANCE]71[WO/2001/080822]87[



]74[

Disclosed here are effervescent granules having a controllable rate of effervescence. Insome embodiments, the such granules comprise an acidic agent, an alkaline agent, apharmacologically active agent, hot-melt extrudable binder capable of forming aeutectic mixture with the acidic agent and, optionally, a plasticizer. The effervescentgranules are made by a hot-melt extrusion process. The present invention also providesa thermal heat process for preparing a pharmacologically active agent containingeffervescent granule. In certain aspects, the granules contain pharmacologically active

]57[


agents such as narcotics, antidiarrheal agents, antiviral agents, anxiolytic agents, acholesterol lowering agent, an alpha adrenergic blocking agent, a phenanthrenederivative. By way of example, some of the narcotics that may be included in thegranules and in the process of preparing the granules include, by way of example:phenanthrene derivatives (e.g., morphine sulfate), and morphine derivatives (e.g.,hydromorphone hydrochloride).

__________________

152414]21][11[

, תתי יחידות של חלבוני קולט� ציטוקי� מיונקי�מגיבי� כימיי� והרכבי� פרמצבטיי� המכילי�

אות�

MAMMALIAN CYTOKINERECEPTOR SUBUNIT PROTEINS,RELATED REAGENTS ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHE SAME

]54[

10.05.2001]22[US]33[10.05.2000]32[60/203426]31[

Int. Cl.(2008.04) A61K 38/17, 393/95, C07K 147/15, 16/18, C12N 15/12]51[SCHERING CORPORATION, U.S.A.]71[WO/2001/085790]87[




]74[

Nucleic acids encoding mammalian, e.g., primate, receptors, purified receptor proteinsand fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided.Methods of using the compositions for both diagnostic and therapeutic utilities aredescribed.

]57[



__________________


152654]21][11[

שיטה לזיהוי מילקולה המעורבת בוויסותליפידי� ושיטה לזיהוי חולה הרגיש למחלות

ע י לפידי�"המתווכות

METHOD FOR IDENTIFYING AMOLECULE INVOLVED IN LIPIDREGULATION AND METHODFOR IDENTIFYING A PATIENTSUSCEPTIBLE TO DISEASESMEDIATED BY LIPIDS

]54[

25.05.2001]22[US]33[26.05.2000]32[578900]31[

Int. Cl.(2009.01) C07K 14/435, 14/705, C12N 15/12, G01N 33/53]51[OSCIENT PHARMACEUTICALSCORPORATION, U.S.A.CREIGHTON UNIVERSITY, U.S.A.

]71[




]74[

The present invention relates to the high bone mass (HBM) gene, the correspondingwild-type gene (Zmax1), and mutants thereof. The genes identified in the presentinvention are implicated in regulation of physiological lipid levels, and thereby lipid-mediated diseases and conditions. The invention also provides nucleic acids, includingcoding sequences, oligonucleotide primers and probes, proteins, cloning vectors,expression vectors, transformed hosts, methods of developing pharmaceuticalcompositions, methods of identifying molecules involved in lipid level regulation in asubject. In preferred embodiments, the present invention is directed to methods fortreating and preventing atherosclerosis, arteriosclerosis cardiovascular disease,atherosclerotic and arteriosclerotic associated conditions.

]57[

__________________


152754]21][11[

תכשירי, תהלי� להכנת�, נגזרות קווינאזולי�רוקחות המכילי� אות� והשימוש בה� כתרופות

ו של/וביצור תרופות לבלימת או לטיפול במחלות גידולי� מוצקי�

QUINAZOLINE DERIVATIVES,PROCESS FOR THEIRPREPARATION,PHARMACEUTICALCOMPOSITIONS CONTAININGTHEM AND USE THEREOF ASMEDICAMENTS AND IN THEMANUFACTURE OFMEDICAMENTS FOR THECONTAINMENT AND / ORTREATMENT OF A SOLIDTUMOUR DISEASE

]54[

01.06.2001]22[EP]33[06.06.2000]32[00401581.4]31[EP07.02.2001 10400297.6 EP05.03.200101400565.6

Int. Cl.(2009.01) A61K 31/498, 31/535, A61P 35/00, C07D 401/12, 401/14, 403/12,403/14, 405/12, 405/14, 409/12, 409/14, 413/12, 413/14, 417/12, 417/14

]51[

ASTRAZENECA AB, SWEDEN]71[WO/2001/094341]87[




]74[

The invention concerns quinazoline derivatives of Formula (I) wherein each of Q1, Z,m, R1, R2, R3 and Q2 have any of the meanings defined in the description; processesfor their preparation, pharmaceutical compositions containing them and their use in themanufacture of a medicament for use as an anti-invasive agent in the containmentand/or treatment of solid tumour disease.

]57[


__________________

153058]21][11[

שימוש בתרכובות ביפנילמתא� בייצור תרופה לטיפול במחלת האלצהיימר

USE OF BIPHENYLMETHANECOMPOUNDS IN THEMANUFACTURE OFMEDICAMENTS FOR THETREATMENT OF ALZHEIMER'SDISEASE

]54[

23.05.2001]22[US]33[24.05.2000]32[60/206854]31[

Int. Cl.(2009.01) A61K 31/09, A61P 25/28, 43/00]51[JORDAN LOYAL HOLTZMAN,U.S.A.

]71[




]74[

The invention includes; a method of modulating a level of chaperone protein, a methodof modulating a level of ERP57, a method of alleviating a symptom of a diseaseassociated with decreased levels of chaperone proteins, and a method of alleviating asymptom of Alzheimer's disease. The methods include administering to a patient asubstituted biphenylmethane compound. Preferably the compound is an analog tomethoxychlor. More preferably the compound is methoxychlor. The invention alsoincludes pharmaceutical compositions. The pharmaceutical compositions includesubstituted biphenylmethanes and a pharmaceutically acceptable carrier. Preferably thepharmaceutical compositions include methoxychlor analogs and a pharmaceuticallyacceptable carrier. More preferably the pharmaceutical compositions includemethoxychlor and a pharmaceutically acceptable carrier.

]57[


__________________

153067]21][11[

GROWTH חומר ממרי+ הפרשת הורמו� גדילה HORMONESECRETAGOGUES

]54[

13.06.2001]22[US]33[13.06.2000]32[60/211326]31[US26.09.2000 60/234928

Int. Cl.(2009.01) A61K 31/405, A61P 05/06, 41/00, C07D 209/20, 401/14, 403/12]51[AETERNA ZENTARIS GMBH,GERMANY

]71[




]74[

The invention relates to compounds of formula (I) which are useful for elevating theplasma level of growth hormone in a mammal as well as for the treatment of growthhormone secretion deficiency, growth retardation in child and metabolic disordersassociated with growth hormone secretion deficiency.

]57[

__________________

153291]21][11[

שיטה ומערכת להערכת מצב והכוונה דינמיתלכלי טייס להשגת ביצועי� אופטימליי� בניהול

קרבות אויר

SYSTEM AND METHOD FORSITUATION ASSESSMENT ANDDYNAMIC GUIDANCE TOAERIAL VEHICLES FOR THEOPTIMAL CONDUCT OF CLOSE-IN MANEUVERING AIRCOMBAT

]54[

05.12.2002]22[Int. Cl.(2009.01) F41G 07/00]51[

NIR ניר פדן PADAN]71[]SOROKER-AGMON,]74,אגמון-סורוקר


14רחוב שנקר, בית נולטון הרצליה פיתוח

14 SHENKAR ST.,HERZLIYA PITUAH 46725

A system for optimizing the performance of an operating crew of at least one aerialvehicle during at least one close-in air combat, comprising:at least one computer;an assessment information database implemented on the at least one computer;an assessment and guidance software application implemented on the at least onecomputer;wherein the information in said database comprises information about at least oneother aerial vehicle participating in combat; andwherein said software is programmed to use the information in said database toprovide in real time an automatic situation assessment, dynamically generate at leastone indication of the assessment, and communicate the at least one indication atguidance to the operating crew of the at least one aerial vehicle, during at least oneclose-in air combat.

]57[

__________________

153317]21][11[

SYSTEM מערכת בעלת מסגרת חלו� זזה WITH SLIDING SASH]54[

08.12.2002]22[Int. Cl.(2009.01) E06B 07/16]51[

KLIL פתח תקוה,מ"קליל תעשיות בע INDUSTRIES LTD.]71[IGOR איגור יוסים YUSIM]72[

,מ"דקל פטנט בע27חדר18מנוחה ונחלה

רחובות

DEKEL PATENT LTD.,18 MENUHA VENEHALA ST.,REHOVOT 76209

]74[

A system comprising:a sash (10) slidingly mounted on a track motion system (20) and pivotable withrespect to the track motion system;a guide member (30) arranged for translation in and out of said sash between a firstposition (32), wherein said guide member protrudes from said sash into a portion ofsaid track motion system sufficiently to prevent substantial pivoting of said sash withrespect to said track motion system, and second position (31), wherein said guidemember is retracted in said sash sufficiently to permit pivoting of said sash withrespect to said track motion system, wherein said guide member is adapted to seal saidsash with respect to said track motion system in said first position; anda sealing element (34) attached to said guide member, adapted to sealingly contactsaid track motion system in said first position.

]57[


__________________

153333]21][11[

הרכבי� לשחרור מושהה של אנטיביוטיקה קינולו� ושיטה להכנת�

SUSTAINED-RELEASEPREPARATIONS OF QUINOLONEANTIBIOTICS AND METHOD FORPREPARATION THEREOF

]54[

13.06.2001]22[DE]33[26.06.2000]32[10031043.5]31[

Int. Cl.(2009.01) A61K 09/00]51[BAYER SCHERING PHARMA AG,GERMANY

]71[





]74[

The invention relates to an orally dosable preparation containing a quinoloneantibiotic, which releases the active ingredient in a sustained manner. A preferredembodiment concerns preparations comprising a mixture of a quinolone free base andthe salt thereof. Particularly preferred are mixtures of ciprofloxacin hydrochloride andciprofloxacin betaine.

]57[

__________________

153656]21][11[

תכשירי� ושיטות לטיפול בכאב של ממברנה רירית

COMPOSITIONS FOR TREATINGPAIN OF THE MUCOUSMEMBRANE

]54[

26.06.2001]22[US]33[26.06.2000]32[60/222164]31[

Int. Cl.(2009.01) A61K 45/00]51[EPICEPT CORPORATION, U.S.A.]71[WO/2002/000195]87[



]74[

Compositions useful for long-lasting pain relief from mucosal damage, such asmucosal inflamation, abrasions, ulcerations, lesions, trauma and incisions, withoutsignificant systemic absorption. The compositions of the invention are particularlysuitable for application to the mucous membrane of the nasal cavity and bucal cavity.To relieve pain, the compositions or the invention are topically applied directly to theaffected area.

]57[

__________________


153682]21][11[

תהליכי� להכנת� ותכשירי, תולדות וריאולי� רוקחות המכילי� אות�

VARIOLIN DERIVATIVES,PROCESSES FORTHEPREPARATION THEREOF ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME

]54[

11.07.2001]22[GB]33[11.07.2000]32[0017055.5]31[GB15.12.2000 0030689.4

Int. Cl.(2009.01) A61K 31/437, 31/505, A61P 35/00, C07D 471/14]51[PHARMA MAR, S.A., SPAIN]71[WO/2002/004447]87[

,ברגמן וגולר, וולף ירושלים1352.ד.ת,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,JERUSALEM 91013

]74[

The invention provides variolin derivatives of formula (I), wherein: R1 and R2 areeach independently selected from the group consisting of H, OH, ORï, SH, SRï, SORï,SO2Rï, NO2, NH2, NHRï, N(Rï)2, NHCORï, N(CORï)2, NHSO2Rï, CN, halogen,C(=O)H, C(=O)Rï, CO2H, CO2Rï, C1-C12 alkyl, C1-C12 haloalkyl, C2-C12 alkenyl,C2-C12 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted aralkyland substituted or unsubstituted heteroaromatic; and R3 is selected from the groupconsisting of H, OH and OMe; wherein the or each group Rï is independently selectedfrom the group consisting of OH, C1-C12 alkyl, C1-C12 haloalkyl, C2-C12 alkenyl,C2-C12 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted aralkyl,substituted or unsubstituted arylalkenyl and substituted or unsubstitutedheteroaromatic, and wherein the group R1, R2 or R3 is a group of formula N(Rï)2 orN(CORï)2, each of the Rï groups may be the same or different, or the two Rï groups,together with the nitrogen atom to which they are attached, may form a 5-14membered heterocyclic ring. These compounds display activity against a range ofmammalian cancer cell lines. New synthetic routes to new and known variolincompounds, together with novel intermediates, are also disclosed. New antitumouractivity of known variolin compounds is also described.

]57[


__________________

153818]21][11[

תהלי� לזיהוי מאפנני� של קולטני� מצומדיG–חלבו�

PROCESS FOR IDENTIFYINGMODULATORS OF G - PROTEIN -COUPLED RECEPTORS

]54[

05.07.2001]22[DE]33[08.07.2000]32[10033353.2]31[

Int. Cl.(2009.01) C12N 15/12, 15/70, 15/81, 15/85, C12Q 01/02, C40B 30/06, G01N21/64

]51[

SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[

WO/2002/004665]87[,לצר וכהן צדק, פרל, איתן

7רחוב שנקר הרצליה12688.ד.ת,

EITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,HERZLIYA 46733

]74[

The invention relates to a method with a wide range of applications, for identifyingchemical compounds that modulate G-protein-coupled receptors by means of novelhybrid G-proteins with an extremely broad receptor specificity and an extremely highexpression. The invention also relates to chemical compounds that can be identified bya method of this type.

]57[

__________________

153894]21][11[

שיטה ומערכת למדידת עובי של שכבות דקות מוליכות

METHOD AND SYSTEM FORTHICKNESS MEASUREMENTSOF THIN CONDUCTIVE LAYERS

]54[

12.01.2003]22[Int. Cl.(2009.01) G01B 07/06]51[

NOVA רחובות,מ"נובה מכשירי מדידה בע MEASURINGINSTRUMENTS LTD.

]71[

,כהן ושותפיו ריינהולד'א26רחוב הברזל רמת החייל

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

]74[


RAMAT HACHAYAL 69710

A method for measuring in an electrically conductive film of a specific sample, themethod comprising:providing data indicative of a free space response of an RF sensing coil unit to ACvoltage applied to the RF sensing coil;locating said sensing coil proximate to the sample at a distanceh substantially notexceeding 0.2r whereinr is the coil radius; supplying an AC voltage in a range from100MHz to a few GHz to the sensing coil to cause generation of an eddy currentpassage through the conductive film;detecting a response of said sensing coil to an effect of the electric current through theconductive field onto a magnetic field of the coil and generating measured dataindicative of said response; and utilizing said data indicative of the free spacemeasurements to analyze the measured data and to determine at least a thickness of theconductive film in said specific sample, the method providing for measuring inconductive films with a sheet resistance R, in a range from about 0.009 to about 2Ohm/m2.

]57[

__________________

154006]21][11[

)HDL(שימוש בליפופרוטאי� בעל ריכוז גבוהמשוק� לייצור תרכובות לטיפול במחלות

וסקולריות לשיפור אקוטי של פעילות אנדותליאלית

USE OF RECONSTITUTED HIGH-DENSITY LIPOPROTEIN (HDL)FOR PRODUCING ACOMPOSITION FOR TREATINGVASCULAR DISORDERS FORACUTE IMPROVEMENT OFENDOTHELIAL FUNCTION

]54[

20.07.2001]22[DE]33[20.07.2000]32[10035352.5]31[

Int. Cl.(2009.01) A61K 38/17, 45/00, A61P 09/10, 43/00, C07K 14/435]51[CSL BEHRING AG, SWITZERLAND]71[WO/2002/007753]87[

,ריינהולד כהן ושותפיו'א26הברזל רחוב

רמת החייל


]74[

The invention relates to the use of reconstituted HDL for improving the endothelialfunction in patients suffering from hypercholesterolaemia and for treating or

]57[


preventing acute coronary diseases such as unstable angina pectoris.

__________________

154155]21][11[

ותכשירי רוקחותBתולדות של וריאולי� כילי� אות�המ

DERIVATIVES OF VARIOLIN BAND PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME

]54[

03.08.2001]22[GB]33[03.08.2000]32[0019117.1]31[

Int. Cl.(2009.01) A61K 31/437, 31/4375, A61P 35/00, C07D 471/14]51[PHARMA MAR S.A., SOCIEDADUNIPERSONAL, SPAIN

]71[



]74[

The invention provides antitumour compounds of formula (I), wherein R1 is anaromatic substituent; R2 is hydrogen or a substituent when the dotted line is absent, orR2 is absent when the dotted line represents a bond to give a double bond between thenitrogen which bears R2 and the carbon which bears R3; R3 is an oxo group = O whenthe dotted line is absent or is a substituent when the dotted line represents a bond togive a double bond between the nitrogen bearing R2 and the carbon bearing R3; R4 ishydrogen or a substituent; and pharmaceutically acceptable salts thereof.

]57[

__________________

154294]21][11[

, שיטות ושמוש שלה�, שמרי� שעברו שינויבייחוד להפקת תולדות סטרואידיות ותכשיר

תאי–לא

MODIFIED YEASTS, METHODS,USES, IN PARTICULAR FORPRODUCING STEROIDDERIVATIVES AND ACELLULARPREPARATION

]54[


24.07.2001]22[FR]33[08.08.2000]32[00/10437]31[

Int. Cl.(2009.01) C12N 01/16, 01/19, C12P 33/06]51[AVENTIS PHARMA S.A., FRANCE]71[WO/2002/012536]87[




]74[

The invention concerns novel yeast strains, methods and genetic constructs forpreparing them, and their use for synthesising or modifying steroid compounds. Moreparticularly, the invention concerns strains having reduced 20α-HSD activity, inparticular by modification of the GCY1 and/or YPR1 genes. The inventive yeaststrains enable to improve the efficacy of synthesis or to increase selectivity or yields ofthe process, as well as the quality of the final product. The inventive strains, methodsand compounds are useful for researching, developing and producing products withtherapeutic or prophylactic activity, in a human or an animal, in particular steroidderivatives.

]57[

__________________

154318]21][11[

PHARMACEUTICAL תכשירי רוקחות לטיפול בהפרעות תנועותCOMPOSITIONS FOR THETREATMENT OF MOVEMENTDISORDERS

]54[

06.02.2003]22[Int. Cl.(2009.01) A61K 45/00]51[

SARAH בית חולים הרצוג עמותת עזרת נשים HERZOG MEMORIAL]71[


HOSPITAL EZRAT NASHIMASSOCIATION

ג DANIEL אוריאל הרסקו, ביט'דניאל C. JAVITT, URIELHERESCO

]72[



]74[

Use of D-serine for the manufacture of a medicament for the treatment of a movementdisorder to alleviate motor disorder symptoms by administration to a patient at a doseof from 250 mg to 20 g per day.

]57[

__________________

154529]21][11[

רצ� משלי� לחלבו� קושר פקטור גידול דמוי)IGFBP(–2–אינסולי�

אוליגודאוקסינוקלאוטידי� לטיפול בפרוסטטה ובגידול אנדוקריני אחר

ANTISENSE INSULIN-LIKEGROWTH FACTOR BINDINGPROTEIN (IGFBP)-2-OLIGODEOXYNUCLEOTIDESFOR PROSTATE AND OTHERENDOCRINE TUMOR THERAPY

]54[

13.09.2001]22[US]33[14.09.2000]32[60/232641]31[

Int. Cl.(2009.01) A61K 48/00, A61P 35/00, 35/04, C12N 15/11]51[THE UNIVERSITY OF BRITISHCOLUMBIA, CANADA

]71[

WO/2002/022642]87[',ר שלמה כהן ושות"ד

124אבן גבירול תל אביב11490.ד.ת,


]74[

Compositions and a method are provided for the treatment of prostate and otherendocrine tumors in mammals, including humans, by administration of an antisenseoligodeoxynucleotide (ODN) which is complementary to a portion of the geneencoding IGFBP-2. Using the human prostate cancer LNCaP tumor modelin vitro andin vivo, the administration of such an ODN was shown to reduce proliferation of tumorcells, and also to delay the progression to androgen independence. Thus, treatment ofprostate and other hormone-regulated cancer in mammals, including humans, anddelay of the progression of prostate tumors to androgen independence is accomplishedby administering to the mammal a therapeutically effectie amount of an antisenseoligodeoxynucleotide which is complementary to a portion of the nucleic acidsequence encoding IGFBP-2 and which reduces the amount of IGFBP-2 in the treated

]57[


cells.

__________________

154544]21][11[

bרצ� קולט� J – b D – b Vשל תא מסוגTT CELL RECEPTOR VBETA-DBETA-JBETA SEQUENCE ANDMETHODS FOR ITS DETECTION

]54[

22.08.2000]22[Int. Cl.(2009.01) A61K 38/02, A61P 25/28, 37/02, C07K 14/705]51[BAYLOR COLLEGE OFMEDICINE, U.S.A.

]71[




]74[

In one embodiment, the present invention is directed to a first oligonucleotidecomprising the sequence of or derived from 5'-CTAGGGCGGGCGGGACTCACCTAC-3' or the nucleic acid sequencecomplementary thereto. The first oligonucleotide can be used with a nucleic acid ofbetween 15 and 30 nucleotides that does not comprise the sequence of the firstoligonucleotide and is found in the region from V(beta) to J(beta) of the Vbeta13.1gene in Vbeta 13.1 T cells, wherein the sequences of the oligonucleotide and thenucleic acid are not found on the same strand of the V(beta)13.1 gene pair, to amplifya portion of the V(beta)13.1 gene. Alternatively, the first oligonucleotide can be usedwith a labeling moiety in methods of detecting a LGRAGLTY motif found in T cellreceptors of V(beta)13.1 T cells. This motif is associated with autoimmune diseases,such as multiple sclerosis (MS). Once the motif is detected, the autoimmune diseasecan be treated or its progress monitored. The autoimmune disease can be treated byadministering one or more peptides comprising the LGRAGLTY motif.

]57[


__________________

154657]21][11[

MULTIPLE זיכרונות לא משתני� מרובי� NONVOLATILEMEMORIES

]54[

27.02.2003]22[US]33[28.02.2002]32[10/085331]31[

Int. Cl.(2009.01) G06F 12/14, G11C 07/08]51[HUGHES ELECTRONICSCORPORATION, U.S.A.

]71[




]74[

One or more embodiments of the invention provide a method, apparatus, and article ofmanufacture for controlling unauthorized access to digital services comprising: Accesscontrol to digital services is distributed among a plurality of physically separate andindependently controlled nonvolatile memory components on a system bus . Theplurality of nonvolatile memory components are communicatively coupled to amicroprocessor . The microprocessor is configured to use state information in thenonvolatile memory components to provide desired functionality and enforce one ormore security policies for accessing the digital services.

]57[

__________________

154658]21][11[

DEDICATED זיכרו� יעודי שאינו משתנה NONVOLATILEMEMORY

]54[

27.02.2003]22[US]33[28.02.2002]32[10/085920]31[

Int. Cl.(2009.01) G06F 12/14, G11C 07/00]51[HUGHES ELECTRONICSCORPORATION, U.S.A.

]71[

ט SANFORD',קולב ושות. סנפורד T.COLB & CO.,]74[


מרמורק,4שער הגיא רחובות2273.ד.ת,

P.O.B. 2273,REHOVOT 76122

One or more embodiments of the invention provide a method, apparatus, and article ofmanufacture for limiting unauthorized access to digital services comprising. Aprotected nonvolatile memory component (614) is configured. The protectednonvolatile memory component (614) is used to contain state information to providedesired functionality and enforce one or more security policies for accessing the digitalservices.Additionally, the protected nonvolatile memory component (614) and amicroprocessor's (602) nonvolatile memory component (606) share a programmingcharge pump and programming control. Once configured, access to the nonvolatilememory component (614) is controlled through a fixed state custom logic block (612).

]57[


__________________

154712]21][11[

MODIFIED וירוס ואקסיניה אנקרה משתנה משופר VACCINIA ANKARAVIRUS VARIANT

]54[

22.11.2001]22[DK]33[23.11.2000]32[PA200001764]31[

Int. Cl.(2009.01) A61K 39/285, A61P 37/04, C12N 07/04, 15/39, 15/863]51[BAVARIAN NORDIC A/S,DENMARK

]71[




]74[

The present invention provides an attenuated virus, which is derived from ModifiedVaccinia Ankara virus and which is characterized by the loss of its capability toreproductively replicate in human cell lines. It further describes recombinant virusesderived from this virus and the use of the virus or its recombinants as medicament orvaccine. Additionally, a method for inducing an immune response even in immuno-compromised patients, patients with pre-existing immunity to the vaccine virus orpatients undergoing antiviral therapies is provided.

]57[



__________________

154790]21][11[

מחק עבור מערכת לשיפור המרה של פני שטח מישורי למתק� אלקטרוני לתפיסת נתוני�

ERASER FOR ARETROFITTABLE APPARATUSFOR CONVERTING ASUBSTANTIALLY PLANARSURFACE INTO ANELECTRONIC DATA CAPTUREDEVICE

]54[


20.02.1998]22[US]33[21.02.1997]32[804491]31[

Int. Cl.(2009.01) G06F 03/033]51[DIVISION FROM 131455]62[LUIDIA, INC., U.S.A.]71[WO/1998/037508]87[



]74[

A retrofittable apparatus adapted for converting a substantially planar surface into awriting surface for an electronic data capture device, comprising:a sensor array including at least two sensors that a fixedly mounted within a singlehousing to establish a fixed relationship between two or more sensors, said sensorarray providing a tracking function to determine the position of a marking implementon said writing surface;a temporary attachment for removably affixing said sensor array proximate to saidsubstantially planar surface; andan eraser comprising a handle, an erasing edge, and at least two transmitters, in whichone transmitter is attached to a first end of said erasing edge and a second transmitter isattached to a second end of said erasing edge,wherein said eraser is operable to erase a thin portion of the writing surface by movingthe eraser in a motion that is parallel to the axis of the eraser, said eraser is operable toerase a wide portion of said marking surface by moving said eraser perpendicular tothe axis of the eraser edge, and said eraser may be operable to eraser a swath having awidth between said wide and narrow swaths by moving said eraser edge diagonally.

]57[

__________________

155018]21][11[

]FITTING]54 מתא�


20.09.2001]22[DE]33[22.09.2000]32[10047559.0]31[DE22.09.2000 10047557.4 DE22.09.200010047558.2DE28.03.200120105539.2

Int. Cl.(2009.01) E05D 05/02]51[DORMA GMBH + CO.KG,GERMANY

]71[




]74[

The invention relates to fittings (1, 21) for the fixing and/or locking arrangement of aglass element (45) on at least one adjacent glass element, whereby the fittings (1, 21)are composed of fitting halves (2, 3, 22, 23, 26, 27) each consisting of a substructure(42) fixed to the glass element (45) and of a covering (25) that crowns the substructure(42). The aim of the invention is to create a fitting (1, 21), which forms a compact andvisually appealing unit having a smallest possible overall height, whereby retaining theexisting diversity of use and the various functions. To this end, the covering (25)comprises a front surface (7, 30), which is fixed between lateral faces (5, 6, 28, 29) andwhich curves in a convex manner from one edge (8, 31) to the opposite edge (9, 32).

]57[

__________________

155123]21][11[

פריימרי� ועילו� לאיבחו� של סיכיזופרניה וערכה לאבחו�

PRIMERS FOR SCREENINGSCHIZOPHRENIA ANDDIAGNOSTIC KIT THEREOF

]54[

25.03.2002]22[Int. Cl.(2009.01) C12Q 01/68]51[COUNCIL OF SCIENTIFIC ANDINDUSTRIAL RESEARCH, INDIA

]71[

SAMIR KUMAR BRAHMACHRI,]72[


VERMA RANJANA, CHAUHANCHITRA, Q. SALIM, S. JAINWO/2003/080867]87[




]74[

The present invention relates to novel primers useful for identifying and screeningnon-sense mutation with codon TGG coding for amino acid tryptophan substitutedwith TAG a non-sense codon at nucleotide No. 825in exon 2 of synaptogyrin 1 geneof chromosome 22q11-13, thereby detecting pre-disposition to schizophreniain asubset of patients and a method thereof.

]57[

__________________

155228]21][11[

GUARDRAIL טרמינלי� של מעקה בטיחות TERMINALS]54[

05.10.2001]22[US]33[05.10.2000]32[09/679902]31[

Int. Cl.(2009.01) E01F 15/04, 15/14]51[THE TEXAS A&M UNIVERSITYSYSTEM, U.S.A.

]71[




]74[

Devices and methods for supporting guardrail terminal installations that incorporatesafety end treatments such as the GET and the SRT. Preferred embodiments aredescribed wherein guardrail terminal installations are primarily anchored to the groundusing weak support posts that are preferably made of metal. The ends of the guardrailinstallation are secured to the ground using breakaway posts. In operation, the weakposts permit the central portion of the guardrail installation to contain and redirect thevehicle during a lateral collision to the rail member. The anchorage provided by thebreakaway end posts helps prevent the guardrail from being excessively displaced,thus preventing the impacting vehicle from breaking through the guardrail. Inoperation, guardrail terminal assemblies constructed in accordance with the presentinvention provide an improved support system for the rail member which is moreforgiving than conventional strong post anchorages, thereby providing an improvement

]57[


in safety.

__________________

155297]21][11[

FKAHALALIDEפורמולציה של קהלאליד F FORMULATION]54[

31.10.2001]22[US]33[31.10.2000]32[60/244471]31[US06.11.2000 60/246229 US19.10.200160/348449

Int. Cl.(2009.01) A61K 09/19, 38/15, 47/12, 47/26, A61P 35/00, C07K 11/02]51[PHARMA MAR, S.A., SPAIN]71[WO/2002/036145]87[




]74[

New formulations and new uses of kahalalide F are provided.]57[

__________________

155466]21][11[

INTEGRATED מצע למעגל משולב בעל גומחות CIRCUIT CARRIERWITH RECESSES

]54[

19.10.2001]22[US]33[20.10.2000]32[09/693707]31[


Int. Cl.(2009.01) H05K 01/14]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA

]71[




]74[

An integrated circuit carrier (10) includes a wafer having a receiving zone (12). Thereceiving zone (12) is demarcated by a bore (60) in the wafer. A plurality of island-defining portions (16) is arranged about the receiving zone (12). Each island-definingportion (16) has an electrical terminal electrically connected to an electrical contact ofsaid at least one receiving zone (12). A rigidity-reducing arrangement (40) connectseach island-defining portion (16) to each of its neighbouring island-defining portions(16).

]57[

__________________

155471]21][11[

מערכת שכפול לתמונות דיגיטליות ע� שחזור איכות תמונה

DIGITAL PHOTOGRAPHDUPLICATION SYSTEM WITHIMAGE QUALITY RESTORATION

]54[

19.10.2001]22[US]33[20.10.2000]32[09/693317]31[

Int. Cl.(2009.01) G06K 07/12]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA

]71[




]74[

An apparatus for printing out recovered image data from a photograph is disclosed.The data is recorded in infrared ink on top of the image itself in an encoded faulttolerant digital form enabling the image to be recovered notwithstanding damage to thephotograph surface. The apparatus can print out the image after processing the data. If

]57[


the data is stored then the image can be printed as many times as required.Alternatively, the photograph can be repeatedly passed through the scanner or readerthe required number of times. In another form of the invention, the apparatus can alsoprint out the image with the image data again recorded in infrared ink using a printerwhich has the necessary number of ink jet nozzles to do so and the apparatus has thenecessary processing capacity to process, compress, scramble and encode the data.

__________________

155611]21][11[

של–נוגדני� חד שבטיי� ואנטיגני� לפני שטחתכשירי� רוקחיי� המכילי� אות�, תא

ושימושי� בה�ליצירת תרופה לטיפול בסרט� )SCLC(של תאי ריאה קטני�

MONOCLONAL ANTIBODIESAND CELL SURFACE ANTIGENS,COMPOSIITONS COMPRISINGTHEM AND USES THEREOF FORPREPARING A MEDICAMENTFOR THE TREATMENT OFSMALL CELL LUNG CANCER(SCLC)

]54[

01.11.2001]22[US]33[02.11.2000]32[60/245340]31[

Int. Cl.(2009.01) A61K 39/395, 49/16, 51/10, A61P 35/00, C07K 16/30, 16/32, 16/42,C12N 05/10, C12P 21/08, G01N 33/574, 33/577

]51[

IMMUNOCELLULARTHERAPEUTICS, LTD, U.S.A.

]71[




]74[

The invention provides new monoclonal antibodies and binding fragments thereofwhich recognize and immunoreact with cell surface antigens found on small cell lung

]57[


cancer (SCLC) cells. The antibodies have tumor specificity and are useful for therapy,diagnosis, monitoring, detecting and imaging of SCLC disease and of patients havingSCLC disease. The antibody-recognized SCLC-specific surface antigens can serve astargets for detecting, diagnosing, inhibiting or killing SCLC cells.

__________________

155612]21][11[

PROCESS תהלי� להכנת תרכובות אזול מסיסות במי� FOR PREPARATION OFWATER SOLUBLE AZOLECOMPOUNDS

]54[

18.10.2001]22[US]33[20.11.2000]32[60/252001]31[

Int. Cl.(2009.01) C07F 09/00, 09/6518, 09/6558]51[EISAI R&D MANAGEMENT CO.,LTD., JAPAN

]71[




]74[

An improved process is provided for preparing water-soluble prodrugs of triazoleantifungal compounds containing a secondary or tertiary hydroxyl group. Moreparticularly, the improved process is directed toward preparation of water-solubletriazole antifungal compounds having the general formula (I) wherein A is the non-hydroxy portion of a triazole antifungal compound of the type containing a secondaryor tertiary hydroxyl group and R and R?1¿ are as defined in the specification.

]57[

__________________


021557]21][11[

תכשירי רוקחות, תרכובות פיפראזינילפיראזי�המכילי� אות� ושימושיה� בהכת תרופה לטיפול

במצבי� רפואיי� הקשורי� בסרוטוני�

PIPERAZINYLPYRAZINECOMPOUNDS,PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM AND USE THEREOF INTHE PREPARATION OFMEDICAMENTS FOR THETREATMENT OF SEROTONINRELATED MEDICALCONDITIONS

]54[

20.11.2001]22[SE]33[20.11.2000]32[0004245-7 ]31[US28.11.2000 60/253509

Int. Cl.(2009.01) A61K 31/395, A61P 25/00, 43/00, C07D 401/12, 403/04, 405/14,409/14, 413/14, 417/14

]51[

BIOVITRUM AB, SWEDEN]71[WO/2002/040456]87[




]74[

A compound of the general formula (I), wherein R1, R2, X, Y and Z are as describedin the specification.

]57[

__________________

155778]21][11[

שיטה והתק� לאפשור תקשורת נתוני� במהירות גבוהה בסביבה סלולרית

METHOD AND APPARATUS FORPROVIDING HIGH SPEED DATACOMMUNICATIONS IN ACELLULAR ENVIRONMENT

]54[

27.10.1997]22[US]33[29.10.1996]32[08/741320]31[

Int. Cl.(2008.04) H04B 7/26, H04L 27/04, H04Q 7/22, 7/38]51[DIVISION FROM 129306]62[QUALCOMM INCORPORATED,U.S.A.

]71[





]74[

A method for a communication system comprising:receiving a signal, carrying digital data, at a mobile station of a plurality of mobilestations, from a base station, in non-overlapping transmission bursts at a fixedpredetermined power level, at a selected encoding rate, for a selected amount of dataand with a selected modulation format, wherein said non-overlapping transmissionbursts are over predefined and fixed duration time frames;decoding said received signal to retrieve said digital data based on said selectedencoding rate, said selected amount of data and said selected modulation format,wherein at least one of said selected encoding rate, said selected modulation formatand said selected amount of data for said receiving at said mobile station of saidplurality of mobile stations from said base station is based on an effective link budgetfor each of said plurality of mobile stations, wherein said link budget includes aparameter indicating transmission set at said fixed and predetermined power level.

]57[

__________________

155823]21][11[

CYLINDER מנעול צילינדר בעל אור� הנית� לכיוו� LOCK WITHADJUSTABLE LENGTH

]54[

08.05.2003]22[Int. Cl.(2009.01) E05B 09/10]51[

MUL-T-LOCK יבנה,מ"מולטילוק טכנולוגיות בע TECHNOLOGIESLTD.

]71[

DANI דני מרקברייט MARKBREIT]72[,מ"דקל פטנט בע

27חדר18ונחלה מנוחה רחובות

DEKEL PATENT LTD.,18 MENUHA VENEHALA ST.,REHOVOT 76209

]74[

A cylinder lock, comprising:a first cylinder housing (12) in which a first rotor (14) is rotatable disposed and iscoupled to a cam (22); anda connecting element (26) attached to said first cylinder housing, said connectingelement comprising an elongate bar with a plurality of housing attachment holes (28)formed therein, said elongate bar comprising a hub (32) with a lock mounting hole(34) formed therein, and a profile element (36) snap fit over said hub.

]57[


__________________

156089]21][11[

APPARATUS מתק� לאינטראקציה ע� מערכת רשת מחשב FORINTERACTION WITH ANETWORK COMPUTERSYSTEM

]54[


27.11.2000]22[Int. Cl.(2009.01) F25D 23/12, 29/00, G06Q 10/00]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA

]71[

WO/2002/042950]87[ל ,וצאטולוצאטו את



]74[

The present invention relates to an apparatus enabling interaction with a networkcomputer system. It has particular application to a system employing a printer forprinting an interface onto a surface to produce an interface surface. According to oneaspect of the invention, there is provided an apparatus enabling interaction with anetwork computer system, the apparatus including: an appliance for storing andcooling produce for use by an appliance user; and a printer device integrated into saidappliance, the printer device being operatively interconnectable with said networkcomputer system, the printer device including a printer module operable to print atleast one form delivered from said network computer system, and the printer devicebeing configured to receive indicating data from a sensing device operated by anappliance user, the sensing device when placed in an operative position relative to saidat least one form sensing the indicating data. By means of the invention, a networkterminal comprising an interactive printer device can be incorporated into, say, thedoor of a domestic refrigerator. Such an appliance is readily accessible, and isregularly visited by those who may be making use of the network terminal.

]57[

__________________

156106]21][11[

קוטלי מזיקי� המכילי�,פירוליני�–1–דלתא אות� ותהלי� להכנת�

DELTA-1-PYRROLINES,PESTICIDES COMPRISING THEMAND PROCESS FORPREPARATION THEREOF

]54[


22.11.2001]22[DE]33[05.12.2000]32[10060412.9]31[

Int. Cl.(2009.01) A01N 43/36, 43/48, C07D 401/04, 401/14, 403/04, 403/14, 405/14,409/14, 413/14, 417/14, C07F 07/10

]51[

BAYER CROPSCIENCE AG,GERMANY

]71[




]74[

The invention relates to novel delta 1-pyrrolines of formula (I), in which R1, R2, R3,m and Q have the meanings as cited in the description, to a number of methods forproducing these substances, and to their use for controlling pests.

]57[

__________________

156111]21][11[

degחסרE.coliזני של Pו–prcובעל ג�spr מוטנטי

E.COLI STRAIN DEFICIENT INDEGP AND PRC ANDHARBORING A MUTANT SPRGENE

]54[

07.12.2001]22[US]33[14.12.2000]32[60/256162]31[

Int. Cl.(2009.01) C12N 01/21, 15/57, 15/70, C12P 21/00, 21/02, 21/08, C12R 01/19]51[GENENTECH, INC., U.S.A.]71[WO/2002/048376]87[



]74[

An E. coli strain is described that is deficient in chromosomal degP and prc encodingprotease DegP and Prc, respectively, and harbors a mutant spr gene that encodes aprotein that suppresses growth phenotypes exhibited by strains harboring prc mutants.Preferably, the strain comprises nucleic acid encoding a polypeptide heterologous tothe strain, so that a heterologous polypeptide can be produced therefrom.

]57[


__________________

156190]21][11[

INFUSION משאבה עבור עירוי PUMP]54[

19.03.1997]22[US]33[19.03.1996]32[617679]31[

Int. Cl.(2008.04) A61M 51/42]51[DIVISION FROM 126207]62[I - FLOW CORPORATION, U.S.A.]71[WO/1997/034651]87[



]74[

An ambulatory infusion pump for expelling fluidfrom a fluid reservoir bag 18, comprising:a generally rectangular housing defining a central axis, said housing having an interiorspace therein;a first wall within said interior space and defining a first surface for contacting saidfluid reservoir bag;a second wall within said interior space and defining a second surface for contactingsaid fluid reservoir bag 18, said second surface facing said first surface, said second

]57[


wall being moveable between a first position and a second position relative to said firstwall, said second position being closer than said first position;and characterized in that an elongated first guide rod and an elongated second guiderod are spaced from said central axis on opposing sides thereof, said first and secondguide rods being oriented generally parallel to said central axis;a first moveable stop and a second moveable stop 23, each of said first and secondmoveable stops being slidably engaged with each of said first and second guide rods;at least one parallelogram linkage assembly having first and second opposing pivots 28connected to said housing and said second wall, respectively, and third and fourthopposing pivots connected to said first and second moveable stops, respectively; andat least one spring 14 configured to apply a force tending to bias said first and secondstops toward one another, thereby moving said third and fourth pivots toward oneanother and moving said second wall toward said second position.

__________________

156214]21][11[

XAGUANIDINEתולדות גואנידי� ואמידי� כמעכבות פקטור AND AMIDINEDERIVATIVES AS FACTOR XAINHIBITORS

]54[

28.11.2001]22[EP]33[06.12.2000]32[00126750.9]31[

Int. Cl.(2009.01) A61K 31/4245, 31/445, A61P 07/02, C07C 257/18, C07D 211/26,211/34, 271/07, 401/04, 413/04

]51[


]71[




]74[

The present invention relates to compounds of the formula (I), in which R0, Q, X, Q',D, R10 and V have the meanings indicated in the claims. The compounds of theformula I are valuable pharmacologically active compounds. They exhibit a strongantithrombotic effect and are suitable, for example, for the therapy and prophylaxis ofcardiovascular disorders like thromboembolic diseases or restenoses. They arereversible inhibitors of the blood clotting enzymes factor Xa(Fxa) and/or factorVIIa(FVIIa), and can in general be applied in conditions in which an undesired activityof factor Xa and/or factor VIIa is present or for the cure or prevention of which aninhibition of factor Xa and/or factor VIIa is intended. The invention furthermorerelates to processes for the preparation of compounds of the formula (I), their use, in

]57[


particular as active ingredients in pharmaceuticals, and pharmaceutical preparationscomprising them.

__________________

156282]21][11[

אנטגוניסטי� של קולט�2PROKINETICIN / VEGF – EG

EG-VEGF/PROKINETICIN 2-RECEPTOR ANTAGONISTS

]54[

03.06.2003]22[DE]33[26.06.2002]32[10229379.1]31[

Int. Cl.(2009.01) A61K 31/7088, 38/18, G01N 33/53]51[BAYER SCHERING PHARMAAKTIENGESELLSCHAFT,GERMANY

]71[



]74[

A composition that contains, as active agent (A), an endocrine gland vascularendothelial growth factor (EG-VEGF) nucleic acid, polypeptide or antisense nucleicacid, antibody against EG-VEGF or its receptor (EG-VEGF-R), or EG-VEGF-Rantisense nucleic acid, is useful for the treatment or prevention of endometrialdiseases. Independent claims are also included for the following: (1) method fordetecting uterine receptivity by determining the amount of EG-VEGF polypeptideand/or nucleic acid, using the new composition; or (2) test system for identifyingantagonists (B) of EG-VEGF-R.

]57[

__________________

156853]21][11[

THERMAL אגירת אנרגיה טרומית ENERGY STORAGE]54[

09.07.2003]22[Int. Cl.(2009.01) F01K 13/02, F28D 20/02]51[

PESSACH מוצא עלית, פסח זיידל SEIDEL]71[עו' דר .DR,פ"אייל ברסלר EYAL BRESSLER,]74[


11תובלגן-רמת

11 TUVAL ST.,RAMAT GAN 52522

In a self-regulating thermal energy storage system employing a thermal energy carrierfluid, for use in conjunction with a thermal energy client, said self-regulating thermalenergy storage system comprising:(a) a thermal energy reservoir for accumulating thermal energy carrier fluid whosetemperature has been changed by a predetermined value, said reservoir containing athermal energy storage medium which is susceptible to thermal layering, and having alower portion and an upper portion, and arranged such that the temperature therewithinis lower within said lower portion and highest within said upper portion;(b) a thermal energy source for imparting to the thermal energycarrier fluid a predetermined temperature change; and(c) a fluid conduit system for permitting circulation of the thermal carrier fluid inthermal exchange communication with said thermal energy unit and into and out ofsaid thermal energy storage reservoir so as to maintain the thermal layering within thethermal energy storage medium within the reservoir, operable to selectably supplyheat to said upper portion of said reservoir, thereby to cause a release of cold from therelatively cold layers of said storage medium in said lower portion thereof; and furtheroperable to selectably supply cold to said lower portion of said reservoir thereby tocause a release of heat from the relatively warm layers of said storage medium in saidupper portion thereof, in accordance with the momentary energy requirements of thethermal energy client and the momentary generation capability of said generationsource;the improvement comprising at least one solar energy collector adapted for conversionof solar energy.

]57[

__________________

156962]21][11[

SYSTEM מערכת ושיטה לקביעת מצב החללי� בגו� החי AND METHOD FORDETERMINING IN VIVO BODYLUMEN CONDITIONS

]54[

16.01.2002]22[US]33[16.01.2001]32[60/261189]31[

Int. Cl.(2009.01) G01N 21/01]51[בע'גיוון אימג GIVEN יקנעם,מ"ינג IMAGING LTD.]71[

GAVRIEL גבריאל יוסף עידן JOSEPH IDDAN]72[WO/2002/055984]87[


PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

]74[


.P.O.B הרצליה12704.ד.ת, 12704,HERZLIYA 46733

The present invention relates to the field of in vivo diagnostics. More specifically, thepresent invention relates to a system and a method for the in vivo and in-situ detectionof chemical and/or biological substances and for the in vivo detection of physicalconditions in body lumens. Figure 1 shows interaction chambers (22), formed by a slabof glass (23), or between two pieces of glass (23A and 23B). A light source (24) isused to illuminate the interaction chambers, and an optical detector (26) detectschanges within the interaction chambers. A reflector (25) may be utilized to re-directlight rays (27') from the light source (24) along an alternate path (27).

]57[

__________________

156973]21][11[

יטציה נוגדני� שקושרי� את איזור האוביקווינTSG 101של

ANTIBODIES THAT BIND TO AUBIQUITINATION REGION OFTSG101

]54[

18.01.2002]22[US]33[19.01.2001]32[60/262763]31[

Int. Cl.(2009.01) A61K 39/395, C07K 14/47, 16/18, C12N 05/10, 15/62, G01N 33/50]51[THE BOARD OF TRUSTEES OF THELELAND STANFORD JUNIORUNIVERSITY, U.S.A.

]71[




]74[

The present invention provides methods and compositions for regulating ubiquitinationin a cell. In particular, the present invention provides purified polypeptides comprisingan ubiquitination-regulating domain. The invention also provides methods of using

]57[


such polypeptides for screening for agents, for producing antibodies, and for treatmentof diseases, e.g., proliferative diseases, neurodegenerative diseases, autoimmunediseases, metabolic disease and developmental abnormalities. The invention furtherprovides antibodies that bind an ubiquitination-regulating domain and agents andantibodies that regulate ubiquitination in cells, e.g., by modulating the interactionbetween a TSG101 protein and an MDM2 protein.

__________________

156984]21][11[

פריקה עליונה של חומר הנית� לשאיבה משקי משלח

TOP DISCHARGE OF PUMPABLEMATERIAL FROM SHIPPERBAGS

]54[

15.01.2002]22[US]33[18.01.2001]32[09/765176]31[US02.01.2002 10/039140

Int. Cl.(2009.01) B65D 35/28, 88/62]51[A.R. ARENA PRODUCTS, INC.,U.S.A.

]71[



]74[

A disposable bag (10) for a liquid shipping container (15) has a multi ply regionarranged to be inflated as the bag empties in such a way as to form a sump at the bagbottom (14) for discharge of pumpable material from the sump. The discharge from thesump preferably extends upward and over a top of the bag and a top of the container.

]57[


__________________

157041]21][11[

ושיטהCLFAשיבוטיי� לחלבו�–נוגדני� חד לשימוש� בטיפול או מניעת זיהומי�

MONOCLONAL ANTIBODIES TOTHE CLFA PROTEIN ANDMETHOD OF USE IN TREATINGAND PREVENTING INFECTIONS

]54[

28.01.2002]22[US]33[26.01.2001]32[60/264072]31[US12.03.2001 60/274611 US18.06.200160/298413US30.07.200160/308116

Int. Cl.(2009.01) A61K 39/085, 39/395, A61P 31/04, C07K 14/31, 16/12, G01N33/577

]51[

INHIBITEX, INC., U.S.A.]71[WO/2002/072600]87[




]74[

Monoclonal antibodies which can bind to the ClfA protein and which are generatedfrom binding subdomains or active fragments of the ClfA protein from Staphylococcusaureus, including the active fragments proteins from its fibrinogen binding domainsuch as Clf40 protein, the Clf33 protein, or ClfA N3, are provided which can be usefulin the treatment and protection against infection from staphylococcal bacteria such asStaphylococcus aureus. In addition, medical instruments can be treated using themonoclonal antibodies of the invention in order to reduce or eliminate the possibilityof their becoming infected or further spreading the infection. In particular, theantibodies of the present invention are advantageous because they can preventadherence of the bacteria to host cells by impairing or inhibiting the ability of S. aureusClfA to bind to fibrinogen or fibrin, and thus can be utilized in methods or treating or

]57[


preventing staphylococcal inventions.

__________________

157123]21][11[

מערכת מיקרואלקטרונית בעלת מצנ� קיירו תהלי� ייצורה ושימושיה, משולב

MICROELECTRONIC SYSTEMWITH INTEGRAL CRYOCOOLERAND ITS FABRICATION AND USE

]54[

29.08.2002]22[US]33[07.09.2001]32[09/952513]31[

Int. Cl.(2009.01) F17C 13/00, F25B 09/00, 09/02, H01J 07/24, H01L 23/44]51[RAYTHEON COMPANY, U.S.A.]71[WO/2003/025476]87[




]74[

A microelectronic system (20) includes a substrate (22) that is preferably silicon and amicroelectronic device (24) supported on the substrate (22). The microelectronicdevice (24) may be a light sensor that include a readout integrated circuit formed in thesilicon substrate (22), and a light detector (28) supported on and electricallyinterconnected with the readout integrated circuit (26). A cryocooler (30) formed inand integral with the substrate (22) includes a gas inflow channel (36) formed in thesubstrate (22), an expansion nozzle (42) formed in the substrate (22) and receiving agas flow from the gas inflow channel (36), and a gas outflow channel (48) that receivesthe gas flow from the outlet of the expansion nozzle (42). The gas inflow channel (36)and the gas outflow channel (48) may be countercurrent spirals.

]57[


__________________

157239]21][11[

שיטה להפרדת גליו� מדיה מודפסת מערמת גיליונות

METHOD OF SEPARATING ASHEET OF PRINT MEDIA FROMA STACK OF SHEETS

]54[

22.01.2002]22[AU]33[07.02.2001]32[PR2925]31[

Int. Cl.(2009.01) B65G 59/04, B65H 03/14]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA

]71[




]74[

A method of separating a sheet of print media from a stack (28) of sheets, the sheetsbeing porous, includes blowing fluid on to a top surface of a topmost sheet (28.1) ofthe print media on the stack (28) so that the fluid passes through at least the topmostsheet (28.1) of the stack (28) and capturing at least a part of the topmost sheet forconveyance to a printing station (13) of a printer (10).

]57[

__________________

157427]21][11[

סיבי� ומטווי�, תהלי� לייצור חוטי� הממבוססי� על פוליאמיד

PROCESS FORMANUFACTURING POLYAMIDE-BASED YARNS, FIBRES ANDFILAMENTS

]54[


21.02.2002]22[FR]33[22.02.2001]32[01/02407]31[FR23.10.2001 01/13656

Int. Cl.(2009.01) C08L 77/00, D01F 06/90]51[RHODIA POLYAMIDEINTERMEDIATES, FRANCE

]71[




]74[

The invention concerns a method for making yarns, fibres and filaments based onpolyamide, and yarns, fibres and filaments obtainable by said method. The inventionconcerns a method for making yarns, fibres and filaments based on a polyamidecomposition having a molecular structure for enhancing overall productivity of thespinning process, in particular by improving the capacity for drawing the yarnsproduced thereby providing, for example, for a single identical spinning speed a muchhigher yarn meterage produced per time unit after drawing. The invention consists in amethod for making synthetic yarns, fibres and filaments based on polyamide,comprising the following steps: i) mixing in molten phase the following compounds Aand B: compound A: a linear polyamide; compound B selected in the groupcomprising: star-shaped or H-shaped macromolecular chains including one or severalcores and at least three polyamide branches or three polyamide segments bound to saidcore, obtained from amino acid monomers and/or lactams, and as the case may belinear polyamide macromolecular chains obtained from amino acid monomers and/orlactams the melt index in molten phase of the polyamide or of the polyamidecomposition measured in accordance with the ISO 1133 standard at 275 °C under 100g load being higher than 20 g/10 min, and a multifunctional compound comprising atleast three identical acid or amine functions; ii) spinning the mixture in molten phase;iii) and optionally drawing said resulting yarns, fibres or filaments.

]57[

__________________

157541]21][11[

βשימוש של ,αאריל סולפוני� לא רוויי� להכנת תכשירי� המגיני� בפני קרינה

USE OF ALPHA, BETAUNSATURATED ARYL SULFONECOMPOUNDS FOR PREPARINGRADIOPROTECTIVECOMPOSITIONS

]54[


28.02.2002]22[US]33[28.02.2001]32[60/271990]31[

Int. Cl.(2009.01) A61K 31/10, 31/34, 31/38, A61P 35/00, 39/00, C07C 317/10, C07D207/333, 209/10, 213/32, 215/12, 217/12, 231/12, 233/64, 235/06, 237/08, 239/26,241/12, 257/04, 261/08, 263/32, 277/26, 277/62, 307/38, 307/79, 333/18, 333/54,473/00, C07F 09/38

]51[

TEMPLE UNIVERSITY OF THECOMMONWEALTH SYSTEM OFHIGHER EDUCATION, U.S.A.ONCONOVA THERAPEUTICS, INC.,U.S.A.

]71[




]74[

Pre-treatment withα, β unsaturated aryl sulfones protects normal cells from the toxicside effects of ionizing radiation. Administration of a radioprotectiveα, β unsaturatedaryl sulfone compound to a patient prior to anticancer radiotherapy reduces thecytotoxic side effects of the radiation on normal cells. The radioprotective effect of theα, β unsaturated aryl sulfone allows the clinician to safely increase the dosage ofanticancer radiation. In some instances, amelioration of toxicity following inadvertentradiation exposure may be mitigated with administration ofα, β unsatured arylsulfone.

.

]57[

__________________

157550]21][11[

פפטידי� הומניי� סינתטיי� ותכשירי רוקחותהמכילי� אות� לטיפול בלופוס אריתמאטוזוס

סיסטמי

SYNTHETIC HUMAN PEPTIDESAND PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM FOR THE TREATMENTOF SYSTEMIC LUPUS

]54[


ERYTHEMATOSUS

26.02.2002]22[IL]33[26.02.2001]32[141647]31[

Int. Cl.(2009.01) C07K 11/00, 14/47, C12P 21/08]51[בע YEDA רחובות,מ"ידע חברה למחקר ופיתוח RESEARCH AND

DEVELOPMENT CO. LTD.]71[

EDNA עדנה מוזס MOZES]72[WO/2002/067848]87[

',בן עמי ושות8מנחם פלאוט


BEN-AMI & ASSOCIATES,8 PLAUT ST.,PARK TAMAR,P.O.B. 94,REHOVOT 76100

]74[

Synthetic peptides of at least 12 and at most 30 amino acid residues comprising asequence consisting of, or found within, a complementarity-determining region (CDR)found in the heavy or light chain of the human anti-DNA 16/6Id monoclonal antibody,or a sequence obtained by replacement and/or deletion and/or addition of one or moreamino residues to said sequence, and salts, chemical derivatives and polymers of saidpeptides can be used for immunomodulation of systemic lupus erythematosus-associated responses.

]57[

__________________

157752]21][11[

ANTIMICROBIAL תכשירי� נוגדי חיידקי�COMPOSITIONS

]54[

04.03.2002]22[JP]33[06.03.2001]32[2001-61158]31[

Int. Cl.(2009.01) A01N 43/08, A61K 31/38]51[JANSSEN PHARMACEUTICA, N.V.,BELGIUM

]71[




]74[

This invention concerns antimicrobial compositions that are useful for industrialapplications. More specifically, it concerns antimicrobial compositions that, by

]57[


combining 3-benzo[b]thiene-2-yl-5,6-dihydro-1,4,2-oxathiazine-4-oxide and one ormore of 1-[[(3-iodo-2-propynyl)oxy]methoxy]-4-methoxy benzene, 1-chloro-4-[[(3-iodo-2-propynyl)oxy]methoxy] benzene, Zinc 2-pyridine thiol-1-oxide, Copper 2-pyridine thiol-1-oxide, 2-pyridine thiol-1-oxide sodium salt, 2,2-dithio-bis(pyridine-1-oxide), 2-methylthio-4-t-butyl amino-6-cyclopropyl amino-s-triazine, 3-iodo-2-propynyl butylcarbamate (IPBC), 2-(n-octyl)-3(2H)-isothiazolone (OIT), 4,5-dichloro-2-(n-octyl)-3(2H)-isothiazolone (DCOIT), 2,4,5,6-tetrachloro-1,3-benzenedicarbonitrile (chlorothalonil), 1,1-dichloro-N-[(dimethylamino)sulfonyl]-1-fluoro-N-phenyl-methanesulfenamide (dichlofluanid), or 1,1-dichloro-N-[(dimethylamino)sulfonyl]-1-fluoro-N-(4-methylphenyl)-methanesulfenamide(tolylfluanid) have the synergistic effect of these compounds.

__________________

157793]21][11[

, תרופות המכילות אות�, נגזרות קלופורוסיד שיטות להכנת� ושימושי� שלה� לטיפול בסרט�

CALOPOROSIDE DERIVATIVES,MEDICAMENTS CONTAININGTHEM, METHODS FOR THEIRPREPARATION AND USESTHEREOF FOR TREATINGCANCER

]54[

23.02.2002]22[DE]33[09.03.2001]32[10111682.9]31[

Int. Cl.(2009.01) A61K 31/7032, A61P 35/00, C07H 13/04, 15/18, C12N 01/14, C12P19/44, C12R 01/645

]51[


]71[




]74[

The invention relates to novel active substances (caloporoside derivatives), which areformed by the microorganism Gloeoporus dichrous (Fr.:Fr.) Bres. ST001714, DSM13784 during fermentation. The invention also relates to methods for producing saidactive substances, to their use as medicaments, to medicaments containingcaloporoside derivatives, and to the microorganism Gloeoporus dichrous (Fr.:Fr.) Bres.ST001714, DSM 13784 itself.

]57[


__________________

158097]21][11[

METHOD שיטה ומערכת לגילוי חפצי� AND SYSTEM FORDETECTION OF OBJECTS

]54[

24.09.2003]22[Int. Cl.(2009.01) G01S 13/04]51[

SOREQ יבנה, המרכז למחקר גרעיני NUCLEAR RESEARCHCENTER

]71[

MENACHEM מנחם מרגליות MARGALIOT]72[,מ"דקל פטנט בע27חדר,18מנוחה ונחלה

רחובות

DEKEL PATENT LTD.,18 MENUHA VENAHALA ST.,REHOVOT 76209

]74[

A method for detection of an object, the method comprising:irradiating a target with two electromagnetic wave energy beams, a first beam at a firstfrequency and a second beam at a second frequency, the first frequency being lowerthan the second frequency, both beams being polarized in a first direction; anddetermining a presence of an object by analyzing reflections of said first and secondbeams, by comparing the reflections with reflections obtained from a control volumeknown to have the object therein, wherein the target is considered to have the object ifthe polarization characteristics of the reflections of the first and second frequenciesmatch the reflections obtained from the control volume within a predefined tolerance.

]57[

__________________

158209]21][11[

תרכובת לשחזור למת� דר� הווריד המכילה COX–2מעכב

RECONSTITUTABLEPARENTERAL COMPOSITIONCONTAINING A COX-2INHIBITOR

]54[

02.04.2002]22[US]33[03.04.2001]32[60/281058]31[

Int. Cl.(2009.01) A61K 31/34, 31/415, 31/42, 31/444, 31/50, 45/06, 47/00, A61P29/00, C07C 311/15, 317/24, C07D 213/61, 231/12, 237/16, 261/08, 307/58, 311/58,401/04

]51[


PHARMACIA CORPORATION,U.S.A.

]71[




]74[

A pharmaceutical composition comprises, in powder form, (a) at least one water-soluble therapeutic agent selected from selective COX-2 inhibitory drugs and prodrugsand salts thereof, for example parecoxib sodium, in a therapeutically effective totalamount constituting about 30% to about 90% by weight, (b) a parenterally acceptablebuffering agent in an amount of about 5% to about 60% by weight, and optionally (c)other parenterally acceptable excipient ingredients in a total amount not greater thanabout 10% by weight, of the composition. The composition is reconstitutable in aparenterally acceptable solvent liquid to form an injectable solution. A lyophilizationprocess is provided for preparation of such a composition.

]57[

__________________

158246]21][11[

איי� לטיפול בגידולי� המבטאי� תכשירי� רפו גנגליוזידי� ביתר ושימושי� שלה�

PHARMACEUTICALCOMPOSITIONS FOR THETREATMENT OF TUMOURSTHAT OVEREXPRESSGANGLIOSIDES AND USESTHEREOF

]54[

08.04.2002]22[CU]33[06.04.2001]32[84/2001]31[

Int. Cl.(2009.01) A61K 39/395, A61P 35/04, 37/04, C07K 16/18, 16/30, 16/42, 16/46,C12N 01/21, 05/20, C12P 21/08

]51[

CENTRO DE INMUNOLOGIAMOLECULAR, CUBA

]71[




]74[

The invention relates to the field of immunology and specifically toimmunotherapeutic combinations that are used to impede the growth of tumour cellsand/or to eliminate said cells. The present invention can be used to observe a

]57[


therapeutic antitumour effect by combining idiotypic vaccines having anantiganglioside antibody (Ab1) as the active principle thereof with idiotypic vaccines,the active principle of which is an anti-idiotype antibody obtained against anantiganglioside antibody (Ab2), or with vaccines, the active principle of which is oneor more gangliosides. The invention relates to combinations of said vaccines whichproduce a synergism of the antitumour effect which is induced separately by each ofthe vaccines. Said combinations can be applied to patients in different clinical stateswith tumours that overexpress gangliosides.

__________________

584271]21][11[

מערכת ושיטה להעברת חו� לתו� מבנה פחמימני האופ� באר להזרקת חו�

SYSTEM AND METHOD FORTRANSMITTING HEAT INTO AHYDROCARBON FORMATIONSURROUNDING A HEATINJECTION WELL

]54[

10.10.2001]22[WO]33[24.04.2001]32[PCT/EP01/04641]31[

Int. Cl.(2009.01) E21B 35/00, 36/02, 43/16, 43/24]51[SHELL INTERNATIONALERESEARCH MAATSCHAPPIJ B.V.,THE NETHERLANDS

]71[




]74[

A method and system for transmitting heat substantially by conduction into ahydrocarbon containing formation surrounding a heat injection well utilise oxidantsupply and combustion gases exhaust conduits disposed in the wellbore of the heatinjection well, wherein an oxidant, such as air, in injected through the oxidant supplyconduit to a reaction zone in the formation in the vicinity of the heat injection wellwhere at least a portion of the hydrocarbons in the formation are oxidized such thatheat and combustion gases are generated, and at least a portion of the combustion gasesare transmitted through the combustion gases exhaust conduit away from the reactionzone such that migration of combustion gases from the reaction zone into thehydrocarbon containing formation is inhibited.

]57[


__________________

158601]21][11[

REVOLVING מערכת מסתובבת לגידול תרבית פטריות APPARATUS FORMUSHROOM CULTIVATIONBEDS

]54[

26.10.2003]22[Int. Cl.(2009.01) A01G 09/02]51[

ZOHAR ערד, זוהר אלינסקי ELINSKI]71[,אפלפלד זר פישר וילר חברת עורכי דין

ב2בן גוריון 16קומה.ר.ס.מגדלגן- רמת

APPELFELD ZER FISHER WEILER,LAW FIRM,B.S.R TOWER 1, FLOOR 162 BEN GURION ST.RAMAT GAN 52573

]74[

A rotating cultivation system for holding a plurality of cultivation beds enabling arotation of said beds, said system comprising:at least one central rotating mechanism and at least one external rotating wheel;a plurality of secondary wheel assemblies connected to the external rotating wheel thatallows rotation of said assemblies around the external rotating wheel's axis, whereineach assembly holds at least one cultivation bed andat least one stand, supporting each external wheel, where said stand comprisesbearings, where said external wheel is mounted upon said bearings that allow theexternal wheel to rotate, wherein the rotation of the external rotating wheel causes thewhole apparatus to rotate around the central axis of said wheel; andwherein each assembly is connected to said at least one central rotating mechanism byat least one frame enabling each assembly to rotate around its own axis, wherein therotation of said assemblies around the external wheel's axis is independent of saidassemblies' rotation around their own axes; andwherein the rotation direction of each secondary wheel assembly is opposite to therotation direction of an adjacent secondary wheel assembly; andwherein the rotation direction of each secondary wheel assembly is opposite to therotation direction of an adjacent secondary wheel assembly.

]57[


__________________

158983]21][11[

PLATE משטח ושיטה לסינו� בעל תפוקה גבוהה AND METHOD FOR HIGHTHROUGHPUT SCREENING

]54[

29.05.2002]22[US]33[30.05.2001]32[60/294430]31[

Int. Cl.(2009.01) B01L 03/00, C12M 01/20, 01/34, 03/00, C12N 05/04]51[BIOLEX THERAPEUTICS, INC.,U.S.A.

]71[




]74[

A multiple well plate and method for media exchange, including a body defining aplurality of cell wells each connected via a channel to one of a plurality of aspirationholes, is provided. The cell wells contain a porous, hydrophilic frit which is suspendedon a ledge above a reservoir of fluid media and supports a tissue sample. Theproperties of the frit wick the fluid media upwards to supply the tissue sample withnutrients for growth and proliferation. Old media is aspirated from the wells by aliquid handling device which inserts a pipette tip into the aspiration holes. The pipettetip applies a suction pressure which draws the media out of the cell well, through thechannel, into the aspiration hole and out through the pipette tip. New media isdispersed through the pipette tip and directly into the cell well.

]57[

__________________


159326]21][11[

CRYSTALLINE הרכב המכיל אסציטלופר� בצורה הגבישית COMPOSITIONCONTAINING ESCITALOPRAM

]54[

25.07.2002]22[DK]33[31.07.2001]32[PA200101164]31[

Int. Cl.(2009.01) A61K 09/14, 31/34, C07D 307/00, 307/87]51[H. LUNDBECK A/S, DENMARK]71[WO/2003/011278]87[




]74[

Crystalline particles of escitalopram oxalate with a particle size of at least 40µm isdisclosed. Method for the manufacture of said crystalline particles and pharmaceuticalcompositions comprising said crystalline particles are also disclosed.

]57[

__________________

159337]21][11[

שיטה והתק� לאחסו� וניהול קשרי� במערכת מחולקת משותפת

METHOD AND APPARATUS FORSTORING AND MANAGINGCONTACTS IN A DISTRIBUTEDCOLLABORATION SYSTEM

]54[

11.12.2003]22[Int. Cl.(2009.01) G06F 01/00, 15/16, G06Q 10/00]51[MICROSOFT CORPORATION,U.S.A.

]71[



]74[

Proper user-to-data associations are maintained in shared spaces created in a peer-to-peer collaborative system by means of a simplified and minimal user interface thatpermits users to easily authenticate other members of a shared space. In particular,support is provided for automatically building authenticated relationships even if users

]57[


do not take the time to authenticate other users. When a user enters a shared space andviews the contacts in that space, the display names of each contact are accompanied bydistinctive icons that identify that authentication status of that contact. A mechanism isprovided for resolving conflicts between contacts with the same display names toprevent confusion and contact "spoofing". Security policies can be established toprovide a uniform approach to authentication. These policies can be set by a user or,alternatively, the policies can be set by an administrator.

__________________

159371]21][11[

וקטור המכיל ג� המקודד גלובי� ממקור אנושי ושימושו בטיפול במחלות הקשורות להמוגלובי�

VECTOR ENCODING HUMANGLOBIN GENE AND USETHEREOF IN TREATMENT OFHEMOGLOBINOPATHIES

]54[

01.07.2002]22[US]33[29.06.2001]32[60/301861]31[US02.07.2001 60/302852

Int. Cl.(2009.01) A61K 31/519, 35/76, 48/00, A61P 07/06, C07K 14/805, C12N15/867

]51[

SLOAN-KETTERING INSTITUTEFOR CANCER RESEARCH, U.S.A.

]71[

WO/2003/002155]87[',ר שלמה כהן ושות"ד

124אבן גבירול תל אביב11490.ד.ת,


]74[

Recombinant lentiviral vectors having a region encoding a functional globin gene; andlarge portions of the beta-globin locus control regions which include DNase Ihypersensitive sites HS2, HS3 and HS4 provides expression of beta-globin whenintroduced into a mammal, for example a human, in vivo. Optionally, the vectorfurther includes a region encoding a dihydrofolate reductase. The vector may be usedin treatment of hemoglobinopathies, including beta-thalessemia and sickle-cell disease.For example, hematopoietic progenitor or stem cells may be transformed ex vivo andthen restored to the patient. Selection processes may be used to increase the percentageof transformed cells in the returned population. For example, a selection marker whichmakes transformed cells more drug resistant than un-transformed cells allows selectionby treatment of the cells with the corresponding drug.

]57[


__________________

159664]21][11[

חיבור של מקטעי מעטה של מכשיר הושטה עבור מת� ממונ� של מוצר הנית� לחלוקה

CONNECTION OF HOUSINGSECTIONS OF ANADMINISTRATION DEVICE FORDOSED ADMINISTRATION OF ADISTRIBUTABLE PRODUCT

]54[

22.07.2002]22[DE]33[30.07.2001]32[20112501.3]31[DE21.12.2001 10163329.7

Int. Cl.(2009.01) A61M 05/00, 05/315]51[TECPHARMA LICENSING AG,SWITZERLAND

]71[



]74[

An administration device for dosed administration of a distributable product, saiddevice comprising: a) a front housing section (1, 3) having a reservoir (2) for theproduct, b) a rear housing section (11), c) an output member (4) which is borne by atleast one (1, 3) of the housing sections (1, 3, 11) for performing a distributingmovement enabling a selected product dose to be distributed, d) a dose adjustmentmember (9; 39) performing a dosing movement for a selection of the product dose inrelation to the output member (4), e) and a dosing and drive mechanism (12; 32) whichcan be displaced in a rotational and translatory manner about an axis of rotation (L) inrelation to the front housing section (1, 3) and which can be coupled during connectionof the housing sections (1;3;11) to the output member (4) and dosing adjustmentmember (9; 39) in such a way that a rotational movement of the dosing and drivedevice (12; 32) results in a dosing movement of the dose adjustment member (9; 39)and a translatory movement of the dosing and drive device (12; 32) results in adistributing movement of the output member (4).

]57[


__________________

159665]21][11[

מתק� נעילה עבור חיבור מקטעי מעטה של מכשיר הושטה

LOCKING DEVICE FORCONNECTING HOUSINGSECTIONS OF ANADMINISTRATION APPLIANCE

]54[

22.07.2002]22[DE]33[30.07.2001]32[201 12 501.3]31[DE21.12.2001 10163325.4

Int. Cl.(2009.01) A61M 05/00, 05/315]51[TECPHARMA LICENSING AG,SWITZERLAND

]71[



]74[

The invention relates to an administration appliance comprising g) a front housingsection (1, 3) containing a reservoir (2) for a diffusable product and a first lockingelement (3a); h) a piston which can be displaced in the reservoir (2) in an advancedirection towards a reservoir outlet in order to diffuse the product; i) a piston rod (4); j)a rear housing section (11) which is detachably connected to the front housing section(1, 3) and has a second locking element (21) which is engaged with the first lockingelement (3a) in a locking manner; k) a drive element (12; 32) which is positioned onthe rear housing section (11) in such a way that it can be moved in and against theadvance direction, said drive element acting on the piston rod (4) in the advancedirection during a diffusion movement in order to move the piston in the advancedirection; and l) a locking device (25) for the locking elements (3a, 21) which iscoupled to the drive element (12; 32) in such a way that the locking engagement canonly be released in a release position of the drive element (12; 32).

]57[

__________________


159717]21][11[

חומצות גרעי� המקודדות אנטיג� רקומביננטי ב�דלטו� מתו�–קילו 250

מירוזואיטי� של אימריה/ספורוזואיטי� מכסימה ושימושיה�

NUCLEIC ACIDS ENCODING ARECOMBINANT 250 KDAANTIGEN FROMSPOROZOITES/MEROZOITES OFEIMERIA MAXIMA AND THEIRUSES

]54[

03.07.2002]22[US]33[06.07.2001]32[60/303670]31[

Int. Cl.(2009.01) A61K 39/012, 39/02, 39/35, C07H 21/02, C07K 01/02, 14/455,C12N 01/20, C12P 21/06

]51[

בית שמש,מ"אביק מעבדות ביולוגיות בעUNIVERSITY OF TECHNOLOGYSYDNEY, AUSTRALIAABIC BIOLOGICALLABORATORIES LTD.

]71[




]74[

The present invention is drawn to an isolated recombinant polynucleic acid comprisinga nucleotide sequence, SEQ.ID.NO: 4 encoding 250kD protein comprising the aminoacid sequence as represented by SEQ.ID.NO:6 from Eimeria maximasporozoites/merozoites. This invention is further drawn to avian coccidiosis vaccinecompositions against E.tenella,E.maxima, E.acervulina, E.necatrix, E.mitis, and

E.brunetti etc.

]57[

__________________

159807]21][11[

תרכובת מוצקת המכילה נבגי� של בקטריה לא פתוגנית של המי� בצילוס

SOLID COMPOSITIONCONTAINING BACILLUS-TYPENON-PATHOGENIC BACTERIALSPORES

]54[

26.07.2002]22[IT]33[27.07.2001]32[MI2001A001632]31[

Int. Cl.(2009.01) A61K 09/16, 35/00, 35/74]51[


SANOFI-SYNTHELABO OTC SPA,ITALY

]71[




]74[

The invention relates to a composition of Bacillus-type non-pathogenic bacterial sporeswhich are adsorbed on a matrix formed by at least one water-insoluble adsorbentcompound and a cellulose derivative. The inventive composition can be obtained usingthe air-fluidised bed technique and said composition is suitable for use in thepharmaceutical, veterinary and nutritional fields.

]57[

__________________

159819]21][11[

CARDIOVASCULAR ערכה לבדיקת מערכת הלב SAFETYASSAY

]54[

02.07.2002]22[EP]33[13.07.2001]32[01202689.4]31[

Int. Cl.(2009.01) G01N 33/50, 33/60, 33/68]51[JANSSEN PHARMACEUTICA N.V.,BELGIUM

]71[


'א26חוב הברזלר רמת החייל


]74[

The present invention provides assays and kits for the screening of test compounds fortheir capability to induce cardiotoxicity in a subject. Said assays and kits are based onthe finding that the interaction of astemizole with the HERG potassium channel can beexploited to predict cardiotoxicity of compounds during the development of newtherapeutics and other agents.

]57[

__________________


159973]21][11[

התק� ושיטה לסריקת קהל והגנתו כגו� דלת מסתובבת

CROWD SCREENING ANDPROTECTION (CSP) FACILITYAND METHOD SUCH AS AROTARY DOOR

]54[

20.01.2004]22[Int. Cl.(2009.01) F41H 13/00]51[

בע"רפא ,מ"ל רשות לפיתוח אמצעי לחימה חיפה

RAFAEL ADVANCED DEFENSESYSTEMS LTD.

]71[

,לוי-גלוקסמןא10רחוב אלחנן

חיפה6202.ד.ת,

GLUCKSMAN - LOWY,10A ELHANAN ST.,P.O.B. 6202,HAIFA 31061

]74[

A facility for crowd screening and protection configured for monitoring a plurality ofindividuals walking through the facility, and for detecting prohibited articles andsubstances carried by an individual of the plurality of individuals, comprising:a laterally-fenced walkway (FW) having an FW entrance open at a first upstream end,and an FW exit open at a second downstream end of the fenced walkway, compellingindividuals to walk in single line queue over the fenced walkway, a confinementstructure (CS) having a CS interior separated from a CS exterior by a peripheral wallaccommodating an open CS entrance opening adjacent the FW exit, and an open CSexit open, the facility being configured for permitting passage of individuals, solelyfrom the FW entrance to the CS exit opening, via the FW exit and the CS entranceopening,at least one one-way passage control device, disposed in the CS interior, operable in afirst passage mode for permitting free-passage of an individual, and in a secondreleasable locked mode for releasably confining a single individual at a time to the CSinterior,a monitoring unit (MU) configured for management, control, and operation of thefacility, including:at least one sensor operative which monitors each individual passing through thefacility, to detect prohibited articles,a processing device which derives results in real time from the monitoring ofindividuals performed by the at least one sensor, anda controller which controls operation of the at least one passage control device,whereby the at least one passage control device is releasably locked by commandwhen prohibited articles and substances carried by an individual are detected by themonitoring unit.

]57[

__________________


160249]21][11[

METHOD שיטה והתק� לזיהוי חומר חיצוני בנוזל AND APPARATUS FORDETECTING EXTRANEOUSMATTER IN A FLUID

]54[

09.08.2002]22[AU]33[09.08.2001]32[PR6922]31[

Int. Cl.(2009.01) G01N 27/02]51[COMMONWEALTH SCIENTIFICAND INDUSTRIAL RESEARCHORGANISATION, AUSTRALIA

]71[




]74[

A method for detecting extraneous matter in a fluid including the steps of applying anenergy source to electrodes located in a fluid, measuring real and imaginary electricalimpedance values across the electrodes for a plurality of different frequencies ofalternating energy and identifying at least one characteristic of an extraneous matter inthe fluid.

]57[

__________________

160329]21][11[

, טרימותמרות–5,4–אמינו–2תולדות תיאזולילתכשירי רוקחות, השימוש בה� לייצור תרופות

המכילי� אות� והתהלי� להכנת�

2-AMINO-4,5-TRISUBSTITUTEDTHIAZOLYL DERIVATIVES,USES THEREOF FOR THEMANUFACTURE OF AMEDICAMENT,

]54[


PHARMACEUTICALCOMPOSITIONS CONTAININGTHEM AND PROCESS OFPREPARATION THEREOF

09.08.2002]22[EP]33[13.08.2001]32[01203087.0]31[

Int. Cl.(2009.01) A61K 31/427, 31/429, A61P 29/00, 31/12, 37/02, 43/00, C07D277/42, 417/04, 417/14, 471/04, 513/04

]51[

JANSSEN PHARMACEUTICA N.V.,BELGIUM

]71[




]74[

This invention concerns the use of a compound of formula (I'), aN-oxide, apharmaceutically acceptable addition salt, a quaternary amine and a stereochemicallyisomeric form thereof, wherein Z is halo; C1-6alkyl; C1-6 alkylcarbonyl; C1-

6alkyloxycarbonyl; aminocarbonyl; C1-6alkyl substituted with hydroxy, carboxyl,cyano, amino, amino substituted with piperidinyl, amino substituted with C1-4alkylsubstituted piperidinyl, mono -or di(C1-6alkyl)amino, aminocarbonyl, mono -or di(C1-

6alkyl)aminocarbonyl, C1-6alkyloxycarbonyl, C1-6alkyloxy, piperidinyl, piperazinyl,morpholinyl, thiomorpholinyl; polyhaloC1-4alkyl; cyano; amino; mono -or di(C1-

6alkyl)aminocarbonyl; C1-6alkyloxycarbonyl; C1-6alkylcarbonyloxy; aminoS(=O)2-;mono -or di(C1-6alkyl)aminoS(=O)2; -C(=N-Rx)NRyRz; Q is optionally substituted C3-

6cycloalkyl, phenyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, benzthiazolyl,benzoxazolyl, benzimidazolyl, indazolyl, or imidazopyridyl, or Q is a radical offormula (b-1), (b-2), or (b-3), L is optionally substituted phenyl or an optionallysubstituted monocyclic 5 or 6-membered partially saturated or aromatic heterocycle ora bicyclic partially saturated or aromatic heterocycle; aryl is optionally substitutedphenyl; for the manufacture of a medicament for the prevention or the treatment ofinflammatory and/or auto-immune diseases mediated through TNF-&agr; and/or IL-12.

]57[

__________________


160389]21][11[

שימוש בפליבנסרי� להכנת תרופות לטיפול באי סדרי� מיניי�

USE OF FLIBANSERIN FOR THEPREPARATION OFMEDICAMENTS FORTREATMENT OF SEXUALDISORDERS

]54[

04.10.2002]22[EP]33[20.10.2001]32[01125020.6]31[

Int. Cl.(2009.01) A61K 31/496, A61P 15/00]51[BOEHRINGER INGELHEIMPHARMA GMBH & CO. KG,GERMANY

]71[




]74[

The invention relates to the use of flibanserin for the preparation of a medicament forthe treatment of disorders of sexual desire.

]57[

__________________

160408]21][11[

גונוקלאוטידי� שיטה לחיזוי פעילות של אולי בעלי קשרי פוספודיאסטר המשרי� אפופטוזי�

METHOD FOR PREDICTINGAPOPTOSIS-INDUCINGACTIVITY OF PHOSPHODIESTEROLIGONUCLEOTIDES

]54[

19.08.2002]22[US]33[17.08.2001]32[60/313290]31[

Int. Cl.(2009.01) C12Q 01/68, C40B 30/10]51[BIONICHE LIFE SCIENCES INC.,CANADA

]71[




]74[

The present invention facilitates in silico evaluation of molecules for biological]57[


activity by providing a computer-based method to predict whether oligonucleotidesmay possess biological activity and the efficacy of the biological activity based on thethree-dimensional structure and charge characteristics of the oligonucleotides.Biological activities include, but are not limited to, cellular proliferation, induction ofcell cycle arrest and apoptosis.

__________________

160527]21][11[

–2(3–אמינו–2תהלי� אנזימטי להכנתחומצה פרופיונית–) אמינופנילסולפניל

בה, מותמרת תוצרי ביניי� שלה והשימושי�

ENZYMATIC PROCESS FOR THEPREPARATION OF SUBSTITUTED2 - AMINO - 3 (2 -AMINOPHENYLSULFANYL) -PROPIONIC ACID ANDINTERMEDIATES THEREFORAND USES THEREOF

]54[

19.09.2002]22[EP]33[25.09.2001]32[01122906.9]31[

Int. Cl.(2009.01) C07C 323/63, C07D 281/10, C12P 13/04]51[F. HOFFMANN-LA ROCHE AG,SWITZERLAND

]71[

WO/2003/029477]87[,תפיוריינהולד כהן ושו



]74[

The compounds of formula (I) are useful for the preparation of 1,5-benzothiazepineswhich are useful as enzyme inhibitors, such as protease, interleukin-1β-convertingenzyme, elastase or angiotensin enzyme, GPCR antagonists (cholecystokinin,angiotensin II receptor). The present invention relates to a new process for thepreparation compounds of formula (I), wherein R1, R2, R3 and n are as described in

]57[


the description which process comprises reacting compounds of formula (II), whereinR1, R2, R3, n and R4 are as described in the description, with a protease in an aqueoussystem containing an organic co-solvent.

__________________

160556]21][11[

תכשירי�, אלקיליות–נגזרות דיאריל ציקלותהלי� לייצור�, רפואיי� המכילי� אות�

ושימוש�

DIARYL CYCLOALKYLDERIVATIVES,PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM, PROCESS FORPREPARING SAME AND USETHEREOF

]54[

17.08.2002]22[DE]33[31.08.2001]32[10142734.4]31[DE24.05.2002 10223273.3

Int. Cl.(2009.01) A61K 31/421, A61P 03/00, 19/10, 25/28, 29/00, 43/00, C07D263/32, 263/36, 413/06, 413/12

]51[


]71[

WO/2003/020269]87[,לצר וכהן צדק, פרל, איתן7שנקר רחוב



]74[

The invention relates to diaryl cycloalkyl derivatives and their physiologicallycompatible salts and physiologically functional derivatives. The invention also relatesto compounds of formula (I), in which the groups are defined as per the description, totheir physiologically compatible salts and to a method for producing the same. Thecompounds have lipid and/or triglyceride reducing properties and are suitable e.g. fortreating lipid metabolic disorders, type II diabetes and syndrome X.

]57[


__________________

161015]21][11[

SUBSTITUTED תיואצטאמידי� חלופיי�THIOACETAMIDES

]54[

25.10.2002]22[US]33[26.10.2001]32[10/014645]31[

Int. Cl.(2008.04) A61K 313/95, A61P 1/14, 25/16, 25/18, 25/28, 9/10, C07D 2072/73,2074/16, 211/74, 211/88, 223/10, 401/04, 403/12, 405/12, 409/04, 409/12, C07F 9/38,C07H 15/02

]51[

CEPHALON, INC., U.S.A.]71[WO/2003/037853]87[




]74[

The present invention is directed to chemical compositions of substitutedthioacetamides, processes for the preparation thereof and uses of the compositions inthe treatment of diseases.

]57[

__________________


161019]21][11[

SINGLE פעמי–צנתר לשימוש חד USE CATHETER]54[

22.03.2004]22[US]33[25.11.2003]32[10/720213]31[

Int. Cl.(2009.01) A61M 25/00]51[INCONTINENT CONTROLDEVICES, U.S.A.

]71[




]74[

The single use catheter has a lumen (20) with a hydrophobic filter tip at one end. Thelumen is divided into two parallel conduits (22, 24). A first conduit terminates in aone-way valve (32). A syringe (52) is attached to the one-way valve. Air, salinesolution or sterilized water can be introduced through the one-way valve and inflate acuff (26) about the lumen. The second parallel conduit terminates in a charcoal filter(44) for elimination of bowel gas. The one-way valve prevents deflation of the cuffunless the lumen is cut to allow the fluid from the cuff to exit and deflate the cuff.

]57[

__________________


161127]21][11[

FAR מדמה מקורי שדה רחק לכיול אנטנה FIELD SOURCE EMULATORFOR ANTENNA CALIBRATION

]54[

22.08.2002]22[US]33[14.11.2001]32[992755]31[

Int. Cl.(2009.01) G01S 07/40, H01Q 01/28, 01/42, 03/26]51[RAYTHEON COMPANY, U.S.A.]71[WO/2003/042714]87[




]74[

A radar antenna for a guided missile is calibrated in flight using a point source ofmicrowave radiation and a lens to emulate a far field source. The microwave sourceand lens fit behind a metal cap at the leading end of the radome and so do notadversely affect the radar. A variety of techniques to power the point source aredisclosed, and a variety of lens arrangements are disclosed. The invention allows aradar antenna to be calibrated in flight, and so insures against mis-calibration due toaging components as well as the heat and mechanical forces associated with storageand/or launch of the missile.

]57[

__________________

161135]21][11[

PROTECTIVE מארז הגנה עבור מחשבי שולח� CASING FORDESK COMPUTERS

]54[

29.03.2004]22[Int. Cl.(2009.01) E05B 73/00]51[

MEIR נחל שורק.נ.ד, מאיר אבגנים AVGANIM]71[',דניאל פריימן ושות

10בית כלל קומה5דרויאנובDANIEL FREIMANN & CO.,5 DROYANOV ST., 10TH FLOOR ,

]74[


TEL תל אביב AVIV 63143An arrangement for protecting a desk computer against theft comprising:

(A) a casing (20) having an open front side, a bottom wall, two side walls. atop wall and at least partly open rear wall, the computer housing beinginsertable into the casing through said open front side;a portion (22) associated with one of the side-walls extending perpendicularlythereto and provided with a through-going passage;means (26) for securing the casing to a stationary support;the rear wall of the computer housing comprising a dedicated slot (14); and(B) a key-operated lock member (30) comprising a turntable tip (34) fitting saidslot and a projection (38) fitting said passage,so that by mounting the lock member while the tip passes the slot and theprojection inserted into the passage, and locking the tip in a 90º turned positionthe computer becomes arrested to the casing intermediate said computer side-wall portion.

]57[

__________________


161136]21][11[

ARTIFICIAL חוליתי–דיסק מלאכותי בי� INTERVERTEBRALDISC

]54[

19.06.2002]22[US]33[01.10.2001]32[09/968045]31[

Int. Cl.(2008.04) A61F 2/44]51[SPINECORE, INC., U.S.A.]71[

JAMES יימס ראלף'ג RALPH, STEPHEN TATAR]72[WO/2003/028595]87[

,ורם צביוןי פארק התעשיה,2הטוחן' רח

קיסריה3148.ד.ת,

YORAM TSIVION,2 HATOCHEN ST.P.O.B. 3148,CAESAREA 38900

]74[

An artificial disc having a pair of opposing plates (330, 400) for seating againstopposing vertebral bone surfaces, separated by at least one spring mechanism. Thepreferred spring mechanism is at least one spirally slotted belleville washer, and insome embodiments the belleville washer (330b) is also radially thinning or thickening.For double washer embodiments, the wide ends of the washers seat against respectiveopposing plates, in some embodiments each being maintained somewhat to a retainingwall (306) and ring (310) or a circular recess and retaining shield. For single washerembodiments, the narrow end of the washer is formed with a curvate socket (332b) forrotatably mounting onto a semispherical protuberance (410) extending from one plates.

]57[

__________________

161147]21][11[

–' תכשיר הכולל חלקיק דמוי וירוס פאגRNA5הקשור לאנטיגני� של–IL, – 13 –

ILאו אוטקסי�

COMPOSITION COMPRISING AVIRUS-LIKE PARTICLE OF A RNA -PHAGE BOUND TO AN IL-5, IL-3OR EOTAXIN ANTIGEN

]54[

07.11.2002]22[


US]33[07.11.2001]32[60/331045]31[US18.01.2002 10/050902 WO21.01.2002PCT/IB02/00166US19.07.200260/396636

Int. Cl.(2009.01) A61K 39/12, 39/385, A61P 11/06, 37/08]51[CYTOS BIOTECHNOLOGY AG,SWITZERLAND

]71[


ה 'א26ברזל רחוב רמת החייל


]74[

The present invention is related to the fields of molecular biology, virology,immunology and medicine. The invention provides a composition comprising anordered and repetitive antigen or antigenic determinant array, and in particular an arraycomprising a protein or peptide of IL-5, IL-13 or eotaxin. More specifically, theinvention provides a composition comprising a virus-like particle and at least oneprotein, or peptide of IL-5, IL-13 and/or eotaxin bound thereto. The invention alsoprovides a process for producing the conjugates and the ordered and repetitive arrays,respectively. The compositions of the invention are useful in the production ofvaccines for the treatment of allergic diseases with an eosinophilic component and as apharmaccine to prevent or cure allergic diseases with an eosinophilic component and toefficiently induce immune responses, in particular antibody responses. Furthermore,the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context.

]57[

__________________

161193]21][11[

חומצה–5שיטה להכנת תכשיר רוקחות המכילאמינו סליצילית לשימוש בטיפול דלקת כיב המעי

הגס ומחלת קרונס

METHOD FOR THEPREPARATION OF APHARMACEUTICALCOMPOSITION COMPRISING 5-AMINOSALICYCLIC ACID FORUSE IN TREATMENT OFULCERATIVE COLITIS ANDCROHN'S DISEASE

]54[

15.10.2001]22[Int. Cl.(2009.01) A61K 09/00, 09/16, 09/20, 31/606, 31/618]51[FERRING B.V., THE]71[


NETHERLANDSWO/2003/032952]87[



]74[

The present invention concerns a new method of preparing granules comprising5−aminosalicyclic acid and a new method of preparing an oral pharmaceuticalcomposition for the treatment of ulcerative colitis or Crohn's disease comprising asactive ingredient 5−aminosalicyclic acid, the method comprising granulation withwater as a solvent.

]57[

__________________

161244]21][11[

CHEMICAL דיגליצרידי�–3,1תהלי� כימי ליצור שמני� PROCESS FOR THEPRODUCTION OF 1,3 -DIGLYCERIDE OILS

]54[

03.10.2002]22[US]33[03.10.2001]32[60/327762]31[

Int. Cl.(2009.01) C11C 01/00, 03/06]51[KAO CORPORATION, JAPAN]71[WO/2003/029392]87[



]74[

A method for producing 1,3-diglyceride oils from triglyceride containing oils isdisclosed. The method uses alkali metal salts or alkali earth metal salts of mono-carboxylic or di-carboxylic acids to drive glycerolysis under conditions such thatcommercial, food-quality 1,3-diglyceride oils are produced.

]57[

__________________


161338]21][11[

מערכת לניהול איכות נתוני� ושליטה במקורות נתוני� הטרוגניי�

SYSTEM FOR DATA QUALITYMANAGEMENT AND CONTROLOF HETEROGENEOUS DATASOURCES

]54[

08.10.2002]22[US]33[12.10.2001]32[09/976813]31[

Int. Cl.(2009.01) G06F 15/173, 17/30]51[DIRECT COMPUTER RESOURCES,INC., U.S.A.

]71[




]74[

System and method for data quality management and control of heterogeneous datasystems. In a preferred embodiment, the system functions as a resource managementtool that simplifies the process of managing data systems. More specifically, thesystem provides connections to source data systems, allows users to view datastructures and enables simple management and manipulation of data acontained withinpossibly heterogenous data systems. The system utilizes an advanced graphical userinterface, which allows users to access and manage systems using a simple point andclick methodology. The system uses portals (16), which are tools that collect,visualize, analyze and directly edit data sets associated with different data sources. Inanother aspect, the system keeps track of its operational status (10), allowing users toautomatically reproduce in one logon session work done in the previous session,without the need to replicate data analysis. Various additional features of the systemand methods are disclosed and illustrated.

]57[

__________________

161533]21][11[


שיטת הכנתו, תצורה פולימורפית של רימונבנט ותרכובות פרמצבטיות המכילות אותה

POLYMORPHOUS FORM OFRIMONABANT, PREPARATIONMETHOD ANDPHARMACEUTICALCOMPOSITIONSCONTAINING SAME

]54[

04.11.2002]22[FR]33[08.11.2001]32[01/14579]31[

Int. Cl.(2009.01) A61K 31/4439, C07D 401/12]51[SANOFI AVENTIS, FRANCE]71[WO/2003/040105]87[




]74[

The invention concerns a novel crystalline polymorph of rimonabant, its preparationmethod and pharmaceutical compositions containing said novel polymorph.

]57[

__________________

161538]21][11[

התק� הגנה בפני מזג אוויר להגנת זני� מיוחדי� לחות של צמחי� מתורבתי�–רגישי

WEATHER PROTECTIONDEVICE FOR THE PROTECTIONOF MOISTURE-SENSITIVESPECIALIZED CULTURES OFPLANT CULTIVATION

]54[

30.10.2002]22[DE]33[31.10.2001]32[10153703.4]31[

Int. Cl.(2009.01) A01G 13/02]51[REINHARD VOEHRINGER,GERMANY

]71[



]74[

Disclosed is a low-cost weather protection device for the protection of special plantcultures (4) which are sensitive to moisture and sunlight, comprising at least onesubstantially waterproof protective skin (2,3) which is fixed to a carrier unit(1,8,9,10,11,12) and offers simple, effective protection of plants in particular (4)

]57[


against the effects of the weather even over long time periods and for large-surfaceapplications e.g. for hectare-sized surfaces to be protected. According to the invention,the protective skin (2,3) is fixed on the carrier unit (1,8,9,10,11,12) in such a way thatit is partially pivotable, being able to swing out of a rest position due to the effect ofwind energy, and at least one net (9), interweaving structure and/or grid structure onwhich the protective skin (2,3) lies is provided.

__________________

161608]21][11[

ו–אראלקוקסי–2סינתזת –2–אדנוסיני� אדנוסיני� ושימוש� הרפואי–אלקוקסי

SYNTHESIS AND THERAPEUTICUSE OF 2-ARALKOXYADENOSINES AND 2-ALKOXYADENOSINES

]54[

24.10.2002]22[US]33[25.10.2001]32[60/335169]31[US26.04.2002 60/375723

Int. Cl.(2009.01) A61K 31/7076, A61P 07/02, C07H 19/167, 19/173]51[KING PHARMACEUTICALSRESEARCH & DEVELOPMENT,INC., U.S.A.

]71[

ALLAN R. MOORMAN]72[WO/2003/035662]87[

בי'ג בע, יי אמ ,מ"פקטור אנד קו הר חוצבים, רחוב המרפא

ירושלים45087.ד.ת,

JMB, FACTOR & CO. LTD.,HAR HOTZVIM HI-TECH PARK,P.O.B. 45087,JERUSALEM 91450

]74[

The invention provides new methods for synthesis of 2-aralkyloxyadenosines and 2-alkoxyadenosines. The invention is particularly useful for synthesis of 2-[2-(4-chlorophenyl)ethoxy]adenosine. Preferred methods of the invention include activatinga guanosine compound followed by hydrolysis; alkylating the hydrolyzed compoundwith subsequent amination to provide a 2-aralkyloxyadenosine or a 2-alkoxyadenosine

]57[


compound.

__________________

161625]21][11[

MEDICAMENT תרופה לטיפול במחלות עור ויראליות ובגידולי� FOR THETREATMENT OF VIRAL SKINAND TUMOUR DISEASES

]54[

18.11.2002]22[DE]33[19.11.2001]32[10156794.4]31[US19.11.2001 60/331705

Int. Cl.(2008.04) A61K 31/12, 31/20, 31/23, 31/25, 313/53, 45/06, 47/06, 47/10, A61P15/00, 17/00, 31/00, C07D 311/00, 311/12

]51[

MEDIGENE AG, GERMANY]71[WO/2003/043628]87[



]74[

The invention relates to a medicament containing a compound of general formula (I),where R1 = independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkinyl group,preferably a C11-C15 alkyl, alkylene or alkinyl group, particularly a C11-C13 alkyl,alkylene or alkinyl group, most preferably a C13 alkyl group, R2 = independently, astraight or branched C1-C8 alkyl, alkylene or alkinyl group, preferably a C1-C6 alkyl,alkylene or alkinyl group, in particular a C2-C4 alkyl, alkylene or alkinyl group, mostpreferably a C3 alkyl group, a -[CH2-(CH2)m-O]nH group with n = 1 to 10, preferablyn = 1 to 5, m = 1 to 5, preferably m = 1 to 3, a -CH2-[CH-(OH)]p [CH2-(R3)]- group,where R3 = independently H or OH, p = 1 to 7, preferably p = 1 to 4, a pentose groupor a hexose group, as therapeutically active agent, alone or in combination with one orseveral further pharmaceutical agents as a combination preparation for the treatment ofviral skin diseases and/or tumour diseases, in particular caused by human papillomavirus (HPV) and/or herpes viruses and a topically acting medicament formulation andthe use thereof.

]57[


__________________

161837]21][11[

MBMSשיטה לשידור אות בקרה עבור מידע במערכת תקשורת ניידת אלחוטית

METHOD FOR TRANSMITTINGCONTROL SIGNAL FOR MBMSDATA IN WIRELESS MOBILECOMMUNICATION SYSTEM

]54[

13.08.2003]22[KR]33[14.08.2002]32[10-2002-

0048262]31[

Int. Cl.(2009.01) H04B 07/24, 07/26, H04W 04/06, 08/00, 76/00, 76/02]51[LG ELECTRONICS INC., REPUBLICOF KOREA

]71[




]74[

A method for transmitting a control signal for multimedia service data of UMTS(Universal Mobile Telecommunications System) includes MBMS service data that canbe transmitted in a wireless system providing various types of MBMS service. AnMBMS scheduling block including an MBMS service identifier list and schedulinginformation of MBMS RB set information and an MBMS service information blockincluding one MBMS service identifier and MBMS RB set information for acorresponding service are transmitted to a terminal group.

]57[


__________________

161889]21][11[

אינטרפרו� לייצור תרופות–שימוש באומגה לטיפול במחלות ויראליות

USE OF OMEGA INTERFERON INTHE MANUFACTURE OF AMEDICAMENT FOR TREATINGVIRAL DISEASE

]54[

08.11.2002]22[US]33[09.11.2001]32[60/337948]31[

Int. Cl.(2009.01) A61K 38/21, A61P 25/02, 31/12, C07K 14/555]51[INTARCIA THERAPEUTICS, INC.,U.S.A.

]71[




]74[

A method of treating an immunologic, proliferative, or infectious disease in a warm-blooded animal is disclosed. The method comprises administering to the animal omegainterferon (IFN) at a dosage and activity for the disease state treated sufficient toinduce a therapeutic response in the animal, which dosage and activity for the diseasestate treated is higher than would be well-tolerated based on data for non-omega IFN's.The omega IFN is administered alone or in combination with a therapeuticallyeffective amount of at least one adjunctive therapeutic agent. Also disclosed is anarticle of manufacture useful for treating an immunologic, proliferative, or infectiousdisease, which article comprises (1) omega IFN in a from suitable for administering atherapeutically effective amount of the omega IFN to the subject in order to induce thedesired therapeutic response (2) instructions for administering the omega IFN asdesired, that is higher than would be well-tolerated based on data for non-omega IFNs.

]57[


__________________

162057]21][11[

ארכיטקטורה לחיבור לקוח רחוק למחשב שולחני מקומי של הלקוח

ARCHITECTURE FORCONNECTING A REMOTECLIENT TO A LOCAL CLIENTDESKTOP

]54[

19.05.2004]22[US]33[06.06.2003]32[456235]31[

Int. Cl.(2009.01) G06F 21/00]51[MICROSOFT CORPORATION,U.S.A.

]71[



]74[

Architecture for generating and maintaining a terminal-services connection from anexternal client (204) to an internal intranet client (206) behind a firewall (210) and\orrouter. The external user is first authenticated after which the external client (204) ispassed to a remote user portal (212). A listing of available internal computers ispresented to the external client user, the selection of one initiates an intranet server(214) to create a listening socket port thereon, and a socket port on the selected internalclient (206). The server (214) creates a thread that manages the terminal-servicesconnection between the external client and the internal client by listening for trafficand forwarding the traffic between the ports.

]57[


__________________


162130]21][11[

תאי� המטופואטיי� המופקי� מתאי גזע עוברי� אנושיי�

HEMATOPOIETIC CELLS FROMHUMAN EMBRYONIC STEMCELLS

]54[

06.12.2002]22[US]33[07.12.2001]32[60/338979]31[

Int. Cl.(2009.01) A61K 35/14, 48/00, A61P 07/00, 35/02, C12N 05/06, 05/08]51[GERON CORPORATION, U.S.A.ROBARTS RESEARCH INSTITUTE,CANADA

]71[




]74[

This invention provides a system for producing cells of the hematopoietic lineage fromembryonic stem cells. Differentiation is conducted in the presence of hematogeniccytokines and other factors listed in the disclosure. The cell population that is obtainedis remarkably enriched in CD45 +ve cells, a marker of early hematopoietic precursorwith self-renewing capacity. Including a bone morphogenic protein during thedifferentiation process enhances the ability of the cell population to form secondarycolonies. Because of the enormous replicative capacity of embryonic stem cells, thisprovides an important new commercial source of hematopoietic cells.

]57[



__________________

162187]21][11[

STAPLING שדכ� DEVICE]54[


27.05.2004]22[Int. Cl.(2009.01) A61B 17/00]51[

MEDIGUS עומר,מ"מדיגוס בע LTD.]71[ELAZAR מינלו זוננשיין, אמיר גוברין, אלעזר זוננשיין SONNENSCHEIN, AMIR

GOVRIN, MINELUSONNENSCHEIN

]72[




]74[

A stapling device comprises of an articulation section (20), a staple cartridge (16)containing one or more arrays of staples 24, two bores associated with each said array,and part of a staple-firing mechanism, and anvil portion (12) comprising two lockingscrews (28), wherein said cartridge is located at one end of said articulation sectionand said anvil portion is located at the other end of said articulation section;characterized in that:(a) the facing surfaces of said anvil and said cartridge are curved surfaces havingmatching curvatures such that, when said articulation section is bent bringing saidcurved facing surfaces of said anvil and said cartridge close to each other, saidcurved surfaces help to correct transverse misalignment; and(b) the center of curvature of the cartridge face in the area of the array is lowedrelative to the center of curvature of the rest of the surface, resulting in a surfacehaving two levels, said two levels assisting in correcting longitudinal misalignment;thereby bringing said locking screws in said anvil directly opposite said bores in saidcartridge, thereby bringing the parts of said stapling device into the correct workingrelationship.

]57[


__________________

162334]21][11[

METHOD שיטה ומתק� לסימו� פריטי� AND APPARATUS FORMARKING ARTICLES

]54[

06.12.2002]22[GB]33[07.12.2001]32[0129369.5]31[

Int. Cl.(2009.01) B41M 03/14]51[FRACTURE CODE CORPORATIONAPS, DENMARK

]71[

STEPHEN PAUL PINCHEN]72[WO/2003/049047]87[


גן-רמת


]74[

Method and apparatus for applying unique composite indicia or markings to asuccession of articles, in which each unique composite indicium comprises two ormore indicium. At least part of each of the indicia may be co-located at apredetermined location on the article with such co-location being unique or distinct foreach composite indicium for each article. The indicium may be overprinted with one ormore images, logos or colour-shemes. A code (e.g. an alphanumeric code) that isstored in a database may be derived from the composite indicium from one or moremathematical properties. The code may be later accessed for identifying or verifyingthe article with indicium.

]57[



199736,199735,The applications for divisionfrom this application havenot yet been published

__________________

162335]21][11[

מערכת ושיטה למעבד מכויל אוטומטית ע� יכולת התאמה עצמית לדירוג מופחת

SYSTEM AND METHOD FORAUTO CALIBRATED REDUCEDRANK ADAPTIVE PROCESSOR

]54[

05.12.2002]22[US]33[05.12.2001]32[60/335800]31[

Int. Cl.(2009.01) G01S 03/72, 07/40, 13/524, H01Q 21/00, H04B 07/08, 07/10]51[LOCKHEED MARTINCORPORATION, U.S.A.

]71[

NORMAN A. LEHTOMAKI,GREGORY A. BAKER, DWIGHTDIVINE III

]72[

WO/2003/050559]87[,אגמון-סורוקר


SOROKER-AGMON,14 SHENKAR ST.,HERZLIYA PITUAH 46725

]74[

The present invention describes a space-time adaptive processing (STAP) system andmethod combining adaptive processing with automatic phase calibration providing animproved signal-to-noise ratio of a received signal. The adaptive processing isaccomplished by calculating a reduced rank approximation of a factorization of acovariance matrix via a partial singular value decomposition of the data matrix.According to the present invention, the calculation of a white noise gain constraintdoes not require knowledge or estimation of the noise floor. Automatic phasecalibration using the signal data as the calibration source combined with the adaptiveprocessing according to the present invention provides and enhance signal-to-noiseratio and clutter suppression.

]57[


__________________

162371]21][11[

MONITORING רשת מעקב וניטור AND TRACKINGNETWORK

]54[

06.06.2004]22[Int. Cl.(2009.01) G06K 07/08, G08B 23/00]51[

DMATEKא"ת,מ"דמטק בע LTD.]71[,אגמון-סורוקר



]74[

A wide area monitoring and tracking system (300) for monitoring and tracking aplurality of individuals, the system comprising:a computerized central monitoring server (302) comprising a processor for processingdata, a memory device for storing data and a display device for displaying data;a plurality of transmitting tags (318, 320) attachable to monitored individuals, eachhaving a unique identification code, each of the plurality of tags includes a transmitterwhich periodically broadcasts a signal carrying a first data regarding the individual towhom the tag is attached, the first data includes the tag's identification code; anda plurality of local monitoring devices (306, 308) distributed at predeterminedlocations, each of the plurality of local monitoring devices comprises a receiverreceptive to signals transmitted from any of the plurality of tags when a tag is withinreception reange of a local monitoring device, a data processor for processing the firstdata carried by said signals, a memory device, and a communication device forcommunicating according to predefined schedule a second data to the centralmonitoring server, the second data includes whole or part of the first data andadditional data concerning identity and status of the local monitoring devicecommunicating the second data,

]57[


__________________

162538]21][11[

�PUNCH מחורר לצינור השקייה מעו TOOL FOR LAYFLATIRRIGATION HOSE

]54[

15.06.2004]22[Int. Cl.(2009.01) A01G 03/00]51[

MORDECHAI אור יהודה, מרדכי אלדר ELDAR]71[,מרדכי אלדר

נוה סביון,12האודם' רח אור יהודה

MORDECHAI ELDAR,12 ODEM ST.,NEVE SAVYON,OR YEHUDA 60406

]74[

A cutting tool for forming a hole in a wall of a plastic flat pipe by virtue of a cuttingelement, capable to penetrate through the wall upon applying a force thereon, the toolcomprising:(a) a body portion defined by a near grasp portion and by a frontal portion, said frontalportion is provided at its lower extremity with a through going vertical passage, saidpassage is adapted for accommodating the cutting element therein and for guiding thecutting element there-along from an uppermost position to a lowermost position;the frontal portion of the body portion is provided with a mounting pin, said bodyportion is provided with an upper compartment for deployment therein a pushingmember and a spring means; and(b) a pressure handle connected by the mounting pin to body portion so as to enablepivotal displacement of the pressure handle between an erected position and adepressed position, wherein said pivotal displacement of the pressure handleentails forcible displacement of the cutting element from the uppermost position to thelowermost position or vice versa, wherein said pushing member is connected to thepressure handle and to the cutting element such that the pushing member pushes thecutting element down when the pressure handle is displaced from the erected position

]57[


to the depressed position or forcibly pulls the cutting element up when the pressurehandle is displaced from the depressed position to the erected position, and saidpressure handle is provided with an auxiliary mounting pin and said pushing memberis provided with a window, wherein said auxiliary pin passed through said window toensure that the pushing member is forcibly pulled up by the pressure handle when thepressure handle displaces from the depressed position to the erected position.

__________________

162557]21][11[

AQUEOUS דיספרסיות מיימיות של חלקיקי פולימר DISPERSIONS OFPOLYMER PARTICLES

]54[

20.12.2002]22[AU]33[21.12.2001]32[PR9708]31[AU14.08.2002 2002/950772

Int. Cl.(2009.01) C08F 02/22, C09D 157/00]51[UNIVERSITY OF SYDNEY,AUSTRALIA

]71[




]74[

The invention provides a method for preparing an aqueous dispersion of polymerparticles comprising the following steps: (i) preparing a dispersion having a continuousaqueous phase, a dispersed organic phase comprising one or more ethylenicallyunsaturated monomers, and an amphiphilic RAFT agent as a stabiliser for said organicphase, and (ii) polymerising said one or more ethylenically unsaturated monomersunder the control of said amphiphilic RAFT agent to form said aqueous dispersion ofpolymer particles, novel amphiphilic RAFT agents for use in this method, novel RAFTagents useful in making these amphiphilic RAFT agents and methods for theirmanufacture.

]57[

__________________


162627]21][11[

מערכת מחשב ותוצר תוכנת מחשב, שיטהכבה הבנויה לעיצוב יצוג וירטואלי של הר

ממרכיבי� רבי�

METHOD, COMPUTER SYSTEMAND COMPUTER PROGRAMPRODUCT FOR CONFIGURING AVIRTUALREPRESENTATION OF ANASSEMBLY OF A PLURALITY OFCOMPONENTS

]54[

19.12.2002]22[US]33[21.12.2001]32[60/343304]31[DK21.12.2001 PA200101937

Int. Cl.(2009.01) G06F 01/00, 17/50]51[3DFACTO A/S, DENMARK]71[WO/2003/056470]87[



]74[

The invention provides a method for configuring a virtual representation of anassembly of a plurality of components, by: I) storing a first set of data representing aplurality of categories of components, and, for each category, parameters andconstraints defining limitations for configurations of each of the components, II)generating and storing a second set of data representing the assembly of a plurality ofcomponents, while respecting the constraints associated with each component andconstraints for the assembly, and generating a third set of data representing a presentconfiguration, III) repeating the step II) by: a) adding, to the second and third set ofdata, data which represent a component and which are derived from the first set ofdata, or b) deleting data representing a component of the second and third set of data,or c) amending data representing a previously added component of the second andthird set of data, while respecting the constraints associated with each component andconstraints for the assembly, so as to arrive at an updated version of the second andthird set of data.

]57[


__________________

162652]21][11[

METHOD שיטה לבדוק ולשלוט על תיסאנופטרא OFMONITORING/CONTROLLINGTHYSANOPTERA

]54[

23.12.2002]22[GB]33[21.12.2001]32[0130577.0]31[

Int. Cl.(2009.01) A01N 37/02, C07C 69/00]51[KEELE UNIVERSITY, UNITEDKINGDOM

]71[

JAMES GORDON CAMPBELLHAMILTON, WILLIAM DANIELJOHN KIRK

]72[

WO/2003/055309]87[בי'ג בע, יי אמ ,מ"פקטור אנד קו

הר חוצבים, רחוב המרפא ירושלים45087.ד.ת,


]74[

A method of monitoring/controlling Thysanoptera (hereafter thrips) by the use of abehaviour modifying compound of Formula (1), wherein Formula (1) is : where R1 is aC8-C12 group and R2 is a C2-C8 group.

]57[

__________________

163016]21][11[

התק� ושיטה לאבחו� רדיאלי וזוויתי אוסיבובי של דמויות לצור� תכולת צורה והתאמה

APPARATUS AND METHOD FORRADIAL AND ANGULAR ORROTATIONAL ANALYSIS OFIMAGES FOR SHAPE CONTENTAND MATCHING

]54[

16.01.2003]22[US]33[18.01.2002]32[10/051364]31[


Int. Cl.(2009.01) G02F 01/01]51[LOOK DYNAMICS, INC., U.S.A.]71[WO/2003/062907]87[



]74[

A segmented radial spatial light modulator (50) has an active optic area (54)comprising a plurality of radially extending active optic modulator sectors (500, 510,520, 530, 540, 550, 560, 580, 600, 610, 620, 630, 640, 650) disposed at variousangular orientations with respect to a central axis (40). The segmented radial spatiallight modulator (50) is used in separating and isolating portions of Fourier transformoptic patterns (32) from images for characterization of images by shape for recording,storing, retrieving, searching, and comparison to other images for matches and nearmatches. The images can be ghosted to increase optical power in the Fourier transformoptic pattern (32) without adding new shape content and for grading comparisons toother image shape characteristics for identifying near matches in addition to matches.

]57[

__________________

163106]21][11[

COMPOSITION תכשיר לבקרת מזיקי� של בעלי חיי� FORCONTROLLING ANIMAL PESTS

]54[

20.01.2003]22[DE]33[31.01.2002]32[10203688.8]31[

Int. Cl.(2009.01) A01N 43/78, 47/10, C07C 323/20, C07D 277/32, 493/10]51[BAYER CROPSCIENCE AG,GERMANY

]71[




]74[


The invention relates to insecticidal mixtures containing a compound of formula (I)and at least one other known agent from the series abamectin, emamectin oremamectin benzoate, methiocarb, ß-cyfluthrin, and lambda-cyhalothrin. Also disclosedis the use of said mixtures for protecting plants from infestations by parasites.

]57[

__________________

163117]21][11[

תולדות אנדאזול ותכשירי רוקחות המכילי� אות�

INDAZOLE DERIVATIVES ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME

]54[

23.01.2003]22[US]33[25.01.2002]32[60/351597]31[

Int. Cl.(2009.01) A61K 31/41, C07D 231/56, 401/12, 403/12, 405/12, 407/12, 409/12,413/02, 413/12, 417/12

]51[

VERTEX PHARMACEUTICALSINCORPORATED, U.S.A.

]71[



]74[

The present invention provides compounds of formula (I), or a pharmaceuticallyacceptable derivative thereof, wherein R1, R2, V1, V2 and V3 are as described in thespecification. These compounds are inhibitors of protein kinase, particularly inhibitorsof AKT, PKA, PDK1, p70S6K, or ROCK kinase, mammalian protein kinases involvedin proliferative and neurodegenerative disorders. The invention also providespharmaceutical compositions comprising the compounds of the invention and methodsof utilizing those compositions in the treatment of various disorders.

]57[


__________________

163186]21][11[

מערכת ושיטה לאספקת מס� הדודי בהתק� אלחוטי בהידוד ע� שרת

SYSTEM AND METHOD FORPROVIDING AN INTERACTIVESCREEN ON A WIRELESSDEVICE INTERACTING WITH ASERVER

]54[

31.01.2003]22[US]33[31.01.2002]32[10/061635]31[

Int. Cl.(2009.01) H04Q 05/20]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2003/065743]87[ט ',קולב ושות. סנפורד רק מרמו,4שער הגיא



]74[

A system and method for displaying an interactive screen, such as an end-user licenseagreement or verification form, on the graphic display (13) of a wireless device (12)when the wireless device connects to a network server (26) on a wireless network (14)and attempts to access or download software applications and data. The user of thewireless device (12) must then affirmatively interact with the interactive screen inorder to access or download a software application or data from the network server.The interactive screen can be transmitted from the network server (26) where thewireless device seeks to access or download an application or data, or can betransmitted from a separate server to the wireless device (12). The records of thewireless device-server interactions can be stored on a network server or other datastores on the wireless network.

]57[




__________________

163277]21][11[

CONTROLLED סינתזה מבוקרת של זיפרסידו� ותכשירי� שלו SYNTHESIS OFZIPRASIDONE ANDCOMPOSITIONS THEREOF

]54[

17.02.2003]22[US]33[20.02.2002]32[60/358806]31[US21.02.2002 60/359038 US27.02.200260/360459

Int. Cl.(2009.01) A61K 31/496, A61P 25/00, C07D 417/00]51[PFIZER PRODUCTS, INC., U.S.A.]71[WO/2003/070246]87[




]74[

The subject invention provides a ziprasidone composition that comprises not greaterthan 1000 ppm des-chloro ziprasidone, preferably not greater than about 500 ppm des-chloro ziprasidone, and more preferably not greater than about 100 ppm des-chloroziprasidone. Methods for synthesizing and using such ziprasidone compositions arealso provided.

]57[

זו בקשות חלוקה מבקשה.שטר פורסמו

201586,The applications for divisionfrom this application have


not yet been published

__________________

163465]21][11[

METHOD נגד מחלות חיידקיותשיטה לחס� צמחי� FOR IMMUNIZINGPLANTS AGAINSTBACTERIOSES

]54[

10.03.2003]22[DE]33[11.03.2002]32[10210473.5]31[US13.02.2003 60/447096

Int. Cl.(2009.01) A01N 35/08, 37/10, 37/44, 43/48, 43/64]51[BASF AKTIENGESELLSCHAFT,GERMANY

]71[




]74[

The invention relates to a method for immunizing plants against bacterioses,characterized in that the plants, the soil, or seeds are treated with an effective quantityof a compound of formula (I), wherein: X represents halogen, C1-C4 alkyl ortrifluoromethyl; m is equal to 0 or 1; Q represents C (=CH-CH3) -COOCH3, C (=CH-OCH3) -COOCH3, C (=CH-OCH3) -CONHCH3, C (=N-OCH3) -COOCH3, C (=N-OCH3) -CONHCH3 or N (-OCH3) -COOCH3; A represents-O-B, -CH2O-B, -CH2S-B,-OCH2-B, -CH=CH-B, -C=C-B, -CH2O-N=C (R1) -B or -CH2O-N=C (R1) -C (R2) =N-OR3, whereby B represents optionally substituted phenyl, naphthyl, 5-membered or 6-membered hetaryl or 5-membered or 6-membered heterocyclyl, containing one to threeN atoms and/or one O atom or S atom or one or two O atoms and/or S atoms; R1

represents hydrogen, cyano, alkyl, alkyl halide, cycloalkyl, alkoxy; R2 representsoptionally substituted phenyl, phenylcarbonyl, phenylsulfonyl, 5-membered or 6-membered hetaryl, 5-membered or 6-membered hetarylcarbonyl or 5-membered or 6-membered hetarylsulfonyl, or alkyl, cycloalkyl, alkenyl, alkynyl, alkylcarbonyl,alkenylcarbonyl, alkynylcarbonyl, alkylsulfonyl, or C (=NOR$g(a)) -OR$g(b), and; R3

represents hydrogen, optionally substituted alkyl, alkenyl and alkynyl. This effectivequantity of the compound is absorbed by the plants or seeds.

]57[


__________________

163557]21][11[

METHOD שיטה ומערכת להגנה משולבת ברשתות אופטיות AND SYSTEM FORHYBRID PROTECTION INOPTICAL NETWORKS

]54[

16.08.2004]22[Int. Cl.(2009.01) H04J 14/02]51[

בע. איי.סי.אי ECI פתח תקוה,מ"טלקום TELECOM LTD.]71[בע. איי.סי.אי ,מ"טלקום

30רחוב הסיבים פתח תקוה

ECI TELECOM LTD.,30 HASIVIM STREETPETACH TIKVA 49517

]74[

A method of carrying out protection of data traffic in a multi-channel multi-sectionring-like optical communications network by simultaneously using OpticalMultiplexed Section (OMS) protection and Optical Channel (OCH) protection, themethod comprises a step of selecting an optical signal in an OCH protected opticalchannel, in case of a fault in a section of said network, by relying on an indicationassociated with OMS switching functionality required to overcome said fault,wherein the communication network consisting of no more than two ring-likeconfigurations respectively formed by no more than two optical fibers connectingnetwork elements, one of said configurations is considered a main configuration andthe other is considered a protecting configuration, the method comprises:providing the OMS protection for at least one section of the network by ensuring, incase of a failure in said section, switching of the data traffic from one of saidconfigurations to another of said configurations at each of two ends of said section;providing the OCH protection for at least one optical channel in the network, bytransmitting data related to said optical channel from one of said network elementsbeing a source point of said channel to another of said network elements being adestination point of said channel by means of two optical signals, wherein one of saidoptical signal is transmitted via the main configuration and another of said opticalsignals is transmitted via the protecting configuration;

]57[


said selection being performed by rejecting the one of the two optical signals of saidOCH protected channel, that has undergone said switching from one of saidconfigurations to another of said configurations at least once, by relying on saidindication.

__________________

163582]21][11[

תהלי� זיקוק פעיל לאלקילציה של פחמימני��ארומטיי

REACTIVE DISTILLATIONPROCESS FOR THEALKYLATION OF AROMATICHYDROCARBONS

]54[

16.01.2003]22[US]33[05.03.2002]32[091199]31[

Int. Cl.(2009.01) C07B 61/00, C07C 02/00, 02/64]51[SASOL NORTH AMERICA INC.,U.S.A.

]71[




]74[

A unified process for reactive distillation under pressure for the alkylation of lightaromatic hydrocarbons such as benzene and cumene with straight chain C6- C18 olefinsusing a solid acid alkylation catalyst supported in the reflux zone of the distillationcolumn (column 2). The process is continuous, using a reactive distillationconfiguration such that at least a portion of the olefin (7) is injected below the benzenerectification zone at the top of the column. The aromatic hydrocarbon (17) is injectedcontinuously at a low rate above the rectification zone (H) at the base of the columnand above the reboiler (40). The alkylation reaction takes place primarily in the liquidphase on the solid acid catalyst and is characterized in that the molar ratio is adjustableup to about 100/1, through adjustment of the internal column operating pressure, thebenzene reflux rate, the amount of benzene removed from the reflux condenser tostorage or from the reboiler with the distillation column operated at or near totalaromatic hydrocarbon reflux. The unexpectedly high liquid phase aromatichydrocarbon to olefin molar ratios achieved in the reactive distillation columnincreases the selectivity to mono-alkylated aromatics and helps stabilize catalystlifetime.

]57[


__________________

163714]21][11[

שיטה לקריאת נתוני�, שבב מעגל משולב לזיהוי ושיטה לכתיבת נתוני�

IC CHIP FOR IDENTIFICATION,DATA-READING METHOD ANDDATA-WRITING METHOD

]54[

24.08.2004]22[JP]33[11.09.2003]32[2003-319280]31[

Int. Cl.(2009.01) G06K 19/07]51[FEC CO., LTD., JAPANTHE GOVERNMENT OFMALAYSIA GOVERNMENTADMINISTRATIVE CENTRE 62502PUTRAJAYA MALAYSIA,MALAYSIA

]71[



]74[

Restrictions on the frequency of a carrier signal are removed. This invention comprisesa power section for receiving the carrier signal and creating an internal voltage, aclock-generating section for creating an internal clock based on a clock pulse that iscarried by the carrier signal, a memory section, a writing section for storing data that iscarried on an optical signal in the memory section, and an output section for readingthe data in the memory and load-modulating the carrier signal.

]57[

__________________


163792]21][11[

שילובי� של חומרי� קוטלי עשבי� המכילי� אוריאה–תרכובות מסויימות של סולפוניל

HERBICIDE COMBINATIONSCOMPRISING SPECIFICSULFONYLUREAS

]54[

20.02.2003]22[DE]33[05.03.2002]32[10209478.0]31[

Int. Cl.(2009.01) A01N 37/00, 39/00, 43/00, 47/00, 57/12, C07C 205/58, 205/59,211/44, 255/12, 275/28, 281/06, 317/24, 317/32, 323/22, 335/00, 59/58, 59/60, C07D209/48, 213/64, 213/71, 213/78, 239/42, 249/12, 251/42, 263/44, 285/16, 403/02,403/12, 471/02, 487/04, C07F 09/38

]51[

BAYER CROPSCIENCE AG,GERMANY

]71[




]74[

Disclosed are synergistic herbicidal agents comprising: (A) one or several herbicidesfrom the group of mesosulfuron or the salts thereof; (B) one or several herbicides fromthe group of iodosulfuron or the salts thereof; and (C) one or several herbicides from alist of 63 agents.

]57[

__________________

164013]21][11[

FOOD תוס� מזו� בעל תכונות תחליביות ADDITIVE WITHEMULSIFYING PROPERTIES

]54[

30.12.2002]22[ES]33[11.03.2002]32[P200200569]31[

Int. Cl.(2009.01) A23L 01/035]51[PREMIUM INGREDIENTS, S.L.,SPAIN

]71[




]74[

The invention relates to a food additive comprising carraghenate iota and sodium]57[


stearyl-2-lactylate (SSL). The inventive food additive, which has emulsifying and/orstabilising properties, can be used in the food industry and in the production of foodproducts.

__________________

640971]21][11[

לרמהTBFשיטה והתק� המספקי� מיפויעליונה בזמ� תפעול ברשת רדיו מטיפוס

EDGE/GSM

METHOD AND APPARATUSPROVIDING MULTIPLETEMPORARY BLOCK FLOW(TBF) MAPPING TO UPPERLAYER WHEN OPERATING INGSM/EDGE RADIO ACCESSNETWORK (GERAN) A/GB MODE

]54[

13.02.2003]22[US]33[22.03.2002]32[104847]31[

Int. Cl.(2009.01) H04B 01/00, H04J 01/00, 03/00, H04L 12/56, 29/08]51[NOKIA CORPORATION, FINLAND]71[WO/2003/081817]87[



]74[

Disclosed is a wireless communications system (5), in the preferred embodiment aGSM/EDGE Radio Access Network system (300), that includes a Logical LinkControl (LLC) layer (265) of a mobile station (100) and a LLC layer (30E) of aServing General Packet Radio Service Support Node (SGSN) (30) that are coupledtogether through a Gb interface (310). The system (5) operates for establishing andoperating a plurality of Temporary Block Flows (TBF) for transferring Packet DataUnits (PDUs) in either an uplink or a downlink direction between the LLC (265) layerof the mobile station (100) and the LLC (30E) layer of the SGSN node (30). Thesystem (5) operates at a level of the LLC (30E) layer and a Radio Link Control (RLC)

]57[


(260) layer for distinguishing PDUs belonging to a first TBF from PDUs belonging toa second TBF based on information associated with each PDU, and maps PDUs intothe appropriate one of the first TBF or the second TBF on the information.

__________________

164108]21][11[

תכשירי, תהליכי� להכנת�, תולדות קווינולי�רוקחות המכילי� אות� ושימוש� בהכנת

ב ובמחלות אחרותCNS–התרופות לטיפול

QUINOLINE DERIVATIVES,PROCESSES FOR THEIRPREPARATION,PHARMACEUTICALCOMPOSITIONS CONTAININGTHEM AND THEIR USE IN THEMANUFACTURE OFMEDICAMENTS FOR THETREATMENT OF CNS ANDOTHER DISORDERS

]54[

25.03.2003]22[GB]33[27.03.2002]32[0207289.0]31[GB04.11.2002 0225678.2

Int. Cl.(2009.01) A61K 31/495, A61P 03/00, 25/00, 43/00, C07D 215/00, 401/10,413/12, 417/12

]51[

GLAXO GROUP LIMITED, UNITEDKINGDOM

]71[




]74[

The present invention relates to quinoline compounds of formula (I) or apharmaceutically acceptable salt thereof, wherein R1 and R2 independently representhydrogen or C1-6 alkyl or R1 is linked to R2 to form a group (CH2)2, (CH2)3 or (CH2)4;

]57[


R3, R4 and R5 independently represent hydrogen, halogen, cyano, -CF3, -CF3O, C1-6 alkyl, C1-6 alkoxy, C1-6 alkanoyl or a group -CONR6R7; m represents an integer from 1to 4, such that when m is an integer greater than 1, two R2 groups may instead belinked to form a group CH2, (CH2)2 or (CH2)3; n represents an integer from 1 to 3; prepresents 1 or 2; A represents a group -Ar1 or -Ar2Ar3; Ar1, Ar2 and Ar3 independentlyrepresent and aryl group or a heteroaryl group, both of which may be optionallysubstituted by one or more substituents having pharmacological activity, to processesfor their preparation, to compositions containing them and to their use in the treatmentof CNS and other disorders.

__________________

164114]21][11[

METHOD שיטה ומערכת לשליטה ברשת אופטית AND SYSTEM FORCONTROLLING OPTICALNETWORK

]54[

15.09.2004]22[Int. Cl.(2009.01) H04J 14/02, H04L 12/24]51[

בע. איי.סי.אי ECI פתח תקוה,מ"טלקום TELECOM LTD.]71[בע. איי.סי. אי ,מ"טלקום

30רחוב הסיביםוהפתח תק

ECI TELECOM LTD.,30 HASIVIM ST.,PETACH TIKVA 49517

]74[

A method for controlling an optical network composed of network elements NEs (12,14, 16, 18, 62, 64, 66, 68, 70, 72, 76, 82, 84), with the aid of a network controller NC(24) being in communication with said network elements, the method including:collecting, by the network controller NC, information on the network elements fromsaid NEs, and being characterized by:whenever a change in the network is requested, simulating, within the networkcontroller, operation of the network with the requested change based on the collectedinformation on the network elements,making in the network controller a decision on acceptability of the requested change,andif the decision is positive, causing implementation of the requested change in thenetwork.

]57[


__________________

164417]21][11[

ואריינטי� של נוגד� המסוגלי� להתקשר לאתרשל–חו+ ופריט מיוצר המכיל אתHER2תאי

ל"הנוגד� הנ

ANTIBODY VARIANTS CAPABLEOF BINDING TO THEEXRACELLULAR DOMAIN OFHER2 AND ARTICLE OFMANUFACTURE COMPRISINGSAID ANTIBODY

]54[

09.04.2003]22[US]33[10.04.2002]32[60/371609]31[

Int. Cl.(2009.01) A61K 39/395, A61P 35/00, C07K 16/28, C12P 21/08]51[GENENTECH, INC., U.S.A.]71[WO/2003/087131]87[



]74[

The present invention concerns novel antibody variants, particularly anti-HER2antibody variants having substitutions at positions within the variable domains of the

]57[


heavy and light chains.



__________________

164435]21][11[

מערכת ושיטה לדיכוי ניצנוצי� בוידיאו דיגיטלי מוגבר

SYSTEM AND METHOD FORSCINTILLATION SUPPRESSIONIN INTENSIFIED DIGITAL VIDEO

]54[

05.10.2004]22[US]33[30.10.2003]32[697198]31[

Int. Cl.(2009.01) H04N 05/213, 05/217, 05/238]51[ITT MANUFACTURINGENTERPRISES, INC.

]71[



]74[

A method for scintillation suppression of video images includes (a) receiving a frameof pixels having intensity values; (b) identifying pixels in the received frame havingscintillation noise; (c) modifying intensity values of pixels in the received frame,identified as having scintillation noise, to form a filtered frame of pixels; (d) countingthe number of pixels modified in step (c); and (e) displaying the filtered frame ofpixels, if the amount of pixels counted is less than a threshold value.

]57[


__________________

164458]21][11[

ACTIVE מחבר אקטיבי לרשת תקשורת מקומית LOCAL AREANETWORK CONNECTOR

]54[

09.06.2004]22[Int. Cl.(2008.04) H01R 13/66, 137/19]51[

אנאלוג מיקסד סינגל-מיקרוסמי קורפ הוד השרון,מ"גרופ בע

MICROSEMI CORP - ANALOGMIXED SIGNAL GROUP LTD

]71[

WO/2003/088426]87[סיימון קהאן אצל מיקרוסמי קורפ אנאלוג

בעמי ,מ"קסד סיגנל גרופ1הנגר' רח

השרון-הוד 7220.ד.ת,

SIMON KAHAN C/O MICROSEMICORP - ANALOG MIXED SIGNALGROUP LTD,1 HANAGAR STREETP.O.BOX 7220HOD HASHARON45421 ISRAEL

]74[

An active connector for use in a local area network (LAN) including at least one LANnode. The active connector includes an active connector housing, at least one firstplurality of first electrical contacts mounted in the housing and arranged fordetachable connection with corresponding electrical contacts of at least one plugs, atleast one second plurality of second electrical contacts mounted in the housing andarranged for connection with corresponding electrical contacts of local area networkequipment and active power control circuitry located within the housing and coupledto at least some of the first and second electrical contacts, the active power controlcircuitry being operative for controlling the supply of electrical power over the localarea network cabling to at least one node of the local area network.

]57[

__________________


164482]21][11[

חישוב ממוצע עקבי למדידת חוסר ליניאריות של גל נוסע בצינור מגבר

COHERENT AVERAGING FORMEASURING TRAVELING WAVETUBE AMPLIFIERNONLINEARITY

]54[

10.10.2004]22[US]33[10.10.2003]32[60/510368]31[

Int. Cl.(2009.01) H04B 01/10]51[THE DIRECTV GROUP, INC., U.S.A.]71[




]74[

A method and system provide the ability to measure a transmission performancecharacteristic. A signal is received and demodulated 1302. An ideal signal 1320 isgenerated 1304 from the demodulated signal. The received signal is coherentlyaveraged 1324/1326 to reduce noise. The performance characteristic is the estimatedTWTA nonlinearity from a difference between the coherently averaged ideal signaland received signal.

]57[

__________________


164568]21][11[

תרכובות ותכשירי רוקחות לטיפול במחלותע VCAM–1י"המתווכות

COMPOUNDS ANDPHARMACEUTICALCOMPOSITIONS FOR TREATINGDISEASES MEDIATED BY VCAM-1

]54[

14.05.1998]22[US]33[14.05.1997]32[60/047020]31[

Int. Cl.(2009.01) A61K 31/10, 31/19, 31/34, A61P 09/00, 29/00, C07C 323/20, C07D257/04, 303/12, 307/70, C07H 15/20

]51[

DIVISION FROM 132797]62[ATHEROGENICS, INC., U.S.A.]71[WO/1998/051662]87[



]74[

This invention is in the area of methods and compositions for the inhibition of theexpression of VCAM-1 and, in particular, for the treatment of diseases mediated byVCAM-1, including cardiovascular and inflammatory diseases.

]57[

__________________

164901]21][11[

אמינוקטוני� פעילי�–תהלי� להכנת בטא אופטית

PROCESS FOR PREPARINGOPTICALLY ACTIVE BETA-AMINOKETONES

]54[

22.04.2003]22[DE]33[03.05.2002]32[10219987.6]31[

Int. Cl.(2009.01) C07D 213/24, 213/74, 401/06, 401/12]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[




]74[


An element (9) in the path of ions (18) in a mass spectrometer is adaptively mountedso that variations in the path ions take can be compensated for in order to improve theresolution of the mass spectrometer. Preferably the element is mounted on at least onevariable shape mounting element (37) which can vary its length in response to signalsfrom remote control means (21).

]57[

__________________

164926]21][11[

משיב לייזר לנטרול משגוח מהירות–משדר המבוסס על לייזר

LASER TRANSPONDER FORDISABLING A LASER-BASEDSPEED MONITOR

]54[

01.05.2003]22[US]33[01.05.2002]32[10/138036]31[

Int. Cl.(2009.01) G01S 07/48, 07/483, 07/495, 17/58]51[TORBEN BOGH-ANDERSEN,DENMARK

]71[




]74[

A laser transponder (1) for disabling a laser-based speed monitor (7), which istransmitting a monitor laser beam at a moving vehicle by transmitting a jamming laserbeam to the laser-based speed monitor. The monitor laser beam is in the shape of amonitor signal (8; s1; sm) comprising monitor pulse trains (65) emitted with a firstfrequency f1, while the jamming laser beam is in the shape of a jamming signal (11;s2; sj) comprising jamming pulse trains (67) emitted with a second frequency f3.

]57[



This specification was examined in accordancewith regulation 35 of the Patent Regulations,5728 - 1968

__________________

165044]21][11[

יצור ציוד משתמש לזיהוי קוד מערבל יחודי עבור ערו+ מהיר בעל שיתו� מבוקר

GENERATION OF USEREQUIPMENT IDENTIFICATIONSPECIFIC SCRAMBLING CODEFOR THE HIGH SPEED SHAREDCONTROL CHANNEL

]54[

05.05.2003]22[US]33[07.05.2002]32[60/378509]31[US13.05.2002 60/378170 US01.07.2002187640

Int. Cl.(2009.01) H04N 07/167]51[INTERDIGITAL TECHNOLOGYCORPORATION, U.S.A.

]71[




]74[

A code is produced for use in scrambling or descrambling data associated with a highspeed shared control channel (HS-SSCH) for a particular user equipment. A useridentification of the particular user equipment comprises L bits. A 1/2 rateconvolutional encoder (14) processes at least the bits of the user identification by a 1/2rate convolutional code to produce the code.

]57[




__________________

165120]21][11[

MEDICAL שתל רפואי ע� ציפוי למניעת זיהו� IMPLANT WITH ACOATING TO INHIBITINFECTION

]54[

27.05.2003]22[US]33[24.05.2002]32[60/383,419]31[

Int. Cl.(2009.01) A61L 27/34]51[ANGIOTECH INTERNATIONALAG., SWITZERLAND

]71[



]74[

Packaging methods and apparatus for bonding a lidding web (108) to a tray web (104),characterized in that the lidding web (108) is placed under tension in both thelongitudinal and lateral directions before being bonded to a tray web (104). A tray web(104) having recesses (606) and channels that form a conduit when the tray web isoverwrapped with a lidding web (108) is provided. A lidding web hasmicroperforations to control the transfer of gases.

]57[

__________________


165265]21][11[

מעכבי� פנילסולפונאמידיי� מותמרי� של ייצור אמילואיד ביטא

SUBSTITUTEDPHENYLSULFONAMIDEINHIBITORS OF BETA AMYLOIDPRODUCTION

]54[

09.06.2003]22[US]33[11.06.2002]32[60/387690]31[

Int. Cl.(2009.01) A61K 31/18, 31/341, 31/357, 31/404, 31/4245, A61P 25/28, C07C311/17, 311/18, C07D 209/14, 271/12, 307/52, 319/06

]51[

ARQULE, INC., U.S.A.WYETH LLC, U.S.A.

]71[




]74[

Compounds of Formula I, wherein R1-R8 are defined herein are provided, togetherwith pharmaceutically acceptable salts, hydrates, metabolites, and/or prodrugs thereof.Uses of these compounds for inhibiting beta amyloid production and for the preventionand treatment of Alzheimer’s Disease and Down’s syndrome are described.

]57[



__________________

165326]21][11[

METHOD התק� ושיטה לטיהור גז AND APPARATUS FORGAS PURIFICATION

]54[


26.05.2003]22[JP]33[24.05.2002]32[2002-150522]31[

Int. Cl.(2009.01) C01B 23/00]51[TADAHIRO OHMI, JAPANTAIYO NIPPON SANSOCORPORATION, JAPAN

]71[



]74[

A method for gas purification wherein a mixed gas containing a rare gas and nitrogenas main components and hydrogen, a reaction product comprising nitrogen andhydrogen and steam as trace components is freed of the trace components, whichcomprises an adsorbing step of removing the reaction product comprising nitrogen andhydrogen and steam, a hydrogen oxidation step of converting hydrogen to steam by acatalytic hydrogen oxidizing reaction in the presence of oxygen, and then a drying stepof removing the steam formed in the hydrogen oxidation step. When the mixed gasfurther contains a nitrogen oxide, a denitration step of converting the nitrogen oxide tonitrogen and steam in the presence of a reducing substance is carried out prior to theabove adsorption step.

]57[

__________________

165341]21][11[

COLLAPSIBLE מיכל מתקפל CONTAINER]54[

23.11.2004]22[US]33[16.12.2003]32[735724]31[US27.07.2004 899314

Int. Cl.(2009.01) B65D 06/16, 21/08]51[DART INDUSTRIES INC., U.S.A.]71[

REINHOLD,ריינהולד כהן ושותפיו COHN ANDPARTNERS,

]74[




A collapsible container (10) with angularly related multiple folding sections (34), eachsection (34) extending at an angle to the vertical, and flexure zones (40) betweenadjacent sections (34) for flexibly moving the sections between a first open position inthe expanded container and a second position folded upon itself in the collapsedcontainer, the flexure zones (40) resisting movement of the sections (34) in both thefully expanded container and the collapsed container, as well as any intermediateposition wherein only selected flexure zones (40) are in an open position.

]57[

__________________

165390]21][11[

METHODS שיטות לזיהוי ומיצוי של אנדוטוקסי� FOR IDENTIFYINGAND EXTRACTING ENDOTOXIN

]54[

24.06.2003]22[DE]33[24.06.2002]32[102 28 133.5]31[DE24.02.2003 103 07793.6


Int. Cl.(2009.01) G01N 33/53, 33/566, 33/569]51[HYGLOS INVEST GMBH,GERMANY

]71[



]74[

A mobile communication terminal with a processor control is disclosed, in which isinstalled at least one independent humidity sensor, controlled by the processor for arecording of humidity in order to reduce or prevent corrosion in mobile radioterminals. Should humidity be recognised within the mobile radio communicationterminal at a particular time, then at that time or possibly later, a complete or partialswitching off of the mobile communication terminal is achieved. In a preferredembodiment of the invention, during a partial shutdown, at least those componentsnecessary for a recognition of humidity and for reactivating the whole device remainactive. Furthermore, functional components can be protected from corrosion just bymeans of a reduction in voltage differentials on the ingress of humidity.

]57[

__________________

165502]21][11[

–H1–דיהדרו– 4,5–הלו–3שיטה להכנת פיראזולי�

METHOD FOR PREPARING 3-HALO-4,5-DIHYDRO-1H-PYRAZOLES

]54[

29.07.2003]22[US]33[31.07.2002]32[60/400356]31[US11.02.2003 60/446451

Int. Cl.(2009.01) C07D 231/00, 401/04]51[E.I. DU PONT DE NEMOURS ANDCOMPANY, U.S.A.

]71[




]74[

This invention relates to a method for preparing 3-halo-4,5-dihydro-1H-pyrazolecompound of Formula (I), comprising contacting with HX1 a different 4,5-dihydro-1H-

]57[


pyrazole compound of Formula (II), wherein X1 is halogen and L, R, k and X2 are asdefined in the disclosure. This invention also discloses preparation of compounds ofFormula (III) wherein X1, R3, R6, R7, R8a, R8b, and n are as defined in the disclosure.



__________________

165519]21][11[

שימוש, שיטה לייצור�, תיאופיני� מותמרי�, שלה� להכנת תרופה או כריאגנט מאבח�

ותכשירי� רפואיי� המכילי� אות�

SUBSTITUTED THIOPHENES,METHOD FOR THEPRODUCTION THEREOF, THEIRUSE IN THE PREPARATION OF AMEDICAMENT OR DIAGNOSTICREAGENT ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME

]54[

26.05.2003]22[DE]33[04.06.2002]32[10224892.3]31[

Int. Cl.(2009.01) A61K 31/4168, A61P 11/00, C07D 409/00, 409/12]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[


גבמ 5שנקר'רח,1ים-רכז הרצליה12704.ד.ת,


]74[

The invention relates to substituted thiophene derivatives of formula (I), wherein: R1to R8 have the meanings as cited in the claims. Medicaments containing compounds ofthis type are useful in preventing or treating various diseases. Thus, these compounds

]57[


can be used, among other things, for treating breathing disturbances and snoring, forimproving the breathing drive, for treating acute and chronic diseases, diseasestriggered by ischemic and/or reperfusion events as well as by proliferative or fibroticevents, for the treatment or prophylaxis of diseases of the central nervous system, lipidmetabolism and diabetes, blood clotting and parasitic infection.

__________________

165529]21][11[

תהליכי� מיקרואורגניזמיי� להכנת חומצתשמני�)PUFA(רוויה–בלתי–שומ� רב

יכי� אלו ותכשירי� המכילי� המתקבלי� בתהל אות�

MICROORGANISM PROCESSESFOR THE PRODUCTION OFPOLYUNSATURATED FATTYACID (PUFA), OILS OBTAINEDFROM SAID PROCESSES ANDCOMPOSITIONS COMPRISINGTHEM

]54[

20.06.2003]22[EP]33[19.06.2002]32[02254262.5]31[EP18.12.2002 02258713.3 EP26.02.200303251169.3

Int. Cl.(2009.01) A23D 09/02, A23K 01/16, A23L 01/30, A61K 31/202, 35/74, A61P25/00, 43/00, C12P 07/62, 07/64

]51[

DSM IP ASSETS B.V., THENETHERLANDS

]71[


עומר, תעשייהגן באר שבע5352.ד.ת,


]74[

The present invention provides a process for the production of a microbial oilcomprising culturing a micro-organism in a two stage fermentation process where, in alast stage that precedes the end of fermentation, the carbon source is: consumed by themicro-organisms at a rate greater than it is added to the medium; added at a rate≤ 0.30

]57[


M carbon/kg medium; or is rate limiting on the growth of the micro-organism. Themicro-organisms thus have the carbon source restricted so that they preferentiallymetabolise fats or lipids other than arachidonic acid (ARA), so increasing theproportion of ARA in the cells. A microbial oil is then recovered from the micro-organism, using hexane as a solvent, that has at least 50% ARA and at least 90%triglycerides.

__________________

165588]21][11[

תרכובת הדברת מזיקי�, תרכובת מלונוניטרילבו, המכילה אותו שיטת בדיקת מזיקי� בשימוש

ושימוש בו בייצור תרכובת הדברת מזיקי�

MALONOITRILE COMPOUND,PESTICIDE COMPOSITIONCONTAINING THE SAME, PESTCONTROLLING METHOD USINGTHE SAME AND USE THEREOFFOR THE MANUFACTURE OFPESTICIDE COMPOSITION

]54[

07.07.2003]22[JP]33[17.07.2002]32[2002-208059]31[

Int. Cl.(2009.01) A01N 43/40, C07D 213/00, 213/57, 213/61, 213/84]51[SUMITOMO CHEMICALCOMPANY, LIMITED., JAPAN

]71[

WO/2004/006677]87[הס"ד ,ושותפיור יצחק

279רחוב הירקון תל אביב6451.ד.ת,

DR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,P.O.B. 6451,TEL AVIV 61063

]74[

The present invention relates to a novel malononitrile compound represented by theformula (I): wherein, R1 represents a C1 to C5 (halo)alkyl and the like, R2 represents aC1 to C5 (halo)alkyl, R3 and R4 are the same or different and are a C1 to C6(halo)alkyl and the like, R5 represents a halogen atom and the like, n is an integer of 0to 4 and when n is 2 or more, R5 may be the same or different. The malononitrilecompound has an efficient pesticidal activity and can control effectively pests such asinsect pests, acarine pests, nematode pests and the like.

]57[


__________________

165658]21][11[

SIGMA מאפנ� סיגמה דלתא DELTA MODULATOR]54[

20.05.2003]22[US]33[16.07.2002]32[10/196343]31[

Int. Cl.(2009.01) H03M 03/02]51[RAYTHEON COMPANY, U.S.A.]71[WO/2004/008643]87[




]74[

A sigma delta modulator having an integrator with a first input for coupling to ananalog signal and a second input for coupling to a reference voltage. A comparator hasa first input coupled to an output of the integrator and a second input coupled to thereference voltage. The comparator produces signal having a logic state in accordancewith the relative magnitude of signals at the first and second inputs thereof. The logicstate is latched at the comparator output during latching transitions of latching pulses.A one-bit quantizer stores the logic state of at the comparator output at samplingtransitions of clock pulses fed to the quantizer. The clock pulses and the latchingpulses are synchronized one with the other. Each one of the latching transitions occursprior to a corresponding one of the sampling transitions.

]57[

__________________

165987]21][11[

מערכת לעיבוד נתוני� שיש לה� מערכות הוראות חיצוניות ופנימיות

DATA PROCESSING SYSTEMHAVING EXTERNAL AND

]54[


INTERNAL INSTRUCTION SETS

15.05.2003]22[GB]33[20.09.2002]32[0221916/0]31[

Int. Cl.(2009.01) G06F 09/30, 09/318, 09/38, 09/44, 09/45, 09/46, 12/00, 15/00]51[ARM LIMITED, UNITED KINGDOM]71[WO/2004/002760]87[




]74[

There is provided a system having: an execution core operable to execute internalinstructions; a translation buffer operable to store a plurality of internal instructionblocks of one or more internal instructions, said internal instruction blocks being adynamic translation of respective external instruction blocks of one or more externalinstructions; a remapper responsive to an execution request for an external instructionthat is within one of said external instruction blocks to identify a correspondinginternal instruction block stored within said translation buffer such that one or moreinternal instructions from said corresponding internal instruction block can be suppliedto said execution core.

]57[

__________________

166274]21][11[

הרכבי� ושיטות לדיכוי של היווצרות כלי הד�siRNAי"ע

COMPOSITIONS AND METHODSFOR SIRNA INHIBITION OFANGIOGENESIS

]54[

18.07.2003]22[US]33[24.07.2002]32[60/398417]31[US14.11.2002 10/294228

Int. Cl.(2009.01) A61K 31/7088, C12N 15/85]51[THE TRUSTEES OF THEUNIVERSITY OF PENNSYLVANIA,

]71[


U.S.A.WO/2004/009769]87[




]74[

RNA interference using small interfering RNAs which are specific for the vascularendothelial growth factor (VEGF) gene and the VEGF receptor genes Flt1 and Flk-l/KDR inhibit expression of these genes. Diseases which involve angiogenesisstimulated by overexpression of VEGF, such as diabetic retinopathy, age relatedmacular degeneration and many types of cancer, can be treated by administering thesmall interfering RNAs.

]57[



__________________

166321]21][11[

TOILET מערכת לניקוי אסלה CLEANING SYSTEM]54[

16.01.2005]22[Int. Cl.(2009.01) E03D 09/00, 09/02, 09/03]51[

YAACOV יבנה, יעקב קולציה KOLCHEH]71[,אדוארד לנגר

רעננה410.ד.ת,EDWARD LANGER,MERKAZ GERON H. 312P.O.B. 410,RAANANNA 43103

]74[

A toilet cleaning system for providing cleansing of a toilet bowl , comprising:a solid or semi-solid cleanser unit; anda bifurcated communicating pipe, for installation and communication between aflushable water tank and a toilet bowl, said communicating pipe comprising:a central channel; andan angled branch for insertion of said cleanser unit therewithin,

]57[


wherein said bifurcated communicating pipe allows a portion at the end of saidcleanser unit to project into said central channel of said communicating pipe forcontacting the flush water, to provide cleansing action.

__________________

166476]21][11[

תולדות לינקומיציניות בעלות פעילות אנטי בקטריאלית

LINCOMYCIN DERIVATIVESPOSSESSING ANTIBACTERIALACTIVITY

]54[

15.08.2003]22[US]33[15.08.2002]32[60/403770]31[

Int. Cl.(2009.01) A61P 31/04, C07H 15/16, 17/00]51[VICURON PHARMACEUTICALSINC., U.S.A.

]71[

WO/2004/016632]87[,וצאטו את לוצאטול



]74[

Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibitantibacterial activity. As the compounds of the subject invention exhibit potentactivities against bacteria, including gram positive organisms, they are usefulantimicrobial agents. Methods of synthesis and of use of the compounds are alsodisclosed.

]57[

__________________

166572]21][11[

מיניאטורי משולב ומערכת–קוצב לב אולטרא קצב מבוזרת

ULTRAMINIATUREINTEGRATED CARDIACPACEMAKER AND DISTRIBUTEDPACING SYSTEM

]54[

04.08.2003]22[WO]33[05.08.2002]32[JP2002/07972]31[

Int. Cl.(2009.01) A61N 01/36]51[


JAPAN AS REPRESENTED BYPRESIDENT OF NATIONALCARDIOVASCULAR CENTER,JAPAN

]71[

KENJI SUNAGAWA, MASARUSUGIMACHI, MASASHI INAGAKI

]72[

WO/2004/001281]87[בע"ד ,מ"ר מרק פרידמן



]74[

A micro integrated cardiac pacemaker comprising a control unit for outputting acontrol signal, heart stimulating means for stimulating a heart tissue in response to thecontrol signal, cardiograph information extracting means for extracting cardiographinformation and outputting it to the control unit, and a power supply unit for supplyingdrive power. The control unit outputs a control signal according to cardiographinformation. The power supply unit is a biological fuel cell that takes out electrons byoxidation of a biological fuel. The biological fuel cell is characterized in that itcomprises an anode and a cathode, an oxidase of a biological fuel and a mediator areimmobilized on the cathode, the blood and/or the body fluid are used as an electrolyticsolution, and a biological fuel and oxygen in the blood and/or the fluid are used. Thebiological fuel cell is attached to the end of a catheter and implanted into the heart, andthe catheter is withdrawn. It is unnecessary to incise the breast.

]57[

__________________

166657]21][11[

תכשירי רוקחות המכילי� גור� יעיל להפחתת הכמות היעילה של קלוסטורי�

PHARMACEUTICALCOMPOSITIONS CONTAININGAN AGENT EFFECTIVE TOREDUCE THE EFFECTIVEAMOUNT OF CLUSTERIN

]54[

21.08.2003]22[


US]33[21.08.2002]32[60/405193]31[US03.09.2002 60/408152 US02.12.200260/319748US20.05.200360/472387

Int. Cl.(2009.01) A61K 31/712, 38/00]51[THE UNIVERSITY OF BRITISHCOLUMBIA, CANADAMARTIN E. GLEAVE, CANADA

]71[



]74[

Treatment of melanoma is achieved through reduction in the effective amount ofclusterin in melanoma cells. Thus, in accordance with one aspect of the invention,there is provided a method for treatment of melanoma in a mammalian subject,preferably a human, comprising the step of administering to the subject a therapeuticagent effective to reduce the effective amount of clusterin in the melanoma cells. Thetherapeutic agent may be, for example, an antisense ODN or small inhibitory RNA(siRNA) compound targeted to clusterin. The present invention also provides a methodfor regulating expression of bcl-xL in a subject or cell line comprising administering tothe subject or cell line an agent effective to modulate the amount of clusterinexpression. In particular, in clusterin expressing cells, the expression of bcl-xL isdown-regulated when the effective amount of clusterin is reduced. Such inhibition issignificant because bcl-xL is known to act as an inhibitor of apoptosis.

]57[

__________________

166680]21][11[

התק� ושיטה להפעלת מעגל קירור ללא ניצו+ קרח

DEVICE AND METHOD FOROPERATING A REFRIGERATIONCYCLE WITHOUT EVAPORATORICING

]54[

04.08.2003]22[US]33[05.08.2002]32[213347]31[


US25.06.2003 603578 Int. Cl.(2009.01) F25B 47/02]51[AIR TO WATER TECHNOLOGIES,INC., U.S.A.

]71[




]74[

The present invention relates to a device and method for operating a refrigeration cyclewithout icing of the evaporative surface (40) of the device using a hot gas bypasssystem (70, 72, 74) operated by a solenoid (75) controlled by a microprocesseur (60).

]57[

__________________

166688]21][11[

LOCKABLE מכלול אבז� הנית� לנעילה HASP ASSEMBLY]54[

03.02.2005]22[Int. Cl.(2008.04) E05B 65/48, E05C 19/08]51[


]71[

BELO אלכס אקרמן, בלו מטיקו MATYKO, ALEX AKERMAN]72[,מ"דקל פטנט בע27חדר,18מנוחה ונחלה

רחובות


]74[

A hasp assembly comprising:a first hasp member (12) and a second hasp member (14), said hasp member havingmounting provision for attachment to a door (26);a plug (30) arranged for rotation in one of said hasp members; anda plurality of locking elements (38) carried inside said first hasp member and adaptedto be moved by rotation of said plug into and out of locking engagement with said

]57[


second hasp member, wherein said locking elements are adapted to be moved indifferent directions by rotation of said plug, wherein the directions are generallyopposite to each other, andwherein each of said locking elements is connected to said plug by a cam (40), saidcam having a cam face (62) that geometrically locks the locking element when movedinto locking engagement with said second hasp member.

__________________

166921]21][11[

מדפסת להזרקת דיו בעל פתח–שיטה לייצור ראש נע בעל סידור הפעלה חיצוני

METHOD OF MANUFACTUREOF AN INK JETPRINTHEADHAVING A MOVING NOZZLEWITH AN EXTERNALLYARRANGED ACTUATOR

]54[

24.05.2000]22[Int. Cl.(2009.01) B41J 02/045, 02/135, 02/14, B81B 05/00, 07/00]51[DIVISION FROM 153027]62[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA

]71[

WO/2001/089840]87[





]74[

A nozzle assembly for an ink jet printhead, theassembly comprising:a nozzle chamber 34 formed in a substrate 16;a nozzle 22 arranged on the substrate to define an opening 24 in fluid communicationwith the nozzle chamber, the nozzle being displaceable relative to the substrate foreffecting ink ejection through the opening on demand; andan actuator 23 arranged on the substrate and connected to the nozzle, the actuatorbeing arranged externally of the nozzle chamber for control displacement of thenozzle.

]57[

__________________

166996]21][11[

SPHERICAL אבקת טונגסט� דיסולפיד כדורית TUNGSTENDISULFIDE POWDER

]54[

20.08.2003]22[US]33[23.08.2002]32[60/319486]31[US10.10.2002 60/319603 US12.08.200310/639542

Int. Cl.(2009.01) C01G 41/00]51[OSRAM SYLVANIA INC., U.S.A.]71[WO/2004/055228]87[

עורכי דין ועורכי, קבוצת איתן מהולל,פטנטים



]74[

A tungsten disulfide powder comprised of macro-spherical particles of tungstendisulfide having an average particle diameter of from about 5 to about 50 micrometersis prepared by successively treating spray-dried powders of ammonium metatungstate

]57[


with heat in air and sulfidizing the resultant tungsten trioxide in a carbon disulfide-containing atmosphere at about 750 °C. The tungsten disulfide powder may also beformed to have a bimodal particle size distribution of the macro-spherical particles andsmaller, dispersed micro- to submicron-sized fine particles.

__________________

167160]21][11[

מערכת תקשורת בעלת פונקציונאליות ברת בחירה ומתודולוגיות עבורה

SELECTABLE FUNCTIONALITYCOMMUNICATION SYSTEM ANDMETHODOLOGIES THEREFOR

]54[

01.09.2003]22[IL]33[02.09.2002]32[151573]31[US14.02.2003 367603 US19.05.200360/471875

Int. Cl.(2009.01) G06F 03/00]51[SPIRAL משגב,מ"ספירל סולושנס בע SOLUTIONS LTD]71[

WO/2004/021714]87[,משרד עורכי דין' נעמי אסיא ושות

רמת החייל32הברזל' רח אביב-תל

NAOMI ASSIA & CO. LAWOFFICES,32 HABARZEL ST.RAMAT HACHAYALTEL AVIV 69710

]74[

A user-interface card for use in the context of an existing call between a voicecommunications device and a server, the user-interface card including a plurality ofinformation modules each operative to actuate an application on the server, a userselectable transmitter for transmitting a selected one of the plurality of informationmodules to the server, via the voice communications device, in response to applicationspecific actuation of the card by a user and an audio transducer driven by thetransmitter for transmitting the selected one of the plurality of information modules tothe voice communications device as sound.

]57[


__________________

167287]21][11[

ROOF התק� למיגו� גגות ושיטה PROTECTION DEVICEAND METHOD

]54[

07.03.2005]22[Int. Cl.(2009.01) E04B 07/18, E04H 09/06, 09/10]51[

רמת,מ"התעשייה הצבאית לישראל בע השרון

ISRAEL MILITARY INDUSTRIESLTD.

]71[

',זליגסון גבריאלי ושות31יבנה' רח


SELIGSOHN GABRIELI & CO.,31 YAVNE ST.,P.O.B. 1426,TEL AVIV 61013

]74[

A roof structure (1) providing protection of buildings against kinetic impact andexplosion of ballistic missiles, comprising:an upper steel plate 2 3-10 mm thick;a lower steel plate 3 5-20 mm thick;a mid-layer (4) comprising elongate 2-5 mm thick steel ribs connecting the upper andthe lower plates, each rib having a length corresponding essentially to a length of theupper and the lower plates and the ribs being spaced from each other along the upperand the lower plates; andsupport structures (5) for supporting the lower plate at a spacing from a pre-existingroof surface (6);said roof structure adapted to be deformed but not penetrated by impact of ballisticmissiles.

]57[


__________________

167291]21][11[

ריסו� והגברת, אלמנט לעשיית מחסה לאדמה מבני�

ELEMENT FOR FORMING GROUNDCOVERING, RESTRAINING ANDREINFORCING STRUCTURES

]54[

18.09.2003]22[IT]33[19.09.2002]32[BO2002A000596]31[

Int. Cl.(2009.01) E02D 17/02, 29/02]51[OFFICINE MACCAFERRI S.P.A.,ITALY

]71[




]74[

An improved element for forming ground covering, restraining and reinforcingstructures, comprising a lower wall (L), an upper wall (U) and a front wall (F)connected in an articulated manner, at one of its end edges (3, 4) at least, to an edge ofthe lower wall (L) or the upper wall (U).

]57[


__________________

167299]21][11[

MIMORATEשיטה שידר המותאמת בקצב למערכות ADAPTIVE TRANSMISSIONSCHEME FOR MIMO SYSTEMS

]54[

14.10.2003]22[US]33[16.10.2002]32[60/419319]31[US14.02.2003 10/367234

Int. Cl.(2009.01) H04B 07/00, 07/04, H04W 52/34, 52/38]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

A rate adaptive transmission scheme for MIMO systems, which can transmit a variablenumber of data symbol streams, provide transmit diversity for each data symbolstream, and fully utilize the total transmit power of the system and the full power ofeach antenna. In one method, at least one data symbol stream is received fortransmission from a plurality of antennas. Each data symbol stream is scaled with arespective weight corresponding to the amount of transmit power allocated to thatstream. The scaled data symbol stream(s) are multiplied with a transmit basis matrix toprovide a plurality of transmit symbol streams for the plurality of antennas. Thetransmit basis matrix (e.g., a Walsh-Hadamard matrix or a DFT matrix) is defined suchthat each data symbol stream is transmitted from all antennas and each transmitsymbol stream is transmitted at (or near) the full power for the associated antenna.

]57[

__________________


167437]21][11[

שיטה והתק� לאופטימזציה של מיקו� המבוסס בנוכחות של טעות בתדר המשתנה בזמ�GPSעל

METHOD AND APPARATUS FOROPTIMIZING GPS-BASEDPOSITION LOCATION INPRESENCE OF TIME VARYINGFREQUENCY ERROR

]54[

22.10.2003]22[US]33[22.10.2002]32[60/420583]31[US 16.01.2003 60/440960 US31.03.200310/404711

Int. Cl.(2009.01) G01S 05/14]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

Position determination accuracy of a wireless communication device may benegatively affected by a large unaccounted GPS doppler bias, which in turn may affectGPS doppler estimations and GPS doppler measurements conducted by the wirelesscommunication device. The quality of GPS doppler measurements is very importantfor position location, because poor quality GPS doppler measurements may prevent thewireless communication device from acquiring satellites in the most sensitive modeswith narrow frequency ranges, which results in reduced GPS pseudorangemeasurement yield. Large unaccounted GPS doppler bias also adversely affectsposition accuracy because of the adverse effect on the GPS code phase measurementstime propagation to common time prior to their use in position location calculation.The same is true in the case of unaccounted CDMA code doppler, through the adverseeffect on the AFLT code phase measurements time propagation to common time priorto their use in a position location engine. This effect is the biggest concern in the caseof large search windows. Therefore, the present disclosure provides a method ofoptimizing GPS based position location in the presence of time-varying frequencyerror, including the steps of continuously measuring and/or calculating resulting GPSdoppler bias and CDMA code doppler bias and then minimizing their adverse effectswith regard to position location determination by re-centering GPS doppler searchwindows based on the GPS doppler bias value, as well as using GPS doppler bias andCDMA code doppler bias value to properly propagate GPS pseudorange and AFLTpilot phase measurements, respectively, to common time prior to their use in a positionlocation engine.

]57[


__________________

167464]21][11[

ANTENNA אנטנה ורוש� מונה הכולל אותה AND METERREGISTER INCLUDING SAME

]54[

07.03.2002]22[US]33[09.03.2001]32[60/274812]31[

Int. Cl.(2009.01) H01Q 01/22]51[DIVISION FROM 163395]62[

ARAD יוקנעם,מ"ארד טכנולוגיות מדידה בע MEASURINGTECHNOLOGIES LTD.

]71[




]74[

A meter register (20), comprising:A sealed register boy (12) having a face portion and a body defining an internal cavity;a rotatable follower magnetic member provided in said internal cavity, said followermagnetic member adapted to be rotated by a driving magnetic member external of saidsealed meter register, said follower magnetic member provided within said internalcavity;an antenna (74) provided within said internal cavity, and a visual display providedwithin said internal cavity and visible through said face portion; anda microprocessor (72) coacting with said antenna, wherein said rotatable membercoacts with said micropcessor to determine a volume of flow and\or a flow ratethrough a meter and wherein said antenna is adapted to transmit a signal identifying

]57[


the flow rate and\or the volume of flow measured by said register, and wherein saidvisual display displays a volume of flow measured by the register that corresponds to anumber of rotation of said rotatable member.

__________________

167597]21][11[

מיפוי כתובת מזיכרו� וירטואלי לזיכרו� פיזיקליבטוח ואזור) דומיי�(בתו� מערכת ע� אזור

לא בטוח) דומיי�(

VIRTUAL TO PHYSICALMEMORY ADDRESS MAPPINGWITHIN A SYSTEM HAVING ASECURE DOMAIN AND A NON-SECURE DOMAIN

]54[

27.10.2003]22[GB]33[18.11.2002]32[0226906.6]31[GB14.02.2003 0303449.3

Int. Cl.(2009.01) G06F 12/00, G11C 07/00]51[ARM LIMITED, UNITED KINGDOM]71[WO/2004/046738]87[




]74[

There is provided apparatus for processing data, said apparatus comprising: aprocessor operable in a plurality of modes and either a secure domain or a non-securedomain including: at least one secure mode being a mode in said secure domain; and atleast one non-secure mode being a mode in said non-secure domain; wherein whensaid processor is executing a program in a secure mode said program has access tosecure data which is not accessible when said processor is operating in a non-securemode; said processor includes a non-secure translation table base address registeroperable in said non-secure domain to indicate a region of memory storing non-securedomain memory mapping data defining how virtual addresses are translated tophysical addresses within said non-secure domain; and said processor includes asecure translation table base address register operable in said secure domain to indicatea region of memory storing secure domain memory mapping data defining how virtualaddresses are translated to physical addresses within said secure domain.

]57[


__________________

167625]21][11[

וליכי� שיטה להקטנת הקשתה במצעי� המ למחצה

METHOD FOR REDUCINGWAFER ARCING

]54[

24.09.2003]22[US]33[30.09.2002]32[10/261403]31[

Int. Cl.(2009.01) H01L 21/311]51[LAM RESEARCH CORPORATION,U.S.A.

]71[

ANDREAS FISCHER]72[WO/2004/032220]87[

בי'ג בע פקטור אנד, יי אמ ,מ"קו הר חוצבים, רחוב המרפא

ירושלים45087.ד.ת,


]74[

A method for reducing wafer damage during an etching process is provided. In one ofthe many embodiments, the method includes assigning a bias voltage to each of at leastone etching process, and generating the assigned bias voltage before initiation of oneof the at least one etching process. The method further includes applying the assignedbias voltage to an electrostatic chuck before initiation of one of the at least one etchingprocesses. The assigned bias voltage level reduces wafer arcing.

]57[


__________________

167655]21][11[

MANUFACTURING יצור מבני� מקופלי� ויריעות ממבני� אלו FOLDEDSTRUCTURES AND SHEETTHEREFOR

]54[

26.09.2003]22[US]33[26.09.2002]32[256870]31[

Int. Cl.(2009.01) B21D 28/00]51[INDUSTRIAL ORIGAMI, INC.,U.S.A.

]71[




]74[

A process for designing and manufacturing precision-folded, high strength, fatigue-resistant structures and a sheet therefore. The techniques include methods for precisionbending of a sheet of material (41, 241, 341, 441, 541) along a bend line (45, 245, 345,445, 543) and a sheet of material formed with bending strap-defining structures, suchas slits or grooves (43, 243, 343, 443, 542), are disclosed. Methods include steps ofdesigning and then separately forming longitudinally extending slits or grooves (43,243, 343, 443, 542) through the sheet of material in axially spaced relation to produceprecise bending of the sheet (41, 241, 341, 441, 541) when bent along the bend line(45, 245, 345, 445, 543).

]57[

__________________

167725]21][11[

SUSTAINED תרופות דר� הפה תכשיר שחרור ממוש� לנתינת RELEASECOMPOSITION FOR ORALADMINISTRATION OF DRUGS

]54[


23.10.2003]22[Int. Cl.(2009.01) A61K 09/22, 31/366, 31/4439, 47/00, 47/36, 47/38]51[HANMI PHARM. CO., LTD.,REPUBLIC OF KOREA

]71[



]74[

A sustained-release composition for oral administration of a drug, comprising thedrug, a mixture of sodium alginate and xanthan gum as a carrier for sustained releaseand a mixture of hydroxypropyl methylcellulose and propylene glycol alginate as a gelhydration accelerator, which is capable of maintaining a constant drug level in bloodfor 24 hours or more owing to the fact that the drug release rate follows zero orderkinetics and does not significantly vary with the degree of gastrointestinal motility dueto rapid gel hydration without forming a non-gelated core.

]57[

__________________

167868]21][11[

, תערובות של פוליסכרידי� מיוצרי� מהפרי� הכנת� ותכשירי רוקחות המכילי� אות�

HEPARIN DERIVEDPOLYSACCHARIDE MIXTURES,PREPARATION THEREOF ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHEM

]54[

08.10.2003]22[FR ]33[10.10.2002]32[02/12584]31[

Int. Cl.(2009.01) A61K 31/727, A61P 07/02, C08B 37/10]51[AVENTIS PHARMA S.A., FRANCE]71[WO/2004/033503]87[


PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,P.O.B. 12704,

]74[


HERZLIYA הרצליה12704.ד.ת, 46733

The invention concerns heparin-derived polysaccharide mixtures having an averagemolecular weight of 1500 to 3000 daltons and an anti-Xa/anti-IIa ratio higher than 30,their preparation method and pharmaceutical compositions containing same.

]57[

__________________

167924]21][11[

שיטה למיצוי תערובת טבעית של אסטרוגני�אקויני� מצומדי� ללא תרכובות ליפופיליות

בלתי מצומדות

METHOD FOR EXTRACTING ANATURAL MIXTURE OFCONJUGATED EQUINEOESTROGENS THAT ISDEPLETED OF NON-CONJUGATED LIPOPHILICCOMPOUNDS

]54[

08.10.2003]22[EP]33[11.10.2002]32[02022763.3]31[

Int. Cl.(2009.01) A61K 31/56, 35/00, 38/22]51[SOLVAY GMBH, GERMANY]71[WO/2004/035067]87[



]74[

The invention relates to a method for extracting an extract, which contains the naturalmixture of conjugated equine estrogens, by the liquid-liquid extraction of the mixtureof conjugated equine estrogens. The extracted mixture is depleted of non-conjugatedlipophilic compounds from the group consisting of non-conjugated flavonoids, non-conjugated isoflavonoids, non-conjugated norisoprenoids, non-conjugated steroids,particularly androstane and pregnane steroids, and comparable non-conjugatedcompounds.

]57[

__________________

168133]21][11[

ב 3, פניל–3תולדות של פירידואינדולו� מותמרות - PHENYL SUBSTITUTED]54[


PYRIDOINDOLONE הכנת� ותכשירי רוקחות המכילי� אות�DERIVATIVES, THEIRPREPARATION ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHEM

21.10.2003]22[FR]33[23.10.2002]32[02/13264]31[

Int. Cl.(2009.01) A61K 31/437, A61P 35/00, C07D 471/04, 471/16]51[SANOFI-AVENTIS, FRANCE]71[WO/2004/041817]87[




]74[

The invention concerns compounds having an anticancer activity, of formula (I)wherein: R1 represents a hydrogen atom, a (C1-C4)alkyl group or a (CH2)nOH, (CH2)n-O-tetrahydropyran-2-yl, (CH2)nNR'6R'7, (CH2)nCN, (CH2)nCO2(C1-C4)Alk or(CH2)nCONR6R7 group; R2 represents a hydrogen atom or a (C1-C4)alkyl group; or R1

and R2 together form a (CH2)3 group; R3 represents a phenyl monosubstituted by ahydroxyl, hydroxymethyl, carboxy, (C1-C4)alkanyl, azido, (C1-C4)alkoxycarbonyl,hydroxyiminomethyl, (C1-C4)alkylsulphonyl, trifluoromethyl, thiol, (C1-C4)alkylthio,cyano group or by a (CH2)mNR'7R10, CONR6R8 or O(CH2)nR9 group; a phenylsubstituted by 2 to 5 identical or different substituents selected among a halogen atom,a (C1-C4)alkyl, trifluoromethyl, hydroxyl, hydroxymethyl, (C1-C4)alkoxy, carboxy,(C1-C4)alkanyl, azido, (C1-C4)alkoxycarbonyl, hydroxyiminomethyl, thiol, (C1-C4)alkylthio, (C1--C4)alkylsulphonyl, a phenyl, cyano group or by a (CH2)mNR'7R10,CONR6R8 or O(CH2)nR9 group; or R3 represents a benzodioxolyl group unsubstitutedor substituted on the phenyl by a halogen atom; R4 and R5, identical or different,represent each independently a hydrogen or halogen or a hydroxyl, (C1-C4)alkyl,trifluoromethyl, phenyl, cyano, (C1-C4)alkoxy, (C1-C4)alkoxycarbonyl, (C1-C4)alkylsulphonyl group or a O-(CH2)nNR6R7 or (CH2)nNR6R7 group.

]57[

__________________

168258]21][11[

PROCESS תהלי� להכנת תרכובות אימידזוליל FOR THE]54[


PREPARATION OF IMIDAZOLYLCOMPOUNDS

17.11.2003]22[EP]33[18.11.2002]32[02079838.5]31[

Int. Cl.(2009.01) A61K 31/4174, 31/4178, A61P 25/18, C07D 233/60, 403/06, 471/06]51[SOLVAY PHARMACEUTICALSB.V., THE NETHERLANDS

]71[




]74[

The present invention relates to a method for the preparation of an imidazolylcompound of the general formula (I), wherein: Ra and Rb each separately are (C1-C6)alkyl, (C1-C6)alkoxyalkyl, optionally substituted aryl or heteroaryl; or wherein Ra

and Rb together form a further homocyclic or heterocyclic system comprising one ormore rings; Ra’ and Rb’ each are hydrogen or together form a carbon-carbon doublebond, said carbon-carbon double bond optionally being part of an aromatic system; Rc

is hydrogen, (C1-C6)alkyl, (C1-C6)alkoxy, (C1,-C6)alkoxyalkyl or halogen; Rd ishydrogen or (C1-C4)aIkyl; Re is hydrogen or (C1-C4)aIkyl; m is 1 or 2; and R1, ishydrogen or (C1-C4)aIkyl; as well as its acid addition salt;characterized in that acompound of the general formula (II) is reacted with a compound of the formula (III),wherein: R is a hydrogen, a (C1-C4)alkyl group optionally substituted with ahydroxygroup or an optionally substituted aryl group, R', R', R'' and R'' eachindividually are a hydrogen or a (C1-C4)aIkyl group; followed by a reaction with acompound of the formula (IV), wherein R1, Rd and Re have the meanings definedabove; and optionally followed by a reaction with a suitable acid. The methodaccording to the present invention is especially useful for the preparation ofondansetron and cilansetron.

]57[

__________________

168343]21][11[

]SUBSTITUTED]54תכשירי� רפואיי�, בנזוקסאזינוני� מותמרי�


תהליכי� להכנת� ושימוש�, המכילי� אות� להכנת תרופות

BENZOXAZINONES,PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM, PROCESSES FOR THEIRPREPARATION AND USETHEREOF IN THE PREPARATIONOF MEDICAMENTS

04.11.2003]22[US]33[08.11.2002]32[60/424946]31[

Int. Cl.(2009.01) A61K 31/538, 31/54, A61P 01/00, 25/28, C07D 265/00, 413/10,413/14, 419/10, 419/14

]51[

F. HOFFMANN-LA ROCHE AG,SWITZERLAND

]71[


עומר,הגן תעשיי באר שבע5352.ד.ת,


]74[

The invention provides compounds of the Formula (I) and pharmaceutically acceptablesalts or prodrugs thereof, wherein Y, Z, R1, R2, R3, R4, R5, R6, R7, R8, R9, m, n, p and qare as defined herein. The invention also provides methods for preparing, compositionscomprising, and methods for using compounds of Formula (I).

]57[

__________________

168453]21][11[

גילוי טעות שיטתי ואקראי והחזרה מטעותשיטתי ואקראי בתו� שלבי עיבוד של מעגל

משולב

SYSTEMATIC AND RANDOMERROR DETECTION ANDRECOVERY WITHINPROCESSING STAGES OF ANINTEGRATED CIRCUIT

]54[


17.03.2004]22[US]33[20.03.2003]32[10/392382]31[US18.02.2004 10/779805

Int. Cl.(2009.01) G06F 11/00, 11/10, G11C 29/00]51[ARM LIMITED, UNITED KINGDOMUNIVERSITY OF MICHIGAN, U.S.A.

]71[




]74[

An integrated circuit includes a plurality of processing stages each includingprocessing logic (1014), a non-delayed signal-capture element (1016), a delayedsignal-capture element (1018) and a comparator (1024). The non-delayed signal-capture element (1016) captures an output from the processing logic (1014) at a non-delayed capture time. At a later delayed capture time, the delayed signal-captureelement (1018) also captures a value from the processing logic (1014). An errordetection circuit (1026) and error correction circuit (1028) detect and correct randomerrors in the delayed value and supplies an error-checked delayed value to thecomparator (1024). The comparator (1024) compares the error-checked delayed valueand the non-delayed value and if they are not equal this indicates that the non-delayedvalue was captured too soon and should be replaced by the error-checked delayedvalue. The non-delayed value is passed to the subsequent processing stage immediatelyfollowing its capture and accordingly error recovery mechanisms are used to suppressthe erroneous processing which has occurred by the subsequent processing stages, suchas gating the clock and allowing the correct signal values to propagate through thesubsequent processing logic before restarting the clock. The operating parameters ofthe integrated circuit, such as the clock frequency, the operating voltage, the bodybiased voltage, temperature and the like are adjusted so as to maintain a finite non-zeroerror rate in a manner that increases overall performance.

]57[

__________________

168475]21][11[

אוליגואדינולט ותכשירי–5,'2'אנלוגי� של רוקחות המכילי� אות�

2',5'-OLIGOADENYLATE]54[


ANALOGS ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME

19.11.2003]22[JP]33[19.11.2002]32[2002-334731]31[

Int. Cl.(2009.01) A61K 31/7125, C07H 21/00, C12N 15/11]51[DAIICHI SANKYO COMPANYLIMITED, JAPAN

]71[



]74[

Analogues represented by the general formula (1) and pharmacologically acceptablesalts thereof: (1) wherein m is 0 or 1; n is 0 to 2; R1 is optionally substituted C1-6 alkoxy, mercapto, mercapto blocked with a protecting group for synthesis of nucleicacid, or optionally substituted C1-4 alkylthio; R2, R3, R4, R5 and R6 are each hydroxyl,hydroxyl blocked with a protecting group for synthesis of nucleic acid, optionallysubstituted C1-6 alkoxy, mercapto, mercapto blocked with a protecting group forsynthesis of nucleic acid, or optionally substituted C1-4 alkylthio; R7 is oxygen or -O(CH2CH2O)q- (wherein q is 2 to 6); R8 is hydrogen, optionally substituted C1-6 alkyl,or a 5’-phosphorylated oligonucleotide analogue lacking one hydroxyl group on the 5’-phosphate group; and E1, E2, E3 and E4 are each a natural or modified nucleic acid unit.

]57[

__________________

168562]21][11[

METHOD שיטה ומתק� להעברת מידע לשלט רחוק AND APPARATUS FORTRANSFERRING INFORMATIONTO A REMOTE CONTROL

]54[

10.11.2003]22[US]33[18.11.2002]32[10/299050]31[

Int. Cl.(2009.01) G08C 19/16, 19/28]51[ICX GLOBAL, INC., U.S.A.]71[WO/2004/047386]87[

ט SANFORD',קולב ושות. סנפורד T.COLB & CO.,]74[


מרמורק,4שער הגיא רחובות2273.ד.ת,

P.O.B. 2273,REHOVOT 76122

A method for transferring information to a remote control includes storing informationin a transfer medium, inserting the transfer medium into a remote control that may ormay not have already been programmed with information of the same type as that inthe transfer medium, inputting the information from the transfer medium, and storingthe information from the transfer medium in memory. Another embodiment of themethod transfers information between remote controls. A remote control includes aprocessor, memory, and a transfer medium port. The processor is responsive to a datasignal and the port is adapted to receive a transfer medium with information to betransferred to the remote control. The processor stores the information in memory. Theremote control may also download information which is to be transferred to otherremote controls into the transfer medium and the transfer medium may be reused toprogram additional remote controls.

]57[

__________________

168728]21][11[

PASSIVE קיו פסיבי ללייזר–מתג Q-SWITCH LASER]54[

25.11.2003]22[US]33[26.11.2002]32[60/429320]31[

Int. Cl.(2009.01) H01S 03/113]51[ חיפה,מ"מוסד הטכניון למחקר ופתוח בע

אופטיקה אלאופ-אלביט מערכות אלקטרו רחובות,מ"בע

TECHNION RESEARCH ANDDEVELOPMENT FOUNDATIONLTD.ELBIT SYSTEMS ELECTRO-OPTICSELOP LTD

]71[

WO/2004/049522]87[,זהר אליעזרי קניין רוחני

8נחלת יצחק אביב-תל

ZOHAR ELIEZRI INTELLECTUALPROPERTY,8 NAHALAT YITSHAKTEL AVIV 67448

]74[


A passive Q-switch (108) for a laser system (100), and a method for its production.The laser (100) is operative at near infrared wavelength region, including the eye-saferegion. The Q-switch (108) includes a saturable absorber based on IV VIsemiconductor nanocrystals (NCs), embedded in a polymer matrix. The NCspreferably include lead selenide or lead sulfide. The NCs may be surface passivated,and may feature a PbSe/PbS core-shell configuration

]57[

__________________

168800]21][11[

שיטה וציוד לקובעת קבוצה של שילובי� מבני הובלה קבילי�

METHOD AND APPARATUS FORDETERMINING A SET OFACCEPTABLE TRANSPORTFORMAT COMBINATIONS

]54[

20.11.2003]22[US]33[26.11.2002]32[10/305656]31[

Int. Cl.(2009.01) H04B 01/38]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

Various embodiments are provided for determining a set of acceptable transport formatcombinations for transmission on a current time frame. A set of acceptable modifiedrate power adjustment values is determined based on a maximum power level, anaccumulated power commands and an initial power control command. A set ofacceptable channel gain factors is determined based on the set of acceptable modifiedrate power adjustments values, and the set of acceptable transport format combinationsis determined based on the set of acceptable channel gain factors. A possible set ofmodified rate power adjustment values is associated to a set of channel gain factors fordetermining the set of acceptable channel gain factors based on various design of atransmitter chain used for transmission of data from the mobile station.

]57[


__________________

168832]21][11[

מערכת ושיטות למת� אוטומטי של קודי זיהוי למכשירי�

SYSTEMS AND METHODS FORAUTOMATIC ASSIGNMENT OFIDENTIFICATION CODES TODEVICES

]54[

25.11.2003]22[US]33[02.12.2002]32[10/308258]31[

Int. Cl.(2009.01) G06F 13/42, 15/177]51[ADC TELECOMMUNICATIONS,INC., U.S.A.

]71[




]74[

A system and method for automatically and uniquely assigning identification codes toa plurality of slave processors: A master processor having communication port islinked to a first slave processor, which, itself, has first and second communicationports. The first communication port is used in support of the aforementioned link to thecomputer. A second slave processor, also having first and second serial ports, is linkedby its first communication port to the second communication port of the first slaveprocessor. The slave processors are programmed to read designated pins on their firstcommunication ports. The read values determine the identification code of eachprocessor. Thereafter, each slave processor outputs to its second port a value onegreater than the value read from its first port. Therefore, each slave processor assignsitself a particular identification code and directs the next slave processor to assignitself an identification code one greater.

]57[


__________________

168882]21][11[

תולדות אימידאזול בעלות פעילות קרובה לקולטי2אלפא

IMIDAZOLE DERIVATIVESHAVING AFFINITY FOR ALPHA 2RECEPTOR ACTIVITY

]54[

05.12.2003]22[FI]33[05.12.2002]32[20022159]31[

Int. Cl.(2009.01) A61K 31/4164, A61P 09/00, 27/06, C07D 233/64]51[ORION CORPORATION, FINLAND]71[WO/2004/050635]87[

,ר יצחק הס ושותפיו"ד 279רחוב הירקון



]74[

The present invention relates to novel prodrugs of MPV-2426, to methods forpreparing said prodrug forms, to pharmaceutical compositions containing such prodrugforms, and to methods for using the prodrug forms. A compound of general formula(I), or pharmaceutically acceptable salts or hydrates thereof, wherein R representsunsubstituted or substituted lower alkyl, unsubstituted or substituted aryl, unsubstitutedor substituted cycloalkyl, unsubstituted or substituted heteroaryl, unsubstituted orsubstituted lower alkylamino or asaturated five or six membered heterocyclic groupcontaining Olle or two nitrogen atoms.

]57[

__________________

168928]21][11[

עיבוד בתו� גילוי טעות ותיקו� טעות בתו� שלבי מעגל משולב

ERROR DETECTION ANDRECOVERY WITHINPROCESSING STAGES OF ANINTEGRATED CIRCUIT

]54[

26.02.2004]22[US]33[20.03.2003]32[10/392382]31[

Int. Cl.(2009.01) G06F 11/00, 11/16]51[ARM LIMITED, UNITED KINGDOMUNIVERSITY OF MICHIGAN, U.S.A.

]71[





]74[

An integrated circuit includes a plurality of processing stages each includingprocessing logic (2), a non-delayed latch (4), a delayed latch (8) and a comparator (6).The non-delayed latch (4) captures an output from the processing logic (2) at a non-delayed capture time. At a later delayed capture time, the delayed latch (8) alsocaptures a value from the processing logic (2). The comparator (6) compares thesevalues and if they are not equal this indicates that the non-delayed value was capturedtoo soon and should be replaced by the delayed value. The non-delayed value is passedto the subsequent processing stage immediately following its capture and accordinglyerror recovery mechanisms are used to suppress the erroneous processing which hasoccurred by the subsequent processing stages, such as gating the clock and allowingthe correct signal values to propagate through the subsequent processing logic beforerestarting the clock. The operating parameters of the integrated circuit, such as theclock frequency, the operating voltage, the body biased voltage, temperature and thelike are adjusted so as to maintain a finite non-zero error rate in a manner thatincreases overall performance.

]57[

__________________

168946]21][11[

�PROCESS מותמר בהלוג�תהלי� להכנת אנילי FOR THEPREPARATION OF SUBSTITUTEDHALOGENATED ANILINE

]54[

16.12.2003]22[US]33[16.12.2002]32[60/433847]31[

Int. Cl.(2009.01) C07C 209/52, 211/52, 249/02, 251/24]51[BASF AKTIENGESELLSCHAFT,GERMANY

]71[




]74[


A process for the preparation of substituted halogenated anilines from substitutedhalogenated 1-chlorobenzenes which comprises( a) reacting a substituted halogenated1-chlorobenzene selectively with an imine in the presence of a transition metal catalystcomplex and a base to form an N-aryl imine;(b) hydrolyzing the N-aryl imine; and( c)isolating the substituted halogenated aniline.

]57[

__________________

169071]21][11[

TECHNIQUE שיטה להמרת קצבי ביטי� FOR CONVERTINGBIT RATES

]54[

08.06.2005]22[Int. Cl.(2009.01) H04J 03/06, 03/07, H04L 25/05]51[150011]61[

בע. איי.סי.אי ECI פתח תקוה,מ"טלקום TELECOM LTD.]71[AMIHAI לב ליטינסקי, יעקב רוטשטיין, עמיחי ויקס VICKS, JACOB

RUTHSTEIN, LEV LITINSKY]72[

בע. איי.סי. אי ,מ"טלקום30רחוב הסיבים

פתח תקוה

ECI TELECOM LTD.,30 HASIVIM ST.,PETACH TIKVA 49517

]74[

A binary tree-like structure for converting bit rates in a telecommunication system andcomprising at least one cyclic generator (CG),wherein each particular CG is adapted to present a higher bit rate called R1substantially as a sum of two lower bit rates called R2 and R3 by cyclically producing,per n clocks of the bit rate R1, m first type signals as clocks of the bit rate R2 and (n-m) second type signals as clocks of the bit rate R3, where m and n are parameters ofsaid CG and integers, m<n;so that said two lower bit rates R2 and R3 are presented as follows, based on itsparameters m and n: R2=mR1/n, R3=(n-m)R1/n;and wherein the higher bit rate R1 of a particular CG is either obtained from outside ofsaid structure or constitutes a lower bit rate of another,upper range GC of the structure, while each of the lower bit rates R2 or R3 of aparticular CG is either dispatched away from the structure or constitutes a higher bitrate of another, lower range CG of the structure.

]57[

__________________


169076]21][11[

ALPHAVIRUS חלקיקי נגי� אלפא ושיטות להכנת� PARTICLES ANDMETHODS FOR THEPREPARATION THEREOF

]54[

12.12.2003]22[US]33[13.12.2002]32[60/433058]31[

Int. Cl.(2009.01) C12N 05/10, 07/02]51[ALPHAVAX, INC., U.S.A.]71[WO/2004/055167]87[



]74[

Provided herein are methods for producing alphavirus replicon particles in high yield;replicon RNAs are electroporated into permissive cells, where the cells are at arelatively high density, together with at least one helper nucleic acid providing thenecessary functions for packaging. After a growth period in appropriate medium,alphavirus replicon particles are harvested from the surfaces of the cells in which theywere produced using a salt wash in which the salt concentration is from about 0.2 toabout 5 M sodium chloride, calcium chloride, magnesium chloride, potassiumchloride, ammonium acetate, ammonium bicarbonate, among others. After dilution, ifnecessary, the particles can be purified by a suitable chromatographic technique.

]57[

__________________

169151]21][11[

וני קריאת נתוני� מערכת זיכרו� שיש לה מנגנ מהיר ואיטי

MEMORY SYSTEM HAVINGFAST AND SLOW DATAREADING MECHANISMS

]54[

17.03.2004]22[US]33[20.03.2003]32[10/392382]31[US18.02.2004 10/779809

Int. Cl.(2009.01) G11C 29/00]51[ARM LIMITED, UNITED KINGDOMUNIVERSITY OF MICHIGAN, U.S.A.

]71[




]74[


There is provided a memory for storing data comprising: a fast data readingmechanism operable to read a data value from said memory to generate a fast readresult that is output from said memory for further processing; a slow data readingmechanism operable to read said data value from said memory to generate a slow readresult available after said fast read result has been output for further processing, saidslow data reading mechanism being less prone to error in reading said data value thansaid fast data reading mechanism; a comparator operable to compare said fast readresult and said slow read result to detect if said fast read result differs from said slowread result; and error repair logic operable if said comparator detects that said fast readresult differs from said slow read result to suppress said further processing using saidfast read result, to output said slow read result in place of said fast read result and torestart said further processing based upon said slow read result.

]57[

__________________

169235]21][11[

צירו� נקודות סיו� לקביעת יכולות של תקשורת כללית

AFFILIATING ENDPOINTS ANDDETERMINING COMMONCOMMUNICATIONCAPABILITIES

]54[

18.12.2003]22[US]33[31.12.2002]32[10/334439]31[

Int. Cl.(2009.01) H04L 29/06, 29/08]51[MOTOROLA, INC., U.S.A.]71[WO/2004/062173]87[



]74[

In a communications system having a plurality of endpoints each including a logicalentity and its physical counterpart, a method of group affiliation. The method includingthe steps of: receiving a first message from a requestor via application layer routingthat includes an affiliation request (602); generating a response to the affiliation

]57[


request as a function of the type of affiliation request received (604); andcommunicating the response to the affiliation request to the requestor via applicationlayer routing (606).

__________________

169270]21][11[

�התק� ושיטה למשלוח של אנרגיית לייזר באור גל ארו� לאתר רקמה

DEVICE AND METHOD FORDELIVERY OF LONGWAVELENGTH LASER ENERGYTO A TISSUE SITE

]54[

19.12.2003]22[US]33[20.12.2002]32[10/324897]31[

Int. Cl.(2009.01) A61B 18/22, G02B 06/10]51[TRIMEDYNE, INC., U.S.A.]71[WO/2004/058328]87[




]74[

A laser energy delivery device is provided that is suitable for irradiating a body tissuewith relatively long wavelength laser energy in the presence of an aqueous liquidwithout significant absorption of the laser energy by the liquid. The device includes anelongate hollow sheath that has an open aperture at its distal end portion and closed atits proximal end, a laser energy conduit such as an optical fiber or hollow wave guide,within the sheath, the distal end of the conduit being disposed near the open aperture atthe distal end portion of the sheath, and the proximal end of the conduit being adaptedfor connection to a source of long wavelength laser energy. The sheath also includesan inlet port, spaced from the proximal end of the sheath, and adapted to receive anddeliver a biologically compatible gas through the sheath to a body tissue site in contactwith the open distal end of the sheath. In use, the open aperture at the distal endportion of the sheath is positioned in contact with a body tissue site. Gas, such ascarbon dioxide, infused through the sheath displaces an aqueous liquid from the region

]57[


between the distal end portion of the sheath and the tissue. Laser energy emitted fromthe distal end portion of the conduit passes through the substantially liquid-free regionat the distal end of the sheath and impinges on the tissueto be irradiated. The laserenergy can be used to ablate, vaporize, coagulate or shrink tissue at the target zonewithout interference from aqueous liquids, which tend to absorb relatively largeamounts of long wavelength laser energy and reduce the efficiency of tissue ablation.

__________________

368169]21][11[

תהלי� ציקליזציה לנגזרות מותמרות של בנזותיאזול

CYCLIZATION PROCESS FORSUBSTITUTED BENZOTHIAZOLEDERIVATIVES

]54[

29.12.2003]22[EP]33[07.01.2003]32[0300048.3]31[

Int. Cl.(2009.01) C07D 277/82, 417/12]51[F. HOFFMANN-LA ROCHE AG,SWITZERLAND

]71[




]74[

The present invention relates to a process for preparation of amino substitutedbenzothiazole derivatives of formula (I), wherein R1, R2 and R3 are independently fromeach other hydrogen, lower alkyl, lower alkoxy or halogen; R4 is hydrogen, loweralkyl, lower alkyloxy, halogen, or is a five or six membered non aromatic heterocyclylgroup, unsubstituted or substituted by lower alkyl or an oxo-group, or is -NR5R6

wherein R5 and R6 are independently from each other hydrogen, lower alkyl, -C(O)-lower alkyl, -(CH2)nO-lower alkyl or benzyl, opionally substituted by lower alkyl, or isan five or six membered heteroaryl group; R1 and R2 or R2 and R3 may form togetherwith the corresponding carbon atoms a ring containing-O-CH2-O- or -CH=CH-CH=CH-; R is hydrogen or -C(O)R'; R' is a five or six membered non aromaticheterocyclyl group, five or six membered heteroaryl group or is aryl, which rings may

]57[


be substituted by the groups, selected from lower alkyl, halogen-lower alkyl, loweralkoxy, cyano, nitro, -C(O)H, -C(O)OH or by pyrrolidin-1-yl-methyl; n is 1 to 4; andto their pharmaceutically acceptable salts, wherein the cyclization is carried out by thetreatment of a compound of formula with sulphoxide/HBr/solvent to give the desiredproducts of formula (I) for R is hydrogen (formula IA) and for R is -C(O)R’ (formulaIB).

__________________

169407]21][11[

מערכת ושיטה למסירת הודעות בשימוש של צורות שונות של תקשורת

SYSTEM AND METHOD FORDELIVERING MESSAGES USINGALTERNATE MODES OFCOMMUNICATION

]54[

29.04.2004]22[US]33[29.04.2003]32[10/424735]31[

Int. Cl.(2009.01) H04L 29/06, H04W 04/12, 24/00]51[AVOCENT HUNTSVILLECORPORATION, U.S.A.

]71[

KEVIN KERSTENS, DAYTONFOSTER, BARRY SHILMOVER

]72[




]74[

There is provided a novel system and method for delivering messages using alternatemodes of communication when a primary mode of communication is not available asmay happen in emergency circumstances such as those that arise during a terroristattack causing damage to communications infrastructure.

]57[


__________________

169498]21][11[

�]POURER]54 שופ

05.01.2004]22[NL]33[02.01.2003]32[1022297]31[

Int. Cl.(2009.01) B65D 23/06, B67D 01/16]51[VACU VIN INNOVATIONS LTD.,UNITED KINGDOM

]71[

ARNOLDUS WILLEMZWEEKHORST, PATRICKLAMBERTUS KERKHOF, EELCOJAN GERARDUS WITTEVEEN

]72[

WO/2004/060752]87[,לוי-גלוקסמן

א10רחוב אלחנן חיפה6202.ד.ת,

GLUCKSMAN - LOWY,10A ELHANAN ST.,P.O.B. 6202,HAIFA 31061

]74[

Pourer (1) consisting of an elongated, tubular part of plastic material. This part ofplastic material is made resilient and has an external diameter greater than that of theassociated bottles. The tubular part is provided with a split (6), as a result of which thediameter can be reduced to some extent and the pourer can be accommodated with aclamping action in a bottle (10). This clamping can be even further promoted byproviding ribs (4). The pourer is provided with a search point (5) to facilitateintroduction into a bottle and the pouring end (2) is flared.

]57[

__________________


169556]21][11[

התק� תצוגה סטריאוסקופי ששימושי במיוחדLCDלמקרני

STEREOSCOPIC DISPLAYAPPARATUS PARTICULARLYUSEFUL WITH LCDPROJECTORS

]54[

07.04.2003]22[US]33[21.01.2003]32[60/441159]31[US28.01.2003 60/442903

Int. Cl.(2009.01) G02B 27/26]51[YITZHAK אביב-תל, יצחק וייסמן WEISSMAN]71[

WO/2003/087884]87[,מ"בע) 1995(ארליך.אי.י'ג



]74[

Stereoscopic display apparatus, includes two projectors (Projector 1, 2) having inputsconnectable to a source of digital data (Eye 1, Eye 2 Image Source) representing thecolor components of two stereoscopic images, and outputs outputting two opticalbeams each having a set of color components (R, B, G) of different polarization states(alpha,beta); a polarization preserving screen; an optical filter system (PolarizationTransformer) using exclusively optical retarders for transforming the polarizations ofthe optical beams outputted by the two projectors into two color sets, in which all thecolor components of one set are polarized in one polarization state (gamma), and allthe color components of the other set are polarized in an orthogonal polarization state(delta); and means for stacking the two color sets onto the polarization preservingscreen, such as to enable stereoscopic viewing of the two color sets via orthogonallypolarized filters (gamma, delta Polarization Filter).

]57[

__________________

169762]21][11[

COCRYSTALS גבישי� משולבי� של חומר פעיל וחומר נוס� OF ACTIVEAGENT AND GUEST

]54[

21.01.2004]22[US]33[21.01.2003]32[60/441561]31[US21.01.2003 60/441557

Int. Cl.(2009.01) A61K 31/19, 45/00, B01D 09/00, C07C 45/81]51[S.S.C.I. INC., U.S.A.]71[


WO/2004/064762]87[ו, קבוצת איתן מהולל עורכי עורכי דין




]74[

The present disclosure relates to novel cocrystals and novel methods forcocrystallization. In particular, the disclosure includes cocrystals comprising a salt ofan active agent, such as a chloride salt of an active pharmaceutical ingredient. Thepresent disclosure also relates to methods of preparing cocrystals and methods forscreening for solid state phases.

]57[

__________________

169766]21][11[

מערכת בטיחות לשרשרת הצתה המפעילה מרעו� של קליע

SAFETY SYSTEM FOR THEIGNITION CHAIN OF APROJECTILE FUZE

]54[

26.01.2004]22[GB]33[24.01.2003]32[0301690.4]31[

Int. Cl.(2009.01) F42C 15/192]51[OLYMPIC TECHNOLOGIESLIMITED, GIBRALTAR

]71[

MICHAEL ALCULUMBRE, FREDSHARP

]72[

WO/2004/065891]87[,אגמון-סורוקר



]74[

A small arms projectile for a small arms weapon, which projectile comprises awarhead (116) having an explosive charge (not shown), an initiator (102), and a firingpin (not shown). The initiator has safe and armed conditions and is capable ofdetonating the explosive charge of the warhead when the initiator is in the armedcondition and impacted with sufficient force by the firing pin. The projectile further

]57[


comprises shielding means (106) positioned between the initiator and the explosivecharge of the warhead, which shielding means is slidable from a safety position inwhich the shielding means shields the explosive charge of the warhead from theinitiator, to an armed position in which the initiator is capable of detonating theexplosive charge of the warhead. The shielding means is slidable from the safe to thearmed position in response to the initiator moving from the safe to the armedcondition.

__________________

170140]21][11[

שיטה לתצוגת מידע קרטוגרפי אווירונאטיי� במס� של מטוס

METHOD OF DISPLAYINGCARTOGRAPHIC INFORMATIONAND AERONAUTICAL ZONES ONAN AIRCRAFT SCREEN

]54[

07.08.2005]22[FR]33[10.08.2004]32[0408801]31[

Int. Cl.(2009.01) G01C 23/00, G06T 17/50]51[THALES, FRANCE]71[




]74[

The field of the invention is that of methods of synthesizing cartographic imagespresented on display devices. This method is applied more specifically to visual flighton rotary-wing aircraft. The method according to the invention is used to present theuseful aeronautical map information superimposed on a conventional altimetricpresentation of the terrain being flown over, while retaining a legibility that isacceptable to the user. Flight safety is thus significantly reinforced. To obtain anenhanced legibility, the method displays only the aeronautical zones included in analtitude band corresponding to the flight phase of the aircraft and dependent on thegeographic location and the vertical position of the aircraft. The method is used todisplay the cartographic representation either on a single window comprising a planview of the terrain being flown over, or on two windows respectively representing aplan view and a crosssectional view of the terrain being flown over.

]57[


__________________

170194]21][11[

MEDICAMENT תרופה לטיפול בהפרעות עצביות FOR TREATMENTOF NEUROTIC DISORDERS

]54[

07.07.2000]22[DK]33[08.07.1999]32[PA199900991]31[

Int. Cl.(2009.01) A61K 31/343, C07D 307/87]51[DIVISION FROM 146131]62[H. LUNDBECK A/S, DENMARK]71[WO/2001/003694]87[




]74[

Use of escitalopram or a pharmaceutically acceptable salt thereof as the sole activeingredient for the preparation of a medicament useful in the treatment of social anxietydisorder.

]57[

__________________

170200]21][11[

יצור תרופה שימוש בלופי� קונגלוטי� ליIIלטיפול בסכרת מסוג

USE OF LUPIN CONGLUTIN FORTHE PREPARATION OF AMEDICAMENT FOR THETREATMENT OF TYPE IIDIABETES

]54[

06.02.2004]22[IT]33[11.02.2003]32[MI2003A000237]31[

Int. Cl.(2009.01) A61K 36/23, 36/48]51[INDENA S.P.A., ITALY]71[WO/2004/071521]87[



]74[


The present invention discloses the use of lupin conglutin gamma or of proteinsshowing homology higher than 50% with lupin conglutin gamma, for the preparationof a medicament, food supplements or foods for the treatment of type II diabetes,pharmaceutical and nutritional compositions containing lupin conglutin gamma, andthe use of lupin conglutin gamma as therapeutical agent, in particular ashypoglycemizing agent. Lupin conglutin gamma may be used in pure form or in formof extracts, mixtures or concentrate

]57[

__________________

170232]21][11[

CLOSURE סגירה ע� פתיחה מסוג דחיפה WITH PUSH TYPEOPENER

]54[

14.02.2004]22[KR]33[14.02.2003]32[10-2003-

0009544]31[

KR21.03.2003 10-2003-0017929

KR27.01.200410-2004-0005212Int. Cl.(2009.01) B65D 51/18, 51/22, 51/24]51[HEE KWON RHO, REPUBLIC OFKOREA

]71[




]74[

A closure with a push type opener and a device for automatically keeping slit sealingmember inside the cloture. The closure includes a closure body detachably coupled atan inlet of a container, a cutting region provided at the closure body and sealing theinlet of the container or the closure body as a hemispherical region descends by apressing method, and a device having a function of keeping the slit sealing member

]57[


therein. The sealing member can be easily by using the cutting region without touchingit by hand, and thus, a content of a container can be hygienically taken. In addition,content separately stored in the container and in the closure can be simply mixed foruse.

__________________

170295]21][11[

UV פלסטר רפואי עמיד לקרינה אולטרה סגולית STABLE TRANSDERMALTHERAPEUTIC PLASTER

]54[

04.02.2004]22[EP]33[21.02.2003]32[03003888.9]31[EP25.02.2003 03004061.2

Int. Cl.(2009.01) A61K 09/70]51[BAYER SCHERING PHARMAAKTIENGESELLSCHAFT,GERMANY

]71[




]74[

The invention relates to a UV stable transdermal therapeutic system (TTS) consistingof a back layer, at least one matrix containing an active substance and, optionally, awithdrawal film and an UV-radiation absorber. An adhesive layer containing said UV-radiation absorber is arranged between the back layer and the matrix containing anactive substance which is distant as much as possible from a surface, a separation layeris arranged between the adhesive layer containing said UV-radiation absorber and thematrix containing an active substance, which is as remote as possible from the surfacewhich is impermeable to the active substance and UV radiation absorber. Theinventive transdermal therapeutic system exhibits a high stability and is devoid ofinconveniences of existing TTS containing a light-sensitive substance.

]57[


__________________

170355]21][11[

תרכובות חיסוניות מבוססות גנגליוסיד עבור עורית–החדרה תת

GANGLIOSIDE BASED VACCINECOMPOSITIONS FORSUBCUTANEOUSADMINISTRATION

]54[

27.02.2004]22[CU]33[27.02.2003]32[47-2003]31[

Int. Cl.(2009.01) A61K 31/70, 39/00, 39/095, 39/385]51[CENTRO DE INMUNOLOGIAMOLECULAR, CUBA

]71[




]74[

The invention relates to vaccine compositions which combine gangliosides and the N.meningitidis outer membrane protein complex (OMPC) in order to form very smallsize proteoliposomes (VSSP) which are intended for subcutaneous administration. Theinventive compositions do not require the use of additional adjuvants. Saidcompositions enable immunological treatments with gangliosides, particularly N-AcGM3/VSSP and N-GcGM3/VSSP, which are advantageous owing to the fact thatthey are less aggressive at the point of injection and can be used more easily with lessdiscomfort for patients.

]57[

__________________

170365]21][11[

ערימות תאי� אלקטרוכימיי� המבוססות בממברנה מקובלות באופ� חיצוני

EXTERNALLY MANIFOLDEDMEMBRANE BASEDELECTROCHEMICAL CELLSTACKS

]54[

27.02.2004]22[US]33[27.02.2003]32[60/450817]31[

Int. Cl.(2009.01) H01M 08/02, 08/10]51[


PROTONEX TECHNOLOGYCORPORATION, U.S.A.

]71[

WO/2004/077590]87[ט ',קולב ושות. סנפורד מורקמר,4שער הגיא



]74[

The present invention provides membrane cassettes and stacks thereof which aresuitable for a use in a variety of electrochemical applications. The invention furtherprovides membrane cassettes which comprise one or more external manifolds whichdeliver reagents and/or coolant to one or more reactant or coolant flow fields of themembrane cassettes. In certain preferred embodiments, the invention providescassettes and stacks which are suitable for use in fuel cell applications.

]57[

__________________

170407]21][11[

IDENTITY תעודת זהות ומסמ� לנסיעה CARD AND TRAVELDOCUMENT

]54[

24.02.2004]22[NL]33[24.02.2003]32[1022766]31[

Int. Cl.(2009.01) B42D 15/10]51[SDU IDENTIFICATION B.V, THENETHERLANDS

]71[

WO/2004/074000]87[ט ',קולב ושות. סנפורד מרמורק,4יא שער הג



]74[

Identity card that can be used, for example, in a travel document or as a separate card.This identity card consists of at least two core layers (6, 7), preferably ofpolycarbonate material, that are fused to one another. In each of the core layers there isa recess (12, 13), each of a different size. On assembly these recesses become situatedon top of one another and a semiconductor chip (14) is accommodated in the largerrecess formed as a result. There is a covering layer (8) fused to at least one of the corelayers (6), whilst a layer that can be written on by laser has also been applied. Therecan be (semi-)transparent windows on top of one another in the core layer and if thecovering layer is transparent light can be transmitted, it being possible to apply aspecific pattern in the windows.

]57[


__________________

170473]21][11[

תכשירי� רפואיי� להשגת ריכוז אמי� של טסטוסטרו� בסירו�

PHARMACEUTICALCOMPOSITIONS FOR RELIABLEACHIEVEMENT OF ACCEPTABLESERUM TESTOSTERONE LEVELS

]54[

15.03.2004]22[DK]33[14.03.2003]32[PA200300399]31[

Int. Cl.(2009.01) A61K 09/00, 09/08, 31/165, 31/56, 31/565]51[BAYER SCHERING PHARMAAKTIENGESELLSCHAFT,GERMANY

]71[




]74[

The present invention relates to pharmaceutical compositions, formulated forinjectable administration, which comprises a testosterone ester, in particularlytestosterone undecanoate, in a vehicle comprising castor oil and a co-solvent. Uponinjecting the compositions according to a particular administration scheme, reliablelevels of testosterone in serum in the normal physiological range is achieved for a longperiod. This allows for the use of the compositions in hormone replacement therapyand male contraception without concomitant monitoring of testosterone levels in serumby a physician.

]57[

__________________

170480]21][11[

DRIVE מנגנו� הנעה להתקני� לשחרור תרופה MECHANISM FOR DRUGDELIVERY DEVICES

]54[

03.03.2004]22[GB]33[03.03.2003]32[0304822.0]31[

Int. Cl.(2009.01) A61M 05/315]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[



5שנקר'רח,1ים-מרכז גב ליההרצ12704.ד.ת,


]74[

Drive mechanism for use in a drug delivery device comprising: a housing having ahelical thread, preferably an internal helical thread; a dose dial sleeve (70) having ahelical thread engaged with the helical thread of the said housing; a drive sleeve (30)releasably connected to the said dose dial sleeve (70); and a clutch means (60) locatedbetween the dose dial sleeve (70) and the drive sleeve (3 0); When the dose dial sleeve(70) and the drive sleeve (30) are coupled, both are allowed to rotate with respect tothe housing. When the dose dial sleeve (70) and the drive sleeve (30) are de-coupled,rotation of the dose dial sleeve (70) with respect to the housing is allowed, whilstrotation of the drive sleeve (30) with respect to the housing is not allowed, wherebyaxial movement of the drive sleeve (30) is allowed so that a force is transferred in thelongitudinal direction to the proximal end of the drug delivery device.

]57[

__________________

170569]21][11[

שיטה ליצירת ביטחו� בהלי� עיבוד מתכות פעילות

METHOD FOR GENERATINGPOLLUTION CREDITS WHILEPROCESSING REACTIVEMETALS

]54[

10.03.2004]22[US]33[22.03.2003]32[10/394853]31[

Int. Cl.(2009.01) C22B 09/00]51[3M INNOVATIVE PROPERTIESCOMPANY, U.S.A.

]71[


'א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

]74[


RAMAT רמת החייל HACHAYAL 69710

This invention relates to a method for generating pollution credits while processingmolten magnesium, aluminum, lithium, and alloys of such metals by contacting themolten metal or alloy with a gaseous mixture comprising a fluorocarbon selected fromthe group consisting of perfluoroketones, hydrofluoroketones, and mixtures thereof.

]57[

__________________

170570]21][11[

שיטה לעיבוד מתכות פעילות מותכות ושגשוגות באמצעות פחממני� פלואורידי�

PROCESSING MOLTENREACTIVE METALS ANDALLOYS USINGFLUOROCARBONS AS COVERGAS

]54[

10.03.2004]22[US]33[22.03.2003]32[10/394852]31[

Int. Cl.(2009.01) B22D 21/00, C07C 45/00, C22B 09/00, 21/00]51[3M INNOVATIVE PROPERTIESCOMPANY, U.S.A.

]71[




]74[

This invention relates to a method for preventing the ignition of molten reactive metalby contacting the molten metal with a gaseous mixture comprising a fluorocarbonselected from the group consisting of perfluoroketones, hydrofluoroketones, andmixtures thereof.

]57[

__________________

170626]21][11[

פירידילסולפונאמידו פירימידיני� לטיפול בנפרופתיה של סוכרת

PYRIDYLSULFONAMIDOPYRIMIDINES FOR USE INTREATING DIABETICNEPHROPATHY

]54[


03.03.2004]22[EP]33[06.03.2003]32[03100549.9]31[

Int. Cl.(2009.01) A61K 31/506, A61P 25/02]51[SPEEDEL PHARMA AG,SWITZERLAND

]71[




]74[

The present invention relates to the use of a compound of formula (I) wherein R1 ispyridyl or thiazolyl, any of which may optionally be substituted with C1-8alkyl or C2-

8alkenyl; and (a) R2 is methoxy and n is zero or one; or (b) R2 is chlorine and n is zeroand pharmaceutically acceptable salts thereof for lowering or controlling proteinuria,in particular for the treatment of diabetic nephropathy.

]57[

__________________

170851]21][11[

שיטה והתק� לפלנריזציה מקומית, מערכת כפול–משופרת מסוג דמשקאי

SYSTEM, METHOD ANDAPPARATUS FOR IMPROVEDLOCAL DUAL-DAMASCENEPLANARIZATION

]54[

10.03.2004]22[US]33[14.03.2003]32[10/390520]31[

Int. Cl.(2009.01) H01L 21/321]51[LAM RESEARCH CORPORATION,U.S.A.

]71[

ANDREW D. BAILEY, III,SHRIKANT P. LOHOKARE, DAVIDHEMKER, JOEL M. COOK

]72[




]74[

A system and method for planarizing a patterned semiconductor substrate includes]57[


receiving a patterned semiconductor substrate (100). The patterned semiconductorsubstrate includes a conductive interconnect material (120) filling multiple of features(102, 104,106) in the pattern. The conductive interconnect material having anoverburden portion (112). The overburden portion (112) includes a localized non-uniformity (indicated in variations 114, 116, 118). An additional layer (202) is formedan the overburden portion. The additional layer and the overburden portion areplanarized. The planarizing process substantially entirely removes the additional layer.

__________________

170864]21][11[

שיטה להכנת קומפלקסי� של גליו� המסומני� רדיואקטיבית באמצעות גלי מיקרו

MICROWAVE METHOD FORPREPARING RADIOLABELLEDGALLIUM COMPLEXES

]54[

08.04.2004]22[GB]33[11.04.2003]32[0308408.4]31[

Int. Cl.(2009.01) A61K 103/34, 51/08]51[GE HEALTHCARE LIMITED,UNITED KINGDOM

]71[




]74[

The present invention relates to a method of producing radiolabelled galliumcomplexes that could be used as diagnostic agents, e.g. for positron emissiontomography (PET) imaging.

]57[

__________________


170983]21][11[

CONDUCTIVE יכה פולימרית לצנרת גלוניתמעטפת מול POLYMERJACKET FOR CORRUGATEDTUBING

]54[

07.04.2004]22[US]33[08.04.2003]32[60/461085]31[

Int. Cl.(2009.01) F16L 11/118, 11/15, 11/16, 11/18, 58/10]51[OMEGA FLEX, INC., U.S.A.]71[WO/2004/092634]87[




]74[

A tubing assembly including conductive corrugated tubing including convolutions ofpeaks and valleys and a conductive polymer jacket disposed in said valleys along alength of said corrugated tubing.

]57[

__________________

171309]21][11[

–מופע דיגיטלי קומפקטי מופחת–לולאה נעולותב הספק נמו�ריצוד

COMPACT, LOW-POWER LOW-JITTER DIGITAL PHASE-LOCKED LOOP

]54[

08.04.2004]22[US]33[09.04.2003]32[60/461889]31[US19.08.2003 10/644490

Int. Cl.(2009.01) H03D 03/24]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

A digital PLL includes an adaptive PFD, an adaptive loop filter, an iDAC, an ICO, anda divider. The adaptive PFD receives a reference signal and a feedback signal,determines phase error between the two signals, and provides a PFD value for each

]57[


phase comparison period. The magnitude of the PFD value is adjusted to achieve fastfrequency acquisition and reduced jitter. The adaptive loop filter updates its outputwhenever a PFD value is received, widens the PLL loop bandwidth if a large phaseerror is detected, and narrows the loop bandwidth if a small average phase error isdetected. The iDAC, which can be implemented with both steered and single-endedcurrent sources, converts the loop filter output into analog current. The ICO providesan oscillator signal having a phase determined by the iDAC output. The divider dividesthe oscillator signal by a factor of N and provides the feedback signal.

__________________

171509]21][11[

�COATED תותבת מצופה למכשיר חיתו CUTTING TOOL INSERT]54[

20.10.2005]22[SE]33[08.11.2004]32[SE0402709-0 ]31[

Int. Cl.(2009.01) C23C 30/00]51[SANDVIK INTELLECTUALPROPERTY AB, SWEDEN

]71[



]74[

The present invention discloses coated milling inserts particularly useful for milling ofgrey cast iron with or without cast skin under dry conditions at preferably rather highcutting speeds and milling of nodular cast iron and compacted graphite iron with orwithout cast skin under dry conditions at rather high cutting speeds.The inserts are characterized by a WC-Co cemented carbide with a low content ofcubic carbides and a highly W-alloyed binder phase and a coating including an innerlayer of TICxNy with columnar grains followed by a wet blasted layer ofα-Al 2O3.

]57[

__________________

171522]21][11[

POLYMORPHS צורות של אלאנזאפי� הידרוכלוריד OF OLANZAPINEHYDROCHLORIDE

]54[

22.04.2004]22[HU]33[22.04.2003]32[P0301082]31[

Int. Cl.(2009.01) A61K 31/551, A61P 25/18, C07D 495/04]51[


EGIS GYOGYSZERGYAR RT.,HUNGARY

]71[




]74[

The present invention relates to new crystalline forms I, II and III of 2-methyl-4-(4-methylpiperazin-l-yl)-10H-thieno[2,3-b] [1,5]-benzodiazepine hydrochloride, aprocess for the preparation thereof and pharmaceutical compositions containing thesame. Said new polymorphic forms are useful as active ingredients for the treatment ofpsychotic conditions.

]57[

__________________

171680]21][11[

שיטות לגידול תאי� המופקי� מתאי6C.PER

METHODS FOR CULTURING CELLSDERIVED FROM PER.C6 CELLS

]54[

06.05.2004]22[EP]33[09.05.2003]32[PCT/EP03/50155]31[EP01.09.2003 PCT/EP03/50390EP04.12.2003PCT/EP03/50940EP30.01.2004PCT/EP04/50061

Int. Cl.(2009.01) C12N 05/10]51[CRUCELL HOLLAND B.V., THENETHERLANDS

]71[

CHRISTOPHER ADAM YALLOP]72[WO/2004/099396]87[




]74[

The invention provides processes for culturing cells derived from embryonicretinoblast cells immortalized by adenovirus E1 sequences, preferably PER.C6TM cells,to improve product yields from such cells. Feed strategies for such cells and cultureswith very high cell densities are provided, resulting in high yields of products, such asrecombinant antibodies.

]57[



198861,The applications for divisionfrom this application have notyet been published

__________________

171734]21][11[

KNITTED התקני� למתמר סרוג TRANSDUCERDEVICES

]54[

19.05.2004]22[GB]33[19.05.2003]32[0311320.6]31[

Int. Cl.(2009.01) A41D 01/00, 13/12, A61B 05/0408, 05/103, A61N 01/04, G01B07/16

]51[

SMARTLIFE TECHNOLOGYLIMITED, UNITED KINGDOM

]71[




]74[

There is disclosed a knitted transducer device (10) comprising a knitted structurehaving at least one transduction zone, in which the transduction zone is knitted withelectrically conductive fibres so that deformation of the knitted structure results in avariation of an electrical property of the transduction zone. Disclosed is also a garmentsuch a unitted transducer.

]57[

__________________


171785]21][11[

מערכת אבטחה סיב אופטי לחישת חדירה למיקומי� מאובטחי�

FIBER OPTIC SECURITY SYSTEMFOR SENSING INTRUSION INTOSECURED LOCATIONS

]54[

03.05.2004]22[US]33[05.05.2003]32[10/429602]31[

Int. Cl.(2009.01) G08B 13/00]51[WOVEN ELECTRONICSCORPORATION,

A SOUTH CAROLINACORPORATION, U.S.A.

]71[



]74[

A sensor for a security system is disclosed to detect intrusions at one or morepredetermined locations wherein each location includes a moveable member (16)which must be moved in order to intrude the location. The system includes a fibernetwork (14) routed in close proximity to one or more locations. The sensor (24)comprises a sensor housing for being disposed at a location to detect a predeterminedmovement of the moveable member from a secure position to an unsecured position,and means for mounting the sensor housing in a stationary position at the locationwithout a physical connection to the moveable member (16). The sensor housingincludes a fiber inlet and a fiber outlet, and a fiber chamber for receiving apredetermined sensor fiber of the fiber network being routed through the sensorhousing. The sensor has a sensor actuator for engaging the sensor fiber to generate anintrusion signal upon detecting predetermined movement of the moveable membercausing the intrusion signal to be transmitted along the sensor fiber to a processorwhereby the intrusion and location of the intrusion may be determined by theprocessor. Preferably, the sensor includes a magnetic actuator having a magneticattraction to the moveable members whose interruption causes activation of the sensorand generation of the intrusion signal, and a signal shaping device acts to produce asignal having a prescribed minimum pulse width to assure detection no matter howquickly the senor actuator returns to a deactivated position.

]57[


__________________

171855]21][11[

התק� לטיפול בחלל הפה הכולל שכבה חוצצת דקה וגמישה ומבנה תת שלדי או תכשיר דביקי

ORAL TREATMENT DEVICESTHAT INCLUDE A THIN,FLEXIBLE BARRIER LAYER ANDAN ENDOSKELETONTREATMENT OR ADHESIVECOMPOSITION

]54[

07.05.2004]22[US]33[23.05.2003]32[10/444242]31[US27.05.2003 10/446235 US08.08.200310/637237US22.08.200310/646484US22.10.200310/692117US04.11.200310/701788US19.02.200410/790446

Int. Cl.(2009.01) A61C 05/00, 17/00, 17/02, 19/00, 19/06]51[ULTRADENT PRODUCTS INC.,U.S.A.

]71[




]74[

Oral treatment devices (100) include a barrier layer (102) and an oral treatmentcomposition (112), and optionally an auxiliary adhesive composition, that acts as anendoskeleton so as to at least partially contribute to maintaining the barrier layer (102)in the shape of a dental tray, or in a tray-like configuration, prior to use. The barrierlayer (102) protects the oral treatment (112) and/or adhesive composition from salivaor moisture during use. The treatment and/or auxiliary adhesive compositions (112)can have a consistency ranging from a sticky, viscous gel or a solid. They preferably

]57[


include a tissue adhesion agent comprising a hydrophilic polymer.

__________________

171886]21][11[

]FOOTSWITCH]54 מתג רגל

21.08.2003]22[US]33[04.09.2002]32[60/408211]31[US 16.10.2002 10/271505

Int. Cl.(2009.01) A61B 17/56, G05G 01/30, H01H 03/14]51[DIVISION FROM 157547]62[ALCON, INC., SWITZERLAND]71[




]74[

A surgical footswitch, comprising:(a) a base;(b) a treadle mounted to the base; and(c) a pivotable heel cup slidably retained on the treadle so as to adjustably increase ordecrease a length of the treadle.

]57[

__________________

171887]21][11[


21.08.2003]22[US]33[04.09.2002]32[60/408211]31[


US16.10.2002 10/271505 Int. Cl.(2009.01) A61B 17/56, G05G 01/30, H01H 03/14]51[DIVISION FROM 157547]62[ALCON, INC., SWITZERLAND]71[

,לוצאטו את לוצאטו עומר, תעשייהגן באר שבע5352.ד.ת,


]74[

A surgical footswitch, comprising:(a) a base;(b) a treadle pivotally and rotationally mounted to the base; and(c) a pair of switches mounted to the treadle so that rotation or counter-rotation of thetreadle operates the switches.

]57[

__________________

171888]21][11[


21.08.2003]22[US]33[04.09.2002]32[60/408211]31[US16.10.2002 10/271505





]74[

A surgical footswitch, comprising:(a) a base;(b) a treadle mounted to the base; and(c) a heel cup rotationally mounted to the treadle so that the heel cup may be rotatedindependently of any movement of the treadle.

]57[

__________________

171889]21][11[



21.08.2003]22[US]33[04.09.2002]32[60/408211]31[US16.10.2002 10/271505





]74[

A surgical footswitch, comprising:(a) a base having a bottom;(b) a treadle mounted to the base;(c) a plurality of plungers retractably mounted within the base; and(d) a relatively high friction material mounted to the base bottom, wherein the plungersretract within the base when weight is placed on the footswitch and extend outwardlyfrom the base and the relatively high friction material when no weight is placed on thefootswitch.

]57[

__________________

171890]21][11[


21.08.2003]22[US]33[04.09.2002]32[60/408211]31[US16.10.2002 10/271505





]74[

A surgical footswitch, comprising:(a) a base having a bottom;(b) a treadle pivotally and rotationally mounted to the base;(c) a pair of side switches rotationally mounted to the base on either side of thetreadle, the side switches being operable without movement of the treadle andadjustable relative to the treadle so as to increase or decrease the distance between theside switches;

]57[


(d) a heel cup slidable and rotatably retained on the treadle so as to adjustably increaseor decrease a length of the treadle;(e) a pair of switches mounted to the treadle so that rotation or counterrotation of thetreadle operates the switches;(f) a plurality of plungers retractably mounted to the bottom; and(g) a relatively high friction material mounted to the base bottom, wherein theplungers retract within the base when weight is placed on the footswitch and extendoutwardly from the base and the relatively high friction material when no weight isplaced on the footswitch.

__________________

171891]21][11[


21.08.2003]22[US]33[04.09.2002]32[60/408211]31[US16.10.2002 10/271505





]74[

A surgical footswitch, comprising:(a) a base;(b) a treadle mounted to the base so as to be pivotal about a pivot axis; and(c) heel cup slidably retained on the treadle so as to adjustably increase or decrease alength of the treadle while maintaining the pivot axis slightly ahead of an anklerotation axis of a foot of a user.

]57[

__________________

172219]21][11[

SUPERFINISHING גימור של מערכות הילוכי� פלנטריות גדולות LARGEPLANETARY GEAR SYSTEMS

]54[


28.05.2004]22[US]33[30.05.2003]32[60/474836]31[US02.06.2003 60/475210

Int. Cl.(2009.01) B24B 31/00]51[REM TECHNOLOGIES, INC., U.S.A.OSRO GMBH, GERMANY

]71[

WO/2004/108356]87[י דין ועורכי עורכ, קבוצת איתן מהולל




]74[

Disclosed herein is a new improved large planetary gear system used on the input stageof wind turbine power generators. This improved planetary gear system reduces oreliminates lubricant debris traditionally generated from the gear teeth, therebyeliminating an initiating source for bearing failure. To achieve these results, some andpreferably all of the gear teeth (4) within the planetary gear system (1, 2, 3) aresuperfinished using chemically accelerated vibratory finishing to a surface roughnessof approximately 0.25 micron or less. Several objects and advantages of the inventionare to provide a gearbox with reduced metal debris, improved bearing life, reducedwear, reduced vibro-frictional noise, improved contact fatigue, improved frettingresistance, improved lubrication, to simplify the run-in process, and to enhance thedurability and efficiency of the gearbox.

]57[



__________________

172312]21][11[

תא פונדקאי, וקטור לביטוי של סולפולובוס המודבק בו ושימושיה�

SULFOLOBUS EXPRESSIONVECTOR, HOST CELLTRANSFORMED THEREWITHAND USES THEREOF

]54[


02.06.2004]22[EP]33[02.06.2003]32[03012552.0]31[

Int. Cl.(2009.01) C12N 15/74]51[B.R.A.I.N. BIOTECHNOLOGYRESEARCH AND INFORMATIONNETWORK AG., GERMANY

]71[

WO/2004/106527]87[',בן עמי ושות8מנחם פלאוט


BEN-AMI & ASSOCIATES,8 PLAUT ST.,PARK TAMAR,P.O.B. 94,REHOVOT 76100

]74[

The present invention relates to a sulfolobus expression vector comprising: (a)sulfolobus origin of replication; (b) the genes encoding the structural proteins and thesite-specific integrase of SSVI, SSV2 or pSSVx, operatively linked to expressioncontrol sequences and a packaging signal; (c) one or more selectable marker gene(s),operatively linked to sulfolobus expression control sequences; and (d) a sulfolobuspromoter followed 3' by a restriction enzyme recognition site or a multiple cloning sitefor insertion of a gene of interest and optionally a 3' regulatory element. Moreover, thepresent invention relates to a shuttle vector comprising the sequences of the expressionvector of the invention and additional sequences for propagation and selection in E.coli, wherein the additional sequences comprise (a) an E.coli on of replication; and (b)a marker for selection in E.coli. Furthermore, the invention relates to host cellstransformed with the expression vector as well as to a kit comprising a vector or a hostcell of the present invention. Finally, the present application also relates to a methodfor generating infectious subviral particles.

]57[

__________________

172431]21][11[

METHOD שיטה לטיפול בדואר FOR PROCESSINGMAIL

]54[

07.06.2004]22[DE]33[10.06.2003]32[10326495.7]31[


Int. Cl.(2008.04) B07C 1/10]51[DEUTSCHE POST AG, GERMANY]71[WO/2004/110654]87[


10דרות אבא אבןש הרצליה2081.ד.ת,


]74[

The invention relates to a method for processing mail (100, 200, 300), wherein aplurality of mailing items inserted into insertion places are collected and subsequentlytransported in a container (120, 220, 320) to postal centres (110, 210, 310) where theyare sorted in sorting devices according to postal categories. The invention ischaracterised in that the mail is placed in transport containers which are transported tounloading areas in postal centres. When the transport container is filled and/or duringthe transportation of the container to the postal centres, random partial pre-sorting ofmail takes place according to postal categories so that, when, the mail is removed fromthe containers at the unloading areas (130, 230, 330), it is in the form of piles formedby the predetermined pre-sorting method and sorted according to the postal categories,whereupon it is guided to subsequent processing stations according to said postalcategories.

]57[

__________________

172446]21][11[

PHYSICAL אופ� הפעולה של חומר הדברה פעיל MODE OF ACTIONPESTICIDE

]54[

04.06.2004]22[US]33[18.06.2003]32[10/463955]31[

Int. Cl.(2009.01) A01N 25/04, 63/02, 65/00]51[BROOK CHANDLER MURPHY,U.S.A.TODD C. STECKLER, U.S.A.

]71[





]74[

A physical mode of action pesticide for application on plants and in soils, and methodsof manufacture and application, comprising an active ingredient in the form of apolymer in a concentration of less than 0.1 % wt., a surfactant, a co-solvent and adiluent in a hydrocolloid suspension. The suspension polymer is preferably apolysaccharide having a molecular weight of 10,000 to 25,000,000 and preferably inthe range of about 600,000. The pesticide preferably also includes a targetingingredient for directing the active ingredient to a particular target.

]57[



__________________

172523]21][11[

PERIODONTAL דונטליות–מגש לאספקת תרופות פריו MEDICAMENTDELIVERY TRAY

]54[

18.06.2004]22[US]33[18.06.2003]32[10/464164]31[

Int. Cl.(2009.01) A61C 05/00]51[DUANE KELLER, U.S.A.]71[WO/2004/112635]87[

עו' דר ,פ"אייל ברסלר11תובלגן-רמת

DR. EYAL BRESSLER,11 TUVAL ST.,RAMAT GAN 52522

]74[

A tray fitted to at least some teeth of a patient’s upper or lower arch is provided for theapplication of medications to the teeth and to adjacent gum tissue for treatment ofperiodontal disease. The tray is constructed from resilient material molded to conformto the teeth and gum tissue. The tray includes at least one recess formed to conform tothe teeth. A seal surrounds the recess at a location corresponding to the patient’s gumline for applying pressure at the patient’s gum line when the patient’s teeth aredisposed in the recess. The recess contains a quantity of a medication. Uponinstallation of the tray on the patient’s teeth, the medication is forced onto the surfaceof the teeth and subgingivally by the seal into any pockets in the patient’s gumsproximate the teeth. If desired, a propulsion agent can be disposed within the recesssuch that upon application of the tray onto the patient’s teeth, the propulsion agentgenerates pressure within the recess so as to positively force the medication onto the

]57[


patient’s teeth and into any of the pockets in the patient’s gums proximate the teeth.Methods for making the tray and for applying medication to a patient’s teeth and gumsalso are disclosed.

__________________

172558]21][11[

MODULE מודיול ומסגרת לכניסות כבל AND FRAME FORCABLE ENTRIES

]54[

14.06.2004]22[SE]33[17.06.2003]32[0301750-6 ]31[

Int. Cl.(2009.01) H02G 03/22]51[ROXTEC AB, SWEDEN]71[WO/2004/112211]87[




]74[

The present invention concerns a module (3) and a frame (1) for cable entries, pipepenetrations etc. The module (3) has end parts (7) and middle parts (8) adaptable toreceive flat cables (6) or the like having an elongated cross section. The end parts (7)may be identical to parts forming a module (2) for receiving cables, pipes etc. having acircular cross section. The frame (1) is to receive one or more of said module (3).

]57[

__________________


172625]21][11[

INKJET התק� ושיטה להתזת דיו DEVICE AND METHOD]54[

11.06.2004]22[GB]33[16.06.2003]32[0313962.3]31[

Int. Cl.(2009.01) B41J 02/175]51[INCA DIGITAL PRINTERSLIMITED, UNITED KINGDOM

]71[




]74[

In an inkjet device for containing, degassing and supplying ink, gas is supplied to acontainer (10) for the ink so that the gas bubbles through the ink in the container (10).A controller controls a gas supplying means to operate in at least two modes includinga degassing mode in which the pressure in the container is at a degassing pressure andthe gas supplying means is controlled to supply the gas at a pressure above thedegassing pressure to bubble through the ink, and an ink supplying mode in which thecontainer (10) is at an ink delivery pressure. In preferred examples, the ink container isarranged for supplying ink to a printhead; using the degassing arrangement, theformation of bubbles in the ink at the printhead can be reduced.

]57[

__________________

172740]21][11[

מערכת סינו� לספקטרו� רחב הכוללת חומרמוספג מבוסס טונגסט� המשמשת לסינו�

מ האויר או מגזי� אחרי�חומרי� מזהמי�

BROAD SPECTRUM FILTERSYSTEM INCLUDING TUNGSTEN-BASED IMPREGNANT ANDBEING USEFUL FOR FILTERINGCONTAMINANTS FROM AIR OR

]54[


OTHER GASES

27.05.2004]22[US]33[26.06.2003]32[10/606548]31[

Int. Cl.(2009.01) B01D 53/04, B01J 20/20]51[3M INNOVATIVE PROPERTIESCOMPANY, U.S.A.

]71[




]74[

Filter systems that are effective against a broad range of contaminants including HCN,cyanogen chloride (CK), acid contaminants. and basic contaminants such as ammoniawithout the need (but with the option, if desired) for using molybdenum or chromiumcontaining materials. The filtering systems of the present invention include a tungsten-based material and other impregnants incorporated into a substrate such as filter mediaparticles.

]57[

__________________

173078]21][11[

או–תכשיר רוקחי רב חלקיקי המכיל פפטידפרוטאי� מוקואדהסיב פעיל ושיטה להכנת

התכשיר

MULTIPARTICLEPHARMACEUTICAL DOSAGEFORM CONTAINING AMUCOADHESIVELYFORMULATED PEPTIDE ORPROTEIN ACTIVE SUBSTANCESAND METHOD FOR PRODUCINGSAID PHARMACEUTICALDOSAGE FORM

]54[

15.07.2004]22[DE]33[15.07.2003]32[10332160.8]31[

Int. Cl.(2009.01) A61K 09/16, 09/26, 09/50, 09/51, 38/00, 47/38, 47/40, 47/42]51[EVONIK ROHM GMBH, GERMANY]71[WO/2005/007139]87[

,ריינהולד כהן ושותפיוה 'א26ברזל רחוב

רמת החייל


]74[

The invention relates to an oral, multiparticle pharmaceutical dosage form containing]57[


pellets, the size of which ranges from 50 to 2500 µm and which essentially consist of:(a) an inner matrix layer containing an active substance which is a peptide or a protein,including the derivatives or conjugates thereof, and which is embedded in a matrixconsisting of a polymer with mucoadhesive effect, and (b) an outer film coatingessentially consisting of an anionic polymer or copolymer, which can be optionallyformulated with pharmaceutically conventional adjuvants, more particularly softeningagents.

__________________

173137]21][11[

ARRANGEMENT מער� המכיל תותב צוארי וכלי החדרה COMPRISING ACERVICAL PROSTHESIS AND ANINSERTION INSTRUMENT

]54[

04.02.2004]22[US]33[15.07.2003]32[10/619179]31[

Int. Cl.(2009.01) A61F 02/44, 02/46]51[CERVITECH, INC., U.S.A.]71[WO/2005/007042]87[



]74[

The invention relates to an arrangement comprising a multipart intervertebralprosthesis (9) that is provided with a top and bottom endplate (91, 92) and anintermediate sliding core (93), a couple of accommodating apertures (96, 97) orprotrusions being associated with each endplate (91, 92), and an insertion instrument(1) that is provided with a handle region (21, 31) and a catching region (22, 32) withretaining protrusions (51, 52) or apertures which can be inserted into theaccommodating apertures or protrusions in order to retain the intervertebralendoprosthesis (9) on the insertion instrument (1). According to the invention, theaccommodating apertures (96, 97) are disposed in lateral faces of the intervertebralendoprosthesis (9) while at least the couple of accommodating apertures (96), whichare associated with one of the endplates (92), are provided with a shape that expands inthe direction of the other endplate (91) such that intervertebral endoprostheses (9)having different thicknesses can be retained securely and without the risk of beingmixed up, without having to make modifications to the insertion instrument (1).

]57[


__________________

173224]21][11[

א ינ� תהלי� עבור ייצור מתקני� אשר דורשי� חומר קבלה נדי� עבור הפעלת�

PROCESS FOR MANUFACTURINGDEVICES WHICH REQUIRE A NONEVAPORABLE GETTER MATERIALFOR THEIR WORKING

]54[

09.11.2004]22[IT]33[14.11.2003]32[MI2003A002209]31[

Int. Cl.(2009.01) C23C 14/14, 22/54]51[SAES GETTERS S.P.A., ITALY]71[WO/2005/047558]87[

,ר יצחק הס ושותפיו"ד 279רחוב הירקון



]74[

There is disclosed a process which allows to simplify the manufacture of devices (20;30) which contain thereinside a deposit of non evaporable getter material (17; 32) on asupport (22; 33), which may be an internal wall of the same devices. The processcomprises the operation of treating the support with the getter material with at least anacid or basic solution.

]57[

__________________

173291]21][11[


OIL תרכיז של תרחי� שמ� המכיל דיפלופניק� SUSPENSIONCONCENTRATE CONTAININGDIFLUFENICAN

]54[

15.07.2004]22[DE]33[28.07.2003]32[10334300.8]31[

Int. Cl.(2009.01) A01N 25/02, 43/40]51[BAYER CROPSCIENCE AG,GERMANY

]71[




]74[

The invention relates to an oil suspension concentrate containing: (a) the herbicideactive ingredient diflufenican, and (b) at least one solvent from the group ofhydrocarbons. Said oil suspension concentrate is suitable for using in the field of plantprotection.

]57[

__________________

173309]21][11[

WAFER קביעת וסימו� פרוסות FIXING AND MARKING]54[

14.07.2004]22[US]33[25.07.2003]32[60/490080]31[US15.07.2004 10/891953

Int. Cl.(2009.01) B65B 09/02, 61/02]51[LTS LOHMANN THERAPIE-SYSTEME AG, GERMANY

]71[

WOLFGANG SCHAFER]72[WO/2005/012097]87[

עורכי דין ועורכי, בוצת איתן מהוללק,פטנטים



]74[

The invention relates to a method for individually packing sheet or film-type materialsin an automatic manner, said materials consisting of at least one material layer, in apacking unit with marked contents. A marking (40) made of a waxy marking materialis applied to a warmed first packing material strip (20). The sheet or film-type material(10) is fixed to the marking with a surface thereof, whereby the roughness of the

]57[


surface thereof is greater than the roughness of the surface of the first packing materialstrip. A second packing material strip (30) is applied to the sheet or film-type materialand is connected to the first packing material strip in order to form a closed packingunit. The packing unit (35) is cooled and the marking is separated from the firstpacking material strip. A secure packing method and a marking for sheet or film-typematerials are developed according to said inventive method.

__________________

173363]21][11[

סנתזה סלקטיבי של פירימידיני� מותמרי�CF3ב

SELECTIVE SYNTHESIS OF CF 3-SUBSTITUTED PYRIMIDINES

]54[

24.08.2004]22[US]33[05.09.2003]32[60/500733]31[

Int. Cl.(2009.01) C07D 239/42, 401/04, 403/04]51[PFIZER PRODUCTS, INC., U.S.A.]71[WO/2005/023780]87[




]74[

The present invention relates to a method of making a compound of the formula(I),wherein X1, X2 and R3-R4 are as defined herein. The method includes reacting acompound of the formula (II)with an amine of formula (III) (HNR3R4) in the presenceof a Lewis Acid and a non-nucleophilic base. The 2,4-diamino pyrimidine moiety is acommon component in a variety of biologically active drug-like molecules andpyrimidine derivatives have been found to be useful in the 10 treatment of abnormalcell growth, such as cancer, in mammals.

]57[

__________________


173530]21][11[

א–2 –דימתיל–3,2(–1גוניסט לא מרגיע אלפא–2–אימידאזול–דיהידרו–3,1–אתיל–)פניל תיאו�

NONSEDATING ALPHA-2AGONIST 1-(2,3-DIMETHYL-PHENYL)-ETHYL-1,3-DIHYDRO-IMIZADOLE-2-THIONE

]54[

20.08.2004]22[US]33[12.09.2003]32[60/502562]31[US15.07.2004 10/891953

Int. Cl.(2009.01) A61K 31/4164, A61P 03/08, 43/00, C07D 233/84]51[ALLERGAN, INC., U.S.A.]71[WO/2005/034946]87[




]74[

The present invention provides an alpha-2A/alpha-1A selective agonist that includes acompound represented by Structure 1 or a pharmaceutically acceptable salt, ester,amide, sterioisomer or racemic mixture thereof. The present invention further providesa pharmaceutical composition that contains a pharmaceutical carrier and atherapeutically effective amount of an alpha-2A/alpha-1A selective agonist thatincludes a compound represented by Structure 1 or a pharmaceutically acceptable salt,ester, amide, sterioisomer or racemic mixture thereof.

]57[

__________________

173609]21][11[

מערכת ושיטה להקלטה, אמצעי להקלטת מידעמערכת ושיטה, עבור אמצעי הקלטת מידע

תוכנת מחשב, עי להקלטת מידעלשכפול אמצומבנה נתוני�, לשליטה בהקלטה או בשכפול

הכולל אות בקרה

INFORMATION RECORDINGMEDIUM, RECORDING DEVICEAND RECORDING METHOD FORINFORMATION RECORDINGMEDIUM, REPRODUCTIONDEVICE AND REPRODUCTIONMETHOD FOR INFORMATIONRECORDING MEDIUM,COMPUTER PROGRAM FORRECORDING ORREPRODUCTION, AND DATASTRUCTURE CONTAINING

]54[


CONTROL SIGNAL

22.07.2004]22[JP]33[12.08.2003]32[2003-207281]31[

Int. Cl.(2009.01) G11B 20/10]51[PIONEER CORPORATION, JAPAN]71[WO/2005/015558]87[



]74[

An information recording medium (100) includes: a user data area (108) for storingrecording data; a plurality of temporary defect management areas (104, 105) fortemporarily recording defect management information (120) as the base for defectmanagement of a defect in the data area; and a flag area (111) for recordingidentification information identifying a temporary defect management area containingvalid defect management information among the plurality of temporary defectmanagement areas. The identification information is recorded as the type of acombination pattern of the area defined as a recorded state by a predetermined rule andthe area remaining as a non-recorded state.

]57[

__________________

173713]21][11[

-PHOSPHORUS אימידזוליני� המכילי� זרח� ותהלי� להכנת� CONTAININGIMIDAZOLINES AND PROCESSFOR THEIR PREPARATION

]54[

26.08.2004]22[CH]33[29.08.2003]32[01484/03]31[

Int. Cl.(2009.01) C07B 53/00, C07C 05/03, 29/17, 41/20, 43/205, 43/21, 67/303,C07F 09/6506, 15/00

]51[

SOLVIAS AG, SWITZERLAND]71[





]74[

Compounds of the formulae (I) and (Ia) where X1 is secondary phosphino; R3 is ahydrocarbon radical having from 1 to 20 C atoms, a heterohydrocarbon radical whichhas from 2 to 20 atoms and at least one heteroatorn selected from the group consistingof O, S, NH and NR, or an -SO2-R radical; R is C1-C18-alkyl, phenyl or benzyl; theradicals R4 are each, or the two radicals R4 together a hydrocarbon radical having from1 to 20 C atoms; R01 is a hydrocarbon radical having from 1 to 20 C atoms; and R02

and R'o2 are each, independently of one another, a hydrogen atom or independentlyhave the meaning of R01, or R01 and R02 together with the C atom to which they arebound form a three- to eight-membered hydrocarbon or hetero hydrocarbon ring. Thecompounds are chiral ligands for complexes of metals of transition groups I and VIIIwhich act as catalysts for asymmetric additions, for example of hydrogen, ontoprochiral unsaturated organic compounds.

]57[



__________________

173745]21][11[

אוקסאתיאולא� 3,1שיטה ליצור� של נוקלאוזידי�

METHOD OF MANUFACTURE OF1,3-OXATHIOLANE NUCLEOSIDEANALOGS

]54[

12.08.1999]22[US]33[12.08.1998]32[60/096214]31[US04.03.1999 60/122841

Int. Cl.(2009.01) C07D 327/00, 327/04, 411/12, 473/00]51[DIVISION FROM 141359]62[EMORY UNIVERSITY, U.S.A.GILEAD SCIENCES, INC., U.S.A.

]71[


'א26רחוב הברזלREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

]74[


RAMATת החיילרמ HACHAYAL 69710

A process for producing a 1,3-oxathiolane nucleoside comprising:(i) preparing a 5-halo-2-protected-oxymethyl-1,3-oxathiolane; and(ii) reacting the 5-halo-2-protected-oxymethyl-1,3-oxathiolane with a protected purineor pyrimidine base in the absence of a Lewis acid.

]57[



__________________

174082]21][11[

–2–פניל–Nמלח מתאנסולפונט של נגזרת שלתהלי� להכנתו ושימושו בהכנת, פירימידינאמי�

"טבליה המכילה אותו

METHANESULFONATE SALT OFN - PHENYL - 2 -PYRIMIDINEAMINEDERIVATIVE, PROCESS FOR ITSPREPARATION AND USE

THEREOF FOR THEPREPARATION OF A TABLETCONTAINING THE SAME

]54[

16.07.1998]22[CH]33[18.07.1997]32[1764/97]31[

Int. Cl.(2009.01) C07D 401/14]51[DIVISION FROM 133906]62[NOVARTIS AG, SWITZERLAND]71[WO/1999/003854]87[




]74[

The invention relates to a new crystalline form of the methanesulfonic acid additionsalt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula (I), which may be used for example for tumourtherapy.

]57[

__________________


174089]21][11[

מערכת ושיטה לאימות ביומטרי דינאמי לשמירת מרחק

SYSTEM AND METHOD FORDYNAMIC STAND-OFFBIOMETRIC VERIFICATION

]54[

30.08.2004]22[US]33[05.09.2003]32[10/655124]31[

Int. Cl.(2009.01) G06K 09/00]51[HONEYWELL INTERNATIONALINC., U.S.A.

]71[




]74[

A system for providing stand-off biometric verification of a driver of a vehicle at acontrol gate while the vehicle is moving, including an RFID vehicle tag reader, anRFID personal tag reader and a facial detection and recognition (verification) system.The RFID vehicle tag reader scans and reads data from an RFID vehicle tag of thevehicle that is trying to pass through the gate. The RFID personal tag reader data froman RFID personal tag carried by personnel who are driving in the vehicle. The facialdetection and verification system scans and reads facial images for the driver. All thedata and facial images detected by the reader are sent to a computer for furtherprocessing (final face verification).

]57[

__________________

174198]21][11[

תכשירי� למת� חלבוני� אוסטיאוגני� הניתני� שיטות להכנת� ושימוש בה�, להזרקה

COMPOSITIONS FORINJECTABLE DELIVERY OFOSTEOGENIC PROTEINS,METHODS FOR THEIRPREPARATION AND USES

]54[


THEREOF

10.09.2004]22[US]33[12.09.2003]32[60/502493]31[

Int. Cl.(2009.01) A61K 38/18, A61L 24/00, 27/22, 27/42, 27/46, 27/50]51[WYETH LLC, U.S.A.ETEX CORPORATION, U.S.A.

]71[




]74[

Osteogenic proteins are delivered via an injectable solid rod or hardenable paste. Theformulation comprises a calcium phosphate material, an osteogenic protein, andoptional additives and active ingredients such as a bone resorption inhibitor. Methodsof making injectable pharmaceutical compositions and methods of using theosteogenic compositions to treat bone defects are also disclosed.

]57[

__________________

174272]21][11[

מכשיר ושיטה להשבחה דיגיטלית של טקסטיל

METHOD AND DEVICE FORDIGITALLY UPGRADING TEXTILE

]54[

22.09.2004]22[NL]33[22.09.2003]32[1024338]31[WO28.11.2003 PCT/NL03/00841

Int. Cl.(2009.01) B41J 03/50, 03/54, 03/60, 11/00, D06B 11/00]51[TEN CATE ADVANCED TEXTILESB.V., THE NETHERLANDS

]71[




]74[

The invention provides a method for digitally upgrading a textile article (T) using atextile upgrading device (1), the device (1) comprising a number of nozzles (12) forapplying one or more substances to the textile (T), in addition to transport means (2)for transporting the textile (T) along the nozzles (12), wherein the nozzles (12) areordered in a number of successively placed rows (4, 5, 6, 7) extending transversely ofthe transporting direction of the textile article (T), the method comprising the steps of:

]57[


guiding the textile article (T) along a first row (4) of nozzles (12); performing with thefirst row (4) of nozzles (12) one of the operations of painting, coating or finishing ofthe textile article (T) carried therealong; subsequently guiding the textile (T) along asecond row (5) of nozzles (12); and performing with the second row (5) of nozzles (12)another of the operations of painting, coating or finishing of the textile article (T)carried therealong.

__________________

174309]21][11[

TISSUE אריזה למטליות ע� מארז נלווה לתכשיר CONTAINER WITHAUXILIARY COMPARTMENT

]54[

14.11.2002]22[Int. Cl.(2009.01) B65D 51/28, 81/32, 83/08]51[DIVISION FROM 152867]62[

קיסריה, פריס-ליאת דהגן-רמת,ד ליאן קהת ככונס נכסים"עו

LIAT DE-VRIESLIAN KEHAT ADV. AS ANOFFICIAL RECEIVER

]71[

,ריינהולד כהן ושותפיו'א26רחוב הברזל

ה חיילרמת


]74[

Abstract]57[Image



The בקשת הורה לבקשה זו שטר פורסמה parent application from whichthis application has been dividedhas not yet been published

The בקשות חלוקה מבקשה זו applications for


division.שטר פורסמו from thisapplication have not yetbeen published

__________________

174487]21][11[

מעטפת של קופסה וקצה של קופסה ע� חיבור כפול

CAN SHELL AND DOUBLESEAMED CAN END

]54[

29.09.2004]22[US]33[30.09.2003]32[10/675370]31[US09.09.2004 10/936834

Int. Cl.(2009.01) B21D 51/44]51[BALL CORPORATION, U.S.A.CONTAINER DEVELOPMENT,LTD., U.S.A.

]71[

WO/2005/032953]87[עורכי דין ועורכי, קבוצת איתן מהולל


יההרצל2081.ד.ת,


]74[

A drawn aluminum can shell has a peripheral crown which is double-seamed with anend portion of an aluminum can body to provide a can end having a generally flatcenter panel connected by an inclined curved or straight panel wall to an inclined innerwall of an annular U-shaped countersink. The countersink has an outer wall whichconnects with an inclined lower wall portion of a chuckwall at a junction below thecenter panel, and the chuckwall has a curved or inclined upper wall portion whichconnects with an inner wall of the crown. The chuckwall also has an intermediate wallportion forming.a break, and the inner bottom width of the countersink is less than theradial width of the panel wall. The inclined upper wall portion of the chuckwallextends at an angle greater than the angle of the inclined lower wall portion of thechuckwall.

]57[


__________________

174496]21][11[

הרכבי תרסיס לשאיפה המכילי� גור� אנטי כולינרגי

AEROSOL FORMULATION FORINHALATION CONTAINING ANANTICHOLINERGIC AGENT

]54[

21.09.2004]22[DE]33[26.09.2003]32[10345065.3]31[

Int. Cl.(2009.01) A61K 31/46, 35/00]51[BOEHRINGER INGELHEIMINTERNATIONAL GMBH,GERMANY

]71[




]74[

The invention relates to a medicament preparation for inhalation, containing acompound of formula (I) as an exclusive active ingredient, wherein X represents ananion which is selected preferably from the groups comprising chloride, bromide,iodide, sulphate, phosphate, methane sulfonate, nitrate, meleate, acetate, citrate,fumarate, tartrate, oxalate, succinate, benzoate and p-toluolsulfonate, as a solventethanol or mixtures of ethanol and water, at least one pharmacologically compatibleacid thereof, in addition to pharmacologically compatible auxiliary agents and/orcomplexing agents.

]57[

__________________


174734]21][11[

ספירופיפרידי� לשימוש–נגזרות של טריאזהבטיפול בהפרעותGLYT–1כמעכבי

פסיכיאטריות–נוירולוגיות ונוירו

TRIAZA-SPIROPIPERIDINEDERIVATIVES FOR USE ASGLYT-1 INHIBITORS IN THETREATMENT OFNEUROLOGICAL ANDNEUROPSYCHIATRICDISORDERS

]54[

14.10.2004]22[EP]33[23.10.2003]32[03024415.6]31[

Int. Cl.(2009.01) A61K 31/438, A61P 25/00, C07D 471/10]51[F. HOFFMANN-LA ROCHE AG,SWITZERLAND

]71[




]74[

The invention relates to compounds of the general formula (I), wherein A-A is -CH2-CH2-, -CH2-CH2-CH2-, -CH2-O- or -O-CH2-; x is hydrogen or hydroxy; R1 is aryl orheteroaryl, unsubstituted or substituted by one or more substituents, selected from thegroup consisting of lower alkyl, lower alkoxy, halogen or trifluoromethyl; R2 is aryl orheteroaryl, unsubstituted or substituted by one or more substituents, selected from thegroup consisting of lower alkyl, lower alkoxy, halogen or trifluoromethyl, or is loweralkyl, -(CH2)n-cycloalkyl, -(CH2)n-CF3, -(CH2)p-O-lower alkyl, -(CH2)1,2-phenyl,optionally substituted by halogen, lower alkyl, lower alkoxy or trifluoromethyl, or is -(CH2)p-NRR', wherein W and R' form together with the N-atom a heterocyclic ring,selected from the group consisting of piperidine, morpholine, thiomorpholine or 1, I-dioxo thiomorpholine; R3, R4 are independently from each other hydrogen, loweralkyl, phenyl or benzyl; R5 is hydrogen, lower alkyl or benzyl; R6 is hydrogen or loweralkyl; n is 0, 1 or 2; and p is 2 or 3; and to pharmaceutically acceptable acid additionsalts thereof for the treatment of psychoses, pain, neurodegenerative disfunction inmemory and learning, schizophrenia, dementia and other diseases in which cognitiveprocesses are impaired, such as attention deficit disorders or Alzheimer's disease.

]57[


__________________

174751]21][11[

MILKING מכשור חליבה ושיטה לשימוש בו APPARATUS ANDMETHOD FOR USE THEREOF

]54[

10.11.2003]22[Int. Cl.(2009.01) A01J 03/00, 05/00]51[

אגודה-אפיקים מערכות חליבה.מ.ח.צ קיבוץ אפיקים,מ"שיתופית חקלאית בע

S.A.E. AFIKIM MILKINGSYSTEMS - AGRICULTURALCOOPERATIVE LTD

]71[

SHIMSHON שמשון שגיב SAGIV]72[WO/2005/043984]87[

,מ"בע) 1995(ארליך.אי.י'ג11רחוב מנחם בגין,15קומה, מגדל איילון

רמת גן


]74[

An apparatus (10) for gripping the teat of an animal assisting in drawing milktherefrom. The apparatus (10) includes a housing and more than one constrictingelement (14a-c) arranged in the housing so that the constricting elements (14a-c),which are operable in both constricting (14a-c) and non-constricting modes,periodically constrict the teat. The apparatus (10) further includes means for switchingthe constricting elements (14a-c) back and forth between non-constricting andconstricting modes. The apparatus (10) includes a controller (56) in communicationwith the means for switching, which in accordance with a predetermined timing andspatial sequence controls the periodic switching of the constricting elements (14a-c)from constricting to non-constricting modes and vice-versa. A system including such agripping apparatus (10) for drawing milk from the teat of an animal is also taught.Similarly, a method for milking an animal which imitates hand milking and does notemploy a vacuum system is described.

]57[


__________________

174956]21][11[

DOOR מנעול לדלת ע� פעולת ידית מבוקרת LOCK WITHCONTROLLABLE HANDLEOPERATION

]54[

05.10.2004]22[FI]33[30.10.2003]32[20031579]31[

Int. Cl.(2009.01) E05B 47/06, 63/04, 63/16]51[ABLOY OY, FINLAND]71[WO/2005/042886]87[



]74[

A door lock with controllable handle operation including a bolt (3), a follower (5) formoving the bolt and an operation axis (4), on both ends of which an actuator can beinstalled for operating the follower (5), whereby force transmission from either side ofthe lock to the follower (5) is established by means of movable coupling members(10a, 10b), which are controlled by a solenoid arrangement (8, 9) or the like, and inwhich the follower (5) is provided with two separate torsion units (6a, 6b) installed onthe operation axis (4) on different sides of the follower (5) and turnably securedthereto, which units can be connected to force transmission with the follower (5) byutilising said coupling members (10a, 10b). The door lock comprises a selectingmember (7) movable from one lock side to the other, which member retains the torsionunit (6a, 6b) selected in each case to be unturnable with respect to the follower (5), sothat force transmission from the operation axis (4) to the follower (5) is connected onthat particular side of the lock, and on the other side of the lock, force transmissionfrom the operation axis (4) to the follower (5) can be selectively either connected ordisconnected by means of said coupling members (10a, 10b) under the control of thesolenoid arrangement (8, 9).

]57[


__________________

175162]21][11[

השיטה לקביעת האנ� על עצמי� ניידי� ומכשיר להוצאה לפועל של השיטה

METHOD FOR DETERMININGTHE VERTICAL ON MOVINGOBJECTS AND DEVICE FOR ITSIMPLEMENTATION

]54[

25.04.2006]22[Int. Cl.(2009.01) G01C 21/00]51[

אביב-תל, מיכאל נאומוב אביב-תל, גאורגי נאומוב

MICHAEL NAUMOVGEORGE NAUMOV

]71[

MICHAEL גאורגי נאומוב, מיכאל נאומוב NAUMOV, GEORGENAUMOV

]72[

,מיכאל נאומוב3צורח

אביב-תל

MICHAEL NAUMOV,HAZOR 3TEL AVIV 69016

]74[

A method for determining a vertical on moving object including in one of the twochannels, at least the following steps:determining an apparent acceleration in a plane to be chosen, it passing throughmutually perpendicular axes of a platform, whereon acceleration being determined,one of which being vertical axis and another being a chosen axis, for example,parallel longitudinal axis of the moving object, in particular, being superposed withthe said longitudinal axis,determining one of the accelerations in the said chosen plane, for example, horizontalacceleration being a part of the said apparent acceleration,determining the difference of the said accelerations, in particular, the said apparentacceleration and the said horizontal acceleration,changing the polarities of the said accelerations in the case of changing the polarity ofanother acceleration, in particular, vertical acceleration one being also part of the saidapparent acceleration,determining a gravitational vertical by the said difference, in particular, by means ofbringing the said difference up to zero.

]57[


__________________

175231]21][11[

PADLOCK מכלול מנעול תלי בעל אבז� HASP ASSEMBLY]54[

26.04.2006]22[Int. Cl.(2009.01) E05B 67/36]51[


]71[

BELO אלכס אקרמן, בלו מטיקו MATYKO, ALEX AKERMAN]72[בעדק ,מ"ל פטנט

27חדר,18מנוחה ונחלה רחובות


]74[

A padlock hasp assembly 10 comprising:a first hasp member 12 and a second has member 14 comprising interface contoursincluding complimentary shaped protrusions and recesses that mate with one another;anda locking assembly housed in said first hasp member, said locking assemblycomprising a cylinder lock 18 including a tumbler 20 adapted to bring a lockingelement 26 into locking engagement with a first notch 24 formed in a locking bolt 16,said locking bolt being arranged for sliding motion through a first bore 28 formed insaid first hasp member, and when said second hasp member is aligned with said firsthasp member, said locking bolt is slidable into a second bore 30 formed in said secondhasp member so as to lock said first and second hasp members together; andwherein said locking element is movable into locking engagement with a second notch25 formed in said locking bolt so as to prevent moving said locking bolt completelyout of said first hasp member.

]57[


.

__________________

175234]21][11[

PROGRAMMABLE מתק� אימו� אוניברסלי הנית� לתכנות UNIVERSALEXERCISE DEVICE

]54[

26.04.2006]22[Int. Cl.(2009.01) A63B 21/22]51[

בע.טי.פי.אל .L.P.T ראש העין,מ"טכנולוגיות TECHNOLOGIES LTD.]71[YORAM יורם דוכובנה DOCHOVNE]72[


גן-רמת


]74[

An exercise device(10) comprising:(a) a first foot-support surface(12);(b) a second foot-support surface(14);(c) an actuator system(16) associated with said first and second foot-support surfacesand configured to displace each of said first and second foot-support surfaces along anarbitrary path defined in at least two dimensions over a range of at least 25 centimetersby 15 centimeters; and(d) a control system(18) associated with said actuator system and configured or

]57[


controlling said actuator system so as to generate an exercise path for each of said firstand second foot-support surface.


__________________

175261]21][11[

CLEANING מעכלי� וחומצות ניקוי ושיטות לשימוש בה� SOLUTIONS ANDETCHANTS AND METHODS FORUSING SAME

]54[

27.10.2004]22[US]33[28.10.2003]32[60/515065]31[

Int. Cl.(2009.01) H01L 21/311]51[SACHEM INC., U.S.A.]71[WILLIAM A WOJTCZAK, DEANDEWULF, SIAN COLLINS

]72[


WO/2005/045895]87[,מ"בע) 1995(ארליך.אי.י'ג



]74[

Composition for cleaning or etching a semiconductor substrate and method for usingthe same. The composition may include a fluorine-containing compound as an activeagent such as a quaternary ammonium fluoride, a quaternary phosphonium fluoride,sulfonium fluoride, more generally an -onium fluoride or 'multi' quaternary -oniumfluoride that includes two or more quaternary -onium groups linked together by one ormore carbon-containing groups. The composition may further include a pH adjustingacid such as a mineral acid, carboxylic acid, dicarboxylic acid, sulfonic acid, orcombination thereof to give a pH of about 2 to 9. The composition can be anhydrousand may further include an organic solvent such as an alcohol, amide, ether, orcombination thereof. The composition are useful for obtaining improved etch rate, etchselectivity, etch uniformity and cleaning criteria on a variety of substrates.

]57[

__________________

175287]21][11[

שיטה להכנת מכשירי� רפואיי� שבה� התרופותומתקני�,)שטיפה(הורחקו באמצעות המסה

להפעלת השיטה הזו

METHOD FOR PREPARINGDRUG ELUTING MEDICALDEVICES AND DEVICESOBTAINED THEREFROM

]54[

07.11.2003]22[Int. Cl.(2009.01) A61L 27/00, 31/16, B05D 01/00]51[NOBIL BIO RICERCHE S.R.L.,ITALY

]71[




]74[

The present invention relates to a method for preparing a drug eluting medical devicecomprising the application to a stent of a polymer having functional groups capable ofchemically binding biological molecules, characterised in that said application iscarried out in a single step by means of cold plasma methods. Moreover, the inventionalso relates to a medical device obtained therefrom.

]57[


__________________

175462]21][11[

OCULAR משק� הגנה PROTECTIVE SHIELD]54[

16.09.2004]22[US]33[12.11.2003]32[10/605992]31[

Int. Cl.(2009.01) A61F 09/04]51[JEAN-FRANCOIS DURETTE,OCULARISTE INC., CANADA

]71[




]74[

External ocular shields for protecting a patient's eyes from medical treatment radiationenergy such as a laser during a medical procedure. Each shield has an external surfacethat absorbs energy that hits the shield. The shields are connected to each other by anose piece, and the nose piece is connected to each shield by a mounting means. Themounting means are positioned perpendicular to the shields and parallel to each otherso that the nose piece can pivot upward towards the user's forehead and downwardtowards the user's chin without altering the fit of the shields over the user's eyes.

]57[

__________________


175501]21][11[

ANTENNA מערכת אנטנה SYSTEM]54[

09.05.2006]22[US]33[28.06.2005]32[11/168950]31[

Int. Cl.(2009.01) H01Q 01/24]51[MOTOROLA, INC., U.S.A.]71[



]74[

A wireless communication device (600) with an antenna system (602) is disclosed.The antenna system (100) is an internal antenna with broadband characteristics whichprovided coverage over multiple frequency bands. The antenna system (100) has afinite ground surface (102), an elongated conductor (104) supported by a dielectricspacer (106), and at least one series signal feed (110).

]57[

__________________

175507]21][11[

MICROBOLOMETER ממער� מיקרובולומטר ושיטה לקריאתו ARRAYAND METHOD FOR READING

]54[


THEREOF

20.12.2001]22[US]33[26.12.2000]32[09/748784]31[

Int. Cl.(2009.01) G01J 01/42]51[DIVISION FROM 156657]62[HONEYWELL INTERNATIONALINC., U.S.A.

]71[


'א26רחוב הברזל החייל רמת


]74[

A method for reading a microbolometer array having a number of microbolometersensor elements that are arranged into a number of rows and a number of columns,each of the microbolometer sensor elements in a column being connected to a differentone of a number of row read out lines when the column is selected, and a selected oneof the number of row read out lines being connected, either directly or indirectly, to anoutput amplifier when a row is selected, the method comprising:selecting a first row ofmicrobolometer sensor elements;reding the microbolometer sensor elements of the first row onto a first read out line byindividually selecting each of the columns of the microbolometer array;deselecting the first row of microbolometer sensor elements;deselecting the columns of the microbolometer array for a predetermined period oftime while a second row is selected;selecting a second row of microbolometer sensor elements; andreading the microbolometer sensor elements of the second row onto a second read outline by individually selecting each of the columns of the microbolometer array.

]57[

__________________

175548]21][11[

SOFT אריגי� מרוכבי� רכי� ונפוחי� AND BULKY COMPOSITEFABRICS

]54[

10.06.2004]22[US]33[23.12.2003]32[10/744606]31[

Int. Cl.(2009.01) D04H 05/02, 13/00]51[KIMBERLY-CLARK WORLDWIDE,INC., U.S.A.

]71[

WO/2005/068702]87[REINHOLD,ריינהולד כהן ושותפיו COHN AND PARTNERS,]74[




A composite fabric is provided that contains staple fibers hydraulically entangled witha nonwoven web formed from continuous filaments. A portion of the staple fibers isentangled with the web, while another portion protrudes through the web. Theresulting surface topography has one surface with a preponderance of the smooth,staple fibers, and another surface with a preponderance of the continuous filamentsfrom the nonwoven web, but also including some of the protruded smooth, staplefibers. Thus, each surface contains smooth staple fibers and is soft.

]57[

__________________

175591]21][11[

GAUGE מד לשימוש בהלי� כירורגי FOR USE IN A SURGICALPROCEDURE

]54[

12.11.2004]22[AU]33[12.11.2003]32[2003906238]31[

Int. Cl.(2009.01) A61B 05/11]51[INTERNATIONAL PATENTOWNERS (CAYMAN) LIMITED,CAYMAN ISLANDS

]71[

WO/2005/046475]87[',זליגסון גבריאלי ושות

31יבנה' רח תל אביב1426.ד.ת,

SELIGSOHN GABRIELI & CO.,31 YAVNE ST.,P.O.B. 1426,TEL AVIV 61013

]74[

As shown in figure (23), for example, a preferred embodiment of the gauge (301)includes a body (302) with a plumb bob (303) mounted to the body (302). The plumbbob (303) hangs from the body (302) under the influence of a local gravitational field.More particularly, the plumb bob (303) is rotatable relative to the body (302) in both a

]57[


first plane and a second plane, said planes being orthogonal to each other. In use, aconnector (322) allows the gauge (301) to be connected to various surgicalimplements. The position of the indicator needle (315) on the plumb bob (303) is notedwith reference to two sets of markings (316 and 317) on the body (302) to allow asurgeon to determine a first angle in a first plane and a second angle in a second plane.In one exemplary application of the invention, the first and second angles areanatomical angles associated with the surgical insertion of prosthetic components.

__________________

175771]21][11[

-FERROCENYL-1,2 ייצור� ושימושיה�, דיפוספיני�–2,1–פרוצנילDIPHOSPHINES, PRODUCTIONTHEREOF AND THEIR USE

]54[

10.12.2004]22[CH]33[12.12.2003]32[02131/03]31[

Int. Cl.(2009.01) C07F 17/02]51[SOLVIAS AG, SWITZERLAND]71[WO/2005/056568]87[



]74[

The invention relates to compounds of formula (I) provided in the form of racemiccompounds, mixtures of diastereomers or essentially pure diastereomers, wherein R1

represents a hydrogen atom or C1-C4-alkyl, and at least one secondary phosphinedepicts an unsubstituted or substituted cyclic phosphine group, or phosphonium saltsthereof having one or two monovalent anions or a divalent anion. The compounds offormula (I) can be obtained by means of a novel method and are valuable ligands forcatalytically active metal complexes in asymmetrical synthesis.

]57[


__________________

175906]21][11[

ANTI-VEGF ע� אפיניות קישור מחוזקתVEGF–נוגדני אנטי ANTIBODIES WITHSTRONGER BINDING AFFINITY

]54[

03.04.1998]22[US]33[07.04.1997]32[08/833504]31[US06.08.1997 08/908469

Int. Cl.(2009.01) A61K 39/395, A61P 25/00, 35/00, C07K 16/22, 16/46, C12N 15/13]51[DIVISION FROM 132240]62[GENENTECH, INC., U.S.A.]71[WO/1998/045331]87[




]74[

A variant of a parent anti-vascular endothelial growth factor (VEGF)antibody, said parent anti-VEGF antibody having a heavy chain variable domaincomprising the amino acid sequence of SEQ ID NO: 7 and a light chain variabledomain comprising the amino acid sequence of SEQ ID NO: 8, wherein:(i) said variant binds human VEGF with stronger binding affinity than the parent andcomprises an amino acid substitution at least in the hypervariable region CDRH1and\or in the hypervariable region CDRH3 of the heavy chain variable domain of saidparent antibody,(ii) the variant has a heavy chain variable domain comprising the followinghypervariable region amino acid sequences:

]57[


CDRH1: GYX1X2X3X4 YGX5N (SEQ ID NO: 117), wherein X1 is D, T or E, X2 is F,W or Y, X3 is T, Q, G or S, X4 is H or N and X5 IS M or I; andCDRH3: YPX1YX2X3X4X5HWYFDV (SEQ ID NO: 119), wherein X1 is H or Y, X2 isY, R, K ,I, T, E or W, X3 is G, N, A, D, Q, E, T, K or S,X4 is S, T, K, Q, N, R, A, E orG and X5 is S or G; and(iii) the variant has an amino acid sequence having at least 90% amino acid identitywith the parent antibody heavy or light chain variable domain of SEQ ID NO:7 or SEQID NO:8.

__________________

176379]21][11[

מימדית–שיטה ליצירת מיקרוסטרוקטורה תלתותוצרי, שימושיה, על פני משטח

מיקרוסטרוקטורה שנבנו בדר� זאת

METHOD OF FORMING ATHREE-DIMENSIONALMICROSTRUCTURE ON ASURFACE, USES THEREOF ANDMICROSTRUCTURED PRODUCTSSO OBTAINED

]54[

03.01.2005]22[EP]33[29.12.2003]32[03079017.4]31[

Int. Cl.(2009.01) B29C 59/02, B31D 01/02, G09F 03/10]51[MACTAC EUROPE S.A., BELGIUM]71[WO/2005/063464]87[




]74[

A method of forming a three-dimensional microstructure on a flat surface of a support,comprising the application of a first flat and uniform layer (2) of silicone on saidsurface of support (1) and the application on the first layer of silicone of a second threedimensionally microstructured layer (3) of silicone, said first layer and second layer ofsilicone become integrally connected to thus form a common three-dimensionalmicrostructure ensuring anti-adhesive properties distributed regularly on the surface ofthe support, so that any flexible surface of substrate, in particular a surface of adhesivedeposited on said layers of silicone will be microstructured by inverse replication ofthe three-dimensional microstructure formed by the two layers of silicone, where saidlayers of silicone are fixed by hardening by heating or by exposure to an ultraviolet orelectronic radiation, or a combination thereof, applications thereof and films, notablyself-adhesive films, such as those microstructured by said method.

]57[




__________________

176455]21][11[

METHOD שיטה ליצור תעלה אופטית תרמופלסטית FOR THEPRODUCTION OF ATHERMOPLASTIC OPTICALCONDUIT

]54[

02.11.2004]22[FR]33[24.12.2003]32[0351207]31[

Int. Cl.(2009.01) B29D 11/00]51[ESSILOR INTERNATIONAL(COMPAGNIE GENERALED'OPTIQUE), FRANCE

]71[




]74[

The invention relates to a method for the production of a thermoplastic optical conduit(14) comprising an optical relay (26) which is formed by a parallelpipedic bar used totransmit light along the longitudinal axis (A-A') thereof, known as the first axis, andprovided with a partition wall (28) on one of the extremities thereof, said partition wallbeing inclined in relation to the first axis and with a lens (32) whose axis of revolution(B-B') is contained on a longitudinal plane of symmetry. The maximum given heightof the conduit (14) independent of the width of the lens is Hmaxand the average givenlength on the longitudinal axis (A-A') is Lmoy . According to the invention, the conduitis made in a single piece by injecting the thermoplastic material into a mould (1)having a cavity whose shape is identical to that of the conduit. Injection occurs via aninjection threshold which is disposed laterally in relation to the cavity on a surfacewhich is substantially parallel to the plane defined by the axes (A-A', B-B'). The height(h) of the threshold lies between 0.2 Hmax and Hmax and the length thereof (l ) liesbetween 0.2 Lmoy and 0.8 Lmoy. The thermoplastic material is injected at a rate of 400 to1500 mm3/s.

]57[


__________________

176466]21][11[

SELECTIVITY בקרת סלקטיביות במערכת לעיבוד פלאזמה CONTROL IN APLASMA PROCESSING SYSTEM

]54[

21.12.2004]22[US]33[23.12.2003]32[10/745846]31[US29.06.2004 10/881410

Int. Cl.(2009.01) A61K 35/00, H01L 21/311]51[LAM RESEARCH CORPORATION,U.S.A.

]71[

KENJI TAKESHITA, ODETTETURMEL, FELIX KOZAKEVICH,ERIC HUDSON

]72[




]74[

A method in a plasma processing system for etching a feature through a given layer ona semiconductor substrate. The method includes placing the substrate in a plasmaprocessing chamber of the plasma processing system. The method also includesflowing an etchant gas mixture into the plasma processing chamber, the etchant gasmixture being configured to etch the given layer. The method additionally includesstriking a plasma from the etchant source gas. Furthermore, the method includesetching the feature at least partially through the given layer while applying a bias RFsignal to the substrate. The bias RF signal has a bias RF frequency of between about27 MHz and about 75 MHz and a bias RF power component that is configured to causethe etch feature to be etched with an etch selectivity to a second layer of the substratethat is higher than a predefined selectivity threshold or configured to cause the featureto be etched in accordance to predefined etch rate parameters and etch profileparameters at the bias RF frequency.

]57[


__________________

176478]21][11[

ו–1–תולדות של הומופיפריזי�–1–פיפריזי�שיטה להכנת� ושימוש�, קרבוכסילאטי�FAAHכמעכבי אנזי�

DERIVATIVES OF 1-PIPERAZINE-AND 1-HOMOPIPERAZINE-CARBOXYLATES, PREPARATIONMETHOD THEREOF AND USE OFSAME AS INHIBITORS OF THEFAAH ENZYME

]54[

17.12.2004]22[FR]33[23.12.2003]32[0315248]31[

Int. Cl.(2009.01) A61K 31/433, 31/495, 31/496, 31/551, A61P 25/00, 29/00, 33/00,35/00, 37/00, C07C 235/06, C07D 295/185, 401/04, 403/04, 405/04, 417/04, 495/04

]51[

SANOFI-AVENTIS, FRANCE]71[WO/2005/070910]87[




]74[

The invention relates to a compound having general formula (I), wherein: m representsan integer equal to 1 or 2; R1 represents an aryl- or heteroaryl-type group that isoptionally substituted by one or more R3 or R4 groups; R2 represents a group havinggeneral formula CHR5CONHR6; R3 represents a halogen atom or a hydroxy, cyano,nitro, C1-6-alkyl, C1-6-alkoxy, C1-6-thioalkyl, C1-6-fluoroalkyl, C1-6-fluoroalkoxy,-O-(C2-3-alkylene)-,-O-(C1-3-alkylene)-O-, C1-6-fluorothioalkyl, C3-7-cycloalkyl, C3-7-cycloalkyl-C1-3-alkylene, piperidinyl, benzyloxy, piperazinyl, pyrrolidinyl,morpholinyl, phenyloxy, NR7R8, NHCOR7, NHSO2R7, COR7, C02R7, CONR7R8,SO2R7 or SO2NR7R8 group; R4 represents an aryl- or heteroaryl-type group, wherebythe R4 group(s) can be substituted by one or more identical or different R3 groups; R5

represents a hydrogen atom or a C1-3-alkyl group; R6 represents a hydrogen atom or aC1-6-alkyl, C3-7-cycloalkyl or C3-7-cycloalkyl-C1-3-alkylene group; and R7 and R8

represent, independently of each other, a hydrogen atom, a C1-3-alkyl group or a phenyl

]57[


group, said compound taking the form of a base, an acid addition salt, a hydrate or asolvate. The compounds are inhibitors of the FAAH enzyme, which can be used for thetreatment of pain, eating disorders, neurological and psychiatric pathologies, etc.

__________________

176593]21][11[

KNITTING מכונת סריגה MACHINE]54[

28.06.2006]22[EP]33[11.04.2006]32[06075860.4]31[

Int. Cl.(2009.01) D04B 27/00]51[KARL MAYERTEXTILMASCHINENFABRIKGMBH, GERMANY

]71[



]74[

A knitting machine (1), with a thread source (2), a knitting region (3), a remover (4)for the knitted product (11) and a piece length counter (17) (connected to the machinecontroller (16)) with a specific action on the machine on reaching a specific piecelength, has a second piece length counter (17) (also connected to the machinecontroller) with a second specific action on the machine on reaching a specific piecelength.

]57[


__________________

176736]21][11[

טה להמרת אנרגיה מסוג נפח במכונת הברגה שי סיבובית

METHOD OF TRANSFORMINGENERGY IN A ROTARY SCREWMACHINE OF VOLUMETRICTYPE

]54[

14.01.2004]22[Int. Cl.(2009.01) F01C 01/107, 11/00]51[ELTHOM ENTERPRISES LIMITED,CYPRUS

]71[

WO/2005/078240]87[,וצאטו את לוצאטול



]74[

A method of transforming energy in a rotary screw machine that comprises a first anda second set of conjugated male and female elements spaced apart from each otheralong a central axis and having inner/outer profiled surfaces. Upon rotary motion ofthe male and/or female elements, working chambers are formed between theseelements. The working chambers perform an axial movement. The rotary motions ofthe different sets (1, 2, 3) are synchronized in such a manner that synchronous andinphase motion of the elements in the different sets is performed with different valuesof angular periods of oscillation of axial movement of the working chambers.Thereby, a working medium transported in these working chambers can becompressed or expanded.

]57[


__________________

176787]21[]11[

על ידי) צורות מקומרות(התק� ליצור כיפות שיקוע אדי�

APPARATUS FOR THEMANUFACTURE OF CHEMICALVAPOR DEPOSITED DOMES

]54[

24.07.2001]22[US]33[07.08.2000]32[09/633210]31[

Int. Cl.(2009.01) B32B 01/00, C23C 16/00, 16/44]51[DIVISION FROM 144552]62[SHIPLEY COMPANY, L.L.C., U.S.A.]71[



]74[

An apparatus for the manufacture of chemical vapor deposited domes comprising: a vapordeposition chamber (64) having a plurality of sides, a base and a top, the base having a reactantport for receiving a flow of chemical reatants from a reactant source and the top having anexhaust port for removal of non-reacted reactants, at least one male mandrel (70) being joinedto one of the plurality of sides of the deposition chamber by an isolation fixture (68) such thatthe flow of chemical reactants in the vapor deposition chamber does not impinge on the at leastone male mandrel.

__________________

177026]21][11[

שלבית להתאמת רפידה–רב, מערכת על אתר ושיטה לפלנריזציה כימית מכנית

MULTI-STEP, IN-SITU PADCONDITIONING SYSTEM ANDMETHOD FOR CHEMICALMECHANICAL PLANARIZATION

]54[


25.01.2005]22[US]33[26.01.2004]32[60/539162]31[US25.01.2005 11/042998

Int. Cl.(2009.01) B24B 37/04, 53/007, 57/02, H01L 21/32]51[TBW INDUSTRIES, INC., U.S.A.]71[WO/2005/072338]87[

עורכי דין ועורכי,ן מהוללקבוצת אית,פטנטים



]74[

An arrangement for performing a multi-step polishing process on a single stagechemical mechanical planarization (CMP) apparatus utilizes an in-situ conditioningoperation to continuously clean and evacuate debris and spent polishing slurry fromthe surface of the polishing pad. By presenting a clean, virtually 'new' polishing padsurface at the beginning of each planarization cycle, polishing agents of differentchemistries, morphologies, temperatures, etc. may be used without the need to removethe wafer to change the polishing source or transfer the wafer to another CMPpolishing station. A multi-positional valve may be used to control the introduction ofvarious process fluids, including a variety of different polishing slurries andconditioning/flushing agents. The use of different conditioning materials allows for thesurface of the polishing pad to be altered for different process conditions (e.g.,neutralizing prior polishing chemicals, modifying the surface temperature of the pad tocontrol polishing rate, use of surfactants to dislodge particles that become attracted tothe pad surface, etc.).

]57[

__________________

177334]21][11[

CUTTING שימת חיתו� וכלי עבור שימוש בה INSERT AND TOOLFOR USING THE SAME

]54[

08.02.2005]22[


AT]33[11.02.2004]32[GM102/2004]31[Int. Cl.(2009.01) B23B 27/04, 29/00, B23C 05/16, 05/20, B25B 23/00]51[CERATIZIT AUSTRIAGESELLSCHAFT M.B.H, AUSTRIA

]71[

WO/2005/077578]87[עורכי דין ועורכי, קבוצת איתן מהולל




]74[

The invention relates to a cutting insert (1) which is constituted of a plurality ofcoherent individual cutting inserts (2) which are disposed one after the other. Saidinsert can be used one after the other using an intermediary weakened point anddetaching the preceding individual cutting insert (2) which was previously used forcutting. According to the invention, the cutting insert (1) is configured as a blade andhas a lower (13) and an upper contact surface (14) to be received in an elongate recess(5) having a lower (15) and an upper mating surface (16) in the tool base (4) of aburring tool or disk milling cutter. Every individual cutting insert (2) is provided witha positioning means (3) which interacts with a complementary positioning means (9)of the tool base (4).

]57[

__________________

177390]21][11[

HIGH בעל יעילות גבוהה דוד לא חסי� EFFICIENCYREFRACTORYLESS KETTLE

]54[

10.02.2005]22[US]33[27.02.2004]32[10/788871]31[US27.02.2004 10/788864

Int. Cl.(2009.01) B28C 05/06]51[UNITED STATES GYPSUMCOMPANY, U.S.A.

]71[

WO/2005/091819]87[


,ינהולד כהן ושותפיורי'א26רחוב הברזל רמת החייל


]74[

An apparatus for calcining gypsum including a housing having a bottom wall, opentop,and a plurality of side walls extending therebetween. A fixture is located adjacent theopen top for receiving gypsum from a source and transferring the gypsum into thehousing. At least one burner is connected to the housing and operable for combustingan air-fuel mixture to heat the gypsum. At least one serpentine burner conduit extendsfrom the burner through the housing and terminates through a support floor of theapparatus. The exhaust flow is then directed through a fluidization pad and into thegypsum to further heat the gypsum product. An agitation mechanism is operable tomix the gypsum adjacent the fluidization pad to prevent pockets of gypsum fromcoagulating and preventing fluidization of the gypsum.

]57[

__________________

177469]21][11[

CAMERA מצלמה לשימוש רפואי בפרט שינני FOR MEDICAL,PARTICULARLY DENTAL USE

]54[

25.02.2005]22[FR]33[01.03.2004]32[0402090]31[

Int. Cl.(2009.01) A61B 01/045]51[SOPRO, FRANCE]71[WO/2005/089631]87[




]74[

The medical, particularly dental imaging camera comprising an elongated housing (2)that can be held by a single hand of a user and provided, at its front end, with imagingmeans, this housing (2) comprising sensitive control means capable of freezing , on

]57[


display means (5), an image selected by the user, these control means having adetection area (9) situated on the housing (2) that is delimited by a surfacediscontinuity such as a recess or a relief (11). The housing (2) encloses a sensorelement associated with an electronic driving circuit and an electrostatic foam elementwhose one end is applied against the sensor element and whose opposite end is appliedagainst an area of the inner face of the housing (2) located to the right of the detectionarea (9).

__________________

177485]21][11[

MORTISE מנעול הנית� לסיכה ע� לוחית זיהוי קטומה LOCK WITH LIGHTEDTRIM PLATE SIGN

]54[

08.12.2004]22[US]33[23.02.2004]32[10/785563]31[

Int. Cl.(2009.01) E05B 17/10, 41/00, F21V 09/16]51[SARGENT MANUFACTURINGCOMPANY, U.S.A.

]71[




]74[

A standard mortise latch lock escutcheon or trim plate having an aperture for housingan electroluminescent strip captured within a two-piece lens structure. A dc or acexternal power supply converter is used in conjunction with the existing grid power.The converter is situated on the mortise lock casing. The electroluminescent strip iscaptured within the lens structure along with partially transparent, lettered signage.The lens structure has an outer lens with a protrusion to align the signage within theaperture. The lettered signage is reversed lettered, such that light emits through theletters and is blocked by an opaque background when the electroluminescent strip issupplied power. In instances where the mortise latch lock is used on doors for purposesother than egress, a switch may be used to toggle power to the signage when the thumblever is turned in a locked position.

]57[


__________________

177517]21][11[

התק� משולב למנעול מקושט הנית� לסיכה חורהמכיל ציר הנמש� לא

MORTISE LOCK INTEGRATEDTRIM ASSEMBLY WITH ARETRACTING SPINDLE

]54[

07.03.2005]22[US]33[26.03.2004]32[10/811464]31[

Int. Cl.(2009.01) E05B 03/00, 03/06, 63/00]51[SARGENT MANUFACTURINGCOMPANY, U.S.A.

]71[

WO/2005/103419]87[,הולד כהן ושותפיוריינ



]74[

A mortise lock integrated trim mechanism is provided for mounting on the surface of adoor and has a handle turning a spindle that extends into the door to operate a lockmechanism mounted therein. The trim assembly is pre-assembled and has a retractingspindle that extends between the trim mechanism and the lock mechanism toaccommodate varying door thicknesses. The preferred assembly utilizes a cover plate,spring and mounting plate assembly holding a pair of alignment pins. This assembly isfit onto a door handle and secured to the door handle by a cap nut. An elongated springis disposed in the handle and is secured to a spindle which axially extends from thehandle. The spindle is automatically retracted to maximally fit into the hub of amortise lock.

]57[


__________________

177521]21][11[

MULTI-FUNCTIONAL פונקציונלי–מנעול הנית� לגירוז רב MORTISELOCK

]54[

24.02.2005]22[US]33[26.03.2004]32[10/811457]31[

Int. Cl.(2009.01) E05C 01/08]51[SARGENT MANUFACTURINGCOMPANY, U.S.A.

]71[

WO/2005/103425]87[ו ,שותפיוריינהולד כהן



]74[

A multi-functional mortise lock that can be rapidly converted between differentfunctions without opening the mortise lock case by installing blocking screws thatextend through threaded blocking openings in a sidewall of the case and into blockinginterference with moving components inside the case. The moving components includea lock/unlock lever, a latch retract lever and a spindle hub. The blocking screws arestored in threaded storage openings in the sidewall of the case. The sidewall of the caseis marked adjacent to the threaded blocking openings and storage openings to identifyfunctions that will be performed when the blocking screws are installed in one or moreof the blocking openings.

]57[


__________________

177600]21][11[

ON-LINE ייצור ממוכ� של כפפות גומי נטולות אבקה MAKING OF POWDER-FREE RUBBER GLOVES

]54[

16.04.2004]22[Int. Cl.(2009.01) A41D 19/00, B29C 41/14, B32B 25/14]51[ANSELL HEALTHCAREPRODUCTS LLC, U.S.A.

]71[




]74[

A powder-free medical glove having a first surface of a powder-free coagulant and asecond surface with a polymer coating to ease donning. The powder-free coagulant onthe first surface comprises micronized high-density polyethylene, a micro-emulsion ofamino silicone, a dimethicone emulsion, calcium salts, an ethoxylated acetylenic diolsurfactant and a cellulose thickener. The medical gloves are made in an on-lineprocess of making latex articles that involves dipping hand-shaped formers into thecoagulant before dipping them into the latex. The gloves are thereafter coated with apolymer to improve donnability before removal from the formers. The novel coagulantformulation permits easy removal of the articles from the formers, eases double-donning of gloves and eliminates the need for off-line processing.

]57[


__________________

177720]21][11[

מקודדות משתנות שיטה ומתק� להנפקת תוויות עבור פריטי� לייצור

METHOD AND APPARATUS FORAPPLYING VARIABLE CODEDLABELS TO ITEMS OF PRODUCE

]54[

03.03.2005]22[US]33[03.03.2004]32[60/549778]31[

Int. Cl.(2009.01) B41M 01/00, B65C 09/46]51[SINCLAIR SYSTEMSINTERNATIONAL, LLC, U.S.A.

]71[

RICHARD EVANS, RICHARDHIRST, MATTHEW SCOTTHOWARTH

]72[

WO/2005/084383]87[,אדוארד לנגר

רעננה410.ד.ת,EDWARD LANGER,MERKAZ GERON H. 312P.O.B. 410,RAANANNA 43103

]74[

An apparatus and method are provided for automatically labeling individual produceitems. Individual produce items are conveyed towards a rotary bellows or otherapplicator. A sensor senses at least one variable characteristic, such as size of each ofthe produce items. The sensed varia+e is transmitted to a laser coding device and avariable human or machine readable code is printed on an individual label prior toapplication of that label to the specific item of produce for which the variablecharacteristic was sensed. The laser coding beam either reacts with a reactive orablatable film on each label.

]57[


__________________

177775]21][11[

BRA בניית רפידה לחזייה PAD CONSTRUCTION]54[

03.03.2005]22[US]33[19.03.2004]32[10/804403]31[US04.08.2004 10/911269 US09.02.200511/054185

Int. Cl.(2009.01) A41C 01/00, 03/00]51[VICTORIA'S SECRET STORESBRAND MANAGEMENT, INC.,U.S.A.

]71[


'א26זל רחוב הבר רמת החייל


]74[

A method of manufacturing a bra pad having a thicker summit area, as well as the paditself, includes holding a sheet of resilient and formable material of uniform thickness,such as thermoplastic foam, and forming the sheet to have a graduated thicker summitarea corresponding to each summit of a bra or bra-like garment for including the pad,and a surrounding thinner area. Each pad thus has a thicker summit area for extendingover the summits of the breasts.

]57[


__________________

177777]21][11[

POLYMER מוצרי� פולימריי� המכילי� גורמי� פעילי� PARTICLESCONTAINING ACTIVE AGENTS

]54[

02.04.2005]22[DE]33[05.04.2004]32[102004016685.4]31[

Int. Cl.(2009.01) A61K 47/32, 47/48, C08F 220/12]51[BASF SE, GERMANY]71[WO/2005/097197]87[



]74[

The invention relates to polymer particles containing active agents, comprising a vinylpolymer of 10- 80 wt. % of monomers comprising amino and/or carboxyl groups,insoluble in a part of the pH range from 0- 10 and soluble in another part range,characterised in that said polymer particles, containing active agents, comprise 3- 1000parts of active agent per part of vinyl polymer, with a particle size in the range 20nm -8µm and the vinyl polymer is made up of > 50 wt. % of polymers with a molecularweight of < 100,000 Daltons.

]57[

__________________

177804]21][11[

ל גילוי התק� לסעירת מבחנה הכולל אמצעי אופטי של המבחנה

TEST-TUBE AGITATION DEVICE,COMPRISING MEANS FOR THE

]54[


OPTICAL DETECTION OF A TEST-TUBE

24.03.2005]22[IT]33[31.03.2004]32[MI2004U000137]31[

Int. Cl.(2009.01) B01F 11/00]51[GIOVANNI PASSONI, ITALY]71[WO/2005/094977]87[



]74[

A powered test-tube agitation device(10) includes a small plate (12) having a rest (13)for a test tube(14) to be agitated and operated in agitation by a powered mechanism(15). The powered mechanism (15) is started by means (17, 117) of optical detection ofthe entry of an object into a predetermined zone above the small plate. Advantageouslythe detection means are photoelectric infrared reflection detection means(17).

]57[

__________________

177846]21][11[

SANDING יחידת שיו� ELEMENT]54[

03.03.2005]22[BE]33[03.03.2004]32[2004/0116]31[

Int. Cl.(2009.01) B24D 13/16]51[CIBO N.V., BELGIUM]71[WO/2005/087436]87[




]74[

The invention concerns a sanding element with a succession of overlapping lamellas]57[


(3, 4) containing sanding grains (9), characterised in that these lamellas (3, 4) arealternately formed of sanding lamellas (3) and compressible lamellas (4), wherebyeach sanding lamella (3) rests on a compressible lamella (4).

__________________

178131]21][11[

SURGICAL מכשיר כירורגי INSTRUMENT]54[

29.03.2005]22[NL]33[31.03.2004]32[1025852]31[US29.12.2004 11/025727

Int. Cl.(2009.01) A61B 17/04]51[GLENGOWAN B.V., THENETHERLANDS

]71[




]74[

The invention relates to a surgical instrument, e.g., forceps, and method to be used forsuturing tissue, the surgical instrument comprising a first arm and a second arm thatare spring-connected at a proximal end, while at a distal end the first arm and thesecond arm can be move towards each other, and wherein at least the first arm and/orthe second arm can be provided with a flexible body that is suitable for receiving andaffixing a surgical needle, wherein the flexible body is designed for being positioned atthe distal end, at an inside and/or lower side of the end of an arm.

]57[


__________________

178204]21][11[

CERVICAL חולייתי צווארי–תותב בי� INTERVERTEBRALPROSTHESIS

]54[

29.03.2005]22[US]33[01.04.2004]32[10/814783]31[

Int. Cl.(2009.01) A61F 02/44]51[CERVITECH, INC., U.S.A.]71[WO/2005/094720]87[



]74[

A cervical intervertebral prosthesis comprising at least one cover plate (3,4), which canbe joined to one of two neighboring intervertebrae (1, 2), and a securing plate (12)securing it ventrally to the vertebra (1,2). According to the invention, the securingplate (12) is a separate part which is not connected to the covering plate (3,4). It can bebiodegradable.

]57[


__________________

178316]21][11[

CEREBRUM מתק� להערכת המוח הגדול EVALUATIONDEVICE

]54[

28.04.2004]22[Int. Cl.(2009.01) A61B 05/16]51[MICHIKO TAKAOKA, JAPANKAKUICHI SHIOMI, JAPANSUSUMU KOBAYASHI, JAPANHITOSHI ABE, JAPANMICHIKO OKIYAMA, JAPANELECTRONIC NAVIGATIONRESEARCH INSTITUTE ANINDEPENDENT ADMINISTRATIVEINSTITUTION, JAPAN

]71[

WO/2005/104950]87[,ר יצחק הס ושותפיו"ד

279רחוב הירקון תל אביב6451.ד.ת,


]74[

There is provided a cerebrum evaluation device for evaluating the state of thecerebrum of an examinee by analyzing a speech signal of the examinee by usingchaological signal processing utilizing the periodicity of the signal. The cerebrumevaluation device evaluates the state of the cerebrum according to the speech signaluttered by the examinee. The cerebrum evaluation device includes: a statisticinformation database containing chaological index values of speech signals of aplurality of examinees; a speech signal acquisition unit for acquiring a speech signal; achaological index value calculation unit for calculating a chaological index value ofthe speech signal by the chaological signal processing utilizing the periodicity of thespeech signal acquired; an evaluation unit for evaluating the state of the cerebrum ofthe examinee according to the calculated chaological index value by referencing thestatistic information database; and an output unit for outputting the result evaluated bythe evaluation unit.

]57[


__________________

178567]21][11[

METHOD שיטה לעיצוב גופי מיכלי� ומערכת תואמת OF SHAPINGCONTAINER BODIES ANDCORRESPONDING APPARATUS

]54[

13.04.2005]22[EP]33[16.04.2004]32[04356053.1]31[

Int. Cl.(2009.01) B21D 26/02]51[IMPRESS GROUP B.V., THENETHERLANDS

]71[


'א26רחוב הברזללרמת החיי


]74[

Said method wherein a) said container (1, 6) is placed in a two halves mould (2)having an internal shaped wall (21), an b) an internal pressure P of a fluid is build upso as to shape said skirt (12), is characterized in that an external pressure P' of a fluid isapplied in a said upper space (101) contiguous to an external or upper surface (100) ofsaid open top end (10) and/or in a said lower space (141) contiguous to an external orlower surface (140) of said shaped bottom end (14), so as to have, during said span oftime , a pressure difference low enough to prevent any distortion of said shaped opentop end (10) and/or said shaped bottom end (14), so as to form a shaped metalliccontainer (1', 6'). An apparatus for carrying out the method is also disclosed.

]57[


__________________

178624]21][11[

INTERNAL שתל דנטלי ע� חיבור פנימי CONNECTIONDENTAL IMPLANT

]54[

23.06.2005]22[US]33[29.06.2004]32[10/879824]31[

Int. Cl.(2009.01) A61C 08/00]51[LIFECORE BIOMEDICAL INC.,U.S.A.

]71[


5שנקר'רח,1ים-מרכז גב ליההרצ12704.ד.ת,


]74[

An internal connection dental implant and implant assembly in which the implantincludes a lobed configuration for installing the implant and a beveled surfacepositioned on the proximal side of the lobed configuration for providing stabilitybetween the implant and a corresponding abutment.

]57[


__________________

178656]21][11[

מערכות תגובת קוב+ מקטעי התפרצות אנוקסית מעורבי�

SURGE ANOXIC MIXSEQUENCING BATCH REACTORSYSTEMS

]54[

03.03.1999]22[US]33[04.03.1998]32[09/034512]31[US02.10.1998 60/102864

Int. Cl.(2009.01) C02F 03/20, 03/30]51[DIVISION FROM 158662]62[MIKKEL G. MANDT, U.S.A.]71[WO/1999/044951]87[




]74[

An integrated sludge reduction method for biooxidation of wastewater comprising thesteps of:providing an anaerobic wastewater treatment zone, an anoxic waste water treatmentzone, and one or more aerobic wastewater treatment zones, wherein the volume of theanaerobic treatment zone comprises from about 20 to about 40 percent, the volume ofthe anoxic treatment zone comprises from about 10 to about 40 percent, and thevolume of the one or more aerobic wastewater treatment zones comprises from about20 to about 60 percent of the total processing volume of the anaerobic, anoxic andaerobic tanks,introducing wastewater having BOD5 and suspended solids to be treated into theanaerobic treatment zone and settling at least a portion of the suspended solids to ananaerobic settled solids zone in the lower portion of the anaerobic treatment zone,circulating fluid from the anaerobic zone to the anoxic treatment zone, from the anoxictreatment zone to the aerobic treatment or zones, and from the anoxic treatment zoneand/or the aerobic treatment zone(s) back to the anaerobic treatment zone, wherein atleast about 50 percent by weight of the microbial sludge and other solids content (TSS)of the waste liquor recycled to the anaerobic zone is settled to the anaerobic settledsolids zone in the lower portion of the anaerobic treatment zone together with settledinfluent wastewater solids, anaerobically digesting at least 50% by weight of thesettled mixture of raw influent solids and the recycled microbial sludge solids toproduce anaerobically digested solid, soluble and gas components in the anaerobictreatment zone which are conduced to the anoxic and aerobic treatment zones formicrobial oxidation, anddischarging treated water from the aerobic treatment zone.

]57[


__________________

178836]21][11[

�CONDITIONING עיניות–מכשיר התניה להזרקת עדשות תו DEVICE FORINJECTING THE INTRAOCULARLENS

]54[

04.05.2005]22[FR]33[06.05.2004]32[0450874]31[

Int. Cl.(2009.01) A61F 02/16]51[LABORATOIRE DECONTACTOLOGIE APPLIQUEE-LCA, FRANCE

]71[




]74[

The invention relates to a unit comprising an intraocular lens injector (10) with a body(11) containing an intraocular lens, and a conditioning device (20). This conditioningdevice (20) is provided for accommodating and storing said injector (10) before its use,is made of a watertight material, and is filled with a storage solution for holding atleast the body (11) of the injector (10) and the intraocular lens in total immersionduring the entire duration of storage. The conditioning device (20) comprises anessentially rigid reservoir (21, 22) and an opening (25) for placing and withdrawing theinjector (10), said reservoir (21, 22) comprising at least one inner shoulder (26, 27)that interacts with a part of the injector (10) in order to center it and hold its injectionend (14) of the lens away from the walls of the reservoir (21, 22).

]57[

__________________


178867]21][11[

HEMOSTATIC אריג טקסטילי הימוסטטי TEXTILEMATERIAL

]54[

26.10.2006]22[Int. Cl.(2009.01) A61K 09/70, 38/00, A61L 15/28]51[

רמת אפעל, אורי מרטינוביץ גליל עליון, צדקיהו סימנהויז

VLADIMIR N. FILATOV, RUSSIAVLADIMIR RYLTSEV, RUSSIAURI MARTINOVITZZIDKIYAHU SIMENHAUS

]71[



]74[

A hemostatic textile material to stop bleeding comprising: a dialdehyde cellulosecarrier; a blood coagulation factor such as chitosan chemically immobilized thereon; a

bacteriolytic agent such as a lysozyme enzyme; and optionally a component thatprevents hemolysis chemically immobilized thereon.

.

]57[

__________________

178949]21][11[

ADMINISTRATION מער� למת� הזנה ומנגנו� לשסתו� FEEDING SETAND VALVE MECHANISM

]54[

25.05.2005]22[US]33[25.05.2004]32[10/853958]31[

Int. Cl.(2009.01) A61M 05/00]51[SHERWOOD SERVICES AG,SWITZERLAND

]71[




]74[

An administration feeding set (10) adapted to be loaded to a flow control apparatus(12) is disclosed. The administration feeding set (10) comprises tubing (60) adaptedsuitably for fluid flow, a valve mechanism (14) suitable for loading the administrationfeeding set (10) to the flow control apparatus (12), and a mounting member (16)adapted suitably for permitting identification of the functional configuration of theadministration feeding set (10). Also disclosed is a method for administering fluid

]57[


utilizing the administration feeding set (10). There are also disclosed novel valvemechanisms (14).



__________________

179027]21][11[

�SPRAY ראש מרסס למזעור תוו HEAD FOR ATOMIZING AMEDIUM

]54[

14.03.2005]22[DE]33[05.05.2004]32[102004022131.6]31[

Int. Cl.(2009.01) B65D 83/16]51[BOEHRINGER INGELHEIMMICROPARTS GMBH, GERMANY

]71[




]74[

The invention relates to a spray head for atomizing a medium with the aid of apressurized propellant. Said spray head comprises a spray head body (10)encompassing a fastening ring (6) and an actuating element (20) that is movablyconnected thereto, a holding element (12) encompassing an inlet port (24), an adjacentduct section (26) and a holding section (28), as well as a duct element (14) which isprovided with an outlet port (62) for the medium and has such a diameter in at leastone section that the medium that is to be discharged atomizes in the propellant flow.The duct element (14) is preferably embodied as a capillary tube or a capillary pipeand/or is provided with a constant diameter along the entire length thereof. The ductelement (14) is arranged in the holding section (28) of the holding element (12),preferably at an angle of about 90° relative to said holding section (28) of the holding

]57[


element, the holding element (12) being preferably joined to the spray head body (10).Mounting of the inventive spray head is made easier by the fact that the holdingelement (12) is provided with at least one clamping element (50) for clampingly orlockingly retaining the duct element (14) on the holding element (12), said at least oneclamping element (50) being located at least in the holding section (28), especially atthe upper end thereof.

__________________

179549]21][11[

INJECTION התק� הזרקה DEVICE]54[

27.05.2005]22[GB]33[28.05.2004]32[0412061.4]31[

Int. Cl.(2009.01) A61M 05/20]51[CILAG GMBH INTERNATIONAL,SWITZERLAND

]71[




]74[

An injection device (210) is described. A housing (212) receives a syringe andincludes a return spring (226) for biasing the syringe from an extended position inwhich its needle (218) extends from the housing to a retracted position in which the itdoes not. A drive spring (230) acts on a first drive element (232) and a second driveelement (234) acts upon the syringe to advance it from its retracted position to itsextended position and discharge its contents through the needle. The first driveelement is capable of movement relative to the second once a nominal decouplingposition has been reached. A release mechanism is activated when the-first driveelement is further advanced to a nominal release position, to release the syringe (214)from the action of the drive spring, whereupon the return spring restores the syringe toits retracted position. A locking mechanism (337, 375) confines the returned syringe in

]57[


its retracted position.

__________________

179551]21][11[

INJECTION רקההתק� הז DEVICE]54[

27.05.2005]22[GB]33[28.05.2004]32[0412053.1]31[

Int. Cl.(2009.01) A61M 05/20]51[CILAG GMBH INTERNATIONAL,SWITZERLAND

]71[




]74[

An injection device (110) is described having a housing (112) that receives a syringe(114) having a needle (118), wherein the syringe is supported in a syringe carrier(150). The syringe and syringe carrier are biased by a return spring (126) from anextended position in which the needle (118) extends from the housing (112) through anexit aperture (128) to a retracted position in which it does not. A drive spring (130)acts via a drive to advance the syringe from its retracted position to its extendedposition and discharge its contents through the needle and a return spring, brought intoplay when the drive has reached a nominal return position, restores the syringe to itsretracted position.

]57[

__________________


180214]21][11[

מאי+ עבור הזנת מכת הד� לתו� גלגל צנטריפוגה

IMPELLER FOR FEEDINGBLASTING SHOTS INTO ACENTRIFUGAL WHEEL

]54[

24.06.2005]22[DE]33[24.06.2004]32[202004009959.4]31[

Int. Cl.(2009.01) B24C 05/06]51[JOST WADEPHUL, GERMANY]71[WO/2006/000426]87[




]74[

The invention relates to an impeller (2) for feeding blasting shots, which are to beaccelerated, into the centrifugal wheel of a shot blasting system. Said impeller (2) isdisposed in the central area of the centrifugal wheel inside a distributing bushing (1),which is provided with a distributing opening (8), and is rotatable in the direction ofrotation of the centrifugal wheel. The impeller (2) comprises mainly plate-shapedguiding elements arranged on the distributing bushing (1) and on at least one lateraldisk (4) for directing the blasting shots outside. At least two adjacent guiding elementsare configured as limbs (5, 6) interconnected to form a single profiled piece (3),wherein adjacent limbs (5, 6) of adjacent profiled pieces (3) form channels throughwhich the blasting shots can be discharged to the outside.

]57[

__________________

180388]21][11[

ש REDUCINGל הצתת פלאזמהצמצו� בלח+ PLASMA IGNITIONPRESSURE

]54[


14.06.2005]22[US]33[30.06.2004]32[10/883583]31[

Int. Cl.(2009.01) B23K 09/02, 10/00]51[LAM RESEARCH CORPORATION,U.S.A.

]71[

MARK WIEPKING, BRADFORD J.LYNDAKER, ANDRAS KUTHI,ANDREAS FISCHER

]72[




]74[

A method in a plasma processing system for processing a semiconductor substrate isdisclosed. The plasma processing system includes a plasma processing chamber and anelectrostatic chuck coupled to a bias compensation circuit. The method includesigniting a plasma in a plasma ignition step. Plasma ignition step is performed while afirst bias compensation voltage provided by the bias compensation circuit to the chuckis substantially zero and while a first chamber pressure within the plasma processingchamber is below about 90 mTorr. The method further includes processing thesubstrate in a substrate-processing step after the plasma is ignited. The substrate-processing step employs a second bias compensation voltage provided by the biascompensation circuit that is higher than the first bias compensation voltage and asecond chamber pressure substantially equal to the first chamber pressure.

]57[

__________________

180473]21][11[

� שיטה ומערכות לאספקת ממשק להתק אינפוזיה

METHOD AND SYSTEMS FORPROVIDING AN INFUSIONDEVICE INTERFACE

]54[

21.07.2005]22[


US]33[21.07.2004]32[60/589623]31[Int. Cl.(2009.01) A61M 05/00, 05/14]51[ANIMAS CORPORATION, U.S.A.]71[WO/2006/012446]87[

,פיוריינהולד כהן ושות'א26רחוב הברזל רמת החייל


]74[

An infusion device (100) comprising an infuser base (105), a cannula (115) and aferrule (120). The infuser base (105) having a bore (104) extending therethrough, thebore (104) having a distal and proximal ends the proximal end having an inside firstdiameter. A flange (135) extends radially outward from the cannula proximal end. Thecannula (115) is positioned in the bore (104) such that the flange (135) is positionedadjacent the shoulder (109). The ferrule (120) has an insertion portion (122), having anoutside second diameter which is substantially equal to the first diameter, and a taperedportion (125) extending from the insertion portion (122). The ferrule (120) ispositioned in the bore (104) such that the insertion portion (122) and a portion of thetapered portion (125) are received in the cannula proximal end and the flange (135) iscompressed between the shoulder (109) and the tapered portion (125) to define a seal(160) between the cannula (115) and the ferrule (120).

]57[

__________________

180922]21][11[

SUCTION רפואיי�מתק� אסו� של נוזל נשאב לשימושי� FLUID COLLECTORFOR MEDICAL APPLICATIONS

]54[

24.01.2007]22[JP]33[08.03.2006]32[2006-62340]31[

Int. Cl.(2009.01) A61J 01/00]51[SHERWOOD SERVICES AG,SWITZERLANDNIPPON SHERWOOD MEDICALINDUSTRIES LTD, JAPAN

]71[

REINHOLD,ד כהן ושותפיוריינהול COHN AND]74[



PARTNERS,26A HABARZEL ST.,RAMAT HACHAYAL 69710

A suction fluid collector includes a transparent reservoir made of a resilient materialwith an upper opening positoned on one side of a flexible suction bag with at least onetransparent side. A plate part made of a resilent material is positioned on another sideof the suction bag opposite said reservoir. An urging means arranged between thereservoir and the plate part provides a force tending to expand a gap between thereservoir and the plate part. A suction tube is positioned partially inside the reservoirand extends through the suction bag.

]57[

__________________

182272]21][11[

DERIVATIVES תולדות של תרכובות טריציקליות דיטרפניות OF TRICYCLICDITERPENE COMPOUNDS

]54[

12.05.2000]22[US]33[14.05.1999]32[60/134295]31[US03.03.2000 60/186853

Int. Cl.(2009.01) A61K 31/015, 31/045, 31/075, 31/16, 31/19, 31/215, 31/22, A61P03/10, 09/00, 11/00, 17/00, 27/00, 29/00, 31/12, 35/00, 37/00, C07C 13/60, 233/57,235/40, 239/02, 33/14, 43/115, 43/162, 61/29, 61/35, 65/00, 69/003, 69/007, 69/753,69/757

]51[

DIVISION FROM 146221]62[THE REGENTS OF THEUNIVERSITY OF CALIFORNIA,U.S.A.NEREUS PHARMACEUTICALS,INC., U.S.A.

]71[




]74[

Compounds are disclosed that have the chemical structure of Formula (II) and (IIB)and their prodrug esters and acid-addition salts, and that are useful as Interleukin-1 andTumor Necrosis Factor-a modulators, and thus are useful in the treatment of variousdiseases, wherein the R groups are defined in the claims.

]57[


__________________

185387]21][11[

FEET-EXERCISE מתק� לתרגול רגליי� DEVICE]54[

20.08.2007]22[Int. Cl.(2009.01) A63B 23/04]51[

SHLOMO קריית טבעון, שלמה וייסברגר WEISBERGER]71[,שלמה וייסברגר

60האלונים קריית טבעון

SHLOMO WEISBERGER,60 HA'ALONIM ST,KIRYAT TIVON 36041

]74[

An exercise device comprising:two containers,medium comprising fluidic material to be placed in said containers, and a motionmechanism for moving the containers in opposite back and forth motions.

]57[



__________________

186144]21][11[

METHOD שיטה לאיפוס ואישור כיוו� מצפ� FOR CALIBRATINGAND VERIFYING THEATTITUDE OF A COMPASS

]54[

03.10.1999]22[Int. Cl.(2009.01) G01C 21/00]51[DIVISION FROM 132191]62[


AZIMUTHמ"אזימוט טכנולוגיות בע TECHNOLOGIES, LTD.]71[עורכי דין ועורכי, קבוצת איתן מהולל




]74[

A method for calibrating the attitude of a compass in relation to the platform on whichthe compass is installed, the compass comprising an attitude determining device andan optical sighting device, the compass being integrally mounted on a platform, themethod comprising:determining the angle between said optical sighting device and said attitudedetermining device;determining the attitude between the optical sighting device and the platform;determining the attitude between said attitude determining device and said platform;andcalibrating the attitude of the compass based on the determined attitude between saidattitude determining device and said platform.

]57[

__________________

187592]21][11[

אוספי� שלה� ושיטות לבחינת, תרכובות לוכדות הפרוטיאו� והרכבי� קומפלקסי�

CAPTURE COMPOUNDS,COLLECTIONS THEREOF ANDMETHODS FOR ANALYZING THEPROTEOME AND COMPLEXCOMPOSITIONS

]54[

16.01.2004]22[US]33[16.01.2003]32[60/441398]31[

Int. Cl.(2009.01) C07C 69/76, G01N 33/68]51[DIVISION FROM 169437]62[CAPROTEC BIOANALYTICSGMBH, GERMANY

]71[

WO/2004/064972]87[,יינהולד כהן ושותפיור



]74[

Capture compounds and collections thereof and methods using the compounds for theanalysis of biomolecules are provided. In particular, collections, compounds andmethods are provided for analyzing complex protein mixtures, such as the proteome.The compounds are multifunctional reagents that provide for the separation andisolation of complex protein mixtures. Automated systems for performing the methods

]57[


also are provided.

The 169437בקשת הורה לבקשה זו שטר פורסמה parent application from whichthis application has been divided hasnot yet been published

__________________

188464]21][11[

APPARATUS מערכת לבקרת כמות נוזל מנוע FORCONTROLLING THE LEVEL OFENGINE FLUID

]54[

27.12.2007]22[Int. Cl.(2009.01) F01P 11/18, G01F 23/30]51[

AHARON אהרון קרישבסקי KRISHEVSKY]71[,ן קרישבסקיאהרו

רמת בית שמש 24/9נהר הירדןAHARON KRISHEVSKY,24 NAHAR HA'YARDEN STREET,APT#9RAMAT BEIT SHEMESH

]74[

An apparatus for controlling coolant level of a cooling system(10w) of an engine, theapparatus comprising:a metering mechanism(26w, 34w, 30w), for metering the coolant level in said coolingsystem, for indicating absence of coolant in said cooling system;an auxiliary coolant reservoir(24w) to said cooling system; anda conveying mechanism(32w), for conveying coolant from said auxiliary coolantreservoir, to said cooling system, upon indicating by said metering mechanismabsence of coolant in said cooling system.

]57[




__________________

189161]21][11[

–קרבוקסי–2'–ניטרו–2תהלי� להכנת נגזרת של דיפנילסולפיד

PROCESS FOR PREPARING A 2-NITRO-2'-CARBOXY-DIPHENYLSULFIDEDERIVATIVE

]54[

09.07.1999]22[Int. Cl.(2009.01) C07D 281/16]51[DIVISION FROM 147379]62[ASTRAZENECA UK LIMITED,UNITED KINGDOMUBE INDUSTRIES, LTD.

]71[

WO/2001/004106]87[',הורוביץ ושות.ש31חוב אחד העםר תל אביב2499.ד.ת,


]74[

A process for producing dibenzothiazepine derivatives typified bydibenzo[b,f][1,4]thiazepin-11-one which are usable as the starting material forproducing 11-[4-(2-(2-hydroxyethoxy)ethyl)]-1-piperazinyldibenzothiazepinederivatives useful as a psychotropic drug, which comprises reacting a nitrobenzenederivative with a thiosalicylic acid derivative, reducing the thus obtained 2-nitro-2'-carboxy-diphenylsulfide derivative, and then further dehydrating and condensing thethus obtained 2-amino-2'-carboxy-diphenylsulfide derivative.

]57[


__________________

189430]21][11[

אטומי� ושימוש� כחומרי�13אזאלידי� בעלי אנטיביוטיי�

13-MEMBERED AZALIDES ANDTHEIR USE AS ANTIBIOTICAGENTS

]54[

09.11.1999]22[US]33[20.11.1998]32[60/109399]31[

Int. Cl.(2009.01) A61K 31/7048, A61P 31/04, 33/02, C07H 17/08]51[DIVISION FROM 142631]62[PFIZER PRODUCTS, INC., U.S.A.]71[WO/2000/031097]87[




]74[

The invention relates to a method of preparing compounds of formula (1) and topharmaceutically acceptable salts thereof. The compounds of formula (1) areantibacterial agents that may be used to treat various bacterial and protozoa infections.The invention also relates to pharmaceutical compositions containing the compoundsof formula (1) and to methods of treating bacterial protozoa infections byadministering the compounds of formula (1). The invention also relates to methods ofpreparing the compounds of formula (1) and to intermediates useful in suchpreparation.

]57[

__________________

190905]21][11[

אמינו חומצות–1–אלקוקסי ציקלואקס�–4 קרבוקסיליות ותהליכי� להכנת�

4-ALKOXY CYCLOHEXANE-1-AMINO CARBOXYLIC ACIDSAND PROCESSES FOR THEIRPREPARATION

]54[

22.06.2001]22[


DE]33[05.07.2000]32[10032587.4]31[Int. Cl.(2009.01) C07C 229/48]51[DIVISION FROM 153561]62[BAYER CROPSCIENCE AG,GERMANY

]71[




]74[

The invention relates to novel 4-alkoxy cyclohexane-1 amino carboxylic acid esters offormula (IV) wherein R1 and R2 have the designation cited in the description;intermediate products; and a method for the production of said esters. The inventionalso relates to the use thereof as intermediate products for the synthesis of insecticide,acaricide and herbicide compounds or pharmaceutical active ingredients.

]57[

__________________

192597]21][11[

מערכת להגנה על החלק הפנימי של מבנה מנזק עקי� הנגר� כתוצאה מרסיסי� עפי�

SYSTEM FOR SHIELDING THEINTERIOR OF A STRUCTUREFROM COLLATERAL DAMAGECAUSED BY FLYING DEBRIS

]54[

02.07.2008]22[US]33[02.07.2007]32[60/929526]31[

Int. Cl.(2009.01) E04H 09/10, F16F 07/12, F41H 05/04]51[בע.ג.ג א,מ"מערכות מיגון .G.G'כפר בילו DEFENSE SYSTEMS LTD]71[

GIDEON גדעון ויטל VITAL]72[בי'ג בע, יי אמ ,מ"פקטור אנד קו



]74[

A system 10 for shielding the interior of a wall construction 14 from collateral damagecaused by flying debris 44 in the presence of shock waves passing through theconstruction,wherein the wall construction has a curtain element 21 disposed between first 18 andsecond 16 load-bearing structural elements, wherein said system includes:

]57[


a tensile generally planar containment matrix 22 adapted for fastening in juxtaposed,substantially non-connected position with respect to the interior side of the wallconstruction, having first and second 34 end portions, said containment matrix beingoperative to flex in the presence of shock waves passing from an exterior side of thewall constructions to the interior side of the wall construction;first connector apparatus for connecting said first end portion of said containmentmatrix to the first load-bearing structural element; andsecond connector apparatus for connecting said second end portion of saidcontainment matrix to the second load-bearing structural element via a hingeconnection 36.


This specification was examined in accordancewith regulation 35 of the Patent Regulations,5728 - 1968

__________________

116442 116433 116421 116398 116385 116376 116364 116353


116538 116494 116492 116484 116460 116458 116444 116443 127079 122211 121263 116614 116555 116549 116541 116539 130177 129729 129497 128996 128872 128634 128165 127491 132445 131848 131443 131211 131192 130919 130888 130874 133032 133025 132994 132946 132803 132802 132739 132639 133324 133313 133310 133309 133289 133269 133139 133082 133399 133395 133375 133371 133352 133350 133326 133325 133662 133661 133630 133576 133537 133505 133481 133400 135492 133976 133828 133827 133805 133761 133752 133720 137931 137830 137821 137780 137620 137519 137425 137279 141515 140820 139950 139556 139298 139142 139141 138065 142993 142915 142875 142766 142755 142216 141749 141564 143093 143092 143091 143076 143065 143058 143031 142998 143209 143184 143151 143150 143149 143145 143112 143104 143293 143280 143253 143239 143234 143233 143232 143229 143448 143432 143429 143428 143389 143345 143313 143299 143541 143528 143500 143478 143477 143474 143462 143458 143604 143595 143591 143579 143575 143571 143570 143566 143662 143661 143648 143645 143639 143638 143637 143624 143715 143700 143698 143691 143673 143671 143666 143663 143809 143792 143778 143751 143750 143733 143732 143728 143862 143859 143858 143846 143839 143838 143833 143830 143977 143934 143907 143899 143893 143891 143888 143871 144443 144152 144135 144134 144132 144004 144001 143994 148624 148302 148150 147582 146368 145849 145371 144485 151425 151408 151287 150810 150633 150134 149967 149689 152989 152935 152868 152446 152351 152177 151942 151647 154759 154563 154177 153968 153623 153622 153478 153473 156154 156126 156030 155608 155580 155440 155178 155163 157342 157193 156976 156925 156910 156751 156550 156175 157948 157930 157800 157750 157621 157575 157416 157400 158973 158951 158893 158892 158870 158578 158223 158067 159264 159189 159188 159186 159170 159163 159158 159157 159990 159653 159611 159457 159417 159319 159318 159294 161235 160793 160686 160546 160500 160469 160387 160081 162026 162011 161920 161650 161495 161336 161273 161241 162900 162718 162672 162590 162580 162367 162344 162050 163328 163309 163215 163209 163205 163111 162935 162905 164947 164647 164497 164493 164069 163861 163805 163464 165885 165884 165842 165583 165571 165371 165355 165321 166530 166392 166218 166172 165975 165970 165955 165886 167708 167651 167315 167309 167268 167102 166934 166683 168785 168684 168633 168485 168248 168159 167827 167717 170245 170172 170032 169491 169281 169251 169227 168970 178224 173501 173459 170790 170584 170562 170452 170396 186734 183570 182675 182674 182673 182118 178769 178768

193578 188489 187294 187126


פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידושPATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL

FEES

154878 154862 154721 154597 135159 134982 134073 134051 155499 155498 155422 155288 155255 155063 154944 154939 113511 113504 113496 113468 113460 155908 155834 155523 113585 113577 113572 113552 113526 113525 113523 113516 113732 113729 113728 113698 113657 113642 113613 113587 129753 129750 129645 129588 129584 129551 113741 113739 131308 129971 129861 129856 129842 129834 129817 129807 98102 98057 98031 98024 97999 97952 97937 97934

138792 138700 138164 122995 120447 120446 98124 98111 139256 139216 139214 139059 139056 138996 138944 138868 139406 139394 139385 139318 139317 139285 139276 139264 139605 139590 139533 139492 139485 139466 139429 139414 139885 139817 139753 139711 139710 139680 139661 139615 162942 143518 127047 160486 141342 140628 140014 139895

166446 164761 164653 163942 163835

פטנטים שחודשו לעשרים שנהPATENTS RENEWED FOR 20 YEARS

168107

צווי הארכה שחודשוEXTENSION ORDERS RENEWED

92208

פטנטים שפג תוקפםPATENTS EXPIRED

91435 91431 91416 91391 91370 91368 91353 91336 91485 91474 91468 91464 91460 91454 91448 91439 91576 91575 91574 91571 91537 91528 91522 91501 91642 91630 91628 91627 91612 91607 91593 91591 91705 91691 91690 91674 91664 91663 91662 91657 91796 91784 91770 91753 91752 91751 91716 91712 91889 91882 91869 91855 91850 91831 91820 91819 92009 92007 92000 91966 91949 91941 91933 91901 92097 92082 92069 92057 92050 92045 92022 92012


NOTICEהודעהלחוק60לפי סעיף 1967-ז"תשכ, הפטנטים

Under section 60 of thePatent Law, 5727-1967

הוגשה בקשה להחזר תוקפו, של הפטנט המפורט מטה

אי שתוקפו פקע מחמתתשלום אגרות החידוש

:הקבועות

Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:

.No 136779 הפטנט' מס of PatentAcceptance 6/2003:'קיבול פורסם ביומן מס published in

journal no::Proprietors:שם בעל הפטנט

MICHAEL LAMTitle:שם האמצאה of invention:

מאזנת לכלי טיס בעל כנ( קבועהAILERON FOR FIXED WING AIRCRAFT

כל אדם רשאי להתנגדלבקשה האמורה תוך

שלושה חודשים מתאריך כפי שנקבע, יומן פטנטים זה

92לחוק ובתקנה61עיף בס-ח"תשכ, לתקנות הפטנטים

1968

Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968


NOTICEעההודלחוק60לפי סעיף 1967-ז"תשכ, הפטנטים


הוגשה בקשה להחזר תוקפו, של הפטנט המפורט מטהשתוקפו פקע מחמת אי

תשלום אגרות החידוש :הקבועות




IBM CORPORATIONTitle:שם האמצאה of invention:

שיטה להצגת תמונה באופ$ בינאריMETHOD FOR IMAGE BINARIZATION



92לחוק ובתקנה61בסעיף -ח"תשכ, לתקנות הפטנטים

1968





ה להחזר תוקפו הוגשה בקש, של הפטנט המפורט מטהשתוקפו פקע מחמת אי






חוטית–שיטה ומערכת ליצירת התקשורת אלSYSTEM AND METHOD FOR ESTABLISHING WIRELESS CONNECTION TO

COMPUTER SYSTEMכל אדם רשאי להתנגדלבקשה האמורה תוך



1968






שלום אגרות החידושת:הקבועות





שה$, עבור מוליכי על שבבי סיליקו$, שיטה לייצור שכבות דיאלקטריות בעלות מקד דיאלקטרי נמו+ בעלות אדהזיה משופרת וצפיפות פגמי נמוכה

METHOD OF FABRICATING LOW-DIELECTRIC CONSTANT INTERLEVELDIELECTRIC FILMS FOR BEOL INTERCONNECTS WITH ENHANCED

ADHESION AND LOW-DEFECT DENSITYכל אדם רשאי להתנגדלבקשה האמורה תוך



1968











ד(DRAMמנגנו$ ושיטה לייצור מערכי אנכיי משובצי ע חיבור ביטלי$) ינאמי אקראיזכרו$ ופוליסיליקו$ ע משטחי סילצידיי

STRUCTURE AND METHOD OF FABRICATING EMBEDDED VERTICAL DRAMARRAYS WITH SILICIDED BITLINE AND POLYSILICON INTERCONNECT


שלושה חודשים מתאריך זהי כפי שנקבע, ומן פטנטים


1968





הוגשה בקשה למחיקת. הפטנט המפורט מטה

Application has been filedfor revocation of the patentrecorded below



THE REGENTS OF THE UNIVERSITY OF CALIFORNIAUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC..

Title:שם האמצאה of invention:B-11ך המייצר כח נטו מריאקציית ריאקטור היתו

FUSION REACTOR THAT PRODUCES NET POWER FROM THE B-11 REACTIONכל אדם רשאי להתנגדלבקשה האמורה תוך


לחוק73בסעיף

Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 73 ofthe law


שינויים בפרטים רשומים בפנקסCHANGES IN PARTICULARS ENTERED IN REGISTER

DESIGNSמדגמים

מדגמים שנרשמוDESIGNS REGISTERED

46111 9Class)07( סוג פרסום

22.06.2008 POLYCADמ"בע) 1989(פוליכד תעשיות INDUSTRIES (1989)

LTD.Salt-cellar מכסה למלחיה cap


17.07.2008 NETTA נטע וינרוט WEINROTH

Chain שרשרת


26.05.2008 ק בעבסט BESTמ"רטון CARTON LTDPackage אריזה



15.05.2008 ר בע.א.תכשיטי R.A.Nמ"ן גוב GOV JEWELRY LTD.

Ring טבעת




Bracelet צמיד

45952 ,45953 11Class)01( סוג פרסום


Jewel תושבת של תכשיט seating

48465 ,48466 26Class)01( סוג פרסום

25.10.2009 AMY-ARTמ"עמי מוצרי נוי בע WORK LTD.

Hanukia חנוכייה

45848 ,45857 8Class)06( סוג פרסום

17.04.2008 בע- אברהם כהן ABRAHAMמ"ידיות ופרופילים COHEN - HANDLES &

PROFILES LTD.Handle ידית


09.09.2009 GABI גבי בקשי BACSHY

Sculpture פסל



28.06.2009 ITZHAK יצחק ישראל ISRAELAVRAHAM אברהם אביב AVIV

Shoe נעל


05.05.2009 SHAAR סהר בצרי BATSRY

Lolipop סוכריה על מקל


28.06.2009 CAESAREAמ"קיסריה עיצוב בנוף בע LANDSCAPE DESIGN

LTD.Container מיכל לאיסוף בקבוקים for collection of bottles

46241 ,46242 23Class)02( סוג פרסום

10.07.2008 OZמ"עוזגום בע GUM LTD.

Showerש מקלחרא head


04.03.2008 REDמ"רד טול בוקס בע TOOL BOX LTD.Electric מלטשת חשמלית sander



17.04.2008 AVI אבי פילו FILO

Liquid מיכל נוזלים container


22.05.2008 ELI און-אלי בר BARON

Motorcycle מנעול לאופנוע lock


12.06.2008 LUCK HOLDINGS, INC.

Pendant תליון


29.07.2008 מ BODYמ"בע. בודי MEM LTD.

Fence עמוד לגדר stand



08.09.2008 NOBELמ"נובל תעשיות מיגון בע SECURITY INDUSTRIES

LTD.Laptop מנעול למחשב נייד lock


18.09.2008 HAIM חיים אברבוך AVERBUCH

Apparatus התקן להשבחת איכות המים for the improvement of waterquality


07.10.2008 YALDEIמ"ילדי החלומות בע HAHALOMOT LTD.

Doll בובה


22.10.2008 LIQUID FIRE TRADE AND INVEST 21 (PTY) LTD.

Limb תיק זרוע bag


15.02.2009 MODUמ"מודיו בע LTD.

Mobile טלפון נייד עם רמקולים phone with speakers


47326 ,47327 ,47328 8Class)08( סוג פרסום

24.02.2009 PLASTOKITמ"פלסטוקיט איכות בע QUALITY LTD.

Fastening התקן הידוק device


16.04.2009 SHUGONמ"שוגון תיקים ומוצרי עור בע BAGS &

LEATHERGOODS LTD.Backpack תיק גב


22.03.2009 NULENSמ"ניולנס בע LTD.

Cartridge מחסנית לעדשה בין עינית for intraocular lens


07.04.2009 בע-פובליק זון PUBLICמ"אלון דרורי עיצוב ZONE-ALON DRORI

DESIGN LTD.Drinking ברזיה fountain



07.04.2009 בע-פובליק זון PUBLICמ"אלון דרורי עיצוב ZONE-ALON DRORI

DESIGN LTD.Trash פח אשפה bin


07.04.2009 עי-פובליק זון בעאלון דרורי PUBLICמ"צוב ZONE-ALON DRORI

DESIGN LTD.Table שולחן


47514 ,47515 ,47516 47517 ,47518

6Class)01( סוג פרסום07.04.2009

בע-פובליק זון PUBLICמ"אלון דרורי עיצוב ZONE-ALON DRORIDESIGN LTD.

Seat כסא


06.05.2009 DAVID דוד פל PEL

Tank מיכל למיחזור מים for recycling water


20.05.2009 UNI-CHARM CORPORATION

Sanitary מסיכה סניטארית mask

47804 ,47805 25Class)01( סוג פרסום

03.06.2009 ACP אביזרי מיזוג

Profile פרופיל


24.06.2009 TAL טל רונן RONEN

Sandwich עטיפה לכריך wrap



23.06.2009 בע-אלו ALU-OZמ"עוז LTD.

Profile פרופיל


01.07.2009 SHIMON שמעון גל GAL

Pipe צינור


16.04.2009 FKA DISTRIBUTING CO., DOING BUSINESS AS HOMEDICS, INC.

Portable רמקול נייד speakerConvention 17.10.2008)ארצות הברית(תאריך האמנה date (U.S.A.)


25.05.2008 CHRISTOPHER SLOWINSKI

Diamond יהלוםConvention 29.04.2008)ארצות הברית(תאריך האמנה date (U.S.A.)


47746 ,47747 4Class)02( סוג פרסום

26.05.2009 COLGATE-PALMOLIVE COMPANY

Toothbrush מברשת שינייםConvention 26.11.2008)ארצות הברית(תאריך האמנה date (U.S.A.)



21.05.2009 THE GILLETTE COMPANY

Shaving מחסנית לסכין גילוח razor cartridgeConvention 24.11.2008)ארצות הברית(ריך האמנה תא date (U.S.A.)


06.07.2009 SONY COMPUTER ENTERTAINMENT, INC.

Arithmetic יחידת חשבון ובקרה and control unitConvention 12.02.2009)יפן(תאריך האמנה date (JAPAN)


09.07.2009 DIRECTA AB

Dental פריט של מכשיר דנטלי instrument detailConvention 27.01.2009)איחוד אירופי(תאריך האמנה date (OHIM)


07.05.2009 SONY ERICSSON MOBILE COMMUNICATIONS AB

Mobile טלפון נייד phoneConvention 11.02.2009)איחוד אירופי(תאריך האמנה date (OHIM)



28.07.2008 VILLEROY & BOCH AG

Tableware מערכת כלי שולחן setConvention 04.02.2008)איחוד אירופי(תאריך האמנה date (OHIM)



26.03.2009 KONINKLIJKE PHILIPS ELECTRONICS N.V.

Drug התקן לשחרור תרופות delivery deviceConvention 01.10.2008)איחוד אירופי(תאריך האמנה date (OHIM)

47321 ,47322 24Class)01( סוג פרסום

25.02.2009 MAVIG GMBH

Clothing בגד הגנה נגד קרינת רנטגן for protection against x-raysConvention 09.09.2008)איחוד אירופי(תאריך האמנה date (OHIM)

46477 ,46478 30Class)03( סוג פרסום

11.08.2008 PARAGON PRODUCTS B.V.

Dog התקן לעיסה לכלב chewing deviceConvention 06.06.2008)אוהיים(תאריך האמנה date (OHIM)


15.06.2009 HEIC HORNBACHNER ENERGIE INNOVATION CONSULTING GMBH

Street מנורת רחוב lampConvention 22.12.2008)הייםאו(תאריך האמנה date (OHIM)


47981 ,47982 13Class)03( סוג פרסום

13.07.2009 HAGER ELECTRO GMBH & CO.KG

Distribution קופסת חלוקה boxConvention 04.02.2009)אוהיים(תאריך האמנה date (OHIM)


46738 ,46739 ,46740 46741 ,46742 ,46743

23Class)01( סוג פרסום12.10.2008

FORMASTER S.A.Water מסנן מים filter

Convention 03.07.2008)אוהיים(תאריך האמנה date (OHIM)


מדגמים שחודשוDESIGNS RENEWED

33002 33001 32625 32582 32561 32558 32557 32540 39905 39902 39899 39850 39846 39237 39096 33088 40188 40071 40046 40045 40044 40026 40011 39929

41844 40213 40197


מדגמים שבוטלוDESIGNS VOID

31451 23623 23606 23605 23582 23546 23544 23537 31505 31504 31502 31475 31469 31460 31458 31452 39210 39209 39207 36459 31589 31554 31551 31546 39248 39224 39220 39219 39216 39215 39213 39211 39259 39256 39255 39254 39253 39252 39250 39249 39278 39275 39272 39271 39269 39264 39262 39260 39291 39290 39288 39287 39286 39285 39283 39280 39315 39309 39305 39304 39301 39300 39299 39293

39333 39332 39331 39322

ר מאיר נועם"ד המדגמים, רשם הפטנטים וסימני מסחר

Dr. Meir NoamCommissioner of Patents,Designs and Trade Marks


מפתחות לבקשות שקובלוINDICES OF APPLICATIONS ACCEPTED

NAMEמפתח שמי INDEX

159717-מ"אביק מעבדות ביולוגיות בע188464-אהרון קרישבסקי

131149-מ"אוסצילון בע178867-אורי מרטינוביץ

186144-מ"אזימוט טכנולוגיות בעבע. איי.סי. אי 163557-מ"טלקוםבע. איי.סי.אי 163557,164114-מ"טלקום

,169071בע.טי.פי.אל 175234-מ"טכנולוגיות

אופטיקה אלאופ-אלביט מערכות אלקטרו168728-מ"בע

167464-מ"ארד טכנולוגיות מדידה בע

- בית חולים הרצוג עמותת עזרת נשים154318

174309-בעז קריסטל

בע.ג.ג 192597-מ"מערכות מיגון175162-גאורגי נאומוב

בע'גיוון אימג 156962-מ"ינגג'ג בע'מטקס אינק 132049-מ"ט פרינטינג

162371-מ"דמטק בע

158097- המרכז למחקר גרעיני-מ"התעשייה הצבאית לישראל בע

167287

158601-זוהר אלינסקי131149-מ"זולי החזקות בע

בע- זון 167160-מ"איי פי151353-זמיר מנור

157550-מ"ידע חברה למחקר ופיתוח בע166321-יעקב קולציה

169556-יצחק וייסמן

174309-פריס-ליאת דה

א 161135-בגנים מאיר162187-מ"מדיגוס בע

,155823-מ"מולטילוק טכנולוגיות בע166688

175231-מ"מולטילוק טכנולוגיות בע-מ"מוסד הטכניון למחקר ופתוח בע

168728175162-מיכאל נאומובאנאלוג מיקסד סינגל-מיקרוסמי קורפ

164458-מ"גרופ בע148261-מ"מלנוקס טכנולוגיות בע

162538-מרדכי אלדר

153894-מ"נובה מכשירי מדידה בע153291-ניר פדן

167160-מ"ספירל סולושנס בע

174309-ד ליאן קהת ככונס נכסים"עו138473-מ"עטרקס בע

156853-פסח זיידל

אגודה-אפיקים מערכות חליבה.מ.ח.צ174751-מ"שיתופית חקלאית בע

178867-צדקיהו סימנהויז

123646-מ"קורינדוס בע153317-מ"קליל תעשיות בע

בע"רפא -מ"ל מערכות לחימה מתקדמות150243


בע"רפא מ"ל רשות לפיתוח אמצעי לחימה-159973

185387-שלמה וייסברגר

3DFACTO A/S -1626273M INNOVATIVE PROPERTIESCOMPANY - 146486, 170569, 170570,172740

A.R. ARENA PRODUCTS, INC. -156984ABBOTT LABORATORIES -145395ABBOTT LABORATORIES -145536ABIC BIOLOGICAL LABORATORIESLTD. - 159717ABLOY OY - 174956ACUSPHERE, INC. -146659ADC TELECOMMUNICATIONS, INC. -168832AETERNA ZENTARIS GMBH -128331,153067AHARON KRISHEVSKY - 188464AIR TO WATER TECHNOLOGIES, INC.- 166680ALCON, INC. - 171886, 171887, 171888,171889, 171890, 171891ALLERGAN, INC. - 173530ALPHAVAX, INC. - 169076ANGIOTECH INTERNATIONAL AG. -165120ANIMAS CORPORATION -180473ANSELL HEALTHCARE PRODUCTSLLC - 177600ANTONIO GARDELLI - 143534ARAD MEASURING TECHNOLOGIESLTD. - 167464ARCHER-DANIELS-MIDLANDCOMPANY - 161244ARM LIMITED - 165987, 167597,168453, 168928, 169151ARQULE, INC. -165265ASTRAZENECA AB -152284, 152754ASTRAZENECA UK LIMITED - 189161ATHEROGENICS, INC. -164568ATTAREX LTD. - 138473AVENTIS PHARMA S.A. -132670,

151211, 154294, 167868AVOCENT HUNTSVILLECORPORATION -169407AZIMUTH TECHNOLOGIES, LTD. -186144

B.R.A.I.N. BIOTECHNOLOGYRESEARCH AND INFORMATIONNETWORK AG. -172312BALL CORPORATION -174487BASF AKTIENGESELLSCHAFT -163465, 168946BASF SE -177777BAVARIAN NORDIC A/S - 154712BAYCO TECH LIMITED - 175287BAYER CROPSCIENCE AG -156106,163106, 163792, 173291, 190905BAYER SCHERING PHARMA AG -153333BAYER SCHERING PHARMAAKTIENGESELLSCHAFT -156282,170295, 170473BAYLOR COLLEGE OF MEDICINE -154544BERKSHIRE LABORATORIES, INC. -141797BIOGEN IDEC MA INC. - 137489BIOLEX THERAPEUTICS, INC. -158983BIONICHE LIFE SCIENCES INC. -160408BIOVITRUM AB - 155702BOAZ KRISTAL - 174309BOEHRINGER INGELHEIMINTERNATIONAL GMBH - 174496BOEHRINGER INGELHEIMMICROPARTS GMBH -179027BOEHRINGER INGELHEIM PHARMAGMBH & CO. KG - 160389BRISTOL-MYERS SQUIBB COMPANY -155612BRISTOL-MYERS SQUIBB PHARMA


COMPANY - 142959BROOK CHANDLER MURPHY -172446

CANCER RESEARCH CAMPAIGNTECHNOLOGY LIMITED - 108328CAPROTEC BIOANALYTICS GMBH -187592CENTRO DE INMUNOLOGIAMOLECULAR - 158246, 170355CEPHALON, INC. -161015CERATIZIT AUSTRIA GESELLSCHAFTM.B.H - 177334CERVITECH, INC. -173137, 178204CHROMOS MOLECULAR SYSTEMS,INC. - 126126CIBO N.V. - 177846CILAG GMBH INTERNATIONAL -179549, 179551COLEY PHARMACEUTICAL GROUP,INC. - 146486COMMONWEALTH SCIENTIFIC ANDINDUSTRIAL RESEARCHORGANISATION -160249CONTAINER DEVELOPMENT, LTD. -174487CORINDUS LTD -123646COUNCIL OF SCIENTIFIC ANDINDUSTRIAL RESEARCH -155123CREIGHTON UNIVERSITY -152654CRUCELL HOLLAND B.V. - 171680CSL BEHRING AG -154006CYTOS BIOTECHNOLOGY AG -161147

DAIICHI SANKYO COMPANY LIMITED- 168475DART INDUSTRIES INC. -165341DCA DESIGN INTERNATIONALLIMITED - 170480DESIGN TECHNOLOGY ANDIRRIGATION LIMITED - 147715DEUTSCHE POST AG -172431DIRECT COMPUTER RESOURCES, INC.- 161338DMATEK LTD. - 162371DORMA GMBH + CO.KG -155018DSM IP ASSETS B.V. -165529DUANE KELLER - 172523

E.I. DU PONT DE NEMOURS ANDCOMPANY - 147715, 165502ECI TELECOM LTD. -163557ECI TELECOM LTD. -163557, 164114,169071EGIS GYOGYSZERGYAR RT. -171522EISAI CO., LTD. -155612EISAI R&D MANAGEMENT CO., LTD. -155612ELBIT SYSTEMS ELECTRO-OPTICSELOP LTD -168728ELECTRONIC NAVIGATIONRESEARCH INSTITUTE ANINDEPENDENT ADMINISTRATIVEINSTITUTION - 178316ELECTRONICS FOR IMAGING, INC. -154790ELTHOM ENTERPRISES LIMITED -176736EMORY UNIVERSITY - 173745EPICEPT CORPORATION -153656ESSILOR INTERNATIONAL(COMPAGNIE GENERALE D'OPTIQUE)- 176455ETEX CORPORATION -174198ETHYPHARM - 152317EURO-CELTIQUE S.A. -131561EVONIK ROHM GMBH - 173078

F. HOFFMANN-LA ROCHE AG -144467F. HOFFMANN-LA ROCHE AG -160527F. HOFFMANN-LA ROCHE AG -168343, 169368, 174734FEC CO., LTD. -163714FERRING B.V. -161193FMC CORPORATION -149282FRACTURE CODE CORPORATION APS- 162334

G.G. DEFENSE SYSTEMS LTD -192597GE HEALTHCARE LIMITED - 170864GENENTECH, INC. -135607, 156111,164417, 175906GEORGE NAUMOV -175162GERON CORPORATION -162130GILEAD SCIENCES, INC. -173745


GIOACCHINO COPPI -143534GIOVANNI PASSONI -177804GIVEN IMAGING LTD. - 156962GLAXO GROUP LIMITED - 164108GLENGOWAN B.V. -178131GR INTELLECTUAL RESERVE, LLC, -141797

H. LUNDBECK A/S - 159326, 170194HANMI PHARM. CO., LTD. - 167725HEE KWON RHO -170232HITOSHI ABE - 178316HK PHARMACEUTICALS, INC. -187592HONEYWELL INTERNATIONAL INC. -174089, 175507HUBERT KOSTER -187592HUGHES ELECTRONICSCORPORATION -154657, 154658HYGLOS INVEST GMBH -165390

I - FLOW CORPORATION -156190ICON GENETICS, INC. -151479ICX GLOBAL, INC. - 168562IMMUNEX CORPORATION -140937IMMUNOCELLULAR THERAPEUTICS,LTD - 148113, 155611IMPRESS GROUP B.V. -178567INCA DIGITAL PRINTERS LIMITED -172625INCONTINENT CONTROL DEVICES -161019INDENA S.P.A. -170200INDUSTRIAL ORIGAMI, INC. - 167655INDUSTRIAL ORIGAMI, LLC. - 167655INHIBITEX, INC. - 157041INSERM -151211INSTITUTO DE BIOTECHNOLOGIA-UNAM - 142516INTARCIA THERAPEUTICS, INC. -161889INTERDIGITAL TECHNOLOGYCORPORATION -165044INTERNATIONAL PATENT OWNERS(CAYMAN) LIMITED - 175591ISRAEL MILITARY INDUSTRIES LTD. -167287ITT MANUFACTURING ENTERPRISES,

INC. - 164435

JANSSEN PHARMACEUTICA N.V. -159819, 160329JANSSEN PHARMACEUTICA, N.V. -157752JAPAN AS REPRESENTED BYPRESIDENT OF NATIONALCARDIOVASCULAR CENTER -166572JEAN-FRANCOIS DURETTE,OCULARISTE INC. -175462JEMTEX INK JET PRINTING LTD. -132049JORDAN L. HOLTZMAN - 142852JORDAN LOYAL HOLTZMAN - 153058JOST WADEPHUL -180214

K.U. LEUVEN RESEARCH &DEVELOPMENT -142516KAKUICHI SHIOMI - 178316KAO CORPORATION -161244KARL MAYERTEXTILMASCHINENFABRIK GMBH -176593KEELE UNIVERSITY - 162652KENNETH D. FINE -151570KIMBERLY-CLARK WORLDWIDE,INC. - 175548KING PHARMACEUTICALSRESEARCH & DEVELOPMENT, INC. -161608KLIL INDUSTRIES LTD. - 153317KOREA KUMNHO PETROCHEMICALCO., LTD. -140090

L.P.T. TECHNOLOGIES LTD. -175234LABORATOIRE DE CONTACTOLOGIEAPPLIQUEE-LCA -178836LAM RESEARCH CORPORATION -167625, 170851, 176466, 180388LG ELECTRONICS INC. -161837LIAN KEHAT ADV. AS AN OFFICIALRECEIVER -174309LIAT DE-VRIES - 174309LIFECORE BIOMEDICAL INC. -178624LOCKHEED MARTIN CORPORATION -162335


LOMA LINDA UNIVERSITY - 126126LOOK DYNAMICS, INC. - 163016LTS LOHMANN THERAPIE-SYSTEMEAG - 173309LUIDIA, INC. - 154790

MACTAC EUROPE S.A. -176379MARTIN E. GLEAVE - 166657MEDIGENE AG -161625MEDIGUS LTD. - 162187MEIR AVGANIM - 161135MELLANOX TECHNOLOGIES LTD. -148261MICHAEL NAUMOV - 175162MICHIKO OKIYAMA - 178316MICHIKO TAKAOKA - 178316MICROSEMI CORP - ANALOG MIXEDSIGNAL GROUP LTD -164458MICROSOFT CORPORATION -147472,162057MICROSOFT CORPORATION -159337MIKKEL G. MANDT - 178656MOLECULAR DISCOVERIES, L.L.C. -148113, 155611MORDECHAI ELDAR - 162538MOTOROLA, INC. -169235MOTOROLA, INC. -175501MUL-T-LOCK TECHNOLOGIES LTD. -155823, 166688MUL-T-LOCK TECHNOLOGIES LTD. -175231

NEREUS PHARMACEUTICALS, INC. -182272NEW YORK UNIVERSITY - 137489NIPPON SHERWOOD MEDICALINDUSTRIES LTD -180922NIR PADAN - 153291NOBIL BIO RICERCHE S.R.L. -175287NOKIA CORPORATION -164097NOVA MEASURING INSTRUMENTSLTD. - 153894NOVARTIS AG - 149142, 174082NSAB, FILIAL AF NEUROSEARCHSWEDEN AB, SVERIGE -150350

OCTAGENE GMBH -151857

OFFICINE MACCAFERRI S.P.A. -167291OLYMPIC TECHNOLOGIES LIMITED -169766OMEGA FLEX, INC. -170983ONCONOVA THERAPEUTICS, INC. -157541ORION CORPORATION -168882OSCIENT PHARMACEUTICALSCORPORATION -152654OSCILLON LTD. - 131149OSRAM SYLVANIA INC. - 166996OSRO GMBH -172219

PESSACH SEIDEL -156853PFIZER PRODUCTS, INC. -142631,163277, 173363, 189430PHARMA MAR S.A., SOCIEDADUNIPERSONAL -154155PHARMA MAR, S.A. - 153682, 155297PHARMACIA CORPORATION -158209PIONEER CORPORATION -173609PREMIUM INGREDIENTS, S.L. -164013PROFOS AG -165390PROTONEX TECHNOLOGYCORPORATION -170365

QUALCOMM INCORPORATED -152215, 155778, 163186, 167437, 171309QUALCOMM INCORPORATED -167299, 168800

RAFAEL ADVANCED DEFENSESYSTEMS LTD. -150243RAFAEL ADVANCED DEFENSESYSTEMS LTD. -159973RAYTHEON COMPANY -157123RAYTHEON COMPANY -161127RAYTHEON COMPANY -165658REINHARD VOEHRINGER -161538REM TECHNOLOGIES, INC. -172219RESEARCH DEVELOPMENTFOUNDATION - 141613RHODIA POLYAMIDEINTERMEDIATES -157427RHODIANYL - 146295ROBARTS RESEARCH INSTITUTE -


162130ROBERTO BENEDINI -143534ROXTEC AB -172558

S.A.E. AFIKIM MILKING SYSTEMS -AGRICULTURAL COOPERATIVE LTD -174751S.S.C.I. INC. -169762SACHEM INC. -175261SAES GETTERS S.P.A. -173224SANDVIK INTELLECTUAL PROPERTYAB - 171509SANOFI AVENTIS -161533SANOFI-AVENTIS -168133, 176478SANOFI-AVENTIS DEUTSCHLANDGMBH - 153818, 156214, 160556SANOFI-AVENTIS DEUTSCHLANDGMBH - 157793SANOFI-AVENTIS DEUTSCHLANDGMBH - 164901, 165519SANOFI-AVENTIS DEUTSCHLANDGMBH - 170480SANOFI-SYNTHELABO OTC SPA -159807SARAH HERZOG MEMORIALHOSPITAL EZRAT NASHIMASSOCIATION -154318SARGENT MANUFACTURINGCOMPANY - 177485, 177517, 177521SASOL NORTH AMERICA INC. -163582SCHERING CORPORATION -152414SDU IDENTIFICATION B.V - 170407SEPRACOR INC. -141531SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. -158427SHERWOOD SERVICES AG -178949,180922SHIPLEY COMPANY, L.L.C. -176787SHLOMO WEISBERGER -185387SILVERBROOK RESEARCH PTY. LTD.- 166921SILVERBROOK RESEARCH PTY. LTD.- 155466, 155471, 156089, 157239SINCLAIR SYSTEMSINTERNATIONAL, LLC - 177720SLOAN-KETTERING INSTITUTE FORCANCER RESEARCH -159371

SMARTLIFE TECHNOLOGY LIMITED -171734SOLVAY GMBH - 167924SOLVAY PHARMACEUTICALS B.V. -168258SOLVIAS AG - 173713SOLVIAS AG - 175771SONIC MOBILITY INC. - 169407SOPRO -177469SOREQ NUCLEAR RESEARCH CENTER- 158097SPEEDEL PHARMA AG -170626SPINECORE, INC. -161136SPIRAL SOLUTIONS LTD -167160SUMITOMO CHEMICAL COMPANY,LIMITED. - 165588SUSUMU KOBAYASHI - 178316

TADAHIRO OHMI - 165326TAIYO NIPPON SANSO CORPORATION- 165326TBW INDUSTRIES, INC. -177026TECHNION RESEARCH ANDDEVELOPMENT FOUNDATION LTD. -168728TECPHARMA LICENSING AG -159664,159665TEMPLE UNIVERSITY OF THECOMMONWEALTH SYSTEM OFHIGHER EDUCATION -157541TEN CATE ADVANCED TEXTILES B.V.- 174272THALES - 170140THE BIOLOGICAL RESEARCHCENTER OF THE HUNGARIANACADEMY OF SCIENCES -126126THE BOARD OF TRUSTEES OF THELELAND STANFORD JUNIORUNIVERSITY - 156973THE DIRECTV GROUP, INC. -164482THE GOVERNMENT OF MALAYSIAGOVERNMENT ADMINISTRATIVECENTRE 62502 PUTRAJAYAMALAYSIA - 163714THE GOVERNMENT OF THE UNITEDSTATES OF AMERICA ASREPRESENTED BY THE SECRETARY


OF THE DEPARTMENT OF HEALTHAND HUMAN SERVICES -147446,147447THE GOVERNMENT OF THE UNITEDSTATES OF AMERICA ASREPRESENTED BY THE UNIFORMEDSERVICES UNIVERSITY OF THEHEALTH SCIENCES -142231THE KENNETH S. WARRENINSTITUTE, INC. -145895THE REGENTS OF THE UNIVERSITYOF CALIFORNIA - 182272THE SCRIPPS RESEARCH INSTITUTE -149142THE TEXAS A&M UNIVERSITYSYSTEM -155228THE TRUSTEES OF THE UNIVERSITYOF PENNSYLVANIA - 166274THE UNIVERSITY OF BRITISHCOLUMBIA - 154529THE UNIVERSITY OF BRITISHCOLUMBIA - 166657THE WATER COMPANY -166680TODD C. STECKLER -172446TORBEN BOGH-ANDERSEN -164926TRELLIS BIOINFORMATICS, INC. -141759TRIMEDYNE, INC. - 169270

U.S. ARMY MEDICAL RESEARCH ANDMATERIEL COMMAND - 146193UBE INDUSTRIES, LTD. -189161ULTRADENT PRODUCTS INC. -171855UNI-CHARM CORPORATION -148582UNITED STATES GYPSUM COMPANY- 177390UNIVERSIDAD DE BARCELONA -154155UNIVERSITY OF MICHIGAN - 168453,168928, 169151UNIVERSITY OF SYDNEY -162557UNIVERSITY OF TECHNOLOGYSYDNEY - 159717

URI MARTINOVITZ - 178867

VACU VIN INNOVATIONS LTD. -169498VERTEX PHARMACEUTICALSINCORPORATED -163117VICTORIA'S SECRET STORES BRANDMANAGEMENT, INC. - 177775VICURON PHARMACEUTICALS INC. -166476VLAAMS INTERUNIVERSITAIRINSTITUUT VOOR BIOTECHNOLOGIEV.Z.W (VIB) - 142516VLADIMIR N. FILATOV - 178867VLADIMIR RYLTSEV - 178867

WISCONSIN ALUMNI RESEARCHFOUNDATION - 121243WOVEN ELECTRONICSCORPORATION, ASOUTH CAROLINA CORPORATION -171785WYETH LLC - 165265WYETH HOLDINGS CORPORATION -142231WYETH LLC - 174198

YAACOV KOLCHEH - 166321YEDA RESEARCH ANDDEVELOPMENT CO. LTD. -157550YITZHAK WEISSMAN - 169556

ZAMIR MANOR - 151353ZIDKIYAHU SIMENHAUS - 178867ZOHAR ELINSKI - 158601ZON - I P LTD - 167160ZULI HOLDINGS LTD. - 131149


SUBJECTמפתח ענייני MATTER INDEX

A01G -158601, 161538, 162538A01H - 142516, 151479A01J -174751A01N - 157752, 163106, 163465,

163792, 172446, 173291A23C -145395A23L - 164013A41C -177775A41D - 177600A47L - 148582A61B - 162187, 171734, 171886,

171887, 171888, 171889,171890, 171891, 175591,177469, 178131, 178316

A61C -171855, 172523, 178624A61F -161136A61F -173137, 175462, 178204,

178836A61J -180922A61K - 137489, 138473, 141531,

142231, 145895, 146659,147446, 147447, 149282,152317, 153058, 153333,153656, 154318, 155611,156282, 159807, 160389,161147, 161193, 161533,161889, 163277, 164417,166274, 166657, 167725,167924, 169762, 170200,170295, 170355, 170473,170626, 170864, 173078,174198, 174496, 177777,178867

A61K - 161625A61L - 165120A61M - 123646, 143534, 159664,

159665, 161019, 170480,178949, 179549, 179551,180473

A61M - 156190A61N - 141797, 166572A63B - 175234, 185387

B01D -147715

B01F -177804B01J -172740B05D -175287B07C -172431B21D -167655, 174487, 178567B23B -177334B23K - 180388B24B -172219B24C -180214B24D -177846B28C -177390B29D -176455B31D -176379B41J -132049, 172625, 174272B41M - 162334B42D -170407B65B -173309B65C -177720B65D -156984, 165341, 169498,

170232, 174309, 179027B65H -157239B81B -166921

C01B -165326C01G -166996C02F -178656C07B -145536C07C -157541, 158209, 160527,

162652, 163582, 164568,165265, 168946, 182272,190905

C07D -108328, 131561, 142959,146486, 150350, 152284,152754, 153067, 153682,154155, 155702, 156106,156214, 159326, 160329,160556, 163117, 164108,164901, 165502, 165519,165588, 168133, 168258,168343, 168882, 169368,170194, 171522, 173363,173530, 173745, 174082,174734, 176478, 189161

C07D -161015


C07F -155612, 173713, 175771C07H -142631, 157793, 161608,

166476, 168475, 189430C07K -128331, 140937, 141613,

148113, 149142, 154006,154544, 155297, 157041,157550, 158246, 175906

C08B -132670, 167868C08F -162557C08G -146295C08L -157427C11C -161244C12M -158983C12N -121243, 126126, 135607,

144467, 151211, 151857,154294, 154529, 154712,156111, 156973, 159371,159717, 162130, 169076,171680, 172312

C12N -152414C12P -165529C12Q -146193, 155123, 160408C22B -170569, 170570C23C -171509, 173224, 176787C40B -153818

D04B -176593D04H -175548

E01F -155228E01H -151353E02D -167291E03D -166321E04H -167287, 192597E05B -155823, 161135, 174956,

175231, 177485, 177517E05B -166688E05C -177521E05D -155018E06B -153317E21B -158427

F01C -176736F01K -156853F01P -188464F16L -170983F25B -166680

F25D -156089F41G -153291F41H -159973F42C -169766

G01B -153894G01C -175162, 186144G01J -175507G01M -150243G01N -141759, 142852, 151570,

152654, 156962, 159819,160249, 165390, 187592

G01R -140090G01S -158097, 161127, 164926,

167437G02B -169270, 169556G02F -163016G06F -147472, 154790, 161338,

162057, 162627, 165987,167160, 168453, 168832,168928

G06K -155471, 163714, 174089G06Q -159337G06T -170140G08B -162371, 171785G08C -168562G11B -173609G11C -154657, 154658, 167597,

169151

H01J -157123H01L - 131149, 167625, 170851,

175261, 176466, 177026H01M - 170365H01Q -162335, 167464, 175501H01R -164458H01S -168728H02G -172558H03D -171309H03M - 165658H04B -164482, 168800H04J -163557, 164097, 169071H04L - 148261, 152215, 164114,

169235H04N -164435, 165044H04Q -155778H04Q -163186


H04W -161837, 167299, 169407H05K - 155466


קודים למדינת המופיעים ביומןCOUNTRY CODES APPEARING IN THIS JOURNAL

Code Country or Organization Code Country or OrganizationAR Argentina MX MexicoAT Austria MY MalaysiaAU Australia NL The NetherlandsBA Herzegovina NO NorwayBE Belgium NZ New ZealandBR Brazil PL PolandCA Canada PT PortugalCH Switzerland RU Russian FederationCN China SE SwedenCU Cuba SG SingaporeCZ Czech Republic SI SloveniaDE Germany SK SlovakiaDK Denmark TH ThailandEC Ecuador TR TurkeyEP European Patent Office TW TaiwanES Spain UA UkraineFI Finland US United States of AmericaFR France UY UruguayGB United Kingdom UZ UzbekistanGE Georgia WO World Intellectual PropertyGR Greece Organization (W.I.P.O.)GT Guatemala ZA South AfricaHR CroatiaHU HungaryIE IrelandIL IsraelIN IndiaIT ItalyJP JapanKR Republic of KoreaLK Sri LankaLU LuxembourgLV Latvia


ע � ירושלי�, משרד המשפטי�,י רשות הפטנטי�"נער

EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM


PATENTS טנטיםפ

פטנטים שניתנוPATENTS GRANTED

132680 130424 129988 124595 122920 122248 108708 108371 137296 137185 135876 135097 134468 133913 133672 132898 141064 141012 141011 140502 140501 139868 139224 137581 145630 145376 143217 143197 143040 142639 142263 141643 149995 149368 149034 148827 148670 148600 148547 146613 151395 151388 151359 151335 151129 150987 150569 150010 152450 152298 152203 152179 151853 151541 151484 151474 153554 153481 153187 153184 153006 152803 152699 152671 154624 154483 154452 154368 154293 153882 153593 153589 155572 155469 155423 155391 155268 155116 155079 155056 156887 156530 156168 156100 155999 155898 155800 155590 157230 157161 157147 157124 157081 157068 157061 156949 158249 158074 158032 157714 157615 157603 157601 157381 158476 158424 158382 158370 158350 158337 158312 158266 159196 159150 159071 158927 158911 158843 158784 158485 160440 160146 160116 160008 159454 159373 159225 159211 160999 160959 160946 160921 160755 160541 160525 160487 161382 161349 161320 161293 161282 161275 161157 161042 162155 162043 161990 161980 161948 161668 161618 161476 163148 163136 163068 163026 162993 162984 162896 162389 164064 163944 163679 163595 163544 163539 163244 163203 166003 165327 165300 165123 165047 164844 164540 164344 167869 167820 167224 166997 166953 166471 166356 166159 169550 169453 169282 169277 169273 168643 168192 167981 171408 171208 170940 170826 170709 170638 170247 169924 174805 173756 173018 172764 172274 171760 171458 171418

187181 184739 181059 177417

פטנטים שחודשוPATENTS RENEWED

100309 100266 100231 100230 100213 100209 100106 99962 100387 100383 100366 100360 100352 100342 100341 100322 100448 100435 100429 100420 100419 100409 100400 100390 113536 107267 100553 100503 100502 100478 100459 100449 116106 116060 116050 116032 116031 115840 115489 114028 116242 116239 116227 116225 116223 116201 116166 116119 116352 116332 116331 116330 116328 116281 116256 116243

193578 188489 187294 187126 186734


קפם פקעו בגלל אי תשלום אגרת חידושפטנטים שתוPATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL

FEES

98102 98057 98031 98024 97999 97952 97937 97934 113516 113511 113504 113496 113468 113460 98124 98111 113587 113585 113577 113572 113552 113526 113525 113523 113739 113732 113729 113728 113698 113657 113642 113613 129588 129584 129551 127047 122995 120447 120446 113741 129856 129842 129834 129817 129807 129753 129750 129645 138164 135159 134982 134073 134051 131308 129971 129861 139214 139059 139056 138996 138944 138868 138792 138700 139385 139318 139317 139285 139276 139264 139256 139216 139533 139492 139485 139466 139429 139414 139406 139394 139753 139711 139710 139680 139661 139615 139605 139590 154597 143518 141342 140628 140014 139895 139885 139817 155288 155255 155063 154944 154939 154878 154862 154721 162942 160486 155908 155834 155523 155499 155498 155422

166446 164761 164653 163942 163835

פטנטים שחודשו לעשרים שנהPATENTS RENEWED FOR 20 YEARS

168107

צווי הארכה שחודשוEXTENSION ORDERS RENEWED

92208

פטנטים שפג תוקפםPATENTS EXPIRED

91435 91431 91416 91391 91370 91368 91353 91336 91485 91474 91468 91464 91460 91454 91448 91439 91576 91575 91574 91571 91537 91528 91522 91501 91642 91630 91628 91627 91612 91607 91593 91591 91705 91691 91690 91674 91664 91663 91662 91657 91796 91784 91770 91753 91752 91751 91716 91712 91889 91882 91869 91855 91850 91831 91820 91819 92009 92007 92000 91966 91949 91941 91933 91901 92097 92082 92069 92057 92050 92045 92022 92012










שיטה להצגת תמונה באופ$ בינאריMETHOD FOR IMAGE BINARIZATION




1968





בקשה להחזר תוקפו הוגשה, של הפטנט המפורט מטהשתוקפו פקע מחמת אי






חוטית–שיטה ומערכת ליצירת התקשורת אלSYSTEM AND METHOD FOR ESTABLISHING WIRELESS CONNECTION TO

COMPUTER SYSTEMכל אדם רשאי להתנגדלבקשה האמורה תוך



1968





הוגשה בקשה להחזר תוקפו, של הפטנט המפורט מטה

אי שתוקפו פקע מחמתתשלום אגרות החידוש

:הקבועות





שה$, עבור מוליכי על שבבי סיליקו$, שיטה לייצור שכבות דיאלקטריות בעלות מקד דיאלקטרי נמו+ בעלות אדהזיה משופרת וצפיפות פגמי נמוכה

METHOD OF FABRICATING LOW-DIELECTRIC CONSTANT INTERLEVELDIELECTRIC FILMS FOR BEOL INTERCONNECTS WITH ENHANCED

ADHESION AND LOW-DEFECT DENSITYכל אדם רשאי להתנגדלבקשה האמורה תוך



1968











אנכיי משובצי ע חיבור ביטלי$) ו$ דינאמי אקראיזכר(DRAMמנגנו$ ושיטה לייצור מערכי ופוליסיליקו$ ע משטחי סילצידיי

STRUCTURE AND METHOD OF FABRICATING EMBEDDED VERTICAL DRAMARRAYS WITH SILICIDED BITLINE AND POLYSILICON INTERCONNECT

כל אדם רשאי להתנגדלבקשה האמורה תוך יך שלושה חודשים מתאר

כפי שנקבע, יומן פטנטים זה92לחוק ובתקנה61בסעיף

-ח"תשכ, לתקנות הפטנטים1968



שינויים בפרטים רשומים בפנקסCHANGES IN PARTICULARS ENTERED IN REGISTER

מפתחות לבקשות שקובלוINDICES OF APPLICATIONS ACCEPTED

NAMEמפתח שמי INDEX

159717-מ"אביק מעבדות ביולוגיות בע188464-אהרון קרישבסקי178867-אורי מרטינוביץ

186144-מ"אזימוט טכנולוגיות בעבע. איי.סי. אי 163557-מ"טלקוםבע. איי.סי.אי 163557,164114-מ"טלקום

,169071בע.טי.פי.אל 175234-מ"טכנולוגיות

אופטיקה אלאופ-ות אלקטרואלביט מערכ168728-מ"בע

416746-מ"ארד טכנולוגיות מדידה בע

- בית חולים הרצוג עמותת עזרת נשים154318

174309-בעז קריסטל

בע.ג.ג 192597-מ"מערכות מיגון175162-גאורגי נאומוב

בע'גגיוון אימ 156962-מ"ינגג'ג בע'מטקס אינק 132049-מ"ט פרינטינג

ב 162371-מ"עדמטק

158097- המרכז למחקר גרעיני-מ"התעשייה הצבאית לישראל בע

167287

158601-זוהר אלינסקי131149-מ"זולי החזקות בע

בע- זון 167160-מ"איי פי151353-זמיר מנור

157550-מ"ידע חברה למחקר ופיתוח בע166321-יעקב קולציה169556-יצחק וייסמן

174309-פריס-ליאת דה

161135-מאיר אבגנים162187-מ"מדיגוס בע

,155823-מ"מולטילוק טכנולוגיות בע166688

בעמולטילוק טכנ 175231-מ"ולוגיות-מ"מוסד הטכניון למחקר ופתוח בע

168728נ 175162-אומוב מיכאל

אנאלוג מיקסד סינגל-מיקרוסמי קורפ164458-מ"גרופ בע

148261-מ"מלנוקס טכנולוגיות בע162538-מרדכי אלדר

בענובה מכשירי 153894-מ"מדידה153291-ניר פדן

167160-מ"ספירל סולושנס בע

174309-ד ליאן קהת ככונס נכסים"עו138473-מ"עטרקס בע

156853-פסח זיידל

מערכות חליבה- אפיקים.מ.ח.צ174751-ממוחשבות


178867-צדקיהו סימנהויז

123646-מ"קורינדוס בע153317-מ"קליל תעשיות בע

בע"רפא -מ"ל מערכות לחימה מתקדמות150243

בע"רפא מ"ל רשות לפיתוח אמצעי לחימה

-159973

185387-שלמה וייסברגר

3DFACTO A/S -1626273M INNOVATIVE PROPERTIESCOMPANY - 146486, 170569, 170570,172740

A.R. ARENA PRODUCTS, INC. -156984ABBOTT LABORATORIES -145395ABBOTT LABORATORIES -145536ABIC BIOLOGICAL LABORATORIESLTD. - 159717ABLOY OY - 174956ACUSPHERE, INC. -146659ADC TELECOMMUNICATIONS, INC. -168832AETERNA ZENTARIS GMBH -128331,153067AHARON KRISHEVSKY - 188464AIR TO WATER TECHNOLOGIES, INC.- 166680ALCON, INC. - 171886, 171887, 171888,171889, 171890, 171891ALLERGAN, INC. - 173530ALPHAVAX, INC. - 169076ANGIOTECH INTERNATIONAL AG. -165120ANIMAS CORPORATION -180473ANSELL HEALTHCARE PRODUCTSLLC - 177600ANTONIO GARDELLI - 143534ARAD MEASURING TECHNOLOGIESLTD. - 167464ARCHER-DANIELS-MIDLANDCOMPANY - 161244ARM LIMITED - 165987, 167597,168453, 168928, 169151

ARQULE, INC. -165265ASTRAZENECA AB -152284, 152754ASTRAZENECA UK LIMITED - 189161ATHEROGENICS, INC. -164568ATTAREX LTD. - 138473AVENTIS PHARMA S.A. -132670,151211, 154294, 167868AVOCENT HUNTSVILLECORPORATION -169407AZIMUTH TECHNOLOGIES, LTD. -186144

B.R.A.I.N. BIOTECHNOLOGYRESEARCH AND INFORMATIONNETWORK AG. -172312BALL CORPORATION -174487BASF AKTIENGESELLSCHAFT -163465, 168946BASF SE -177777BAVARIAN NORDIC A/S - 154712BAYCO TECH LIMITED - 175287BAYER CROPSCIENCE AG -156106,163106, 163792, 173291, 190905BAYER SCHERING PHARMA AG -153333BAYER SCHERING PHARMAAKTIENGESELLSCHAFT -156282,170295, 170473BAYLOR COLLEGE OF MEDICINE -154544BERKSHIRE LABORATORIES, INC. -141797BIOGEN IDEC MA INC. - 137489BIOLEX THERAPEUTICS, INC. -158983BIONICHE LIFE SCIENCES INC. -


160408BIOVITRUM AB - 155702BOAZ KRISTAL - 174309BOEHRINGER INGELHEIMINTERNATIONAL GMBH - 174496BOEHRINGER INGELHEIMMICROPARTS GMBH -179027BOEHRINGER INGELHEIM PHARMAGMBH & CO. KG - 160389BRISTOL-MYERS SQUIBB COMPANY -155612BRISTOL-MYERS SQUIBB PHARMACOMPANY - 142959BROOK CHANDLER MURPHY -172446

CANCER RESEARCH CAMPAIGNTECHNOLOGY LIMITED - 108328CAPROTEC BIOANALYTICS GMBH -187592CENTRO DE INMUNOLOGIAMOLECULAR - 158246, 170355CEPHALON, INC. -161015CERATIZIT AUSTRIA GESELLSCHAFTM.B.H - 177334CERVITECH, INC. -173137, 178204CHROMOS MOLECULAR SYSTEMS,INC. - 126126CIBO N.V. - 177846CILAG GMBH INTERNATIONAL -179549, 179551COLEY PHARMACEUTICAL GROUP,INC. - 146486COMMONWEALTH SCIENTIFIC ANDINDUSTRIAL RESEARCHORGANISATION -160249CONTAINER DEVELOPMENT, LTD. -174487CORINDUS LTD -123646COUNCIL OF SCIENTIFIC ANDINDUSTRIAL RESEARCH -155123CREIGHTON UNIVERSITY -152654CRUCELL HOLLAND B.V. - 171680CSL BEHRING AG -154006CYTOS BIOTECHNOLOGY AG -161147

DAIICHI SANKYO COMPANY LIMITED- 168475

DART INDUSTRIES INC. -165341DCA DESIGN INTERNATIONALLIMITED - 170480DESIGN TECHNOLOGY ANDIRRIGATION LIMITED - 147715DEUTSCHE POST AG -172431DIRECT COMPUTER RESOURCES, INC.- 161338DMATEK LTD. - 162371DORMA GMBH + CO.KG -155018DSM IP ASSETS B.V. -165529DUANE KELLER - 172523

E.I. DU PONT DE NEMOURS ANDCOMPANY - 147715, 165502ECI TELECOM LTD. -163557ECI TELECOM LTD. -163557, 164114,169071EGIS GYOGYSZERGYAR RT. -171522EISAI CO., LTD. -155612EISAI R&D MANAGEMENT CO., LTD. -155612ELBIT SYSTEMS ELECTRO-OPTICSELOP LTD -168728ELECTRONIC NAVIGATIONRESEARCH INSTITUTE ANINDEPENDENT ADMINISTRATIVEINSTITUTION - 178316ELECTRONICS FOR IMAGING, INC. -154790ELTHOM ENTERPRISES LIMITED -176736EMORY UNIVERSITY - 173745EPICEPT CORPORATION -153656ESSILOR INTERNATIONAL(COMPAGNIE GENERALE D'OPTIQUE)- 176455ETEX CORPORATION -174198ETHYPHARM - 152317EURO-CELTIQUE S.A. -131561EVONIK ROHM GMBH - 173078

F. HOFFMANN-LA ROCHE AG -144467F. HOFFMANN-LA ROCHE AG -160527F. HOFFMANN-LA ROCHE AG -168343, 169368, 174734FEC CO., LTD. -163714


FERRING B.V. -161193FMC CORPORATION -149282FRACTURE CODE CORPORATION APS- 162334

G.G. DEFENSE SYSTEMS LTD -192597GE HEALTHCARE LIMITED - 170864GENENTECH, INC. -135607, 156111,164417, 175906GEORGE NAUMOV -175162GERON CORPORATION -162130GILEAD SCIENCES, INC. -173745GIOACCHINO COPPI -143534GIOVANNI PASSONI -177804GIVEN IMAGING LTD. - 156962GLAXO GROUP LIMITED - 164108GLEAVE, MARTIN, E. - 166657GLENGOWAN B.V. -178131GR INTELLECTUAL RESERVE, LLC, -141797

H. LUNDBECK A/S - 159326, 170194HANMI PHARM. CO., LTD. - 167725HEE KWON RHO -170232HITOSHI ABE - 178316HK PHARMACEUTICALS, INC. -187592HONEYWELL INTERNATIONAL INC. -174089, 175507HUBERT KOSTER -187592HUGHES ELECTRONICSCORPORATION -154657, 154658

I - FLOW CORPORATION -156190ICON GENETICS, INC. -151479ICX GLOBAL, INC. - 168562IMMUNEX CORPORATION -140937IMMUNOCELLULAR THERAPEUTICS,LTD - 148113, 155611IMPRESS GROUP B.V. -178567INCA DIGITAL PRINTERS LIMITED -172625INCONTINENT CONTROL DEVICES -161019INDENA S.P.A. -170200INDUSTRIAL ORIGAMI, INC. - 167655INDUSTRIAL ORIGAMI, LLC. - 167655INHIBITEX, INC. - 157041

INSERM -151211INSTITUTO DE BIOTECHNOLOGIA-UNAM - 142516INTARCIA THERAPEUTICS, INC. -161889INTERDIGITAL TECHNOLOGYCORPORATION -165044INTERNATIONAL PATENT OWNERS(CAYMAN) LIMITED - 175591ISRAEL MILITARY INDUSTRIES LTD. -167287ITT MANUFACTURING ENTERPRISES,INC. - 164435

JANSSEN PHARMACEUTICA N.V. -159819, 160329JANSSEN PHARMACEUTICA, N.V. -157752JAPAN AS REPRESENTED BYPRESIDENT OF NATIONALCARDIOVASCULAR CENTER -166572JEAN-FRANCOIS DURETTE,OCULARISTE INC. -175462JEMTEX INK JET PRINTING LTD. -132049JORDAN L. HOLTZMAN - 142852JORDAN LOYAL HOLTZMAN - 153058JOST WADEPHUL -180214

K.U. LEUVEN RESEARCH &DEVELOPMENT -142516KAKUICHI SHIOMI - 178316KAO CORPORATION -161244KARL MAYERTEXTILMASCHINENFABRIK GMBH -176593KEELE UNIVERSITY - 162652KENNETH D. FINE -151570KIMBERLY-CLARK WORLDWIDE,INC. - 175548KING PHARMACEUTICALSRESEARCH & DEVELOPMENT, INC. -161608KLIL INDUSTRIES LTD. - 153317KOREA KUMNHO PETROCHEMICALCO., LTD. -140090


L.P.T. TECHNOLOGIES LTD. -175234LABORATOIRE DE CONTACTOLOGIEAPPLIQUEE-LCA -178836LAM RESEARCH CORPORATION -167625, 170851, 176466, 180388LG ELECTRONICS INC. -161837LIAN KEHAT ADV. AS AN OFFICIALRECIVER -174309LIAT DE-VRIES - 174309LIFECORE BIOMEDICAL INC. -178624LOCKHEED MARTIN CORPORATION -162335LOMA LINDA UNIVERSITY - 126126LOOK DYNAMICS, INC. - 163016LTS LOHMANN THERAPIE-SYSTEMEAG - 173309LUIDIA, INC. - 154790

MACTAC EUROPE S.A. -176379MEDIGENE AG -161625MEDIGUS LTD. - 162187MEIR AVGANIM - 161135MELLANOX TECHNOLOGIES LTD. -148261MICHAEL NAUMOV - 175162MICHIKO OKIYAMA - 178316MICHIKO TAKAOKA - 178316MICROSEMI CORP - ANALOG MIXEDSIGNAL GROUP LTD -164458MICROSOFT CORPORATION -147472,162057MICROSOFT CORPORATION -159337MICROTECH MEDICALTECHNOLOGIES LTD. -131149MIKKEL G. MANDT - 178656MOLECULAR DISCOVERIES, L.L.C. -148113, 155611MORDECHAI ELDAR - 162538MOTOROLA, INC. -169235MOTOROLA, INC. -175501MUL-T-LOCK TECHNOLOGIES LTD. -155823, 166688MUL-T-LOCK TECHNOLOGIES LTD. -175231

NEREUS PHARMACEUTICALS, INC. -182272

NEW YORK UNIVERSITY - 137489NIPPON SHERWOOD MEDICALINDUSTRIES LTD -180922NIR PADAN - 153291NOBIL BIO RICERCHE S.R.L. -175287NOKIA CORPORATION -164097NOVA MEASURING INSTRUMENTSLTD. - 153894NOVARTIS AG - 149142, 174082NSAB, FILIAL AF NEUROSEARCHSWEDEN AB, SVERIGE -150350

OCTAGENE GMBH -151857OFFICINE MACCAFERRI S.P.A. -167291OLYMPIC TECHNOLOGIES LIMITED -169766OMEGA FLEX, INC. -170983ONCONOVA THERAPEUTICS, INC. -157541ORION CORPORATION -168882OSCIENT PHARMACEUTICALSCORPORATION -152654OSRAM SYLVANIA INC. - 166996OSRO GMBH -172219

PESSACH SEIDEL -156853PFIZER PRODUCTS, INC. -142631,163277, 173363, 189430PHARMA MAR S.A., SOCIEDADUNIPERSONAL -154155PHARMA MAR, S.A. - 153682, 155297PHARMACIA CORPORATION -158209PIONEER CORPORATION -173609PREMIUM INGREDIENTS, S.L. -164013PROFOS AG -165390PROTONEX TECHNOLOGYCORPORATION -170365

QUALCOMM INCORPORATED -152215, 155778, 163186, 167437, 171309QUALCOMM INCORPORATED -167299, 168800

RAFAEL ADVANCED DEFENSESYSTEMS LTD -159973RAFAEL ADVANCED DEFENSE


SYSTEMS LTD. -150243RAYTHEON COMPANY -157123RAYTHEON COMPANY -161127RAYTHEON COMPANY -165658REINHARD VOEHRINGER -161538REM TECHNOLOGIES, INC. -172219RESEARCH DEVELOPMENTFOUNDATION - 141613RHODIA POLYAMIDEINTERMEDIATES -157427RHODIANYL - 146295ROBARTS RESEARCH INSTITUTE -162130ROBERTO BENEDINI -143534ROXTEC AB -172558

S.A.E. AFIKIM- COMPUTERIZEDDAIRY MANAGEMENT SYSTEMS -174751S.S.C.I. INC. -169762SACHEM INC. -175261SAES GETTERS S.P.A. -173224SANDVIK INTELLECTUAL PROPERTYAB - 171509SANOFI AVENTIS -161533SANOFI-AVENTIS -168133, 176478SANOFI-AVENTIS DEUTSCHLANDGMBH - 153818, 156214, 160556SANOFI-AVENTIS DEUTSCHLANDGMBH - 157793SANOFI-AVENTIS DEUTSCHLANDGMBH - 164901, 165519SANOFI-AVENTIS DEUTSCHLANDGMBH - 170480SANOFI-SYNTHELABO OTC SPA -159807SARAH HERZOG MEMORIALHOSPITAL EZRAT NASHIMASSOCIATION -154318SARGENT MANUFACTURINGCOMPANY - 177485, 177517, 177521SASOL NORTH AMERICA INC. -163582SCHERING CORPORATION -152414SDU IDENTIFICATION B.V - 170407SEPRACOR INC. -141531SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. -158427

SHERWOOD SERVICES AG -178949,180922SHIPLEY COMPANY, L.L.C. -176787SHLOMO WEISBERGER -185387SILVERBROOK RESEARCH PTY. LTD.- 166921SILVERBROOK RESEARCH PTY. LTD.- 155466, 155471, 156089, 157239SINCLAIR SYSTEMSINTERNATIONAL, LLC - 177720SLOAN-KETTERING INSTITUTE FORCANCER RESEARCH -159371SMARTLIFE TECHNOLOGY LIMITED -171734SOLVAY GMBH - 167924SOLVAY PHARMACEUTICALS B.V. -168258SOLVIAS AG - 173713SOLVIAS AG - 175771SONIC MOBILITY INC. - 169407SOPRO -177469SOREQ NUCLEAR RESEARCH CENTER- 158097SPEEDEL PHARMA AG -170626SPINECORE, INC. -161136SPIRAL SOLUTIONS LTD -167160SUMITOMO CHEMICAL COMPANY,LIMITED. - 165588SUSUMU KOBAYASHI - 178316

TADAHIRO OHMI - 165326TAIYO NIPPON SANSO CORPORATION- 165326TBW INDUSTRIES, INC. -177026TECHNION RESEARCH ANDDEVELOPMENT FOUNDATION LTD. -168728TECPHARMA LICENSING AG -159664,159665TEMPLE UNIVERSITY OF THECOMMONWEALTH SYSTEM OFHIGHER EDUCATION -157541TEN CATE ADVANCED TEXTILES B.V.- 174272THALES - 170140THE BIOLOGICAL RESEARCHCENTER OF THE HUNGARIAN


ACADEMY OF SCIENCES -126126THE BOARD OF TRUSTEES OF THELELAND STANFORD JUNIORUNIVERSITY - 156973THE DIRECTV GROUP, INC. -164482THE GOVERNMENT OF MALAYSIAGOVERNMENT ADMINISTRATIVECENTRE 62502 PUTRAJAYAMALAYSIA - 163714THE GOVERNMENT OF THE UNITEDSTATES OF AMERICA ASREPRESENTED BY THE SECRETARYOF THE DEPARTMENT OF HEALTHAND HUMAN SERVICES -147446,147447THE GOVERNMENT OF THE UNITEDSTATES OF AMERICA ASREPRESENTED BY THE UNIFORMEDSERVICES UNIVERSITY OF THEHEALTH SCIENCES -142231THE KENNETH S. WARRENINSTITUTE, INC. -145895THE REGENTS OF THE UNIVERSITYOF CALIFORNIA - 182272THE SCRIPPS RESEARCH INSTITUTE -149142THE TEXAS A&M UNIVERSITYSYSTEM -155228THE TRUSTEES OF THE UNIVERSITYOF PENNSYLVANIA - 166274THE UNIVERSITY OF BRITISHCOLUMBIA - 154529THE UNIVERSITY OF BRITISHCOLUMBIA - 166657THE WATER COMPANY -166680TODD C. STECKLER -172446TORBEN BOGH-ANDERSEN -164926TRELLIS BIOINFORMATICS, INC. -141759TRIMEDYNE, INC. - 169270

U.S. ARMY MEDICAL RESEARCH ANDMATERIEL COMMAND - 146193UBE INDUSTRIES, LTD. -189161ULTRADENT PRODUCTS INC. -171855UNI-CHARM CORPORATION -148582UNITED STATES GYPSUM COMPANY

- 177390UNIVERSIDAD DE BARCELONA -154155UNIVERSITY OF MICHIGAN - 168453,168928, 169151UNIVERSITY OF SYDNEY -162557UNIVERSITY OF TECHNOLOGYSYDNEY - 159717URI MARTINOVITZ - 178867

VACU VIN INNOVATIONS LTD. -169498VERTEX PHARMACEUTICALSINCORPORATED -163117VICTORIA'S SECRET STORES BRANDMANAGEMENT, INC. - 177775VICURON PHARMACEUTICALS INC. -166476VLAAMS INTERUNIVERSITAIRINSTITUUT VOOR BIOTECHNOLOGIEV.Z.W (VIB) - 142516VLADIMIR N. FILATOV - 178867VLADIMIR RYLTSEV - 178867

WISCONSIN ALUMNI RESEARCHFOUNDATION - 121243WOVEN ELECTRONICSCORPORATION, ASOUTH CAROLINA CORPORATION -171785WYETH LLC - 165265WYETH HOLDINGS CORPORATION -142231WYETH LLC - 174198

YAACOV KOLCHEH - 166321YEDA RESEARCH ANDDEVELOPMENT CO. LTD. -157550YITZHAK WEISSMAN - 169556

ZAMIR MANOR - 151353ZIDKIYAHU SIMENHAUS - 178867ZOHAR ELINSKI - 158601ZON - I P LTD - 167160ZULI HOLDINGS LTD. - 131149


SUBJECTמפתח ענייני MATTER INDEX

A01G -158601, 161538, 162538A01H - 142516, 151479A01J -174751A01N - 157752, 163106, 163465,

163792, 172446, 173291A23C -145395A23L - 164013A41C -177775A41D - 177600A47L - 148582A61B - 162187, 171734, 171886,

171887, 171888, 171889,171890, 171891, 175591,177469, 178131, 178316

A61C -171855, 172523, 178624A61F -161136A61F -173137, 175462, 178204,

178836A61J -180922A61K - 131561, 137489, 138473,

141531, 142231, 145895,146659, 147446, 147447,149282, 152317, 153058,153333, 153656, 154318,155611, 156282, 159807,160389, 161147, 161193,161533, 161889, 163277,164417, 166274, 166657,167725, 167924, 169762,170200, 170295, 170355,170473, 170626, 170864,173078, 174198, 174496,177777, 178867

A61K - 161625A61L - 165120A61M - 123646, 143534, 159664,

159665, 161019, 170480,178949, 179549, 179551,180473

A61M - 156190A61N - 141797, 166572A63B - 175234, 185387

B01D -147715B01F -177804B01J -172740B05D -175287B07C -172431B21D -167655, 174487, 178567B23B -177334B23K - 180388B24B -172219B24C -180214B24D -177846B28C -177390B29D -176455B31D -176379B41J -132049, 172625, 174272B41M - 162334B42D -170407B65B -173309B65C -177720B65D -156984, 165341, 169498,

170232, 174309, 179027B65H -157239B81B -166921

C01B -165326C01G -166996C02F -178656C07B -145536C07C -157541, 158209, 160527,

162652, 163582, 164568,165265, 168946, 182272,190905

C07D -108328, 142959, 146486,150350, 152284, 152754,153067, 153682, 154155,


155702, 156106, 156214,159326, 160329, 160556,163117, 164108, 164901,165502, 165519, 165588,168133, 168258, 168343,168882, 169368, 170194,171522, 173363, 173530,173745, 174082, 174734,176478, 189161

C07D -161015C07F -155612, 173713, 175771C07H -142631, 157793, 161608,

166476, 168475, 189430C07K -128331, 140937, 141613,

148113, 149142, 154006,154544, 155297, 157041,157550, 158246, 175906

C08B -132670, 167868C08F -162557C08G -146295C08L -157427C11C -161244C12M -158983C12N -121243, 126126, 135607,

144467, 151211, 151857,154294, 154529, 154712,156111, 156973, 159371,159717, 162130, 169076,171680, 172312

C12N -152414C12P -165529C12Q -146193, 155123, 160408C22B -170569, 170570C23C -171509, 173224, 176787C40B -153818

D04B -176593D04H -175548

E01F -155228E01H -151353E02D -167291E03D -166321E04H -167287, 192597E05B -155823, 161135, 174956,

175231, 177485, 177517E05B -166688

E05C -177521E05D -155018E06B -153317E21B -158427

F01C -176736F01K -156853F01P -188464F16L -170983F25B -166680F25D -156089F41G -153291F41H -159973F42C -169766

G01B -153894G01C -175162, 186144G01J -175507G01M -150243G01N -141759, 142852, 151570,

152654, 156962, 159819,160249, 165390, 187592

G01R -140090G01S -158097, 161127, 164926,

167437G02B -169270, 169556G02F -163016G06F -147472, 154790, 161338,

162057, 162627, 165987,167160, 168453, 168832,168928

G06K -155471, 163714, 174089G06Q -159337G06T -170140G08B -162371, 171785G08C -168562G11B -173609G11C -154657, 154658, 167597,

169151

H01J -157123H01L - 131149, 167625, 170851,

175261, 176466, 177026H01M - 170365H01Q -162335, 167464, 175501H01R -164458H01S -168728


H02G -172558H03D -171309H03M - 165658H04B -164482, 168800H04J -163557, 164097, 169071H04L - 148261, 152215, 164114,

169235H04N -164435, 165044H04Q -155778

H04Q -163186H04W -161837, 167299, 169407H05K - 155466

487

ת המופיעים ביומןוקודים למדינCOUNTRY CODES APPEARING IN THIS JOURNAL

Code Country or Organization Code Country or OrganizationAR Argentina MX MexicoAT Austria MY MalaysiaAU Australia NL The NetherlandsBA Herzegovina NO NorwayBE Belgium NZ New ZealandBR Brazil PL PolandCA Canada PT PortugalCH Switzerland RU Russian FederationCN China SE SwedenCU Cuba SG SingaporeCZ Czech Republic SI SloveniaDE Germany SK SlovakiaDK Denmark TH ThailandEC Ecuador TR TurkeyEP European Patent Office TW TaiwanES Spain UA UkraineFI Finland US United States of AmericaFR France UY UruguayGB United Kingdom UZ UzbekistanGE Georgia WO World Intellectual PropertyGR Greece Organization (W.I.P.O.)GT Guatemala ZA South AfricaHR CroatiaHU HungaryIE IrelandIL IsraelIN IndiaIT ItalyJP JapanKR Republic of KoreaLK Sri Lanka

488

LU LuxembourgLV Latvia

ע � ירושלי�, משרד המשפטי�,י רשות הפטנטי�"נער

EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM

patents and designs journal - nevo.co.il · 3 may 31, 2010- " "patents 16 % 1967 notice...

Documents